id	sid	tid	token	lemma	pos
ajfti-2033	1	1	pa	pa	PROPN
ajfti-2033	1	2	ge	ge	PROPN
ajfti-2033	1	3	1	1	NUM
ajfti-2033	1	4	pa	pa	PROPN
ajfti-2033	1	5	ge	ge	PROPN
ajfti-2033	1	6	24	24	NUM
ajfti-2033	1	7	american	american	PROPN
ajfti-2033	1	8	journal	journal	PROPN
ajfti-2033	1	9	of	of	ADP
ajfti-2033	1	10	financial	financial	ADJ
ajfti-2033	1	11	technology	technology	NOUN
ajfti-2033	1	12	and	and	CCONJ
ajfti-2033	1	13	innovation	innovation	NOUN
ajfti-2033	1	14	(	(	PUNCT
ajfti-2033	1	15	ajfti	ajfti	NOUN
ajfti-2033	1	16	)	)	PUNCT
ajfti-2033	1	17	the	the	DET
ajfti-2033	1	18	impact	impact	NOUN
ajfti-2033	1	19	of	of	ADP
ajfti-2033	1	20	drug	drug	NOUN
ajfti-2033	1	21	pricing	pricing	NOUN
ajfti-2033	1	22	and	and	CCONJ
ajfti-2033	1	23	insurance	insurance	NOUN
ajfti-2033	1	24	coverage	coverage	NOUN
ajfti-2033	1	25	on	on	ADP
ajfti-2033	1	26	medication	medication	NOUN
ajfti-2033	1	27	adherence	adherence	NOUN
ajfti-2033	1	28	in	in	ADP
ajfti-2033	1	29	saudi	saudi	ADJ
ajfti-2033	1	30	turki	turki	PROPN
ajfti-2033	1	31	m.	m.	NOUN
ajfti-2033	1	32	alsagoor1	alsagoor1	PROPN
ajfti-2033	1	33	*	*	PUNCT
ajfti-2033	1	34	volume	volume	NOUN
ajfti-2033	1	35	1	1	NUM
ajfti-2033	1	36	issue	issue	NOUN
ajfti-2033	1	37	1	1	NUM
ajfti-2033	1	38	,	,	PUNCT
ajfti-2033	1	39	year	year	NOUN
ajfti-2033	1	40	2023	2023	NUM
ajfti-2033	1	41	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	PROPN
ajfti-2033	1	42	article	article	NOUN
ajfti-2033	1	43	information	information	NOUN
ajfti-2033	1	44	abstract	abstract	ADV
ajfti-2033	1	45	received	receive	VERB
ajfti-2033	1	46	:	:	PUNCT
ajfti-2033	1	47	october	october	PROPN
ajfti-2033	1	48	05	05	NUM
ajfti-2033	1	49	,	,	PUNCT
ajfti-2033	1	50	2023	2023	NUM
ajfti-2033	1	51	accepted	accept	VERB
ajfti-2033	1	52	:	:	PUNCT
ajfti-2033	1	53	november	november	PROPN
ajfti-2033	1	54	01	01	NUM
ajfti-2033	1	55	,	,	PUNCT
ajfti-2033	1	56	2023	2023	NUM
ajfti-2033	1	57	published	publish	VERB
ajfti-2033	1	58	:	:	PUNCT
ajfti-2033	1	59	november	november	PROPN
ajfti-2033	1	60	08	08	NUM
ajfti-2033	1	61	,	,	PUNCT
ajfti-2033	1	62	2023	2023	NUM
ajfti-2033	1	63	this	this	DET
ajfti-2033	1	64	study	study	NOUN
ajfti-2033	1	65	explores	explore	VERB
ajfti-2033	1	66	the	the	DET
ajfti-2033	1	67	complex	complex	ADJ
ajfti-2033	1	68	interactions	interaction	NOUN
ajfti-2033	1	69	in	in	ADP
ajfti-2033	1	70	saudi	saudi	PROPN
ajfti-2033	1	71	arabia	arabia	PROPN
ajfti-2033	1	72	between	between	ADP
ajfti-2033	1	73	medicine	medicine	NOUN
ajfti-2033	1	74	costs	cost	NOUN
ajfti-2033	1	75	,	,	PUNCT
ajfti-2033	1	76	insurance	insurance	NOUN
ajfti-2033	1	77	coverage	coverage	NOUN
ajfti-2033	1	78	,	,	PUNCT
ajfti-2033	1	79	and	and	CCONJ
ajfti-2033	1	80	medication	medication	NOUN
ajfti-2033	1	81	adherence	adherence	NOUN
ajfti-2033	1	82	.	.	PUNCT
ajfti-2033	2	1	250	250	NUM
ajfti-2033	2	2	individuals	individual	NOUN
ajfti-2033	2	3	’	'	PUNCT
ajfti-2033	2	4	data	datum	NOUN
ajfti-2033	2	5	were	be	AUX
ajfti-2033	2	6	analysed	analyse	VERB
ajfti-2033	2	7	,	,	PUNCT
ajfti-2033	2	8	and	and	CCONJ
ajfti-2033	2	9	significant	significant	ADJ
ajfti-2033	2	10	relationships	relationship	NOUN
ajfti-2033	2	11	were	be	AUX
ajfti-2033	2	12	found	find	VERB
ajfti-2033	2	13	.	.	PUNCT
ajfti-2033	3	1	with	with	ADP
ajfti-2033	3	2	a	a	DET
ajfti-2033	3	3	significant	significant	ADJ
ajfti-2033	3	4	coefficient	coefficient	NOUN
ajfti-2033	3	5	of	of	ADP
ajfti-2033	3	6	-0.773	-0.773	PROPN
ajfti-2033	3	7	(	(	PUNCT
ajfti-2033	3	8	p	p	X
ajfti-2033	3	9	=	=	NOUN
ajfti-2033	3	10	0.006	0.006	NUM
ajfti-2033	3	11	)	)	PUNCT
ajfti-2033	3	12	,	,	PUNCT
ajfti-2033	3	13	high	high	ADJ
ajfti-2033	3	14	medicine	medicine	NOUN
ajfti-2033	3	15	prices	price	NOUN
ajfti-2033	3	16	were	be	AUX
ajfti-2033	3	17	shown	show	VERB
ajfti-2033	3	18	to	to	PART
ajfti-2033	3	19	be	be	AUX
ajfti-2033	3	20	a	a	DET
ajfti-2033	3	21	significant	significant	ADJ
ajfti-2033	3	22	barrier	barrier	NOUN
ajfti-2033	3	23	to	to	ADP
ajfti-2033	3	24	medication	medication	NOUN
ajfti-2033	3	25	adherence	adherence	NOUN
ajfti-2033	3	26	.	.	PUNCT
ajfti-2033	4	1	on	on	ADP
ajfti-2033	4	2	the	the	DET
ajfti-2033	4	3	other	other	ADJ
ajfti-2033	4	4	hand	hand	NOUN
ajfti-2033	4	5	,	,	PUNCT
ajfti-2033	4	6	complete	complete	ADJ
ajfti-2033	4	7	insurance	insurance	NOUN
ajfti-2033	4	8	protection	protection	NOUN
ajfti-2033	4	9	showed	show	VERB
ajfti-2033	4	10	a	a	DET
ajfti-2033	4	11	favorable	favorable	ADJ
ajfti-2033	4	12	connection	connection	NOUN
ajfti-2033	4	13	with	with	ADP
ajfti-2033	4	14	adherence	adherence	NOUN
ajfti-2033	4	15	,	,	PUNCT
ajfti-2033	4	16	highlighting	highlight	VERB
ajfti-2033	4	17	its	its	PRON
ajfti-2033	4	18	crucial	crucial	ADJ
ajfti-2033	4	19	function	function	NOUN
ajfti-2033	4	20	.	.	PUNCT
ajfti-2033	5	1	the	the	DET
ajfti-2033	5	2	fact	fact	NOUN
ajfti-2033	5	3	that	that	SCONJ
ajfti-2033	5	4	69	69	NUM
ajfti-2033	5	5	%	%	NOUN
ajfti-2033	5	6	of	of	ADP
ajfti-2033	5	7	the	the	DET
ajfti-2033	5	8	participants	participant	NOUN
ajfti-2033	5	9	had	have	AUX
ajfti-2033	5	10	health	health	NOUN
ajfti-2033	5	11	coverage	coverage	NOUN
ajfti-2033	5	12	and	and	CCONJ
ajfti-2033	5	13	31	31	NUM
ajfti-2033	5	14	%	%	NOUN
ajfti-2033	5	15	did	do	AUX
ajfti-2033	5	16	not	not	PART
ajfti-2033	5	17	highlights	highlight	VERB
ajfti-2033	5	18	a	a	DET
ajfti-2033	5	19	sizable	sizable	ADJ
ajfti-2033	5	20	insurance	insurance	NOUN
ajfti-2033	5	21	gap	gap	NOUN
ajfti-2033	5	22	.	.	PUNCT
ajfti-2033	6	1	males	male	NOUN
ajfti-2033	6	2	comprised	comprise	VERB
ajfti-2033	6	3	80	80	NUM
ajfti-2033	6	4	%	%	NOUN
ajfti-2033	6	5	of	of	ADP
ajfti-2033	6	6	the	the	DET
ajfti-2033	6	7	sample	sample	NOUN
ajfti-2033	6	8	,	,	PUNCT
ajfti-2033	6	9	62	62	NUM
ajfti-2033	6	10	%	%	NOUN
ajfti-2033	6	11	of	of	ADP
ajfti-2033	6	12	respondents	respondent	NOUN
ajfti-2033	6	13	were	be	AUX
ajfti-2033	6	14	in	in	ADP
ajfti-2033	6	15	the	the	DET
ajfti-2033	6	16	29–39	29–39	NUM
ajfti-2033	6	17	age	age	NOUN
ajfti-2033	6	18	range	range	NOUN
ajfti-2033	6	19	,	,	PUNCT
ajfti-2033	6	20	and	and	CCONJ
ajfti-2033	6	21	56	56	NUM
ajfti-2033	6	22	%	%	NOUN
ajfti-2033	6	23	had	have	VERB
ajfti-2033	6	24	bachelor	bachelor	NOUN
ajfti-2033	6	25	’s	’s	PART
ajfti-2033	6	26	degrees	degree	NOUN
ajfti-2033	6	27	.	.	PUNCT
ajfti-2033	7	1	the	the	DET
ajfti-2033	7	2	income	income	NOUN
ajfti-2033	7	3	range	range	NOUN
ajfti-2033	7	4	showed	show	VERB
ajfti-2033	7	5	that	that	SCONJ
ajfti-2033	7	6	43	43	NUM
ajfti-2033	7	7	%	%	NOUN
ajfti-2033	7	8	made	make	VERB
ajfti-2033	7	9	more	more	ADJ
ajfti-2033	7	10	than	than	ADP
ajfti-2033	7	11	20,000	20,000	NUM
ajfti-2033	7	12	sar	sar	NOUN
ajfti-2033	7	13	monthly	monthly	ADV
ajfti-2033	7	14	.	.	PUNCT
ajfti-2033	8	1	the	the	DET
ajfti-2033	8	2	significant	significant	ADJ
ajfti-2033	8	3	effects	effect	NOUN
ajfti-2033	8	4	of	of	ADP
ajfti-2033	8	5	medicine	medicine	NOUN
ajfti-2033	8	6	cost	cost	NOUN
ajfti-2033	8	7	and	and	CCONJ
ajfti-2033	8	8	insurance	insurance	NOUN
ajfti-2033	8	9	coverage	coverage	NOUN
ajfti-2033	8	10	on	on	ADP
ajfti-2033	8	11	medication	medication	NOUN
ajfti-2033	8	12	adherence	adherence	NOUN
ajfti-2033	8	13	were	be	AUX
ajfti-2033	8	14	highlighted	highlight	VERB
ajfti-2033	8	15	by	by	ADP
ajfti-2033	8	16	regression	regression	NOUN
ajfti-2033	8	17	analysis	analysis	NOUN
ajfti-2033	8	18	(	(	PUNCT
ajfti-2033	8	19	beta	beta	NOUN
ajfti-2033	8	20	=	=	SYM
ajfti-2033	8	21	-0.749	-0.749	NOUN
ajfti-2033	8	22	,	,	PUNCT
ajfti-2033	8	23	p	p	NOUN
ajfti-2033	8	24	=	=	NOUN
ajfti-2033	8	25	0.001	0.001	NUM
ajfti-2033	8	26	,	,	PUNCT
ajfti-2033	8	27	and	and	CCONJ
ajfti-2033	8	28	0.759	0.759	NUM
ajfti-2033	8	29	,	,	PUNCT
ajfti-2033	8	30	p	p	NOUN
ajfti-2033	8	31	=	=	NOUN
ajfti-2033	8	32	0.006	0.006	NUM
ajfti-2033	8	33	,	,	PUNCT
ajfti-2033	8	34	respectively	respectively	ADV
ajfti-2033	8	35	)	)	PUNCT
ajfti-2033	8	36	.	.	PUNCT
ajfti-2033	9	1	these	these	DET
ajfti-2033	9	2	results	result	NOUN
ajfti-2033	9	3	highlight	highlight	VERB
ajfti-2033	9	4	the	the	DET
ajfti-2033	9	5	criticality	criticality	NOUN
ajfti-2033	9	6	of	of	ADP
ajfti-2033	9	7	addressing	address	VERB
ajfti-2033	9	8	the	the	DET
ajfti-2033	9	9	affordability	affordability	NOUN
ajfti-2033	9	10	of	of	ADP
ajfti-2033	9	11	prescription	prescription	NOUN
ajfti-2033	9	12	costs	cost	NOUN
ajfti-2033	9	13	and	and	CCONJ
ajfti-2033	9	14	advocating	advocate	VERB
ajfti-2033	9	15	for	for	ADP
ajfti-2033	9	16	open	open	ADJ
ajfti-2033	9	17	insurance	insurance	NOUN
ajfti-2033	9	18	programmes	programme	NOUN
ajfti-2033	9	19	to	to	PART
ajfti-2033	9	20	improve	improve	VERB
ajfti-2033	9	21	healthcare	healthcare	NOUN
ajfti-2033	9	22	outcomes	outcome	NOUN
ajfti-2033	9	23	in	in	ADP
ajfti-2033	9	24	saudi	saudi	PROPN
ajfti-2033	9	25	arabia	arabia	PROPN
ajfti-2033	9	26	.	.	PUNCT
ajfti-2033	10	1	prioritising	prioritise	VERB
ajfti-2033	10	2	actions	action	NOUN
ajfti-2033	10	3	can	can	AUX
ajfti-2033	10	4	help	help	VERB
ajfti-2033	10	5	reduce	reduce	VERB
ajfti-2033	10	6	costs	cost	NOUN
ajfti-2033	10	7	and	and	CCONJ
ajfti-2033	10	8	provide	provide	VERB
ajfti-2033	10	9	comprehensive	comprehensive	ADJ
ajfti-2033	10	10	coverage	coverage	NOUN
ajfti-2033	10	11	,	,	PUNCT
ajfti-2033	10	12	say	say	VERB
ajfti-2033	10	13	policymakers	policymaker	NOUN
ajfti-2033	10	14	.	.	PUNCT
ajfti-2033	11	1	this	this	DET
ajfti-2033	11	2	study	study	NOUN
ajfti-2033	11	3	emphasises	emphasise	VERB
ajfti-2033	11	4	the	the	DET
ajfti-2033	11	5	need	need	NOUN
ajfti-2033	11	6	for	for	SCONJ
ajfti-2033	11	7	more	more	ADJ
ajfti-2033	11	8	research	research	NOUN
ajfti-2033	11	9	to	to	PART
ajfti-2033	11	10	dive	dive	VERB
ajfti-2033	11	11	further	far	ADV
ajfti-2033	11	12	into	into	ADP
ajfti-2033	11	13	the	the	DET
ajfti-2033	11	14	intricacies	intricacy	NOUN
ajfti-2033	11	15	of	of	ADP
ajfti-2033	11	16	healthcare	healthcare	NOUN
ajfti-2033	11	17	accessibility	accessibility	NOUN
ajfti-2033	11	18	,	,	PUNCT
ajfti-2033	11	19	particularly	particularly	ADV
ajfti-2033	11	20	in	in	ADP
ajfti-2033	11	21	a	a	DET
ajfti-2033	11	22	healthcare	healthcare	NOUN
ajfti-2033	11	23	environment	environment	NOUN
ajfti-2033	11	24	that	that	PRON
ajfti-2033	11	25	is	be	AUX
ajfti-2033	11	26	continually	continually	ADV
ajfti-2033	11	27	expanding	expand	VERB
ajfti-2033	11	28	.	.	PUNCT
ajfti-2033	12	1	keywords	keyword	VERB
ajfti-2033	12	2	medical	medical	ADJ
ajfti-2033	12	3	adherence	adherence	NOUN
ajfti-2033	12	4	,	,	PUNCT
ajfti-2033	12	5	drug	drug	NOUN
ajfti-2033	12	6	pricing	pricing	NOUN
ajfti-2033	12	7	,	,	PUNCT
ajfti-2033	12	8	insurance	insurance	NOUN
ajfti-2033	12	9	coverage	coverage	NOUN
ajfti-2033	12	10	,	,	PUNCT
ajfti-2033	12	11	medical	medical	ADJ
ajfti-2033	12	12	insurance	insurance	NOUN
ajfti-2033	12	13	,	,	PUNCT
ajfti-2033	12	14	medicine	medicine	NOUN
ajfti-2033	12	15	cost	cost	NOUN
ajfti-2033	12	16	introduction	introduction	NOUN
ajfti-2033	12	17	pharmaceutical	pharmaceutical	ADJ
ajfti-2033	12	18	pricing	pricing	NOUN
ajfti-2033	12	19	is	be	AUX
ajfti-2033	12	20	a	a	DET
ajfti-2033	12	21	complex	complex	ADJ
ajfti-2033	12	22	process	process	NOUN
ajfti-2033	12	23	considering	consider	VERB
ajfti-2033	12	24	profit	profit	NOUN
ajfti-2033	12	25	margins	margin	NOUN
ajfti-2033	12	26	,	,	PUNCT
ajfti-2033	12	27	manufacturing	manufacturing	NOUN
ajfti-2033	12	28	costs	cost	NOUN
ajfti-2033	12	29	,	,	PUNCT
ajfti-2033	12	30	and	and	CCONJ
ajfti-2033	12	31	costs	cost	NOUN
ajfti-2033	12	32	associated	associate	VERB
ajfti-2033	12	33	with	with	ADP
ajfti-2033	12	34	research	research	NOUN
ajfti-2033	12	35	and	and	CCONJ
ajfti-2033	12	36	development	development	NOUN
ajfti-2033	12	37	(	(	PUNCT
ajfti-2033	12	38	schlander	schlander	NOUN
ajfti-2033	12	39	et	et	PROPN
ajfti-2033	12	40	al	al	PROPN
ajfti-2033	12	41	.	.	PROPN
ajfti-2033	12	42	,	,	PUNCT
ajfti-2033	12	43	2021	2021	NUM
ajfti-2033	12	44	)	)	PUNCT
ajfti-2033	12	45	.	.	PUNCT
ajfti-2033	13	1	pharmaceutical	pharmaceutical	ADJ
ajfti-2033	13	2	firms	firm	NOUN
ajfti-2033	13	3	,	,	PUNCT
ajfti-2033	13	4	wholesalers	wholesaler	NOUN
ajfti-2033	13	5	,	,	PUNCT
ajfti-2033	13	6	distributors	distributor	NOUN
ajfti-2033	13	7	,	,	PUNCT
ajfti-2033	13	8	pharmacies	pharmacy	NOUN
ajfti-2033	13	9	,	,	PUNCT
ajfti-2033	13	10	insurance	insurance	NOUN
ajfti-2033	13	11	companies	company	NOUN
ajfti-2033	13	12	,	,	PUNCT
ajfti-2033	13	13	and	and	CCONJ
ajfti-2033	13	14	public	public	ADJ
ajfti-2033	13	15	healthcare	healthcare	NOUN
ajfti-2033	13	16	programs	program	NOUN
ajfti-2033	13	17	are	be	AUX
ajfti-2033	13	18	a	a	DET
ajfti-2033	13	19	few	few	ADJ
ajfti-2033	13	20	of	of	ADP
ajfti-2033	13	21	the	the	DET
ajfti-2033	13	22	many	many	ADJ
ajfti-2033	13	23	parties	party	NOUN
ajfti-2033	13	24	involved	involve	VERB
ajfti-2033	13	25	in	in	ADP
ajfti-2033	13	26	this	this	DET
ajfti-2033	13	27	complex	complex	ADJ
ajfti-2033	13	28	process	process	NOUN
ajfti-2033	13	29	,	,	PUNCT
ajfti-2033	13	30	substantially	substantially	ADV
ajfti-2033	13	31	impacting	impact	VERB
ajfti-2033	13	32	patients	patient	NOUN
ajfti-2033	13	33	’	'	PUNCT
ajfti-2033	13	34	access	access	NOUN
ajfti-2033	13	35	to	to	ADP
ajfti-2033	13	36	pharmaceuticals	pharmaceutical	NOUN
ajfti-2033	13	37	(	(	PUNCT
ajfti-2033	13	38	wong	wong	PROPN
ajfti-2033	13	39	et	et	PROPN
ajfti-2033	13	40	al	al	PROPN
ajfti-2033	13	41	.	.	PROPN
ajfti-2033	13	42	,	,	PUNCT
ajfti-2033	13	43	2023	2023	NUM
ajfti-2033	13	44	)	)	PUNCT
ajfti-2033	13	45	.	.	PUNCT
ajfti-2033	14	1	due	due	ADP
ajfti-2033	14	2	to	to	ADP
ajfti-2033	14	3	this	this	PRON
ajfti-2033	14	4	,	,	PUNCT
ajfti-2033	14	5	the	the	DET
ajfti-2033	14	6	challenge	challenge	NOUN
ajfti-2033	14	7	of	of	ADP
ajfti-2033	14	8	high	high	ADJ
ajfti-2033	14	9	drug	drug	NOUN
ajfti-2033	14	10	prices	price	NOUN
ajfti-2033	14	11	becomes	become	VERB
ajfti-2033	14	12	even	even	ADV
ajfti-2033	14	13	more	more	ADV
ajfti-2033	14	14	daunting	daunting	ADJ
ajfti-2033	14	15	due	due	ADP
ajfti-2033	14	16	to	to	ADP
ajfti-2033	14	17	the	the	DET
ajfti-2033	14	18	scarcity	scarcity	NOUN
ajfti-2033	14	19	of	of	ADP
ajfti-2033	14	20	essential	essential	ADJ
ajfti-2033	14	21	affordability	affordability	NOUN
ajfti-2033	14	22	for	for	ADP
ajfti-2033	14	23	patients	patient	NOUN
ajfti-2033	14	24	(	(	PUNCT
ajfti-2033	14	25	adebisi	adebisi	PROPN
ajfti-2033	14	26	et	et	PROPN
ajfti-2033	14	27	al	al	PROPN
ajfti-2033	14	28	.	.	PROPN
ajfti-2033	14	29	,	,	PUNCT
ajfti-2033	14	30	2022	2022	NUM
ajfti-2033	14	31	)	)	PUNCT
ajfti-2033	14	32	.	.	PUNCT
ajfti-2033	15	1	the	the	DET
ajfti-2033	15	2	expensive	expensive	ADJ
ajfti-2033	15	3	cost	cost	NOUN
ajfti-2033	15	4	of	of	ADP
ajfti-2033	15	5	medication	medication	NOUN
ajfti-2033	15	6	can	can	AUX
ajfti-2033	15	7	create	create	VERB
ajfti-2033	15	8	barriers	barrier	NOUN
ajfti-2033	15	9	,	,	PUNCT
ajfti-2033	15	10	causing	cause	VERB
ajfti-2033	15	11	individuals	individual	NOUN
ajfti-2033	15	12	to	to	PART
ajfti-2033	15	13	stop	stop	VERB
ajfti-2033	15	14	taking	take	VERB
ajfti-2033	15	15	their	their	PRON
ajfti-2033	15	16	prescribed	prescribed	ADJ
ajfti-2033	15	17	drugs	drug	NOUN
ajfti-2033	15	18	,	,	PUNCT
ajfti-2033	15	19	resulting	result	VERB
ajfti-2033	15	20	in	in	ADP
ajfti-2033	15	21	detrimental	detrimental	ADJ
ajfti-2033	15	22	health	health	NOUN
ajfti-2033	15	23	problems	problem	NOUN
ajfti-2033	15	24	(	(	PUNCT
ajfti-2033	15	25	ding	ding	NOUN
ajfti-2033	15	26	et	et	PROPN
ajfti-2033	15	27	al	al	PROPN
ajfti-2033	15	28	.	.	PROPN
ajfti-2033	15	29	,	,	PUNCT
ajfti-2033	15	30	2022	2022	NUM
ajfti-2033	15	31	)	)	PUNCT
ajfti-2033	15	32	.	.	PUNCT
ajfti-2033	16	1	furthermore	furthermore	ADV
ajfti-2033	16	2	,	,	PUNCT
ajfti-2033	16	3	between	between	ADP
ajfti-2033	16	4	medication	medication	NOUN
ajfti-2033	16	5	acquisition	acquisition	NOUN
ajfti-2033	16	6	and	and	CCONJ
ajfti-2033	16	7	fulfilling	fulfil	VERB
ajfti-2033	16	8	other	other	ADJ
ajfti-2033	16	9	essential	essential	ADJ
ajfti-2033	16	10	requirements	requirement	NOUN
ajfti-2033	16	11	,	,	PUNCT
ajfti-2033	16	12	such	such	ADJ
ajfti-2033	16	13	as	as	ADP
ajfti-2033	16	14	housing	housing	NOUN
ajfti-2033	16	15	,	,	PUNCT
ajfti-2033	16	16	sustenance	sustenance	NOUN
ajfti-2033	16	17	,	,	PUNCT
ajfti-2033	16	18	or	or	CCONJ
ajfti-2033	16	19	utilities	utility	NOUN
ajfti-2033	16	20	,	,	PUNCT
ajfti-2033	16	21	patients	patient	NOUN
ajfti-2033	16	22	may	may	AUX
ajfti-2033	16	23	be	be	AUX
ajfti-2033	16	24	forced	force	VERB
ajfti-2033	16	25	to	to	PART
ajfti-2033	16	26	make	make	VERB
ajfti-2033	16	27	arduous	arduous	ADJ
ajfti-2033	16	28	decisions	decision	NOUN
ajfti-2033	16	29	due	due	ADP
ajfti-2033	16	30	to	to	ADP
ajfti-2033	16	31	monetary	monetary	ADJ
ajfti-2033	16	32	constraints	constraint	NOUN
ajfti-2033	16	33	(	(	PUNCT
ajfti-2033	16	34	malecha	malecha	PROPN
ajfti-2033	16	35	et	et	PROPN
ajfti-2033	16	36	al	al	PROPN
ajfti-2033	16	37	.	.	PROPN
ajfti-2033	16	38	,	,	PUNCT
ajfti-2033	16	39	2018	2018	NUM
ajfti-2033	16	40	)	)	PUNCT
ajfti-2033	16	41	.	.	PUNCT
ajfti-2033	17	1	consequences	consequence	NOUN
ajfti-2033	17	2	of	of	ADP
ajfti-2033	17	3	treatment	treatment	NOUN
ajfti-2033	17	4	failure	failure	NOUN
ajfti-2033	17	5	may	may	AUX
ajfti-2033	17	6	lead	lead	VERB
ajfti-2033	17	7	to	to	ADP
ajfti-2033	17	8	individuals	individual	NOUN
ajfti-2033	17	9	resorting	resort	VERB
ajfti-2033	17	10	to	to	ADP
ajfti-2033	17	11	reduced	reduce	VERB
ajfti-2033	17	12	doses	dose	NOUN
ajfti-2033	17	13	,	,	PUNCT
ajfti-2033	17	14	missed	miss	VERB
ajfti-2033	17	15	doses	dose	NOUN
ajfti-2033	17	16	,	,	PUNCT
ajfti-2033	17	17	or	or	CCONJ
ajfti-2033	17	18	treatment	treatment	NOUN
ajfti-2033	17	19	discontinuation	discontinuation	NOUN
ajfti-2033	17	20	,	,	PUNCT
ajfti-2033	17	21	resulting	result	VERB
ajfti-2033	17	22	in	in	ADP
ajfti-2033	17	23	non	non	ADJ
ajfti-2033	17	24	-	-	NOUN
ajfti-2033	17	25	adherence	adherence	NOUN
ajfti-2033	17	26	.	.	PUNCT
ajfti-2033	18	1	non	non	ADJ
ajfti-2033	18	2	-	-	NOUN
ajfti-2033	18	3	compliance	compliance	NOUN
ajfti-2033	18	4	with	with	ADP
ajfti-2033	18	5	treatment	treatment	NOUN
ajfti-2033	18	6	guidelines	guideline	NOUN
ajfti-2033	18	7	can	can	AUX
ajfti-2033	18	8	lead	lead	VERB
ajfti-2033	18	9	to	to	ADP
ajfti-2033	18	10	costlier	costly	ADJ
ajfti-2033	18	11	care	care	NOUN
ajfti-2033	18	12	and	and	CCONJ
ajfti-2033	18	13	a	a	DET
ajfti-2033	18	14	greater	great	ADJ
ajfti-2033	18	15	chance	chance	NOUN
ajfti-2033	18	16	of	of	ADP
ajfti-2033	18	17	developing	develop	VERB
ajfti-2033	18	18	complications	complication	NOUN
ajfti-2033	18	19	,	,	PUNCT
ajfti-2033	18	20	according	accord	VERB
ajfti-2033	18	21	to	to	ADP
ajfti-2033	18	22	(	(	PUNCT
ajfti-2033	18	23	emadi	emadi	VERB
ajfti-2033	18	24	et	et	PROPN
ajfti-2033	18	25	al	al	PROPN
ajfti-2033	18	26	.	.	PROPN
ajfti-2033	18	27	,	,	PUNCT
ajfti-2033	18	28	2022	2022	NUM
ajfti-2033	18	29	)	)	PUNCT
ajfti-2033	18	30	.	.	PUNCT
ajfti-2033	19	1	emadi	emadi	PROPN
ajfti-2033	19	2	et	et	PROPN
ajfti-2033	19	3	al	al	PROPN
ajfti-2033	19	4	.	.	PROPN
ajfti-2033	20	1	(	(	PUNCT
ajfti-2033	20	2	2022	2022	NUM
ajfti-2033	20	3	)	)	PUNCT
ajfti-2033	20	4	state	state	NOUN
ajfti-2033	20	5	that	that	SCONJ
ajfti-2033	20	6	the	the	DET
ajfti-2033	20	7	interplay	interplay	NOUN
ajfti-2033	20	8	between	between	ADP
ajfti-2033	20	9	drug	drug	NOUN
ajfti-2033	20	10	pricing	pricing	NOUN
ajfti-2033	20	11	and	and	CCONJ
ajfti-2033	20	12	insurance	insurance	NOUN
ajfti-2033	20	13	coverage	coverage	NOUN
ajfti-2033	20	14	profoundly	profoundly	ADV
ajfti-2033	20	15	affects	affect	VERB
ajfti-2033	20	16	ma	ma	PROPN
ajfti-2033	20	17	,	,	PUNCT
ajfti-2033	20	18	touching	touch	VERB
ajfti-2033	20	19	numerous	numerous	ADJ
ajfti-2033	20	20	parties	party	NOUN
ajfti-2033	20	21	,	,	PUNCT
ajfti-2033	20	22	including	include	VERB
ajfti-2033	20	23	individuals	individual	NOUN
ajfti-2033	20	24	,	,	PUNCT
ajfti-2033	20	25	healthcare	healthcare	NOUN
ajfti-2033	20	26	providers	provider	NOUN
ajfti-2033	20	27	,	,	PUNCT
ajfti-2033	20	28	and	and	CCONJ
ajfti-2033	20	29	society	society	NOUN
ajfti-2033	20	30	.	.	PUNCT
ajfti-2033	21	1	extending	extend	VERB
ajfti-2033	21	2	it	it	PRON
ajfti-2033	21	3	further	far	ADV
ajfti-2033	21	4	frieden	frieden	PROPN
ajfti-2033	21	5	et	et	PROPN
ajfti-2033	21	6	al	al	PROPN
ajfti-2033	21	7	.	.	PROPN
ajfti-2033	21	8	,(2019	,(2019	PUNCT
ajfti-2033	21	9	)	)	PUNCT
ajfti-2033	21	10	has	have	AUX
ajfti-2033	21	11	highlighted	highlight	VERB
ajfti-2033	21	12	that	that	SCONJ
ajfti-2033	21	13	due	due	ADP
ajfti-2033	21	14	to	to	ADP
ajfti-2033	21	15	the	the	DET
ajfti-2033	21	16	combination	combination	NOUN
ajfti-2033	21	17	of	of	ADP
ajfti-2033	21	18	mounting	mount	VERB
ajfti-2033	21	19	drug	drug	NOUN
ajfti-2033	21	20	prices	price	NOUN
ajfti-2033	21	21	and	and	CCONJ
ajfti-2033	21	22	suboptimal	suboptimal	ADJ
ajfti-2033	21	23	insurance	insurance	NOUN
ajfti-2033	21	24	coverage	coverage	NOUN
ajfti-2033	21	25	,	,	PUNCT
ajfti-2033	21	26	ma	ma	PROPN
ajfti-2033	21	27	reduction	reduction	NOUN
ajfti-2033	21	28	can	can	AUX
ajfti-2033	21	29	lead	lead	VERB
ajfti-2033	21	30	to	to	ADP
ajfti-2033	21	31	adverse	adverse	ADJ
ajfti-2033	21	32	impacts	impact	NOUN
ajfti-2033	21	33	on	on	ADP
ajfti-2033	21	34	patient	patient	ADJ
ajfti-2033	21	35	health	health	NOUN
ajfti-2033	21	36	and	and	CCONJ
ajfti-2033	21	37	the	the	DET
ajfti-2033	21	38	larger	large	ADJ
ajfti-2033	21	39	healthcare	healthcare	NOUN
ajfti-2033	21	40	system	system	NOUN
ajfti-2033	21	41	(	(	PUNCT
ajfti-2033	21	42	emadi	emadi	VERB
ajfti-2033	21	43	et	et	PROPN
ajfti-2033	21	44	al	al	PROPN
ajfti-2033	21	45	.	.	PROPN
ajfti-2033	21	46	,	,	PUNCT
ajfti-2033	21	47	2022	2022	NUM
ajfti-2033	21	48	;	;	PUNCT
ajfti-2033	21	49	frieden	frieden	PROPN
ajfti-2033	21	50	et	et	PROPN
ajfti-2033	21	51	al	al	PROPN
ajfti-2033	21	52	.	.	PROPN
ajfti-2033	21	53	,	,	PUNCT
ajfti-2033	21	54	2019	2019	NUM
ajfti-2033	21	55	)	)	PUNCT
ajfti-2033	21	56	.	.	PUNCT
ajfti-2033	22	1	high	high	ADJ
ajfti-2033	22	2	prescription	prescription	NOUN
ajfti-2033	22	3	drug	drug	NOUN
ajfti-2033	22	4	prices	price	NOUN
ajfti-2033	22	5	are	be	AUX
ajfti-2033	22	6	prominent	prominent	ADJ
ajfti-2033	22	7	in	in	ADP
ajfti-2033	22	8	countries	country	NOUN
ajfti-2033	22	9	with	with	ADP
ajfti-2033	22	10	market	market	NOUN
ajfti-2033	22	11	-	-	PUNCT
ajfti-2033	22	12	based	base	VERB
ajfti-2033	22	13	healthcare	healthcare	NOUN
ajfti-2033	22	14	systems	system	NOUN
ajfti-2033	22	15	,	,	PUNCT
ajfti-2033	22	16	such	such	ADJ
ajfti-2033	22	17	as	as	ADP
ajfti-2033	22	18	the	the	DET
ajfti-2033	22	19	united	united	PROPN
ajfti-2033	22	20	states	states	PROPN
ajfti-2033	22	21	(	(	PUNCT
ajfti-2033	22	22	patel	patel	PROPN
ajfti-2033	22	23	et	et	PROPN
ajfti-2033	22	24	al	al	PROPN
ajfti-2033	22	25	.	.	PROPN
ajfti-2033	22	26	,	,	PUNCT
ajfti-2033	22	27	2018	2018	NUM
ajfti-2033	22	28	)	)	PUNCT
ajfti-2033	22	29	.	.	PUNCT
ajfti-2033	23	1	these	these	DET
ajfti-2033	23	2	soaring	soar	VERB
ajfti-2033	23	3	prices	price	NOUN
ajfti-2033	23	4	result	result	VERB
ajfti-2033	23	5	from	from	ADP
ajfti-2033	23	6	research	research	NOUN
ajfti-2033	23	7	and	and	CCONJ
ajfti-2033	23	8	development	development	NOUN
ajfti-2033	23	9	expenses	expense	NOUN
ajfti-2033	23	10	,	,	PUNCT
ajfti-2033	23	11	regulatory	regulatory	ADJ
ajfti-2033	23	12	clearance	clearance	NOUN
ajfti-2033	23	13	costs	cost	NOUN
ajfti-2033	23	14	,	,	PUNCT
ajfti-2033	23	15	pricing	pricing	NOUN
ajfti-2033	23	16	strategies	strategy	NOUN
ajfti-2033	23	17	employed	employ	VERB
ajfti-2033	23	18	by	by	ADP
ajfti-2033	23	19	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	23	20	companies	company	NOUN
ajfti-2033	23	21	,	,	PUNCT
ajfti-2033	23	22	and	and	CCONJ
ajfti-2033	23	23	limited	limited	ADJ
ajfti-2033	23	24	negotiation	negotiation	NOUN
ajfti-2033	23	25	leverage	leverage	NOUN
ajfti-2033	23	26	held	hold	VERB
ajfti-2033	23	27	by	by	ADP
ajfti-2033	23	28	payers	payer	NOUN
ajfti-2033	23	29	(	(	PUNCT
ajfti-2033	23	30	bhide	bhide	ADJ
ajfti-2033	23	31	,	,	PUNCT
ajfti-2033	23	32	2022	2022	NUM
ajfti-2033	23	33	)	)	PUNCT
ajfti-2033	23	34	.	.	PUNCT
ajfti-2033	24	1	according	accord	VERB
ajfti-2033	24	2	to	to	ADP
ajfti-2033	24	3	gonzález	gonzález	PROPN
ajfti-2033	24	4	vera	vera	PROPN
ajfti-2033	24	5	et	et	PROPN
ajfti-2033	24	6	al	al	PROPN
ajfti-2033	24	7	.	.	PROPN
ajfti-2033	24	8	’s	’s	PART
ajfti-2033	24	9	(	(	PUNCT
ajfti-2033	24	10	2022	2022	NUM
ajfti-2033	24	11	)	)	PUNCT
ajfti-2033	24	12	findings	finding	NOUN
ajfti-2033	24	13	,	,	PUNCT
ajfti-2033	24	14	patients	patient	NOUN
ajfti-2033	24	15	frequently	frequently	ADV
ajfti-2033	24	16	struggle	struggle	VERB
ajfti-2033	24	17	with	with	ADP
ajfti-2033	24	18	adherence	adherence	NOUN
ajfti-2033	24	19	due	due	ADP
ajfti-2033	24	20	to	to	ADP
ajfti-2033	24	21	financial	financial	ADJ
ajfti-2033	24	22	burdens	burden	NOUN
ajfti-2033	24	23	(	(	PUNCT
ajfti-2033	24	24	gonzález	gonzález	PROPN
ajfti-2033	24	25	vera	vera	PROPN
ajfti-2033	24	26	et	et	PROPN
ajfti-2033	24	27	al	al	PROPN
ajfti-2033	24	28	.	.	PROPN
ajfti-2033	24	29	,	,	PUNCT
ajfti-2033	24	30	2022	2022	NUM
ajfti-2033	24	31	)	)	PUNCT
ajfti-2033	24	32	.	.	PUNCT
ajfti-2033	25	1	by	by	ADP
ajfti-2033	25	2	covering	cover	VERB
ajfti-2033	25	3	the	the	DET
ajfti-2033	25	4	cost	cost	NOUN
ajfti-2033	25	5	of	of	ADP
ajfti-2033	25	6	prescription	prescription	NOUN
ajfti-2033	25	7	medications	medication	NOUN
ajfti-2033	25	8	,	,	PUNCT
ajfti-2033	25	9	insurance	insurance	NOUN
ajfti-2033	25	10	plays	play	VERB
ajfti-2033	25	11	a	a	DET
ajfti-2033	25	12	critical	critical	ADJ
ajfti-2033	25	13	role	role	NOUN
ajfti-2033	25	14	in	in	ADP
ajfti-2033	25	15	reducing	reduce	VERB
ajfti-2033	25	16	the	the	DET
ajfti-2033	25	17	financial	financial	ADJ
ajfti-2033	25	18	strain	strain	NOUN
ajfti-2033	25	19	.	.	PUNCT
ajfti-2033	26	1	comprehensive	comprehensive	ADJ
ajfti-2033	26	2	insurance	insurance	NOUN
ajfti-2033	26	3	plans	plan	NOUN
ajfti-2033	26	4	enhance	enhance	VERB
ajfti-2033	26	5	medication	medication	NOUN
ajfti-2033	26	6	adherence	adherence	NOUN
ajfti-2033	26	7	,	,	PUNCT
ajfti-2033	26	8	and	and	CCONJ
ajfti-2033	26	9	lower	lower	VERB
ajfti-2033	26	10	out	out	ADV
ajfti-2033	26	11	-	-	PUNCT
ajfti-2033	26	12	of	of	ADP
ajfti-2033	26	13	-	-	PUNCT
ajfti-2033	26	14	pocket	pocket	NOUN
ajfti-2033	26	15	costs	cost	NOUN
ajfti-2033	26	16	are	be	AUX
ajfti-2033	26	17	made	make	VERB
ajfti-2033	26	18	possible	possible	ADJ
ajfti-2033	26	19	(	(	PUNCT
ajfti-2033	26	20	reynolds	reynold	NOUN
ajfti-2033	26	21	et	et	PROPN
ajfti-2033	26	22	al	al	PROPN
ajfti-2033	26	23	.	.	PROPN
ajfti-2033	26	24	,	,	PUNCT
ajfti-2033	26	25	2020	2020	NUM
ajfti-2033	26	26	)	)	PUNCT
ajfti-2033	26	27	.	.	PUNCT
ajfti-2033	27	1	wide	wide	ADJ
ajfti-2033	27	2	variation	variation	NOUN
ajfti-2033	27	3	exists	exist	VERB
ajfti-2033	27	4	in	in	ADP
ajfti-2033	27	5	insurance	insurance	NOUN
ajfti-2033	27	6	coverage	coverage	NOUN
ajfti-2033	27	7	,	,	PUNCT
ajfti-2033	27	8	leaving	leave	VERB
ajfti-2033	27	9	room	room	NOUN
ajfti-2033	27	10	for	for	ADP
ajfti-2033	27	11	confusion	confusion	NOUN
ajfti-2033	27	12	and	and	CCONJ
ajfti-2033	27	13	frustration	frustration	NOUN
ajfti-2033	27	14	.	.	PUNCT
ajfti-2033	28	1	according	accord	VERB
ajfti-2033	28	2	to	to	ADP
ajfti-2033	28	3	meng	meng	PROPN
ajfti-2033	28	4	et	et	PROPN
ajfti-2033	28	5	al	al	PROPN
ajfti-2033	28	6	.	.	PROPN
ajfti-2033	29	1	(	(	PUNCT
ajfti-2033	29	2	2015	2015	NUM
ajfti-2033	29	3	)	)	PUNCT
ajfti-2033	29	4	and	and	CCONJ
ajfti-2033	29	5	yang	yang	PROPN
ajfti-2033	29	6	et	et	PROPN
ajfti-2033	29	7	al	al	PROPN
ajfti-2033	29	8	.	.	PROPN
ajfti-2033	30	1	(	(	PUNCT
ajfti-2033	30	2	2020	2020	NUM
ajfti-2033	30	3	)	)	PUNCT
ajfti-2033	30	4	,	,	PUNCT
ajfti-2033	30	5	such	such	ADJ
ajfti-2033	30	6	measures	measure	NOUN
ajfti-2033	30	7	as	as	ADP
ajfti-2033	30	8	prior	prior	ADJ
ajfti-2033	30	9	authorisation	authorisation	NOUN
ajfti-2033	30	10	and	and	CCONJ
ajfti-2033	30	11	step	step	NOUN
ajfti-2033	30	12	therapy	therapy	NOUN
ajfti-2033	30	13	create	create	VERB
ajfti-2033	30	14	challenges	challenge	NOUN
ajfti-2033	30	15	to	to	ADP
ajfti-2033	30	16	accessing	access	VERB
ajfti-2033	30	17	vital	vital	ADJ
ajfti-2033	30	18	medications	medication	NOUN
ajfti-2033	30	19	(	(	PUNCT
ajfti-2033	30	20	meng	meng	PROPN
ajfti-2033	30	21	et	et	PROPN
ajfti-2033	30	22	al	al	PROPN
ajfti-2033	30	23	.	.	PROPN
ajfti-2033	30	24	,	,	PUNCT
ajfti-2033	30	25	2015	2015	NUM
ajfti-2033	30	26	;	;	PUNCT
ajfti-2033	30	27	yang	yang	PROPN
ajfti-2033	30	28	et	et	PROPN
ajfti-2033	30	29	al	al	PROPN
ajfti-2033	30	30	.	.	PROPN
ajfti-2033	30	31	,	,	PUNCT
ajfti-2033	30	32	2020	2020	NUM
ajfti-2033	30	33	)	)	PUNCT
ajfti-2033	30	34	.	.	PUNCT
ajfti-2033	31	1	all	all	DET
ajfti-2033	31	2	stakeholders	stakeholder	NOUN
ajfti-2033	31	3	,	,	PUNCT
ajfti-2033	31	4	including	include	VERB
ajfti-2033	31	5	patients	patient	NOUN
ajfti-2033	31	6	,	,	PUNCT
ajfti-2033	31	7	healthcare	healthcare	NOUN
ajfti-2033	31	8	providers	provider	NOUN
ajfti-2033	31	9	,	,	PUNCT
ajfti-2033	31	10	insurance	insurance	NOUN
ajfti-2033	31	11	companies	company	NOUN
ajfti-2033	31	12	,	,	PUNCT
ajfti-2033	31	13	and	and	CCONJ
ajfti-2033	31	14	policymakers	policymaker	NOUN
ajfti-2033	31	15	,	,	PUNCT
ajfti-2033	31	16	must	must	AUX
ajfti-2033	31	17	join	join	VERB
ajfti-2033	31	18	forces	force	NOUN
ajfti-2033	31	19	to	to	PART
ajfti-2033	31	20	find	find	VERB
ajfti-2033	31	21	practical	practical	ADJ
ajfti-2033	31	22	solutions	solution	NOUN
ajfti-2033	31	23	for	for	ADP
ajfti-2033	31	24	complex	complex	ADJ
ajfti-2033	31	25	challenges	challenge	NOUN
ajfti-2033	31	26	(	(	PUNCT
ajfti-2033	31	27	bali	bali	PROPN
ajfti-2033	31	28	&	&	CCONJ
ajfti-2033	31	29	ramesh	ramesh	PROPN
ajfti-2033	31	30	,	,	PUNCT
ajfti-2033	31	31	2023	2023	NUM
ajfti-2033	31	32	)	)	PUNCT
ajfti-2033	31	33	.	.	PUNCT
ajfti-2033	32	1	measures	measure	NOUN
ajfti-2033	32	2	to	to	PART
ajfti-2033	32	3	advance	advance	VERB
ajfti-2033	32	4	price	price	NOUN
ajfti-2033	32	5	transparency	transparency	NOUN
ajfti-2033	32	6	,	,	PUNCT
ajfti-2033	32	7	boost	boost	VERB
ajfti-2033	32	8	competition	competition	NOUN
ajfti-2033	32	9	in	in	ADP
ajfti-2033	32	10	the	the	DET
ajfti-2033	32	11	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	32	12	sector	sector	NOUN
ajfti-2033	32	13	,	,	PUNCT
ajfti-2033	32	14	and	and	CCONJ
ajfti-2033	32	15	control	control	NOUN
ajfti-2033	32	16	prescription	prescription	NOUN
ajfti-2033	32	17	pricing	pricing	NOUN
ajfti-2033	32	18	can	can	AUX
ajfti-2033	32	19	be	be	AUX
ajfti-2033	32	20	undertaken	undertake	VERB
ajfti-2033	32	21	by	by	ADP
ajfti-2033	32	22	policymakers	policymaker	NOUN
ajfti-2033	32	23	(	(	PUNCT
ajfti-2033	32	24	ahmad	ahmad	PROPN
ajfti-2033	32	25	et	et	PROPN
ajfti-2033	32	26	al	al	PROPN
ajfti-2033	32	27	.	.	PROPN
ajfti-2033	32	28	,	,	PUNCT
ajfti-2033	32	29	2020	2020	NUM
ajfti-2033	32	30	)	)	PUNCT
ajfti-2033	32	31	.	.	PUNCT
ajfti-2033	33	1	mandating	mandate	VERB
ajfti-2033	33	2	prescription	prescription	NOUN
ajfti-2033	33	3	drug	drug	NOUN
ajfti-2033	33	4	coverage	coverage	NOUN
ajfti-2033	33	5	by	by	ADP
ajfti-2033	33	6	insurance	insurance	NOUN
ajfti-2033	33	7	providers	provider	NOUN
ajfti-2033	33	8	could	could	AUX
ajfti-2033	33	9	increase	increase	VERB
ajfti-2033	33	10	patient	patient	ADJ
ajfti-2033	33	11	compliance	compliance	NOUN
ajfti-2033	33	12	rates	rate	NOUN
ajfti-2033	33	13	.	.	PUNCT
ajfti-2033	34	1	saudi	saudi	PROPN
ajfti-2033	34	2	arabia	arabia	PROPN
ajfti-2033	34	3	’s	’s	PART
ajfti-2033	34	4	study	study	NOUN
ajfti-2033	34	5	aims	aim	VERB
ajfti-2033	34	6	to	to	PART
ajfti-2033	34	7	investigate	investigate	VERB
ajfti-2033	34	8	the	the	DET
ajfti-2033	34	9	effect	effect	NOUN
ajfti-2033	34	10	of	of	ADP
ajfti-2033	34	11	drug	drug	NOUN
ajfti-2033	34	12	pricing	pricing	NOUN
ajfti-2033	34	13	and	and	CCONJ
ajfti-2033	34	14	insurance	insurance	NOUN
ajfti-2033	34	15	coverage	coverage	NOUN
ajfti-2033	34	16	on	on	ADP
ajfti-2033	34	17	medication	medication	NOUN
ajfti-2033	34	18	adherence	adherence	NOUN
ajfti-2033	34	19	(	(	PUNCT
ajfti-2033	34	20	ma	ma	PROPN
ajfti-2033	34	21	)	)	PUNCT
ajfti-2033	34	22	(	(	PUNCT
ajfti-2033	34	23	alqarni	alqarni	PROPN
ajfti-2033	34	24	et	et	PROPN
ajfti-2033	34	25	al	al	PROPN
ajfti-2033	34	26	.	.	PROPN
ajfti-2033	34	27	,	,	PUNCT
ajfti-2033	34	28	2019	2019	NUM
ajfti-2033	34	29	)	)	PUNCT
ajfti-2033	34	30	.	.	PUNCT
ajfti-2033	35	1	high	high	ADJ
ajfti-2033	35	2	1	1	NUM
ajfti-2033	35	3	saudi	saudi	ADJ
ajfti-2033	35	4	food	food	NOUN
ajfti-2033	35	5	and	and	CCONJ
ajfti-2033	35	6	drug	drug	NOUN
ajfti-2033	35	7	authority	authority	NOUN
ajfti-2033	35	8	,	,	PUNCT
ajfti-2033	35	9	saudi	saudi	PROPN
ajfti-2033	35	10	arabia	arabia	PROPN
ajfti-2033	35	11	*	*	PUNCT
ajfti-2033	35	12	corresponding	correspond	VERB
ajfti-2033	35	13	author	author	NOUN
ajfti-2033	35	14	’s	’s	PART
ajfti-2033	35	15	e	e	NOUN
ajfti-2033	35	16	-	-	NOUN
ajfti-2033	35	17	mail	mail	NOUN
ajfti-2033	35	18	:	:	PUNCT
ajfti-2033	35	19	tmsagoor@sfda.gov.sa	tmsagoor@sfda.gov.sa	PROPN
ajfti-2033	35	20	pa	pa	PROPN
ajfti-2033	35	21	ge	ge	PROPN
ajfti-2033	35	22	25	25	NUM
ajfti-2033	35	23	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	35	24	am	be	AUX
ajfti-2033	35	25	.	.	PUNCT
ajfti-2033	36	1	j.	j.	PROPN
ajfti-2033	36	2	financ	financ	PROPN
ajfti-2033	36	3	.	.	PUNCT
ajfti-2033	37	1	technol	technol	PROPN
ajfti-2033	37	2	.	.	PUNCT
ajfti-2033	37	3	innov	innov	PROPN
ajfti-2033	37	4	.	.	PUNCT
ajfti-2033	38	1	1(1	1(1	NUM
ajfti-2033	38	2	)	)	PUNCT
ajfti-2033	38	3	24	24	NUM
ajfti-2033	38	4	-	-	SYM
ajfti-2033	38	5	34	34	NUM
ajfti-2033	38	6	,	,	PUNCT
ajfti-2033	38	7	2023	2023	NUM
ajfti-2033	38	8	medicine	medicine	NOUN
ajfti-2033	38	9	costs	cost	NOUN
ajfti-2033	38	10	and	and	CCONJ
ajfti-2033	38	11	subpar	subpar	ADJ
ajfti-2033	38	12	insurance	insurance	NOUN
ajfti-2033	38	13	protection	protection	NOUN
ajfti-2033	38	14	in	in	ADP
ajfti-2033	38	15	light	light	NOUN
ajfti-2033	38	16	of	of	ADP
ajfti-2033	38	17	the	the	DET
ajfti-2033	38	18	increasing	increase	VERB
ajfti-2033	38	19	frequency	frequency	NOUN
ajfti-2033	38	20	of	of	ADP
ajfti-2033	38	21	persistent	persistent	ADJ
ajfti-2033	38	22	non	non	ADJ
ajfti-2033	38	23	-	-	ADJ
ajfti-2033	38	24	communicable	communicable	ADJ
ajfti-2033	38	25	disorders	disorder	NOUN
ajfti-2033	38	26	impact	impact	VERB
ajfti-2033	38	27	patient	patient	ADJ
ajfti-2033	38	28	compliance	compliance	NOUN
ajfti-2033	38	29	with	with	ADP
ajfti-2033	38	30	medication	medication	NOUN
ajfti-2033	38	31	(	(	PUNCT
ajfti-2033	38	32	dias	dias	PROPN
ajfti-2033	38	33	,	,	PUNCT
ajfti-2033	38	34	2023	2023	NUM
ajfti-2033	38	35	)	)	PUNCT
ajfti-2033	38	36	.	.	PUNCT
ajfti-2033	39	1	by	by	ADP
ajfti-2033	39	2	examining	examine	VERB
ajfti-2033	39	3	the	the	DET
ajfti-2033	39	4	interplay	interplay	NOUN
ajfti-2033	39	5	of	of	ADP
ajfti-2033	39	6	drug	drug	NOUN
ajfti-2033	39	7	pricing	pricing	NOUN
ajfti-2033	39	8	,	,	PUNCT
ajfti-2033	39	9	insurance	insurance	NOUN
ajfti-2033	39	10	coverage	coverage	NOUN
ajfti-2033	39	11	,	,	PUNCT
ajfti-2033	39	12	and	and	CCONJ
ajfti-2033	39	13	ma	ma	PROPN
ajfti-2033	39	14	in	in	ADP
ajfti-2033	39	15	saudi	saudi	PROPN
ajfti-2033	39	16	arabia	arabia	PROPN
ajfti-2033	39	17	,	,	PUNCT
ajfti-2033	39	18	the	the	DET
ajfti-2033	39	19	research	research	NOUN
ajfti-2033	39	20	will	will	AUX
ajfti-2033	39	21	identify	identify	VERB
ajfti-2033	39	22	evidence	evidence	NOUN
ajfti-2033	39	23	-	-	PUNCT
ajfti-2033	39	24	based	base	VERB
ajfti-2033	39	25	approaches	approach	NOUN
ajfti-2033	39	26	to	to	PART
ajfti-2033	39	27	strengthen	strengthen	VERB
ajfti-2033	39	28	medication	medication	NOUN
ajfti-2033	39	29	affordability	affordability	NOUN
ajfti-2033	39	30	,	,	PUNCT
ajfti-2033	39	31	coverage	coverage	NOUN
ajfti-2033	39	32	,	,	PUNCT
ajfti-2033	39	33	and	and	CCONJ
ajfti-2033	39	34	adherence	adherence	NOUN
ajfti-2033	39	35	.	.	PUNCT
ajfti-2033	40	1	as	as	SCONJ
ajfti-2033	40	2	they	they	PRON
ajfti-2033	40	3	relate	relate	VERB
ajfti-2033	40	4	to	to	ADP
ajfti-2033	40	5	public	public	ADJ
ajfti-2033	40	6	health	health	NOUN
ajfti-2033	40	7	,	,	PUNCT
ajfti-2033	40	8	these	these	DET
ajfti-2033	40	9	findings	finding	NOUN
ajfti-2033	40	10	offer	offer	VERB
ajfti-2033	40	11	significant	significant	ADJ
ajfti-2033	40	12	improvement	improvement	NOUN
ajfti-2033	40	13	opportunities	opportunity	NOUN
ajfti-2033	40	14	,	,	PUNCT
ajfti-2033	40	15	cost	cost	NOUN
ajfti-2033	40	16	containment	containment	NOUN
ajfti-2033	40	17	,	,	PUNCT
ajfti-2033	40	18	and	and	CCONJ
ajfti-2033	40	19	access	access	NOUN
ajfti-2033	40	20	enhancements	enhancement	NOUN
ajfti-2033	40	21	,	,	PUNCT
ajfti-2033	40	22	thus	thus	ADV
ajfti-2033	40	23	contributing	contribute	VERB
ajfti-2033	40	24	positively	positively	ADV
ajfti-2033	40	25	to	to	ADP
ajfti-2033	40	26	society	society	NOUN
ajfti-2033	40	27	.	.	PUNCT
ajfti-2033	41	1	literature	literature	NOUN
ajfti-2033	41	2	review	review	NOUN
ajfti-2033	41	3	across	across	ADP
ajfti-2033	41	4	the	the	DET
ajfti-2033	41	5	globe	globe	NOUN
ajfti-2033	41	6	,	,	PUNCT
ajfti-2033	41	7	there	there	PRON
ajfti-2033	41	8	has	have	AUX
ajfti-2033	41	9	been	be	AUX
ajfti-2033	41	10	an	an	DET
ajfti-2033	41	11	increase	increase	NOUN
ajfti-2033	41	12	in	in	ADP
ajfti-2033	41	13	research	research	NOUN
ajfti-2033	41	14	on	on	ADP
ajfti-2033	41	15	drug	drug	NOUN
ajfti-2033	41	16	pricing	pricing	NOUN
ajfti-2033	41	17	,	,	PUNCT
ajfti-2033	41	18	insurance	insurance	NOUN
ajfti-2033	41	19	,	,	PUNCT
ajfti-2033	41	20	and	and	CCONJ
ajfti-2033	41	21	medication	medication	NOUN
ajfti-2033	41	22	adherence	adherence	NOUN
ajfti-2033	41	23	(	(	PUNCT
ajfti-2033	41	24	ma	ma	PROPN
ajfti-2033	41	25	)	)	PUNCT
ajfti-2033	41	26	in	in	ADP
ajfti-2033	41	27	recent	recent	ADJ
ajfti-2033	41	28	times	time	NOUN
ajfti-2033	41	29	.	.	PUNCT
ajfti-2033	42	1	diving	diving	NOUN
ajfti-2033	42	2	deeper	deeply	ADV
ajfti-2033	42	3	into	into	ADP
ajfti-2033	42	4	the	the	DET
ajfti-2033	42	5	intricacies	intricacy	NOUN
ajfti-2033	42	6	of	of	ADP
ajfti-2033	42	7	the	the	DET
ajfti-2033	42	8	issue	issue	NOUN
ajfti-2033	42	9	,	,	PUNCT
ajfti-2033	42	10	manna	manna	NOUN
ajfti-2033	42	11	et	et	PROPN
ajfti-2033	42	12	al	al	PROPN
ajfti-2033	42	13	(	(	PUNCT
ajfti-2033	42	14	2020	2020	NUM
ajfti-2033	42	15	)	)	PUNCT
ajfti-2033	42	16	has	have	AUX
ajfti-2033	42	17	highlighted	highlight	VERB
ajfti-2033	42	18	a	a	DET
ajfti-2033	42	19	significant	significant	ADJ
ajfti-2033	42	20	need	need	NOUN
ajfti-2033	42	21	to	to	PART
ajfti-2033	42	22	shed	shed	VERB
ajfti-2033	42	23	light	light	NOUN
ajfti-2033	42	24	on	on	ADP
ajfti-2033	42	25	its	its	PRON
ajfti-2033	42	26	implications	implication	NOUN
ajfti-2033	42	27	for	for	ADP
ajfti-2033	42	28	public	public	ADJ
ajfti-2033	42	29	health	health	NOUN
ajfti-2033	42	30	outcomes	outcome	NOUN
ajfti-2033	42	31	.	.	PUNCT
ajfti-2033	43	1	the	the	DET
ajfti-2033	43	2	study	study	NOUN
ajfti-2033	43	3	has	have	AUX
ajfti-2033	43	4	further	far	ADV
ajfti-2033	43	5	emphasised	emphasise	VERB
ajfti-2033	43	6	examining	examine	VERB
ajfti-2033	43	7	the	the	DET
ajfti-2033	43	8	relationship	relationship	NOUN
ajfti-2033	43	9	between	between	ADP
ajfti-2033	43	10	drug	drug	NOUN
ajfti-2033	43	11	pricing	pricing	NOUN
ajfti-2033	43	12	,	,	PUNCT
ajfti-2033	43	13	insurance	insurance	NOUN
ajfti-2033	43	14	coverage	coverage	NOUN
ajfti-2033	43	15	,	,	PUNCT
ajfti-2033	43	16	and	and	CCONJ
ajfti-2033	43	17	ma	ma	PROPN
ajfti-2033	43	18	in	in	ADP
ajfti-2033	43	19	saudi	saudi	PROPN
ajfti-2033	43	20	arabia	arabia	PROPN
ajfti-2033	43	21	,	,	PUNCT
ajfti-2033	43	22	as	as	ADV
ajfti-2033	43	23	well	well	ADV
ajfti-2033	43	24	as	as	ADP
ajfti-2033	43	25	evidence	evidence	NOUN
ajfti-2033	43	26	-	-	PUNCT
ajfti-2033	43	27	based	base	VERB
ajfti-2033	43	28	solutions	solution	NOUN
ajfti-2033	43	29	that	that	PRON
ajfti-2033	43	30	can	can	AUX
ajfti-2033	43	31	be	be	AUX
ajfti-2033	43	32	applied	apply	VERB
ajfti-2033	43	33	to	to	PART
ajfti-2033	43	34	address	address	VERB
ajfti-2033	43	35	these	these	DET
ajfti-2033	43	36	challenges	challenge	NOUN
ajfti-2033	43	37	(	(	PUNCT
ajfti-2033	43	38	manna	manna	NOUN
ajfti-2033	43	39	et	et	PROPN
ajfti-2033	43	40	al	al	PROPN
ajfti-2033	43	41	.	.	PROPN
ajfti-2033	43	42	,	,	PUNCT
ajfti-2033	43	43	2020	2020	NUM
ajfti-2033	43	44	)	)	PUNCT
ajfti-2033	43	45	.	.	PUNCT
ajfti-2033	44	1	a	a	DET
ajfti-2033	44	2	complexity	complexity	NOUN
ajfti-2033	44	3	in	in	ADP
ajfti-2033	44	4	drug	drug	NOUN
ajfti-2033	44	5	pricing	pricing	NOUN
ajfti-2033	44	6	and	and	CCONJ
ajfti-2033	44	7	insurance	insurance	NOUN
ajfti-2033	44	8	characterises	characterise	VERB
ajfti-2033	44	9	:	:	PUNCT
ajfti-2033	44	10	the	the	DET
ajfti-2033	44	11	current	current	ADJ
ajfti-2033	44	12	setup	setup	NOUN
ajfti-2033	44	13	in	in	ADP
ajfti-2033	44	14	saudi	saudi	PROPN
ajfti-2033	44	15	arabia	arabia	PROPN
ajfti-2033	44	16	and	and	CCONJ
ajfti-2033	44	17	numerous	numerous	ADJ
ajfti-2033	44	18	other	other	ADJ
ajfti-2033	44	19	nations	nation	NOUN
ajfti-2033	44	20	,	,	PUNCT
ajfti-2033	44	21	drug	drug	NOUN
ajfti-2033	44	22	pricing	pricing	NOUN
ajfti-2033	44	23	is	be	AUX
ajfti-2033	44	24	an	an	DET
ajfti-2033	44	25	intricate	intricate	ADJ
ajfti-2033	44	26	process	process	NOUN
ajfti-2033	44	27	influenced	influence	VERB
ajfti-2033	44	28	by	by	ADP
ajfti-2033	44	29	multiple	multiple	ADJ
ajfti-2033	44	30	factors	factor	NOUN
ajfti-2033	44	31	(	(	PUNCT
ajfti-2033	44	32	almutairi	almutairi	NOUN
ajfti-2033	44	33	et	et	PROPN
ajfti-2033	44	34	al	al	PROPN
ajfti-2033	44	35	.	.	PROPN
ajfti-2033	44	36	,	,	PUNCT
ajfti-2033	44	37	2023	2023	NUM
ajfti-2033	44	38	)	)	PUNCT
ajfti-2033	44	39	.	.	PUNCT
ajfti-2033	45	1	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	45	2	companies	company	NOUN
ajfti-2033	45	3	et	et	PROPN
ajfti-2033	45	4	al	al	PROPN
ajfti-2033	45	5	.	.	PROPN
ajfti-2033	45	6	,	,	PUNCT
ajfti-2033	45	7	play	play	VERB
ajfti-2033	45	8	a	a	DET
ajfti-2033	45	9	part	part	NOUN
ajfti-2033	45	10	in	in	ADP
ajfti-2033	45	11	deciding	decide	VERB
ajfti-2033	45	12	how	how	SCONJ
ajfti-2033	45	13	much	much	ADJ
ajfti-2033	45	14	patients	patient	NOUN
ajfti-2033	45	15	or	or	CCONJ
ajfti-2033	45	16	their	their	PRON
ajfti-2033	45	17	insurance	insurance	NOUN
ajfti-2033	45	18	providers	provider	NOUN
ajfti-2033	45	19	ultimately	ultimately	ADV
ajfti-2033	45	20	pay	pay	VERB
ajfti-2033	45	21	in	in	ADP
ajfti-2033	45	22	the	the	DET
ajfti-2033	45	23	end	end	NOUN
ajfti-2033	45	24	.	.	PUNCT
ajfti-2033	46	1	per	per	ADP
ajfti-2033	46	2	iqvia	iqvia	NOUN
ajfti-2033	46	3	(	(	PUNCT
ajfti-2033	46	4	2021	2021	NUM
ajfti-2033	46	5	)	)	PUNCT
ajfti-2033	46	6	,	,	PUNCT
ajfti-2033	46	7	saudi	saudi	PROPN
ajfti-2033	46	8	arabia	arabia	PROPN
ajfti-2033	46	9	’s	’s	PART
ajfti-2033	46	10	pharmaceutical	pharmaceutical	ADJ
ajfti-2033	46	11	market	market	NOUN
ajfti-2033	46	12	,	,	PUNCT
ajfti-2033	46	13	valued	value	VERB
ajfti-2033	46	14	at	at	ADP
ajfti-2033	46	15	$	$	SYM
ajfti-2033	46	16	7.23	7.23	NUM
ajfti-2033	46	17	billion	billion	NUM
ajfti-2033	46	18	in	in	ADP
ajfti-2033	46	19	2021	2021	NUM
ajfti-2033	46	20	,	,	PUNCT
ajfti-2033	46	21	is	be	AUX
ajfti-2033	46	22	poised	poise	VERB
ajfti-2033	46	23	for	for	ADP
ajfti-2033	46	24	significant	significant	ADJ
ajfti-2033	46	25	growth	growth	NOUN
ajfti-2033	46	26	in	in	ADP
ajfti-2033	46	27	the	the	DET
ajfti-2033	46	28	forthcoming	forthcoming	ADJ
ajfti-2033	46	29	year	year	NOUN
ajfti-2033	46	30	.	.	PUNCT
ajfti-2033	47	1	as	as	SCONJ
ajfti-2033	47	2	cited	cite	VERB
ajfti-2033	47	3	by	by	ADP
ajfti-2033	47	4	yang	yang	PROPN
ajfti-2033	47	5	eta	eta	PROPN
ajfti-2033	47	6	al	al	PROPN
ajfti-2033	47	7	,	,	PUNCT
ajfti-2033	47	8	(	(	PUNCT
ajfti-2033	47	9	2020	2020	NUM
ajfti-2033	47	10	)	)	PUNCT
ajfti-2033	47	11	,	,	PUNCT
ajfti-2033	47	12	the	the	DET
ajfti-2033	47	13	above	above	ADJ
ajfti-2033	47	14	factors	factor	NOUN
ajfti-2033	47	15	contribute	contribute	VERB
ajfti-2033	47	16	to	to	ADP
ajfti-2033	47	17	the	the	DET
ajfti-2033	47	18	growth	growth	NOUN
ajfti-2033	47	19	seen	see	VERB
ajfti-2033	47	20	here	here	ADV
ajfti-2033	47	21	.	.	PUNCT
ajfti-2033	48	1	examining	examine	VERB
ajfti-2033	48	2	the	the	DET
ajfti-2033	48	3	current	current	ADJ
ajfti-2033	48	4	drug	drug	NOUN
ajfti-2033	48	5	pricing	pricing	NOUN
ajfti-2033	48	6	schemes	scheme	NOUN
ajfti-2033	48	7	is	be	AUX
ajfti-2033	48	8	essential	essential	ADJ
ajfti-2033	48	9	since	since	SCONJ
ajfti-2033	48	10	they	they	PRON
ajfti-2033	48	11	directly	directly	ADV
ajfti-2033	48	12	impact	impact	VERB
ajfti-2033	48	13	the	the	DET
ajfti-2033	48	14	saudi	saudi	ADJ
ajfti-2033	48	15	healthcare	healthcare	NOUN
ajfti-2033	48	16	system	system	NOUN
ajfti-2033	48	17	(	(	PUNCT
ajfti-2033	48	18	yang	yang	PROPN
ajfti-2033	48	19	et	et	PROPN
ajfti-2033	48	20	al	al	PROPN
ajfti-2033	48	21	.	.	PROPN
ajfti-2033	48	22	,	,	PUNCT
ajfti-2033	48	23	2020	2020	NUM
ajfti-2033	48	24	)	)	PUNCT
ajfti-2033	48	25	.	.	PUNCT
ajfti-2033	49	1	patients	patient	NOUN
ajfti-2033	49	2	in	in	ADP
ajfti-2033	49	3	saudi	saudi	PROPN
ajfti-2033	49	4	arabia	arabia	PROPN
ajfti-2033	49	5	may	may	AUX
ajfti-2033	49	6	face	face	VERB
ajfti-2033	49	7	drug	drug	NOUN
ajfti-2033	49	8	cost	cost	NOUN
ajfti-2033	49	9	increases	increase	NOUN
ajfti-2033	49	10	due	due	ADJ
ajfti-2033	49	11	to	to	ADP
ajfti-2033	49	12	poorly	poorly	ADV
ajfti-2033	49	13	designed	design	VERB
ajfti-2033	49	14	pricing	pricing	NOUN
ajfti-2033	49	15	structures	structure	NOUN
ajfti-2033	49	16	.	.	PUNCT
ajfti-2033	50	1	ding	de	VERB
ajfti-2033	50	2	et	et	PROPN
ajfti-2033	50	3	al	al	PROPN
ajfti-2033	50	4	.	.	PROPN
ajfti-2033	51	1	(	(	PUNCT
ajfti-2033	51	2	2022	2022	NUM
ajfti-2033	51	3	)	)	PUNCT
ajfti-2033	51	4	,	,	PUNCT
ajfti-2033	51	5	has	have	AUX
ajfti-2033	51	6	highlighted	highlight	VERB
ajfti-2033	51	7	that	that	SCONJ
ajfti-2033	51	8	with	with	ADP
ajfti-2033	51	9	high	high	ADJ
ajfti-2033	51	10	medication	medication	NOUN
ajfti-2033	51	11	costs	cost	NOUN
ajfti-2033	51	12	,	,	PUNCT
ajfti-2033	51	13	individuals	individual	NOUN
ajfti-2033	51	14	may	may	AUX
ajfti-2033	51	15	need	need	VERB
ajfti-2033	51	16	help	help	VERB
ajfti-2033	51	17	prioritising	prioritise	VERB
ajfti-2033	51	18	necessities	necessity	NOUN
ajfti-2033	51	19	or	or	CCONJ
ajfti-2033	51	20	their	their	PRON
ajfti-2033	51	21	medications	medication	NOUN
ajfti-2033	51	22	.	.	PUNCT
ajfti-2033	52	1	the	the	DET
ajfti-2033	52	2	ministry	ministry	PROPN
ajfti-2033	52	3	of	of	ADP
ajfti-2033	52	4	health	health	PROPN
ajfti-2033	52	5	of	of	ADP
ajfti-2033	52	6	saudi	saudi	PROPN
ajfti-2033	52	7	arabia	arabia	PROPN
ajfti-2033	52	8	(	(	PUNCT
ajfti-2033	52	9	2020	2020	NUM
ajfti-2033	52	10	)	)	PUNCT
ajfti-2033	52	11	notes	note	VERB
ajfti-2033	52	12	that	that	SCONJ
ajfti-2033	52	13	approximately	approximately	ADV
ajfti-2033	52	14	60	60	NUM
ajfti-2033	52	15	%	%	NOUN
ajfti-2033	52	16	of	of	ADP
ajfti-2033	52	17	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	52	18	spending	spending	NOUN
ajfti-2033	52	19	in	in	ADP
ajfti-2033	52	20	saudi	saudi	PROPN
ajfti-2033	52	21	arabia	arabia	PROPN
ajfti-2033	52	22	was	be	AUX
ajfti-2033	52	23	financed	finance	VERB
ajfti-2033	52	24	through	through	ADP
ajfti-2033	52	25	direct	direct	ADJ
ajfti-2033	52	26	patient	patient	NOUN
ajfti-2033	52	27	payments(ministry	payments(ministry	NOUN
ajfti-2033	52	28	of	of	ADP
ajfti-2033	52	29	health	health	PROPN
ajfti-2033	52	30	&	&	CCONJ
ajfti-2033	52	31	saudi	saudi	PROPN
ajfti-2033	52	32	arabia	arabia	PROPN
ajfti-2033	52	33	,	,	PUNCT
ajfti-2033	52	34	(	(	PUNCT
ajfti-2033	52	35	2017	2017	NUM
ajfti-2033	52	36	)	)	PUNCT
ajfti-2033	52	37	.	.	PUNCT
ajfti-2033	53	1	due	due	ADP
ajfti-2033	53	2	to	to	ADP
ajfti-2033	53	3	this	this	DET
ajfti-2033	53	4	alarming	alarming	ADJ
ajfti-2033	53	5	statistic	statistic	NOUN
ajfti-2033	53	6	,	,	PUNCT
ajfti-2033	53	7	the	the	DET
ajfti-2033	53	8	population	population	NOUN
ajfti-2033	53	9	’s	’s	PART
ajfti-2033	53	10	access	access	NOUN
ajfti-2033	53	11	to	to	ADP
ajfti-2033	53	12	affordable	affordable	ADJ
ajfti-2033	53	13	medication	medication	NOUN
ajfti-2033	53	14	is	be	AUX
ajfti-2033	53	15	imperative	imperative	ADJ
ajfti-2033	53	16	.	.	PUNCT
ajfti-2033	54	1	distinct	distinct	ADJ
ajfti-2033	54	2	policies	policy	NOUN
ajfti-2033	54	3	offer	offer	VERB
ajfti-2033	54	4	varied	varied	ADJ
ajfti-2033	54	5	levels	level	NOUN
ajfti-2033	54	6	of	of	ADP
ajfti-2033	54	7	coverage	coverage	NOUN
ajfti-2033	54	8	when	when	SCONJ
ajfti-2033	54	9	it	it	PRON
ajfti-2033	54	10	comes	come	VERB
ajfti-2033	54	11	to	to	ADP
ajfti-2033	54	12	insurance	insurance	NOUN
ajfti-2033	54	13	in	in	ADP
ajfti-2033	54	14	saudi	saudi	PROPN
ajfti-2033	54	15	arabia	arabia	PROPN
ajfti-2033	54	16	(	(	PUNCT
ajfti-2033	54	17	albugmi	albugmi	ADJ
ajfti-2033	54	18	,	,	PUNCT
ajfti-2033	54	19	2021	2021	NUM
ajfti-2033	54	20	)	)	PUNCT
ajfti-2033	54	21	.	.	PUNCT
ajfti-2033	55	1	depending	depend	VERB
ajfti-2033	55	2	on	on	ADP
ajfti-2033	55	3	the	the	DET
ajfti-2033	55	4	plan	plan	NOUN
ajfti-2033	55	5	,	,	PUNCT
ajfti-2033	55	6	some	some	DET
ajfti-2033	55	7	insurance	insurance	NOUN
ajfti-2033	55	8	policies	policy	NOUN
ajfti-2033	55	9	may	may	AUX
ajfti-2033	55	10	cover	cover	VERB
ajfti-2033	55	11	drugs	drug	NOUN
ajfti-2033	55	12	comprehensively	comprehensively	ADV
ajfti-2033	55	13	,	,	PUNCT
ajfti-2033	55	14	while	while	SCONJ
ajfti-2033	55	15	others	other	NOUN
ajfti-2033	55	16	may	may	AUX
ajfti-2033	55	17	levy	levy	VERB
ajfti-2033	55	18	high	high	ADJ
ajfti-2033	55	19	co	co	NOUN
ajfti-2033	55	20	-	-	NOUN
ajfti-2033	55	21	payments	payment	NOUN
ajfti-2033	55	22	and	and	CCONJ
ajfti-2033	55	23	deductibles	deductible	NOUN
ajfti-2033	55	24	upon	upon	SCONJ
ajfti-2033	55	25	patients	patient	NOUN
ajfti-2033	55	26	(	(	PUNCT
ajfti-2033	55	27	meng	meng	PROPN
ajfti-2033	55	28	et	et	PROPN
ajfti-2033	55	29	al	al	PROPN
ajfti-2033	55	30	.	.	PROPN
ajfti-2033	55	31	,	,	PUNCT
ajfti-2033	55	32	2015	2015	NUM
ajfti-2033	55	33	)	)	PUNCT
ajfti-2033	55	34	.	.	PUNCT
ajfti-2033	56	1	a	a	DET
ajfti-2033	56	2	sama	sama	PROPN
ajfti-2033	56	3	study	study	NOUN
ajfti-2033	56	4	found	find	VERB
ajfti-2033	56	5	that	that	SCONJ
ajfti-2033	56	6	in	in	ADP
ajfti-2033	56	7	2021	2021	NUM
ajfti-2033	56	8	,	,	PUNCT
ajfti-2033	56	9	only	only	ADV
ajfti-2033	56	10	24	24	NUM
ajfti-2033	56	11	%	%	NOUN
ajfti-2033	56	12	of	of	ADP
ajfti-2033	56	13	the	the	DET
ajfti-2033	56	14	population	population	NOUN
ajfti-2033	56	15	had	have	VERB
ajfti-2033	56	16	health	health	NOUN
ajfti-2033	56	17	insurance	insurance	NOUN
ajfti-2033	56	18	coverage	coverage	NOUN
ajfti-2033	56	19	,	,	PUNCT
ajfti-2033	56	20	indicating	indicate	VERB
ajfti-2033	56	21	restricted	restrict	VERB
ajfti-2033	56	22	access	access	NOUN
ajfti-2033	56	23	to	to	ADP
ajfti-2033	56	24	coverage	coverage	NOUN
ajfti-2033	56	25	.	.	PUNCT
ajfti-2033	57	1	insurance	insurance	NOUN
ajfti-2033	57	2	coverage	coverage	NOUN
ajfti-2033	57	3	disparities	disparity	NOUN
ajfti-2033	57	4	substantially	substantially	ADV
ajfti-2033	57	5	hinder	hinder	VERB
ajfti-2033	57	6	all	all	DET
ajfti-2033	57	7	demographic	demographic	ADJ
ajfti-2033	57	8	groups	group	NOUN
ajfti-2033	57	9	’	'	PUNCT
ajfti-2033	57	10	access	access	NOUN
ajfti-2033	57	11	to	to	ADP
ajfti-2033	57	12	essential	essential	ADJ
ajfti-2033	57	13	medications	medication	NOUN
ajfti-2033	57	14	(	(	PUNCT
ajfti-2033	57	15	adebisi	adebisi	PROPN
ajfti-2033	57	16	et	et	PROPN
ajfti-2033	57	17	al	al	PROPN
ajfti-2033	57	18	.	.	PROPN
ajfti-2033	57	19	,	,	PUNCT
ajfti-2033	57	20	2022	2022	NUM
ajfti-2033	57	21	)	)	PUNCT
ajfti-2033	57	22	.	.	PUNCT
ajfti-2033	58	1	relationship	relationship	NOUN
ajfti-2033	58	2	between	between	ADP
ajfti-2033	58	3	drug	drug	NOUN
ajfti-2033	58	4	pricing	pricing	NOUN
ajfti-2033	58	5	and	and	CCONJ
ajfti-2033	58	6	insurance	insurance	NOUN
ajfti-2033	58	7	and	and	CCONJ
ajfti-2033	58	8	its	its	PRON
ajfti-2033	58	9	impact	impact	NOUN
ajfti-2033	58	10	on	on	ADP
ajfti-2033	58	11	medical	medical	ADJ
ajfti-2033	58	12	adherence	adherence	NOUN
ajfti-2033	58	13	the	the	DET
ajfti-2033	58	14	effect	effect	NOUN
ajfti-2033	58	15	of	of	ADP
ajfti-2033	58	16	prescription	prescription	NOUN
ajfti-2033	58	17	drug	drug	NOUN
ajfti-2033	58	18	pricing	pricing	NOUN
ajfti-2033	58	19	and	and	CCONJ
ajfti-2033	58	20	insurance	insurance	NOUN
ajfti-2033	58	21	coverage	coverage	NOUN
ajfti-2033	58	22	is	be	AUX
ajfti-2033	58	23	substantial	substantial	ADJ
ajfti-2033	58	24	in	in	ADP
ajfti-2033	58	25	saudi	saudi	PROPN
ajfti-2033	58	26	arabia	arabia	PROPN
ajfti-2033	58	27	’s	’s	PART
ajfti-2033	58	28	changing	change	VERB
ajfti-2033	58	29	healthcare	healthcare	NOUN
ajfti-2033	58	30	landscape	landscape	NOUN
ajfti-2033	58	31	.	.	PUNCT
ajfti-2033	59	1	patients	patient	NOUN
ajfti-2033	59	2	’	'	PUNCT
ajfti-2033	59	3	capacity	capacity	NOUN
ajfti-2033	59	4	to	to	PART
ajfti-2033	59	5	follow	follow	VERB
ajfti-2033	59	6	their	their	PRON
ajfti-2033	59	7	prescribed	prescribed	ADJ
ajfti-2033	59	8	medicine	medicine	NOUN
ajfti-2033	59	9	regimens	regimen	NOUN
ajfti-2033	59	10	depends	depend	VERB
ajfti-2033	59	11	largely	largely	ADV
ajfti-2033	59	12	on	on	ADP
ajfti-2033	59	13	their	their	PRON
ajfti-2033	59	14	financial	financial	ADJ
ajfti-2033	59	15	situation	situation	NOUN
ajfti-2033	59	16	(	(	PUNCT
ajfti-2033	59	17	emadi	emadi	VERB
ajfti-2033	59	18	et	et	PROPN
ajfti-2033	59	19	al	al	PROPN
ajfti-2033	59	20	.	.	PROPN
ajfti-2033	59	21	,	,	PUNCT
ajfti-2033	59	22	2022	2022	NUM
ajfti-2033	59	23	)	)	PUNCT
ajfti-2033	59	24	.	.	PUNCT
ajfti-2033	60	1	evidence	evidence	NOUN
ajfti-2033	60	2	supports	support	VERB
ajfti-2033	60	3	that	that	SCONJ
ajfti-2033	60	4	medication	medication	NOUN
ajfti-2033	60	5	prices	price	NOUN
ajfti-2033	60	6	,	,	PUNCT
ajfti-2033	60	7	insurance	insurance	NOUN
ajfti-2033	60	8	coverage	coverage	NOUN
ajfti-2033	60	9	,	,	PUNCT
ajfti-2033	60	10	and	and	CCONJ
ajfti-2033	60	11	adherence	adherence	NOUN
ajfti-2033	60	12	are	be	AUX
ajfti-2033	60	13	connected	connect	VERB
ajfti-2033	60	14	,	,	PUNCT
ajfti-2033	60	15	such	such	ADJ
ajfti-2033	60	16	as	as	ADP
ajfti-2033	60	17	the	the	DET
ajfti-2033	60	18	study	study	NOUN
ajfti-2033	60	19	by	by	ADP
ajfti-2033	60	20	smith	smith	PROPN
ajfti-2033	60	21	et	et	PROPN
ajfti-2033	60	22	al	al	PROPN
ajfti-2033	60	23	.	.	PROPN
ajfti-2033	60	24	,	,	PUNCT
ajfti-2033	60	25	(	(	PUNCT
ajfti-2033	60	26	2019	2019	NUM
ajfti-2033	60	27	)	)	PUNCT
ajfti-2033	60	28	,	,	PUNCT
ajfti-2033	60	29	stresses	stress	VERB
ajfti-2033	60	30	that	that	SCONJ
ajfti-2033	60	31	patients	patient	NOUN
ajfti-2033	60	32	who	who	PRON
ajfti-2033	60	33	experienced	experience	VERB
ajfti-2033	60	34	financial	financial	ADJ
ajfti-2033	60	35	constraints	constraint	NOUN
ajfti-2033	60	36	due	due	ADJ
ajfti-2033	60	37	to	to	ADP
ajfti-2033	60	38	limited	limited	ADJ
ajfti-2033	60	39	insurance	insurance	NOUN
ajfti-2033	60	40	coverage	coverage	NOUN
ajfti-2033	60	41	had	have	VERB
ajfti-2033	60	42	lower	low	ADJ
ajfti-2033	60	43	medication	medication	NOUN
ajfti-2033	60	44	adherence	adherence	NOUN
ajfti-2033	60	45	(	(	PUNCT
ajfti-2033	60	46	smith	smith	PROPN
ajfti-2033	60	47	et	et	PROPN
ajfti-2033	60	48	al	al	PROPN
ajfti-2033	60	49	.	.	PROPN
ajfti-2033	60	50	,	,	PUNCT
ajfti-2033	60	51	2019	2019	NUM
ajfti-2033	60	52	)	)	PUNCT
ajfti-2033	60	53	.	.	PUNCT
ajfti-2033	61	1	lifestyle	lifestyle	NOUN
ajfti-2033	61	2	factors	factor	NOUN
ajfti-2033	61	3	and	and	CCONJ
ajfti-2033	61	4	socio	socio	NOUN
ajfti-2033	61	5	-	-	PUNCT
ajfti-2033	61	6	economic	economic	ADJ
ajfti-2033	61	7	changes	change	NOUN
ajfti-2033	61	8	have	have	AUX
ajfti-2033	61	9	caused	cause	VERB
ajfti-2033	61	10	a	a	DET
ajfti-2033	61	11	notable	notable	ADJ
ajfti-2033	61	12	increase	increase	NOUN
ajfti-2033	61	13	in	in	ADP
ajfti-2033	61	14	the	the	DET
ajfti-2033	61	15	prevalence	prevalence	NOUN
ajfti-2033	61	16	of	of	ADP
ajfti-2033	61	17	chronic	chronic	ADJ
ajfti-2033	61	18	non	non	ADJ
ajfti-2033	61	19	-	-	ADJ
ajfti-2033	61	20	communicable	communicable	ADJ
ajfti-2033	61	21	diseases	disease	NOUN
ajfti-2033	61	22	such	such	ADJ
ajfti-2033	61	23	as	as	ADP
ajfti-2033	61	24	diabetes	diabetes	NOUN
ajfti-2033	61	25	and	and	CCONJ
ajfti-2033	61	26	cardiovascular	cardiovascular	ADJ
ajfti-2033	61	27	diseases	disease	NOUN
ajfti-2033	61	28	in	in	ADP
ajfti-2033	61	29	saudi	saudi	PROPN
ajfti-2033	61	30	arabia	arabia	PROPN
ajfti-2033	61	31	(	(	PUNCT
ajfti-2033	61	32	al	al	PROPN
ajfti-2033	61	33	-	-	PUNCT
ajfti-2033	61	34	hanawi	hanawi	PROPN
ajfti-2033	61	35	&	&	CCONJ
ajfti-2033	61	36	keetile	keetile	PROPN
ajfti-2033	61	37	,	,	PUNCT
ajfti-2033	61	38	2021	2021	NUM
ajfti-2033	61	39	)	)	PUNCT
ajfti-2033	61	40	,	,	PUNCT
ajfti-2033	61	41	.	.	PUNCT
ajfti-2033	62	1	managing	manage	VERB
ajfti-2033	62	2	diseases	disease	NOUN
ajfti-2033	62	3	via	via	ADP
ajfti-2033	62	4	medication	medication	NOUN
ajfti-2033	62	5	makes	make	VERB
ajfti-2033	62	6	non	non	ADJ
ajfti-2033	62	7	-	-	NOUN
ajfti-2033	62	8	adherence	adherence	VERB
ajfti-2033	62	9	a	a	DET
ajfti-2033	62	10	critical	critical	ADJ
ajfti-2033	62	11	problem	problem	NOUN
ajfti-2033	62	12	.	.	PUNCT
ajfti-2033	63	1	mohiuddin	mohiuddin	NOUN
ajfti-2033	63	2	,	,	PUNCT
ajfti-2033	63	3	(	(	PUNCT
ajfti-2033	63	4	2019	2019	NUM
ajfti-2033	63	5	)	)	PUNCT
ajfti-2033	63	6	found	find	VERB
ajfti-2033	63	7	that	that	SCONJ
ajfti-2033	63	8	approximately	approximately	ADV
ajfti-2033	63	9	60	60	NUM
ajfti-2033	63	10	%	%	NOUN
ajfti-2033	63	11	of	of	ADP
ajfti-2033	63	12	patients	patient	NOUN
ajfti-2033	63	13	with	with	ADP
ajfti-2033	63	14	chronic	chronic	ADJ
ajfti-2033	63	15	conditions	condition	NOUN
ajfti-2033	63	16	in	in	ADP
ajfti-2033	63	17	saudi	saudi	PROPN
ajfti-2033	63	18	arabia	arabia	PROPN
ajfti-2033	63	19	fail	fail	VERB
ajfti-2033	63	20	to	to	PART
ajfti-2033	63	21	comply	comply	VERB
ajfti-2033	63	22	with	with	ADP
ajfti-2033	63	23	medical	medical	ADJ
ajfti-2033	63	24	regimens	regimen	NOUN
ajfti-2033	63	25	.	.	PUNCT
ajfti-2033	64	1	the	the	DET
ajfti-2033	64	2	study	study	NOUN
ajfti-2033	64	3	has	have	AUX
ajfti-2033	64	4	also	also	ADV
ajfti-2033	64	5	noted	note	VERB
ajfti-2033	64	6	adverse	adverse	ADJ
ajfti-2033	64	7	effects	effect	NOUN
ajfti-2033	64	8	are	be	AUX
ajfti-2033	64	9	experienced	experience	VERB
ajfti-2033	64	10	at	at	ADP
ajfti-2033	64	11	both	both	CCONJ
ajfti-2033	64	12	the	the	DET
ajfti-2033	64	13	personal	personal	ADJ
ajfti-2033	64	14	and	and	CCONJ
ajfti-2033	64	15	communal	communal	ADJ
ajfti-2033	64	16	levels	level	NOUN
ajfti-2033	64	17	due	due	ADP
ajfti-2033	64	18	to	to	ADP
ajfti-2033	64	19	medication	medication	NOUN
ajfti-2033	64	20	adherence	adherence	NOUN
ajfti-2033	64	21	(	(	PUNCT
ajfti-2033	64	22	mohiuddin	mohiuddin	NOUN
ajfti-2033	64	23	,	,	PUNCT
ajfti-2033	64	24	2019	2019	NUM
ajfti-2033	64	25	)	)	PUNCT
ajfti-2033	64	26	.	.	PUNCT
ajfti-2033	65	1	emadi	emadi	PROPN
ajfti-2033	65	2	et	et	PROPN
ajfti-2033	65	3	al	al	PROPN
ajfti-2033	65	4	.	.	PROPN
ajfti-2033	66	1	(	(	PUNCT
ajfti-2033	66	2	2022	2022	NUM
ajfti-2033	66	3	)	)	PUNCT
ajfti-2033	66	4	highlight	highlight	VERB
ajfti-2033	66	5	that	that	SCONJ
ajfti-2033	66	6	individuals	individual	NOUN
ajfti-2033	66	7	may	may	AUX
ajfti-2033	66	8	suffer	suffer	VERB
ajfti-2033	66	9	from	from	ADP
ajfti-2033	66	10	uncontrolled	uncontrolled	ADJ
ajfti-2033	66	11	disease	disease	NOUN
ajfti-2033	66	12	progression	progression	NOUN
ajfti-2033	66	13	,	,	PUNCT
ajfti-2033	66	14	resulting	result	VERB
ajfti-2033	66	15	in	in	ADP
ajfti-2033	66	16	higher	high	ADJ
ajfti-2033	66	17	morbidity	morbidity	NOUN
ajfti-2033	66	18	and	and	CCONJ
ajfti-2033	66	19	mortality	mortality	NOUN
ajfti-2033	66	20	rates	rate	NOUN
ajfti-2033	66	21	(	(	PUNCT
ajfti-2033	66	22	emadi	emadi	PROPN
ajfti-2033	66	23	et	et	PROPN
ajfti-2033	66	24	al	al	PROPN
ajfti-2033	66	25	.	.	PROPN
ajfti-2033	66	26	,	,	PUNCT
ajfti-2033	66	27	2022	2022	NUM
ajfti-2033	66	28	)	)	PUNCT
ajfti-2033	66	29	.	.	PUNCT
ajfti-2033	67	1	according	accord	VERB
ajfti-2033	67	2	to	to	ADP
ajfti-2033	67	3	anderson	anderson	PROPN
ajfti-2033	67	4	et	et	PROPN
ajfti-2033	67	5	al	al	PROPN
ajfti-2033	67	6	.	.	PUNCT
ajfti-2033	68	1	the	the	DET
ajfti-2033	68	2	potential	potential	NOUN
ajfti-2033	68	3	for	for	ADP
ajfti-2033	68	4	preventable	preventable	ADJ
ajfti-2033	68	5	hospitalisations	hospitalisation	NOUN
ajfti-2033	68	6	and	and	CCONJ
ajfti-2033	68	7	complications	complication	NOUN
ajfti-2033	68	8	has	have	VERB
ajfti-2033	68	9	significant	significant	ADJ
ajfti-2033	68	10	consequences	consequence	NOUN
ajfti-2033	68	11	at	at	ADP
ajfti-2033	68	12	the	the	DET
ajfti-2033	68	13	societal	societal	ADJ
ajfti-2033	68	14	level	level	NOUN
ajfti-2033	68	15	(	(	PUNCT
ajfti-2033	68	16	anderson	anderson	PROPN
ajfti-2033	68	17	et	et	PROPN
ajfti-2033	68	18	al	al	PROPN
ajfti-2033	68	19	.	.	PROPN
ajfti-2033	68	20	,	,	PUNCT
ajfti-2033	68	21	2020	2020	NUM
ajfti-2033	68	22	)	)	PUNCT
ajfti-2033	68	23	.	.	PUNCT
ajfti-2033	69	1	approximately	approximately	ADV
ajfti-2033	69	2	13.5	13.5	NUM
ajfti-2033	69	3	billion	billion	NUM
ajfti-2033	69	4	saudi	saudi	ADJ
ajfti-2033	69	5	riyals	riyal	NOUN
ajfti-2033	69	6	(	(	PUNCT
ajfti-2033	69	7	$	$	SYM
ajfti-2033	69	8	3.6	3.6	NUM
ajfti-2033	69	9	billion	billion	NUM
ajfti-2033	69	10	)	)	PUNCT
ajfti-2033	69	11	more	more	ADJ
ajfti-2033	69	12	was	be	AUX
ajfti-2033	69	13	added	add	VERB
ajfti-2033	69	14	by	by	ADP
ajfti-2033	69	15	non	non	ADJ
ajfti-2033	69	16	-	-	NOUN
ajfti-2033	69	17	adherence	adherence	NOUN
ajfti-2033	69	18	to	to	ADP
ajfti-2033	69	19	medical	medical	ADJ
ajfti-2033	69	20	therapies	therapy	NOUN
ajfti-2033	69	21	,	,	PUNCT
ajfti-2033	69	22	as	as	SCONJ
ajfti-2033	69	23	reported	report	VERB
ajfti-2033	69	24	by	by	ADP
ajfti-2033	69	25	saudi	saudi	PROPN
ajfti-2033	69	26	aramco	aramco	PROPN
ajfti-2033	69	27	,	,	PUNCT
ajfti-2033	69	28	(	(	PUNCT
ajfti-2033	69	29	2023	2023	NUM
ajfti-2033	69	30	)	)	PUNCT
ajfti-2033	69	31	.	.	PUNCT
ajfti-2033	70	1	these	these	DET
ajfti-2033	70	2	statistics	statistic	NOUN
ajfti-2033	70	3	showcase	showcase	PROPN
ajfti-2033	70	4	,	,	PUNCT
ajfti-2033	70	5	non	non	ADJ
ajfti-2033	70	6	-	-	NOUN
ajfti-2033	70	7	adherence	adherence	NOUN
ajfti-2033	70	8	in	in	ADP
ajfti-2033	70	9	the	the	DET
ajfti-2033	70	10	saudi	saudi	PROPN
ajfti-2033	70	11	healthcare	healthcare	PROPN
ajfti-2033	70	12	ecosystem	ecosystem	NOUN
ajfti-2033	70	13	demands	demand	VERB
ajfti-2033	70	14	immediate	immediate	ADJ
ajfti-2033	70	15	attention	attention	NOUN
ajfti-2033	70	16	(	(	PUNCT
ajfti-2033	70	17	aramco	aramco	PROPN
ajfti-2033	70	18	,	,	PUNCT
ajfti-2033	70	19	2023	2023	NUM
ajfti-2033	70	20	)	)	PUNCT
ajfti-2033	70	21	.	.	PUNCT
ajfti-2033	71	1	evidence	evidence	NOUN
ajfti-2033	71	2	-	-	PUNCT
ajfti-2033	71	3	based	base	VERB
ajfti-2033	71	4	approaches	approach	NOUN
ajfti-2033	71	5	for	for	ADP
ajfti-2033	71	6	enhancing	enhance	VERB
ajfti-2033	71	7	medical	medical	ADJ
ajfti-2033	71	8	adherence	adherence	NOUN
ajfti-2033	71	9	evidence	evidence	NOUN
ajfti-2033	71	10	-	-	PUNCT
ajfti-2033	71	11	based	base	VERB
ajfti-2033	71	12	methods	method	NOUN
ajfti-2033	71	13	are	be	AUX
ajfti-2033	71	14	essential	essential	ADJ
ajfti-2033	71	15	to	to	PART
ajfti-2033	71	16	promote	promote	VERB
ajfti-2033	71	17	adherence	adherence	NOUN
ajfti-2033	71	18	among	among	ADP
ajfti-2033	71	19	the	the	DET
ajfti-2033	71	20	saudi	saudi	ADJ
ajfti-2033	71	21	population	population	NOUN
ajfti-2033	71	22	,	,	PUNCT
ajfti-2033	71	23	and	and	CCONJ
ajfti-2033	71	24	understanding	understand	VERB
ajfti-2033	71	25	how	how	SCONJ
ajfti-2033	71	26	drug	drug	NOUN
ajfti-2033	71	27	pricing	pricing	NOUN
ajfti-2033	71	28	and	and	CCONJ
ajfti-2033	71	29	coverage	coverage	NOUN
ajfti-2033	71	30	contribute	contribute	VERB
ajfti-2033	71	31	to	to	ADP
ajfti-2033	71	32	this	this	PRON
ajfti-2033	71	33	is	be	AUX
ajfti-2033	71	34	vital	vital	ADJ
ajfti-2033	71	35	.	.	PUNCT
ajfti-2033	72	1	value	value	NOUN
ajfti-2033	72	2	-	-	PUNCT
ajfti-2033	72	3	based	base	VERB
ajfti-2033	72	4	pricing	pricing	NOUN
ajfti-2033	72	5	models	model	NOUN
ajfti-2033	72	6	gaining	gain	VERB
ajfti-2033	72	7	favor	favor	NOUN
ajfti-2033	72	8	,	,	PUNCT
ajfti-2033	72	9	value	value	NOUN
ajfti-2033	72	10	-	-	PUNCT
ajfti-2033	72	11	based	base	VERB
ajfti-2033	72	12	pricing	pricing	NOUN
ajfti-2033	72	13	models	model	NOUN
ajfti-2033	72	14	now	now	ADV
ajfti-2033	72	15	prioritise	prioritise	VERB
ajfti-2033	72	16	drug	drug	NOUN
ajfti-2033	72	17	price	price	NOUN
ajfti-2033	72	18	alignment	alignment	NOUN
ajfti-2033	72	19	with	with	ADP
ajfti-2033	72	20	therapeutic	therapeutic	ADJ
ajfti-2033	72	21	value	value	NOUN
ajfti-2033	72	22	.	.	PUNCT
ajfti-2033	73	1	according	accord	VERB
ajfti-2033	73	2	to	to	ADP
ajfti-2033	73	3	stecker	stecker	NOUN
ajfti-2033	73	4	et	et	PROPN
ajfti-2033	73	5	al	al	PROPN
ajfti-2033	73	6	.	.	PROPN
ajfti-2033	74	1	(	(	PUNCT
ajfti-2033	74	2	2015	2015	NUM
ajfti-2033	74	3	)	)	PUNCT
ajfti-2033	74	4	,	,	PUNCT
ajfti-2033	74	5	determining	determine	VERB
ajfti-2033	74	6	the	the	DET
ajfti-2033	74	7	cost	cost	NOUN
ajfti-2033	74	8	of	of	ADP
ajfti-2033	74	9	a	a	DET
ajfti-2033	74	10	medication	medication	NOUN
ajfti-2033	74	11	involves	involve	VERB
ajfti-2033	74	12	considering	consider	VERB
ajfti-2033	74	13	factors	factor	NOUN
ajfti-2033	74	14	including	include	VERB
ajfti-2033	74	15	efficacy	efficacy	NOUN
ajfti-2033	74	16	,	,	PUNCT
ajfti-2033	74	17	safety	safety	NOUN
ajfti-2033	74	18	,	,	PUNCT
ajfti-2033	74	19	and	and	CCONJ
ajfti-2033	74	20	alternative	alternative	ADJ
ajfti-2033	74	21	treatments	treatment	NOUN
ajfti-2033	74	22	(	(	PUNCT
ajfti-2033	74	23	stecker	stecker	NOUN
ajfti-2033	74	24	et	et	PROPN
ajfti-2033	74	25	al	al	PROPN
ajfti-2033	74	26	.	.	PROPN
ajfti-2033	74	27	,	,	PUNCT
ajfti-2033	74	28	2015	2015	NUM
ajfti-2033	74	29	)	)	PUNCT
ajfti-2033	74	30	.	.	PUNCT
ajfti-2033	75	1	alignment	alignment	NOUN
ajfti-2033	75	2	with	with	ADP
ajfti-2033	75	3	their	their	PRON
ajfti-2033	75	4	benefits	benefit	NOUN
ajfti-2033	75	5	and	and	CCONJ
ajfti-2033	75	6	subsequent	subsequent	ADJ
ajfti-2033	75	7	cost	cost	NOUN
ajfti-2033	75	8	reduction	reduction	NOUN
ajfti-2033	75	9	is	be	AUX
ajfti-2033	75	10	what	what	PRON
ajfti-2033	75	11	patients	patient	NOUN
ajfti-2033	75	12	may	may	AUX
ajfti-2033	75	13	see	see	VERB
ajfti-2033	75	14	by	by	ADP
ajfti-2033	75	15	implementing	implement	VERB
ajfti-2033	75	16	value	value	NOUN
ajfti-2033	75	17	-	-	PUNCT
ajfti-2033	75	18	based	base	VERB
ajfti-2033	75	19	pricing	pricing	NOUN
ajfti-2033	75	20	in	in	ADP
ajfti-2033	75	21	saudi	saudi	PROPN
ajfti-2033	75	22	arabia	arabia	PROPN
ajfti-2033	75	23	.	.	PUNCT
ajfti-2033	76	1	increasing	increase	VERB
ajfti-2033	76	2	price	price	NOUN
ajfti-2033	76	3	transparency	transparency	NOUN
ajfti-2033	76	4	in	in	ADP
ajfti-2033	76	5	addition	addition	NOUN
ajfti-2033	76	6	to	to	ADP
ajfti-2033	76	7	other	other	ADJ
ajfti-2033	76	8	factors	factor	NOUN
ajfti-2033	76	9	,	,	PUNCT
ajfti-2033	76	10	price	price	NOUN
ajfti-2033	76	11	transparency	transparency	NOUN
ajfti-2033	76	12	is	be	AUX
ajfti-2033	76	13	vital	vital	ADJ
ajfti-2033	76	14	in	in	ADP
ajfti-2033	76	15	controlling	control	VERB
ajfti-2033	76	16	medication	medication	NOUN
ajfti-2033	76	17	costs	cost	NOUN
ajfti-2033	76	18	.	.	PUNCT
ajfti-2033	77	1	transparency	transparency	NOUN
ajfti-2033	77	2	in	in	ADP
ajfti-2033	77	3	pricing	price	VERB
ajfti-2033	77	4	assures	assure	VERB
ajfti-2033	77	5	decision	decision	NOUN
ajfti-2033	77	6	-	-	PUNCT
ajfti-2033	77	7	making	making	NOUN
ajfti-2033	77	8	across	across	ADP
ajfti-2033	77	9	all	all	DET
ajfti-2033	77	10	groups	group	NOUN
ajfti-2033	77	11	for	for	ADP
ajfti-2033	77	12	medication	medication	NOUN
ajfti-2033	77	13	choices	choice	NOUN
ajfti-2033	77	14	and	and	CCONJ
ajfti-2033	77	15	coverage	coverage	NOUN
ajfti-2033	77	16	(	(	PUNCT
ajfti-2033	77	17	godman	godman	NOUN
ajfti-2033	77	18	et	et	NOUN
ajfti-2033	77	19	al	al	PROPN
ajfti-2033	77	20	.	.	PROPN
ajfti-2033	77	21	,	,	PUNCT
ajfti-2033	77	22	2021	2021	NUM
ajfti-2033	77	23	)	)	PUNCT
ajfti-2033	77	24	.	.	PUNCT
ajfti-2033	78	1	saudi	saudi	PROPN
ajfti-2033	78	2	arabia	arabia	PROPN
ajfti-2033	78	3	’s	’s	PART
ajfti-2033	78	4	increased	increase	VERB
ajfti-2033	78	5	price	price	NOUN
ajfti-2033	78	6	openness	openness	NOUN
ajfti-2033	78	7	paves	pave	VERB
ajfti-2033	78	8	the	the	DET
ajfti-2033	78	9	way	way	NOUN
ajfti-2033	78	10	for	for	ADP
ajfti-2033	78	11	pharmaceutical	pharmaceutical	ADJ
ajfti-2033	78	12	company	company	NOUN
ajfti-2033	78	13	competition	competition	NOUN
ajfti-2033	78	14	,	,	PUNCT
ajfti-2033	78	15	resulting	result	VERB
ajfti-2033	78	16	in	in	ADP
ajfti-2033	78	17	more	more	ADJ
ajfti-2033	78	18	affordable	affordable	ADJ
ajfti-2033	78	19	drugs	drug	NOUN
ajfti-2033	78	20	.	.	PUNCT
ajfti-2033	79	1	pa	pa	PROPN
ajfti-2033	79	2	ge	ge	PROPN
ajfti-2033	79	3	26	26	NUM
ajfti-2033	79	4	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	PROPN
ajfti-2033	79	5	am	be	AUX
ajfti-2033	79	6	.	.	PUNCT
ajfti-2033	80	1	j.	j.	PROPN
ajfti-2033	80	2	financ	financ	PROPN
ajfti-2033	80	3	.	.	PUNCT
ajfti-2033	81	1	technol	technol	PROPN
ajfti-2033	81	2	.	.	PUNCT
ajfti-2033	81	3	innov	innov	PROPN
ajfti-2033	81	4	.	.	PUNCT
ajfti-2033	82	1	1(1	1(1	NUM
ajfti-2033	82	2	)	)	PUNCT
ajfti-2033	82	3	24	24	NUM
ajfti-2033	82	4	-	-	SYM
ajfti-2033	82	5	34	34	NUM
ajfti-2033	82	6	,	,	PUNCT
ajfti-2033	82	7	2023	2023	NUM
ajfti-2033	82	8	expanding	expand	VERB
ajfti-2033	82	9	insurance	insurance	NOUN
ajfti-2033	82	10	coverage	coverage	NOUN
ajfti-2033	82	11	expanding	expand	VERB
ajfti-2033	82	12	insurance	insurance	NOUN
ajfti-2033	82	13	coverage	coverage	NOUN
ajfti-2033	82	14	is	be	AUX
ajfti-2033	82	15	crucial	crucial	ADJ
ajfti-2033	82	16	to	to	PART
ajfti-2033	82	17	achieve	achieve	VERB
ajfti-2033	82	18	medication	medication	NOUN
ajfti-2033	82	19	availability	availability	NOUN
ajfti-2033	82	20	for	for	ADP
ajfti-2033	82	21	all	all	PRON
ajfti-2033	82	22	.	.	PUNCT
ajfti-2033	83	1	cairney	cairney	NOUN
ajfti-2033	83	2	and	and	CCONJ
ajfti-2033	83	3	oliver	oliver	PROPN
ajfti-2033	83	4	(	(	PUNCT
ajfti-2033	83	5	2017	2017	NUM
ajfti-2033	83	6	)	)	PUNCT
ajfti-2033	83	7	suggest	suggest	VERB
ajfti-2033	83	8	that	that	SCONJ
ajfti-2033	83	9	policymakers	policymaker	NOUN
ajfti-2033	83	10	in	in	ADP
ajfti-2033	83	11	saudi	saudi	PROPN
ajfti-2033	83	12	arabia	arabia	PROPN
ajfti-2033	83	13	should	should	AUX
ajfti-2033	83	14	focus	focus	VERB
ajfti-2033	83	15	on	on	ADP
ajfti-2033	83	16	expanding	expand	VERB
ajfti-2033	83	17	public	public	ADJ
ajfti-2033	83	18	health	health	NOUN
ajfti-2033	83	19	insurance	insurance	NOUN
ajfti-2033	83	20	systems	system	NOUN
ajfti-2033	83	21	while	while	SCONJ
ajfti-2033	83	22	offering	offer	VERB
ajfti-2033	83	23	financial	financial	ADJ
ajfti-2033	83	24	support	support	NOUN
ajfti-2033	83	25	to	to	ADP
ajfti-2033	83	26	low	low	ADJ
ajfti-2033	83	27	-	-	PUNCT
ajfti-2033	83	28	income	income	NOUN
ajfti-2033	83	29	individuals	individual	NOUN
ajfti-2033	83	30	and	and	CCONJ
ajfti-2033	83	31	ensuring	ensure	VERB
ajfti-2033	83	32	that	that	SCONJ
ajfti-2033	83	33	insurance	insurance	NOUN
ajfti-2033	83	34	companies	company	NOUN
ajfti-2033	83	35	include	include	VERB
ajfti-2033	83	36	comprehensive	comprehensive	ADJ
ajfti-2033	83	37	prescription	prescription	NOUN
ajfti-2033	83	38	coverage	coverage	NOUN
ajfti-2033	83	39	in	in	ADP
ajfti-2033	83	40	their	their	PRON
ajfti-2033	83	41	policies	policy	NOUN
ajfti-2033	83	42	(	(	PUNCT
ajfti-2033	83	43	cairney	cairney	NOUN
ajfti-2033	83	44	&	&	CCONJ
ajfti-2033	83	45	oliver	oliver	PROPN
ajfti-2033	83	46	,	,	PUNCT
ajfti-2033	83	47	2017	2017	NUM
ajfti-2033	83	48	)	)	PUNCT
ajfti-2033	83	49	.	.	PUNCT
ajfti-2033	84	1	through	through	ADP
ajfti-2033	84	2	these	these	DET
ajfti-2033	84	3	measures	measure	NOUN
ajfti-2033	84	4	,	,	PUNCT
ajfti-2033	84	5	the	the	DET
ajfti-2033	84	6	gap	gap	NOUN
ajfti-2033	84	7	in	in	ADP
ajfti-2033	84	8	insurance	insurance	NOUN
ajfti-2033	84	9	coverage	coverage	NOUN
ajfti-2033	84	10	can	can	AUX
ajfti-2033	84	11	be	be	AUX
ajfti-2033	84	12	closed	close	VERB
ajfti-2033	84	13	,	,	PUNCT
ajfti-2033	84	14	resulting	result	VERB
ajfti-2033	84	15	in	in	ADP
ajfti-2033	84	16	increased	increase	VERB
ajfti-2033	84	17	accessibility	accessibility	NOUN
ajfti-2033	84	18	to	to	ADP
ajfti-2033	84	19	medications	medication	NOUN
ajfti-2033	84	20	for	for	ADP
ajfti-2033	84	21	the	the	DET
ajfti-2033	84	22	public	public	NOUN
ajfti-2033	84	23	(	(	PUNCT
ajfti-2033	84	24	knapp	knapp	PROPN
ajfti-2033	84	25	&	&	CCONJ
ajfti-2033	84	26	wong	wong	PROPN
ajfti-2033	84	27	,	,	PUNCT
ajfti-2033	84	28	2020	2020	NUM
ajfti-2033	84	29	)	)	PUNCT
ajfti-2033	84	30	.	.	PUNCT
ajfti-2033	85	1	healthcare	healthcare	PROPN
ajfti-2033	85	2	provider	provider	NOUN
ajfti-2033	85	3	interventions	intervention	NOUN
ajfti-2033	85	4	healthcare	healthcare	NOUN
ajfti-2033	85	5	providers	provider	NOUN
ajfti-2033	85	6	have	have	VERB
ajfti-2033	85	7	a	a	DET
ajfti-2033	85	8	significant	significant	ADJ
ajfti-2033	85	9	role	role	NOUN
ajfti-2033	85	10	in	in	ADP
ajfti-2033	85	11	ma	ma	PROPN
ajfti-2033	85	12	,	,	PUNCT
ajfti-2033	85	13	including	include	VERB
ajfti-2033	85	14	selecting	select	VERB
ajfti-2033	85	15	economical	economical	ADJ
ajfti-2033	85	16	treatment	treatment	NOUN
ajfti-2033	85	17	options	option	NOUN
ajfti-2033	85	18	,	,	PUNCT
ajfti-2033	85	19	considering	consider	VERB
ajfti-2033	85	20	patients	patient	NOUN
ajfti-2033	85	21	’	'	PUNCT
ajfti-2033	85	22	financial	financial	ADJ
ajfti-2033	85	23	conditions	condition	NOUN
ajfti-2033	85	24	,	,	PUNCT
ajfti-2033	85	25	and	and	CCONJ
ajfti-2033	85	26	collaborating	collaborate	VERB
ajfti-2033	85	27	with	with	ADP
ajfti-2033	85	28	patients	patient	NOUN
ajfti-2033	85	29	in	in	ADP
ajfti-2033	85	30	shared	shared	ADJ
ajfti-2033	85	31	decision	decision	NOUN
ajfti-2033	85	32	-	-	PUNCT
ajfti-2033	85	33	making	making	NOUN
ajfti-2033	85	34	to	to	PART
ajfti-2033	85	35	overcome	overcome	VERB
ajfti-2033	85	36	adherence	adherence	NOUN
ajfti-2033	85	37	challenges	challenge	NOUN
ajfti-2033	85	38	(	(	PUNCT
ajfti-2033	85	39	ahmed	ahmed	PROPN
ajfti-2033	85	40	et	et	PROPN
ajfti-2033	85	41	al	al	PROPN
ajfti-2033	85	42	.	.	PROPN
ajfti-2033	85	43	,	,	PUNCT
ajfti-2033	85	44	2018	2018	NUM
ajfti-2033	85	45	)	)	PUNCT
ajfti-2033	85	46	(	(	PUNCT
ajfti-2033	85	47	ahmed	ahmed	PROPN
ajfti-2033	85	48	et	et	PROPN
ajfti-2033	85	49	al	al	PROPN
ajfti-2033	85	50	.	.	PROPN
ajfti-2033	85	51	,	,	PUNCT
ajfti-2033	85	52	2018	2018	NUM
ajfti-2033	85	53	)	)	PUNCT
ajfti-2033	85	54	.	.	PUNCT
ajfti-2033	86	1	following	follow	VERB
ajfti-2033	86	2	al	al	PROPN
ajfti-2033	86	3	jeraisy	jeraisy	PROPN
ajfti-2033	86	4	et	et	PROPN
ajfti-2033	86	5	al	al	PROPN
ajfti-2033	86	6	.	.	PROPN
ajfti-2033	87	1	(	(	PUNCT
ajfti-2033	87	2	2023	2023	NUM
ajfti-2033	87	3	)	)	PUNCT
ajfti-2033	87	4	lead	lead	NOUN
ajfti-2033	87	5	,	,	PUNCT
ajfti-2033	87	6	they	they	PRON
ajfti-2033	87	7	help	help	VERB
ajfti-2033	87	8	ease	ease	VERB
ajfti-2033	87	9	the	the	DET
ajfti-2033	87	10	financial	financial	ADJ
ajfti-2033	87	11	pressure	pressure	NOUN
ajfti-2033	87	12	on	on	ADP
ajfti-2033	87	13	patients	patient	NOUN
ajfti-2033	87	14	by	by	ADP
ajfti-2033	87	15	coordinating	coordinate	VERB
ajfti-2033	87	16	their	their	PRON
ajfti-2033	87	17	access	access	NOUN
ajfti-2033	87	18	to	to	ADP
ajfti-2033	87	19	assistance	assistance	NOUN
ajfti-2033	87	20	programs	program	NOUN
ajfti-2033	87	21	(	(	PUNCT
ajfti-2033	87	22	al	al	PROPN
ajfti-2033	87	23	jeraisy	jeraisy	PROPN
ajfti-2033	87	24	et	et	PROPN
ajfti-2033	87	25	al	al	PROPN
ajfti-2033	87	26	.	.	PROPN
ajfti-2033	87	27	,	,	PUNCT
ajfti-2033	87	28	2023	2023	NUM
ajfti-2033	87	29	)	)	PUNCT
ajfti-2033	87	30	.	.	PUNCT
ajfti-2033	88	1	government	government	NOUN
ajfti-2033	88	2	initiatives	initiative	NOUN
ajfti-2033	88	3	it	it	PRON
ajfti-2033	88	4	is	be	AUX
ajfti-2033	88	5	pertinent	pertinent	ADJ
ajfti-2033	88	6	for	for	SCONJ
ajfti-2033	88	7	policymakers	policymaker	NOUN
ajfti-2033	88	8	to	to	PART
ajfti-2033	88	9	create	create	VERB
ajfti-2033	88	10	laws	law	NOUN
ajfti-2033	88	11	that	that	PRON
ajfti-2033	88	12	restrain	restrain	VERB
ajfti-2033	88	13	drug	drug	NOUN
ajfti-2033	88	14	costs	cost	NOUN
ajfti-2033	88	15	,	,	PUNCT
ajfti-2033	88	16	promote	promote	VERB
ajfti-2033	88	17	competition	competition	NOUN
ajfti-2033	88	18	in	in	ADP
ajfti-2033	88	19	the	the	DET
ajfti-2033	88	20	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	88	21	business	business	NOUN
ajfti-2033	88	22	,	,	PUNCT
ajfti-2033	88	23	and	and	CCONJ
ajfti-2033	88	24	guarantee	guarantee	VERB
ajfti-2033	88	25	price	price	NOUN
ajfti-2033	88	26	negotiations	negotiation	NOUN
ajfti-2033	88	27	for	for	ADP
ajfti-2033	88	28	prescription	prescription	NOUN
ajfti-2033	88	29	medications	medication	NOUN
ajfti-2033	88	30	.	.	PUNCT
ajfti-2033	89	1	according	accord	VERB
ajfti-2033	89	2	to	to	ADP
ajfti-2033	89	3	sanders	sanders	PROPN
ajfti-2033	89	4	et	et	PROPN
ajfti-2033	89	5	al	al	PROPN
ajfti-2033	89	6	.	.	PUNCT
ajfti-2033	90	1	(	(	PUNCT
ajfti-2033	90	2	2016	2016	NUM
ajfti-2033	90	3	)	)	PUNCT
ajfti-2033	90	4	,	,	PUNCT
ajfti-2033	90	5	tax	tax	NOUN
ajfti-2033	90	6	breaks	break	NOUN
ajfti-2033	90	7	may	may	AUX
ajfti-2033	90	8	be	be	AUX
ajfti-2033	90	9	offered	offer	VERB
ajfti-2033	90	10	to	to	PART
ajfti-2033	90	11	reduce	reduce	VERB
ajfti-2033	90	12	patients	patient	NOUN
ajfti-2033	90	13	’	'	PUNCT
ajfti-2033	90	14	financial	financial	ADJ
ajfti-2033	90	15	responsibilities	responsibility	NOUN
ajfti-2033	90	16	.	.	PUNCT
ajfti-2033	91	1	multistakeholder	multistakeholder	NOUN
ajfti-2033	91	2	collaboration	collaboration	NOUN
ajfti-2033	91	3	multiple	multiple	ADJ
ajfti-2033	91	4	stakeholders	stakeholder	NOUN
ajfti-2033	91	5	must	must	AUX
ajfti-2033	91	6	work	work	VERB
ajfti-2033	91	7	together	together	ADV
ajfti-2033	91	8	,	,	PUNCT
ajfti-2033	91	9	and	and	CCONJ
ajfti-2033	91	10	lastly	lastly	ADV
ajfti-2033	91	11	.	.	PUNCT
ajfti-2033	92	1	findings	finding	NOUN
ajfti-2033	92	2	from	from	ADP
ajfti-2033	92	3	ding	ding	PROPN
ajfti-2033	92	4	et	et	PROPN
ajfti-2033	92	5	al	al	PROPN
ajfti-2033	92	6	.	.	PROPN
ajfti-2033	93	1	(	(	PUNCT
ajfti-2033	93	2	2022	2022	NUM
ajfti-2033	93	3	)	)	PUNCT
ajfti-2033	93	4	underscore	underscore	VERB
ajfti-2033	93	5	the	the	DET
ajfti-2033	93	6	importance	importance	NOUN
ajfti-2033	93	7	of	of	ADP
ajfti-2033	93	8	cooperative	cooperative	ADJ
ajfti-2033	93	9	efforts	effort	NOUN
ajfti-2033	93	10	from	from	ADP
ajfti-2033	93	11	all	all	DET
ajfti-2033	93	12	parties	party	NOUN
ajfti-2033	93	13	concerned	concerned	ADJ
ajfti-2033	93	14	patients	patient	NOUN
ajfti-2033	93	15	,	,	PUNCT
ajfti-2033	93	16	healthcare	healthcare	PROPN
ajfti-2033	93	17	professionals	professional	NOUN
ajfti-2033	93	18	,	,	PUNCT
ajfti-2033	93	19	insurers	insurer	NOUN
ajfti-2033	93	20	,	,	PUNCT
ajfti-2033	93	21	pharmaceutical	pharmaceutical	ADJ
ajfti-2033	93	22	companies	company	NOUN
ajfti-2033	93	23	,	,	PUNCT
ajfti-2033	93	24	and	and	CCONJ
ajfti-2033	93	25	policymakers	policymaker	NOUN
ajfti-2033	93	26	when	when	SCONJ
ajfti-2033	93	27	it	it	PRON
ajfti-2033	93	28	comes	come	VERB
ajfti-2033	93	29	to	to	ADP
ajfti-2033	93	30	enhancing	enhance	VERB
ajfti-2033	93	31	adherence	adherence	NOUN
ajfti-2033	93	32	and	and	CCONJ
ajfti-2033	93	33	overcoming	overcome	VERB
ajfti-2033	93	34	economic	economic	ADJ
ajfti-2033	93	35	obstacles	obstacle	NOUN
ajfti-2033	93	36	.	.	PUNCT
ajfti-2033	94	1	intertwined	intertwine	VERB
ajfti-2033	94	2	factors	factor	NOUN
ajfti-2033	94	3	of	of	ADP
ajfti-2033	94	4	drug	drug	NOUN
ajfti-2033	94	5	pricing	pricing	NOUN
ajfti-2033	94	6	,	,	PUNCT
ajfti-2033	94	7	insurance	insurance	NOUN
ajfti-2033	94	8	coverage	coverage	NOUN
ajfti-2033	94	9	,	,	PUNCT
ajfti-2033	94	10	and	and	CCONJ
ajfti-2033	94	11	medication	medication	NOUN
ajfti-2033	94	12	adherence	adherence	NOUN
ajfti-2033	94	13	necessitate	necessitate	ADJ
ajfti-2033	94	14	harmonious	harmonious	ADJ
ajfti-2033	94	15	coordination	coordination	NOUN
ajfti-2033	94	16	between	between	ADP
ajfti-2033	94	17	these	these	DET
ajfti-2033	94	18	parties	party	NOUN
ajfti-2033	94	19	for	for	ADP
ajfti-2033	94	20	effective	effective	ADJ
ajfti-2033	94	21	resolution	resolution	NOUN
ajfti-2033	94	22	(	(	PUNCT
ajfti-2033	94	23	kanyongo	kanyongo	PROPN
ajfti-2033	94	24	&	&	CCONJ
ajfti-2033	94	25	ezugwu	ezugwu	PROPN
ajfti-2033	94	26	,	,	PUNCT
ajfti-2033	94	27	2023	2023	NUM
ajfti-2033	94	28	)	)	PUNCT
ajfti-2033	94	29	.	.	PUNCT
ajfti-2033	95	1	hypothesis	hypothesis	NOUN
ajfti-2033	95	2	the	the	DET
ajfti-2033	95	3	following	follow	VERB
ajfti-2033	95	4	hypothesis	hypothesis	NOUN
ajfti-2033	95	5	has	have	AUX
ajfti-2033	95	6	been	be	AUX
ajfti-2033	95	7	formed	form	VERB
ajfti-2033	95	8	by	by	ADP
ajfti-2033	95	9	examining	examine	VERB
ajfti-2033	95	10	the	the	DET
ajfti-2033	95	11	relationship	relationship	NOUN
ajfti-2033	95	12	between	between	ADP
ajfti-2033	95	13	medical	medical	ADJ
ajfti-2033	95	14	adherence	adherence	NOUN
ajfti-2033	95	15	and	and	CCONJ
ajfti-2033	95	16	drug	drug	NOUN
ajfti-2033	95	17	prices	price	NOUN
ajfti-2033	95	18	and	and	CCONJ
ajfti-2033	95	19	the	the	DET
ajfti-2033	95	20	influence	influence	NOUN
ajfti-2033	95	21	of	of	ADP
ajfti-2033	95	22	medical	medical	ADJ
ajfti-2033	95	23	insurance	insurance	NOUN
ajfti-2033	95	24	.	.	PUNCT
ajfti-2033	96	1	hypothesis	hypothesis	NOUN
ajfti-2033	96	2	1	1	NUM
ajfti-2033	96	3	h1a	h1a	NOUN
ajfti-2033	96	4	:	:	PUNCT
ajfti-2033	96	5	high	high	ADJ
ajfti-2033	96	6	medicine	medicine	NOUN
ajfti-2033	96	7	prices	price	NOUN
ajfti-2033	96	8	negatively	negatively	ADV
ajfti-2033	96	9	impact	impact	VERB
ajfti-2033	96	10	ma	ma	PROPN
ajfti-2033	96	11	in	in	ADP
ajfti-2033	96	12	saudi	saudi	PROPN
ajfti-2033	96	13	arabia	arabia	PROPN
ajfti-2033	96	14	.	.	PUNCT
ajfti-2033	97	1	hypothesis	hypothesis	NOUN
ajfti-2033	97	2	2	2	NUM
ajfti-2033	97	3	h2a	h2a	NOUN
ajfti-2033	97	4	:	:	PUNCT
ajfti-2033	97	5	lower	low	ADJ
ajfti-2033	97	6	ma	ma	PROPN
ajfti-2033	97	7	in	in	ADP
ajfti-2033	97	8	saudi	saudi	PROPN
ajfti-2033	97	9	arabia	arabia	PROPN
ajfti-2033	97	10	is	be	AUX
ajfti-2033	97	11	related	relate	VERB
ajfti-2033	97	12	to	to	ADP
ajfti-2033	97	13	insufficient	insufficient	ADJ
ajfti-2033	97	14	insurance	insurance	NOUN
ajfti-2033	97	15	coverage	coverage	NOUN
ajfti-2033	97	16	.	.	PUNCT
ajfti-2033	98	1	hypothesis	hypothesis	NOUN
ajfti-2033	98	2	3	3	NUM
ajfti-2033	98	3	h3a	h3a	NOUN
ajfti-2033	98	4	:	:	PUNCT
ajfti-2033	98	5	increasing	increase	VERB
ajfti-2033	98	6	insurance	insurance	NOUN
ajfti-2033	98	7	coverage	coverage	NOUN
ajfti-2033	98	8	and	and	CCONJ
ajfti-2033	98	9	implementing	implement	VERB
ajfti-2033	98	10	policy	policy	NOUN
ajfti-2033	98	11	changes	change	NOUN
ajfti-2033	98	12	can	can	AUX
ajfti-2033	98	13	help	help	VERB
ajfti-2033	98	14	with	with	ADP
ajfti-2033	98	15	ma	ma	PROPN
ajfti-2033	98	16	in	in	ADP
ajfti-2033	98	17	saudi	saudi	PROPN
ajfti-2033	98	18	arabia	arabia	PROPN
ajfti-2033	98	19	.	.	PUNCT
ajfti-2033	99	1	material	material	NOUN
ajfti-2033	99	2	and	and	CCONJ
ajfti-2033	99	3	methods	method	NOUN
ajfti-2033	99	4	the	the	DET
ajfti-2033	99	5	study	study	NOUN
ajfti-2033	99	6	employed	employ	VERB
ajfti-2033	99	7	a	a	DET
ajfti-2033	99	8	quantitative	quantitative	ADJ
ajfti-2033	99	9	research	research	NOUN
ajfti-2033	99	10	method	method	NOUN
ajfti-2033	99	11	to	to	PART
ajfti-2033	99	12	examine	examine	VERB
ajfti-2033	99	13	the	the	DET
ajfti-2033	99	14	linkages	linkage	NOUN
ajfti-2033	99	15	between	between	ADP
ajfti-2033	99	16	drug	drug	NOUN
ajfti-2033	99	17	pricing	pricing	NOUN
ajfti-2033	99	18	and	and	CCONJ
ajfti-2033	99	19	insurance	insurance	NOUN
ajfti-2033	99	20	coverage	coverage	NOUN
ajfti-2033	99	21	and	and	CCONJ
ajfti-2033	99	22	their	their	PRON
ajfti-2033	99	23	influence	influence	NOUN
ajfti-2033	99	24	on	on	ADP
ajfti-2033	99	25	medication	medication	NOUN
ajfti-2033	99	26	adherence	adherence	NOUN
ajfti-2033	99	27	among	among	ADP
ajfti-2033	99	28	individuals	individual	NOUN
ajfti-2033	99	29	residing	reside	VERB
ajfti-2033	99	30	in	in	ADP
ajfti-2033	99	31	saudi	saudi	PROPN
ajfti-2033	99	32	arabia	arabia	PROPN
ajfti-2033	99	33	.	.	PUNCT
ajfti-2033	100	1	through	through	ADP
ajfti-2033	100	2	the	the	DET
ajfti-2033	100	3	cross	cross	ADJ
ajfti-2033	100	4	-	-	ADJ
ajfti-2033	100	5	sectional	sectional	ADJ
ajfti-2033	100	6	method	method	NOUN
ajfti-2033	100	7	,	,	PUNCT
ajfti-2033	100	8	interrelationships	interrelationship	NOUN
ajfti-2033	100	9	were	be	AUX
ajfti-2033	100	10	scrutinised	scrutinise	VERB
ajfti-2033	100	11	and	and	CCONJ
ajfti-2033	100	12	grasped	grasp	VERB
ajfti-2033	100	13	.	.	PUNCT
ajfti-2033	101	1	the	the	DET
ajfti-2033	101	2	selection	selection	NOUN
ajfti-2033	101	3	of	of	ADP
ajfti-2033	101	4	quantitative	quantitative	ADJ
ajfti-2033	101	5	research	research	NOUN
ajfti-2033	101	6	hinges	hinge	NOUN
ajfti-2033	101	7	on	on	ADP
ajfti-2033	101	8	its	its	PRON
ajfti-2033	101	9	efficient	efficient	ADJ
ajfti-2033	101	10	and	and	CCONJ
ajfti-2033	101	11	impartial	impartial	ADJ
ajfti-2033	101	12	data	datum	NOUN
ajfti-2033	101	13	collection	collection	NOUN
ajfti-2033	101	14	and	and	CCONJ
ajfti-2033	101	15	analysis	analysis	NOUN
ajfti-2033	101	16	capabilities	capability	NOUN
ajfti-2033	101	17	.	.	PUNCT
ajfti-2033	102	1	the	the	DET
ajfti-2033	102	2	positivist	positivist	PROPN
ajfti-2033	102	3	perspective	perspective	NOUN
ajfti-2033	102	4	emphasises	emphasise	VERB
ajfti-2033	102	5	using	use	VERB
ajfti-2033	102	6	objective	objective	ADJ
ajfti-2033	102	7	and	and	CCONJ
ajfti-2033	102	8	verifiable	verifiable	ADJ
ajfti-2033	102	9	evidence	evidence	NOUN
ajfti-2033	102	10	to	to	PART
ajfti-2033	102	11	bolster	bolster	VERB
ajfti-2033	102	12	the	the	DET
ajfti-2033	102	13	advancement	advancement	NOUN
ajfti-2033	102	14	of	of	ADP
ajfti-2033	102	15	the	the	DET
ajfti-2033	102	16	process	process	NOUN
ajfti-2033	102	17	.	.	PUNCT
ajfti-2033	103	1	mahajan	mahajan	PROPN
ajfti-2033	103	2	(	(	PUNCT
ajfti-2033	103	3	2020	2020	NUM
ajfti-2033	103	4	)	)	PUNCT
ajfti-2033	103	5	states	state	VERB
ajfti-2033	103	6	that	that	SCONJ
ajfti-2033	103	7	larger	large	ADJ
ajfti-2033	103	8	sample	sample	NOUN
ajfti-2033	103	9	sizes	size	NOUN
ajfti-2033	103	10	translate	translate	VERB
ajfti-2033	103	11	to	to	ADP
ajfti-2033	103	12	greater	great	ADJ
ajfti-2033	103	13	generalizability	generalizability	NOUN
ajfti-2033	103	14	.	.	PUNCT
ajfti-2033	104	1	as	as	SCONJ
ajfti-2033	104	2	creswell	creswell	PROPN
ajfti-2033	104	3	and	and	CCONJ
ajfti-2033	104	4	hirose	hirose	PROPN
ajfti-2033	104	5	(	(	PUNCT
ajfti-2033	104	6	2018	2018	NUM
ajfti-2033	104	7	)	)	PUNCT
ajfti-2033	104	8	described	describe	VERB
ajfti-2033	104	9	,	,	PUNCT
ajfti-2033	104	10	quantitative	quantitative	ADJ
ajfti-2033	104	11	research	research	NOUN
ajfti-2033	104	12	excels	excel	NOUN
ajfti-2033	104	13	when	when	SCONJ
ajfti-2033	104	14	utilising	utilise	VERB
ajfti-2033	104	15	standardised	standardised	ADJ
ajfti-2033	104	16	and	and	CCONJ
ajfti-2033	104	17	systematic	systematic	ADJ
ajfti-2033	104	18	data	datum	NOUN
ajfti-2033	104	19	collection	collection	NOUN
ajfti-2033	104	20	methods	method	NOUN
ajfti-2033	104	21	.	.	PUNCT
ajfti-2033	105	1	research	research	NOUN
ajfti-2033	105	2	design	design	VERB
ajfti-2033	105	3	the	the	DET
ajfti-2033	105	4	study	study	NOUN
ajfti-2033	105	5	employed	employ	VERB
ajfti-2033	105	6	a	a	DET
ajfti-2033	105	7	cross	cross	ADJ
ajfti-2033	105	8	-	-	ADJ
ajfti-2033	105	9	sectional	sectional	ADJ
ajfti-2033	105	10	approach	approach	NOUN
ajfti-2033	105	11	to	to	PART
ajfti-2033	105	12	collect	collect	VERB
ajfti-2033	105	13	information	information	NOUN
ajfti-2033	105	14	simultaneously	simultaneously	ADV
ajfti-2033	105	15	from	from	ADP
ajfti-2033	105	16	a	a	DET
ajfti-2033	105	17	diverse	diverse	ADJ
ajfti-2033	105	18	population	population	NOUN
ajfti-2033	105	19	.	.	PUNCT
ajfti-2033	106	1	medication	medication	NOUN
ajfti-2033	106	2	adherence	adherence	NOUN
ajfti-2033	106	3	can	can	AUX
ajfti-2033	106	4	be	be	AUX
ajfti-2033	106	5	influenced	influence	VERB
ajfti-2033	106	6	by	by	ADP
ajfti-2033	106	7	reviewing	review	VERB
ajfti-2033	106	8	three	three	NUM
ajfti-2033	106	9	factors	factor	NOUN
ajfti-2033	106	10	:	:	PUNCT
ajfti-2033	106	11	drug	drug	NOUN
ajfti-2033	106	12	pricing	pricing	NOUN
ajfti-2033	106	13	,	,	PUNCT
ajfti-2033	106	14	insurance	insurance	NOUN
ajfti-2033	106	15	coverage	coverage	NOUN
ajfti-2033	106	16	,	,	PUNCT
ajfti-2033	106	17	and	and	CCONJ
ajfti-2033	106	18	income	income	NOUN
ajfti-2033	106	19	.	.	PUNCT
ajfti-2033	107	1	correlation	correlation	NOUN
ajfti-2033	107	2	analysis	analysis	NOUN
ajfti-2033	107	3	between	between	ADP
ajfti-2033	107	4	variables	variable	NOUN
ajfti-2033	107	5	was	be	AUX
ajfti-2033	107	6	enabled	enable	VERB
ajfti-2033	107	7	through	through	ADP
ajfti-2033	107	8	bhardwaj	bhardwaj	PROPN
ajfti-2033	107	9	’s	’s	PART
ajfti-2033	107	10	design	design	NOUN
ajfti-2033	107	11	(	(	PUNCT
ajfti-2033	107	12	2019	2019	NUM
ajfti-2033	107	13	)	)	PUNCT
ajfti-2033	107	14	.	.	PUNCT
ajfti-2033	108	1	further	further	ADJ
ajfti-2033	108	2	characteristics	characteristic	NOUN
ajfti-2033	108	3	of	of	ADP
ajfti-2033	108	4	the	the	DET
ajfti-2033	108	5	research	research	NOUN
ajfti-2033	108	6	process	process	NOUN
ajfti-2033	108	7	are	be	AUX
ajfti-2033	108	8	described	describe	VERB
ajfti-2033	108	9	in	in	ADP
ajfti-2033	108	10	the	the	DET
ajfti-2033	108	11	following	follow	VERB
ajfti-2033	108	12	sections	section	NOUN
ajfti-2033	108	13	:	:	PUNCT
ajfti-2033	108	14	target	target	VERB
ajfti-2033	108	15	population	population	NOUN
ajfti-2033	108	16	and	and	CCONJ
ajfti-2033	108	17	sampling	sample	VERB
ajfti-2033	108	18	due	due	ADP
ajfti-2033	108	19	to	to	ADP
ajfti-2033	108	20	drug	drug	NOUN
ajfti-2033	108	21	pricing	pricing	NOUN
ajfti-2033	108	22	,	,	PUNCT
ajfti-2033	108	23	income	income	NOUN
ajfti-2033	108	24	,	,	PUNCT
ajfti-2033	108	25	and	and	CCONJ
ajfti-2033	108	26	insurance	insurance	NOUN
ajfti-2033	108	27	coverage	coverage	NOUN
ajfti-2033	108	28	,	,	PUNCT
ajfti-2033	108	29	the	the	DET
ajfti-2033	108	30	study	study	NOUN
ajfti-2033	108	31	group	group	NOUN
ajfti-2033	108	32	included	include	VERB
ajfti-2033	108	33	all	all	DET
ajfti-2033	108	34	saudi	saudi	ADJ
ajfti-2033	108	35	arabian	arabian	ADJ
ajfti-2033	108	36	citizens	citizen	NOUN
ajfti-2033	108	37	experiencing	experience	VERB
ajfti-2033	108	38	difficulties	difficulty	NOUN
ajfti-2033	108	39	with	with	ADP
ajfti-2033	108	40	medication	medication	NOUN
ajfti-2033	108	41	adherence	adherence	NOUN
ajfti-2033	108	42	.	.	PUNCT
ajfti-2033	109	1	according	accord	VERB
ajfti-2033	109	2	to	to	ADP
ajfti-2033	109	3	bujang	bujang	PROPN
ajfti-2033	109	4	et	et	PROPN
ajfti-2033	109	5	al	al	PROPN
ajfti-2033	109	6	.	.	PROPN
ajfti-2033	110	1	(	(	PUNCT
ajfti-2033	110	2	2018	2018	NUM
ajfti-2033	110	3	)	)	PUNCT
ajfti-2033	110	4	,	,	PUNCT
ajfti-2033	110	5	a	a	DET
ajfti-2033	110	6	sample	sample	NOUN
ajfti-2033	110	7	of	of	ADP
ajfti-2033	110	8	250	250	NUM
ajfti-2033	110	9	individuals	individual	NOUN
ajfti-2033	110	10	was	be	AUX
ajfti-2033	110	11	surveyed	survey	VERB
ajfti-2033	110	12	using	use	VERB
ajfti-2033	110	13	randomised	randomised	ADJ
ajfti-2033	110	14	sampling	sampling	NOUN
ajfti-2033	110	15	to	to	PART
ajfti-2033	110	16	obtain	obtain	VERB
ajfti-2033	110	17	a	a	DET
ajfti-2033	110	18	reliable	reliable	ADJ
ajfti-2033	110	19	representative	representative	NOUN
ajfti-2033	110	20	of	of	ADP
ajfti-2033	110	21	the	the	DET
ajfti-2033	110	22	general	general	ADJ
ajfti-2033	110	23	public	public	NOUN
ajfti-2033	110	24	.	.	PUNCT
ajfti-2033	111	1	95	95	NUM
ajfti-2033	111	2	%	%	NOUN
ajfti-2033	111	3	confidence	confidence	NOUN
ajfti-2033	111	4	and	and	CCONJ
ajfti-2033	111	5	a	a	DET
ajfti-2033	111	6	5	5	NUM
ajfti-2033	111	7	%	%	NOUN
ajfti-2033	111	8	margin	margin	NOUN
ajfti-2033	111	9	of	of	ADP
ajfti-2033	111	10	error	error	NOUN
ajfti-2033	111	11	governed	govern	VERB
ajfti-2033	111	12	the	the	DET
ajfti-2033	111	13	investigation	investigation	NOUN
ajfti-2033	111	14	process	process	NOUN
ajfti-2033	111	15	.	.	PUNCT
ajfti-2033	112	1	data	datum	NOUN
ajfti-2033	112	2	collection	collection	NOUN
ajfti-2033	112	3	approach	approach	NOUN
ajfti-2033	112	4	data	datum	NOUN
ajfti-2033	112	5	collection	collection	NOUN
ajfti-2033	112	6	comprised	comprise	VERB
ajfti-2033	112	7	a	a	DET
ajfti-2033	112	8	questionnaire	questionnaire	NOUN
ajfti-2033	112	9	disseminated	disseminate	VERB
ajfti-2033	112	10	online	online	ADV
ajfti-2033	112	11	using	use	VERB
ajfti-2033	112	12	google	google	PROPN
ajfti-2033	112	13	forms	form	NOUN
ajfti-2033	112	14	to	to	PART
ajfti-2033	112	15	ensure	ensure	VERB
ajfti-2033	112	16	confidentiality	confidentiality	NOUN
ajfti-2033	112	17	and	and	CCONJ
ajfti-2033	112	18	ease	ease	NOUN
ajfti-2033	112	19	.	.	PUNCT
ajfti-2033	113	1	participants	participant	NOUN
ajfti-2033	113	2	were	be	AUX
ajfti-2033	113	3	evaluated	evaluate	VERB
ajfti-2033	113	4	on	on	ADP
ajfti-2033	113	5	their	their	PRON
ajfti-2033	113	6	opinions	opinion	NOUN
ajfti-2033	113	7	of	of	ADP
ajfti-2033	113	8	prescription	prescription	NOUN
ajfti-2033	113	9	cost	cost	NOUN
ajfti-2033	113	10	,	,	PUNCT
ajfti-2033	113	11	insurance	insurance	NOUN
ajfti-2033	113	12	coverage	coverage	NOUN
ajfti-2033	113	13	,	,	PUNCT
ajfti-2033	113	14	and	and	CCONJ
ajfti-2033	113	15	medication	medication	NOUN
ajfti-2033	113	16	adherence	adherence	NOUN
ajfti-2033	113	17	using	use	VERB
ajfti-2033	113	18	closed	close	VERB
ajfti-2033	113	19	-	-	PUNCT
ajfti-2033	113	20	ended	end	VERB
ajfti-2033	113	21	questions	question	NOUN
ajfti-2033	113	22	on	on	ADP
ajfti-2033	113	23	a	a	DET
ajfti-2033	113	24	likert	likert	ADJ
ajfti-2033	113	25	-	-	PUNCT
ajfti-2033	113	26	type	type	NOUN
ajfti-2033	113	27	scale	scale	NOUN
ajfti-2033	113	28	.	.	PUNCT
ajfti-2033	114	1	validity	validity	NOUN
ajfti-2033	114	2	and	and	CCONJ
ajfti-2033	114	3	reliability	reliability	NOUN
ajfti-2033	114	4	were	be	AUX
ajfti-2033	114	5	established	establish	VERB
ajfti-2033	114	6	through	through	ADP
ajfti-2033	114	7	pretesting	preteste	VERB
ajfti-2033	114	8	on	on	ADP
ajfti-2033	114	9	a	a	DET
ajfti-2033	114	10	representative	representative	ADJ
ajfti-2033	114	11	sample	sample	NOUN
ajfti-2033	114	12	(	(	PUNCT
ajfti-2033	114	13	bujang	bujang	PROPN
ajfti-2033	114	14	et	et	PROPN
ajfti-2033	114	15	al	al	PROPN
ajfti-2033	114	16	.	.	PROPN
ajfti-2033	114	17	,	,	PUNCT
ajfti-2033	114	18	2018	2018	NUM
ajfti-2033	114	19	)	)	PUNCT
ajfti-2033	114	20	.	.	PUNCT
ajfti-2033	115	1	data	datum	NOUN
ajfti-2033	115	2	analysis	analysis	NOUN
ajfti-2033	115	3	spss	spss	PROPN
ajfti-2033	115	4	and	and	CCONJ
ajfti-2033	115	5	microsoft	microsoft	PROPN
ajfti-2033	115	6	excel	excel	PROPN
ajfti-2033	115	7	are	be	AUX
ajfti-2033	115	8	employed	employ	VERB
ajfti-2033	115	9	for	for	ADP
ajfti-2033	115	10	data	datum	NOUN
ajfti-2033	115	11	analysis	analysis	NOUN
ajfti-2033	115	12	because	because	SCONJ
ajfti-2033	115	13	of	of	ADP
ajfti-2033	115	14	their	their	PRON
ajfti-2033	115	15	versatility	versatility	NOUN
ajfti-2033	115	16	in	in	ADP
ajfti-2033	115	17	social	social	ADJ
ajfti-2033	115	18	sciences	science	NOUN
ajfti-2033	115	19	and	and	CCONJ
ajfti-2033	115	20	how	how	SCONJ
ajfti-2033	115	21	they	they	PRON
ajfti-2033	115	22	easily	easily	ADV
ajfti-2033	115	23	handle	handle	VERB
ajfti-2033	115	24	vast	vast	ADJ
ajfti-2033	115	25	amounts	amount	NOUN
ajfti-2033	115	26	of	of	ADP
ajfti-2033	115	27	data	datum	NOUN
ajfti-2033	115	28	to	to	PART
ajfti-2033	115	29	provide	provide	VERB
ajfti-2033	115	30	essential	essential	ADJ
ajfti-2033	115	31	insights(baker	insights(baker	PROPN
ajfti-2033	115	32	et	et	PROPN
ajfti-2033	115	33	al	al	PROPN
ajfti-2033	115	34	.	.	PROPN
ajfti-2033	115	35	,	,	PUNCT
ajfti-2033	115	36	2022	2022	NUM
ajfti-2033	115	37	)	)	PUNCT
ajfti-2033	115	38	.	.	PUNCT
ajfti-2033	116	1	data	data	PROPN
ajfti-2033	116	2	’s	’s	PART
ajfti-2033	116	3	characteristics	characteristic	NOUN
ajfti-2033	116	4	can	can	AUX
ajfti-2033	116	5	be	be	AUX
ajfti-2033	116	6	understood	understand	VERB
ajfti-2033	116	7	using	use	VERB
ajfti-2033	116	8	descriptive	descriptive	ADJ
ajfti-2033	116	9	statistics	statistic	NOUN
ajfti-2033	116	10	,	,	PUNCT
ajfti-2033	116	11	which	which	PRON
ajfti-2033	116	12	consist	consist	VERB
ajfti-2033	116	13	of	of	ADP
ajfti-2033	116	14	the	the	DET
ajfti-2033	116	15	mean	mean	ADJ
ajfti-2033	116	16	,	,	PUNCT
ajfti-2033	116	17	median	median	ADJ
ajfti-2033	116	18	,	,	PUNCT
ajfti-2033	116	19	mode	mode	NOUN
ajfti-2033	116	20	,	,	PUNCT
ajfti-2033	116	21	and	and	CCONJ
ajfti-2033	116	22	standard	standard	ADJ
ajfti-2033	116	23	deviation	deviation	NOUN
ajfti-2033	116	24	(	(	PUNCT
ajfti-2033	116	25	creswell	creswell	PROPN
ajfti-2033	116	26	&	&	CCONJ
ajfti-2033	116	27	hirose	hirose	PROPN
ajfti-2033	116	28	,	,	PUNCT
ajfti-2033	116	29	2019	2019	NUM
ajfti-2033	116	30	)	)	PUNCT
ajfti-2033	116	31	.	.	PUNCT
ajfti-2033	117	1	the	the	DET
ajfti-2033	117	2	correlation	correlation	NOUN
ajfti-2033	117	3	matrix	matrix	NOUN
ajfti-2033	117	4	,	,	PUNCT
ajfti-2033	117	5	shown	show	VERB
ajfti-2033	117	6	by	by	ADP
ajfti-2033	117	7	graff	graff	NOUN
ajfti-2033	117	8	elman	elman	NOUN
ajfti-2033	117	9	and	and	CCONJ
ajfti-2033	117	10	de	de	X
ajfti-2033	117	11	leeuw	leeuw	X
ajfti-2033	117	12	(	(	PUNCT
ajfti-2033	117	13	2023	2023	NUM
ajfti-2033	117	14	)	)	PUNCT
ajfti-2033	117	15	,	,	PUNCT
ajfti-2033	117	16	discovered	discover	VERB
ajfti-2033	117	17	ties	tie	NOUN
ajfti-2033	117	18	among	among	ADP
ajfti-2033	117	19	variables	variable	NOUN
ajfti-2033	117	20	(	(	PUNCT
ajfti-2033	117	21	graffelman	graffelman	NOUN
ajfti-2033	117	22	&	&	CCONJ
ajfti-2033	117	23	de	de	PROPN
ajfti-2033	117	24	leeuw	leeuw	PROPN
ajfti-2033	117	25	,	,	PUNCT
ajfti-2033	117	26	2023	2023	NUM
ajfti-2033	117	27	)	)	PUNCT
ajfti-2033	117	28	.	.	PUNCT
ajfti-2033	118	1	employed	employ	VERB
ajfti-2033	118	2	in	in	ADP
ajfti-2033	118	3	an	an	DET
ajfti-2033	118	4	analysis	analysis	NOUN
ajfti-2033	118	5	process	process	NOUN
ajfti-2033	118	6	,	,	PUNCT
ajfti-2033	118	7	pca	pca	PROPN
ajfti-2033	118	8	and	and	CCONJ
ajfti-2033	118	9	fa	fa	PROPN
ajfti-2033	118	10	helped	helped	AUX
ajfti-2033	118	11	identify	identify	VERB
ajfti-2033	118	12	patterns	pattern	NOUN
ajfti-2033	118	13	(	(	PUNCT
ajfti-2033	118	14	li	li	PROPN
ajfti-2033	118	15	et	et	PROPN
ajfti-2033	118	16	al	al	PROPN
ajfti-2033	118	17	.	.	PROPN
ajfti-2033	118	18	,	,	PUNCT
ajfti-2033	118	19	2021	2021	NUM
ajfti-2033	118	20	)	)	PUNCT
ajfti-2033	118	21	.	.	PUNCT
ajfti-2033	119	1	additionally	additionally	ADV
ajfti-2033	119	2	,	,	PUNCT
ajfti-2033	119	3	their	their	PRON
ajfti-2033	119	4	importance	importance	NOUN
ajfti-2033	119	5	extended	extend	VERB
ajfti-2033	119	6	beyond	beyond	ADP
ajfti-2033	119	7	the	the	DET
ajfti-2033	119	8	realm	realm	NOUN
ajfti-2033	119	9	of	of	ADP
ajfti-2033	119	10	data	datum	NOUN
ajfti-2033	119	11	analysis	analysis	NOUN
ajfti-2033	119	12	alone	alone	ADV
ajfti-2033	119	13	.	.	PUNCT
ajfti-2033	120	1	employed	employ	VERB
ajfti-2033	120	2	by	by	ADP
ajfti-2033	120	3	mooi	mooi	NOUN
ajfti-2033	120	4	et	et	PROPN
ajfti-2033	120	5	al	al	PROPN
ajfti-2033	120	6	.	.	PROPN
ajfti-2033	121	1	(	(	PUNCT
ajfti-2033	121	2	2018	2018	NUM
ajfti-2033	121	3	)	)	PUNCT
ajfti-2033	121	4	,	,	PUNCT
ajfti-2033	121	5	multiple	multiple	ADJ
ajfti-2033	121	6	linear	linear	ADJ
ajfti-2033	121	7	regression	regression	NOUN
ajfti-2033	121	8	examined	examine	VERB
ajfti-2033	121	9	the	the	DET
ajfti-2033	121	10	relationships	relationship	NOUN
ajfti-2033	121	11	between	between	ADP
ajfti-2033	121	12	dependent	dependent	ADJ
ajfti-2033	121	13	and	and	CCONJ
ajfti-2033	121	14	independent	independent	ADJ
ajfti-2033	121	15	variables	variable	NOUN
ajfti-2033	121	16	.	.	PUNCT
ajfti-2033	122	1	furthermore	furthermore	ADV
ajfti-2033	122	2	,	,	PUNCT
ajfti-2033	122	3	bujang	bujang	PROPN
ajfti-2033	122	4	et	et	PROPN
ajfti-2033	122	5	al	al	PROPN
ajfti-2033	122	6	.	.	PROPN
ajfti-2033	122	7	(	(	PUNCT
ajfti-2033	122	8	2018	2018	NUM
ajfti-2033	122	9	)	)	PUNCT
ajfti-2033	122	10	,	,	PUNCT
ajfti-2033	122	11	has	have	AUX
ajfti-2033	122	12	stressed	stress	VERB
ajfti-2033	122	13	pa	pa	PROPN
ajfti-2033	122	14	ge	ge	PROPN
ajfti-2033	122	15	27	27	NUM
ajfti-2033	122	16	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	122	17	am	be	AUX
ajfti-2033	122	18	.	.	PUNCT
ajfti-2033	123	1	j.	j.	PROPN
ajfti-2033	123	2	financ	financ	PROPN
ajfti-2033	123	3	.	.	PUNCT
ajfti-2033	124	1	technol	technol	PROPN
ajfti-2033	124	2	.	.	PUNCT
ajfti-2033	124	3	innov	innov	PROPN
ajfti-2033	124	4	.	.	PUNCT
ajfti-2033	125	1	1(1	1(1	NUM
ajfti-2033	125	2	)	)	PUNCT
ajfti-2033	125	3	24	24	NUM
ajfti-2033	125	4	-	-	SYM
ajfti-2033	125	5	34	34	NUM
ajfti-2033	125	6	,	,	PUNCT
ajfti-2033	125	7	2023	2023	NUM
ajfti-2033	125	8	that	that	PRON
ajfti-2033	125	9	cronbach	cronbach	VERB
ajfti-2033	125	10	’s	’s	PART
ajfti-2033	125	11	alpha	alpha	NOUN
ajfti-2033	125	12	was	be	AUX
ajfti-2033	125	13	used	use	VERB
ajfti-2033	125	14	to	to	PART
ajfti-2033	125	15	determine	determine	VERB
ajfti-2033	125	16	survey	survey	NOUN
ajfti-2033	125	17	reliability	reliability	NOUN
ajfti-2033	125	18	(	(	PUNCT
ajfti-2033	125	19	bujang	bujang	PROPN
ajfti-2033	125	20	et	et	PROPN
ajfti-2033	125	21	al	al	PROPN
ajfti-2033	125	22	.	.	PROPN
ajfti-2033	125	23	,	,	PUNCT
ajfti-2033	125	24	2018	2018	NUM
ajfti-2033	125	25	;	;	PUNCT
ajfti-2033	125	26	mooi	mooi	NOUN
ajfti-2033	125	27	et	et	PROPN
ajfti-2033	125	28	al	al	PROPN
ajfti-2033	125	29	.	.	PROPN
ajfti-2033	125	30	,	,	PUNCT
ajfti-2033	125	31	2018	2018	NUM
ajfti-2033	125	32	)	)	PUNCT
ajfti-2033	125	33	.	.	PUNCT
ajfti-2033	126	1	ethical	ethical	ADJ
ajfti-2033	126	2	considerations	consideration	NOUN
ajfti-2033	126	3	maintaining	maintain	VERB
ajfti-2033	126	4	ethical	ethical	ADJ
ajfti-2033	126	5	principles	principle	NOUN
ajfti-2033	126	6	was	be	AUX
ajfti-2033	126	7	crucial	crucial	ADJ
ajfti-2033	126	8	throughout	throughout	ADP
ajfti-2033	126	9	the	the	DET
ajfti-2033	126	10	research	research	NOUN
ajfti-2033	126	11	.	.	PUNCT
ajfti-2033	127	1	participants	participant	NOUN
ajfti-2033	127	2	provided	provide	VERB
ajfti-2033	127	3	informed	informed	ADJ
ajfti-2033	127	4	consent	consent	NOUN
ajfti-2033	127	5	after	after	ADP
ajfti-2033	127	6	being	be	AUX
ajfti-2033	127	7	informed	inform	VERB
ajfti-2033	127	8	about	about	ADP
ajfti-2033	127	9	the	the	DET
ajfti-2033	127	10	potential	potential	ADJ
ajfti-2033	127	11	benefits	benefit	NOUN
ajfti-2033	127	12	and	and	CCONJ
ajfti-2033	127	13	risks	risk	NOUN
ajfti-2033	127	14	.	.	PUNCT
ajfti-2033	128	1	privacy	privacy	NOUN
ajfti-2033	128	2	is	be	AUX
ajfti-2033	128	3	safeguarded	safeguard	VERB
ajfti-2033	128	4	thanks	thank	NOUN
ajfti-2033	128	5	to	to	ADP
ajfti-2033	128	6	identification	identification	NOUN
ajfti-2033	128	7	codes	code	NOUN
ajfti-2033	128	8	and	and	CCONJ
ajfti-2033	128	9	data	datum	NOUN
ajfti-2033	128	10	encryption	encryption	NOUN
ajfti-2033	128	11	.	.	PUNCT
ajfti-2033	129	1	no	no	DET
ajfti-2033	129	2	consequences	consequence	NOUN
ajfti-2033	129	3	existed	exist	VERB
ajfti-2033	129	4	for	for	ADP
ajfti-2033	129	5	participants	participant	NOUN
ajfti-2033	129	6	who	who	PRON
ajfti-2033	129	7	chose	choose	VERB
ajfti-2033	129	8	not	not	PART
ajfti-2033	129	9	to	to	PART
ajfti-2033	129	10	participate	participate	VERB
ajfti-2033	129	11	in	in	ADP
ajfti-2033	129	12	the	the	DET
ajfti-2033	129	13	study	study	NOUN
ajfti-2033	129	14	.	.	PUNCT
ajfti-2033	130	1	preventing	prevent	VERB
ajfti-2033	130	2	research	research	NOUN
ajfti-2033	130	3	abuse	abuse	NOUN
ajfti-2033	130	4	requires	require	VERB
ajfti-2033	130	5	maintaining	maintain	VERB
ajfti-2033	130	6	data	datum	NOUN
ajfti-2033	130	7	evaluation	evaluation	NOUN
ajfti-2033	130	8	transparency	transparency	NOUN
ajfti-2033	130	9	and	and	CCONJ
ajfti-2033	130	10	integrity	integrity	NOUN
ajfti-2033	130	11	(	(	PUNCT
ajfti-2033	130	12	see	see	VERB
ajfti-2033	130	13	ethical	ethical	ADJ
ajfti-2033	130	14	considerations	consideration	NOUN
ajfti-2033	130	15	)	)	PUNCT
ajfti-2033	130	16	.	.	PUNCT
ajfti-2033	131	1	great	great	ADJ
ajfti-2033	131	2	care	care	NOUN
ajfti-2033	131	3	was	be	AUX
ajfti-2033	131	4	taken	take	VERB
ajfti-2033	131	5	to	to	PART
ajfti-2033	131	6	observe	observe	VERB
ajfti-2033	131	7	ethical	ethical	ADJ
ajfti-2033	131	8	principles	principle	NOUN
ajfti-2033	131	9	throughout	throughout	ADP
ajfti-2033	131	10	the	the	DET
ajfti-2033	131	11	research	research	NOUN
ajfti-2033	131	12	to	to	PART
ajfti-2033	131	13	guarantee	guarantee	VERB
ajfti-2033	131	14	the	the	DET
ajfti-2033	131	15	security	security	NOUN
ajfti-2033	131	16	and	and	CCONJ
ajfti-2033	131	17	comfort	comfort	NOUN
ajfti-2033	131	18	of	of	ADP
ajfti-2033	131	19	participants	participant	NOUN
ajfti-2033	131	20	.	.	PUNCT
ajfti-2033	132	1	ethical	ethical	ADJ
ajfti-2033	132	2	considerations	consideration	NOUN
ajfti-2033	132	3	demand	demand	VERB
ajfti-2033	132	4	the	the	DET
ajfti-2033	132	5	protection	protection	NOUN
ajfti-2033	132	6	of	of	ADP
ajfti-2033	132	7	integrity	integrity	NOUN
ajfti-2033	132	8	and	and	CCONJ
ajfti-2033	132	9	respect	respect	NOUN
ajfti-2033	132	10	for	for	ADP
ajfti-2033	132	11	participants	participant	NOUN
ajfti-2033	132	12	’	'	PUNCT
ajfti-2033	132	13	rights	right	NOUN
ajfti-2033	132	14	.	.	PUNCT
ajfti-2033	133	1	informed	inform	VERB
ajfti-2033	133	2	consent	consent	NOUN
ajfti-2033	133	3	collaboration	collaboration	NOUN
ajfti-2033	133	4	was	be	AUX
ajfti-2033	133	5	fostered	foster	VERB
ajfti-2033	133	6	when	when	SCONJ
ajfti-2033	133	7	participants	participant	NOUN
ajfti-2033	133	8	were	be	AUX
ajfti-2033	133	9	presented	present	VERB
ajfti-2033	133	10	with	with	ADP
ajfti-2033	133	11	thorough	thorough	ADJ
ajfti-2033	133	12	information	information	NOUN
ajfti-2033	133	13	regarding	regard	VERB
ajfti-2033	133	14	the	the	DET
ajfti-2033	133	15	study	study	NOUN
ajfti-2033	133	16	’s	’s	PART
ajfti-2033	133	17	goals	goal	NOUN
ajfti-2033	133	18	,	,	PUNCT
ajfti-2033	133	19	procedures	procedure	NOUN
ajfti-2033	133	20	,	,	PUNCT
ajfti-2033	133	21	and	and	CCONJ
ajfti-2033	133	22	potential	potential	ADJ
ajfti-2033	133	23	gains	gain	NOUN
ajfti-2033	133	24	and	and	CCONJ
ajfti-2033	133	25	drawbacks	drawback	NOUN
ajfti-2033	133	26	.	.	PUNCT
ajfti-2033	134	1	consent	consent	NOUN
ajfti-2033	134	2	from	from	ADP
ajfti-2033	134	3	all	all	DET
ajfti-2033	134	4	participants	participant	NOUN
ajfti-2033	134	5	was	be	AUX
ajfti-2033	134	6	obtained	obtain	VERB
ajfti-2033	134	7	after	after	ADP
ajfti-2033	134	8	educating	educate	VERB
ajfti-2033	134	9	them	they	PRON
ajfti-2033	134	10	on	on	ADP
ajfti-2033	134	11	the	the	DET
ajfti-2033	134	12	process	process	NOUN
ajfti-2033	134	13	.	.	PUNCT
ajfti-2033	135	1	privacy	privacy	NOUN
ajfti-2033	135	2	protection	protection	NOUN
ajfti-2033	135	3	safeguarding	safeguard	VERB
ajfti-2033	135	4	participants	participant	NOUN
ajfti-2033	135	5	’	'	PUNCT
ajfti-2033	135	6	privacy	privacy	NOUN
ajfti-2033	135	7	and	and	CCONJ
ajfti-2033	135	8	data	datum	NOUN
ajfti-2033	135	9	required	require	VERB
ajfti-2033	135	10	the	the	DET
ajfti-2033	135	11	implementation	implementation	NOUN
ajfti-2033	135	12	of	of	ADP
ajfti-2033	135	13	specific	specific	ADJ
ajfti-2033	135	14	measures	measure	NOUN
ajfti-2033	135	15	.	.	PUNCT
ajfti-2033	136	1	individual	individual	ADJ
ajfti-2033	136	2	anonymity	anonymity	NOUN
ajfti-2033	136	3	was	be	AUX
ajfti-2033	136	4	maintained	maintain	VERB
ajfti-2033	136	5	by	by	ADP
ajfti-2033	136	6	assigning	assign	VERB
ajfti-2033	136	7	unique	unique	ADJ
ajfti-2033	136	8	identification	identification	NOUN
ajfti-2033	136	9	codes	code	NOUN
ajfti-2033	136	10	,	,	PUNCT
ajfti-2033	136	11	data	datum	NOUN
ajfti-2033	136	12	encryption	encryption	NOUN
ajfti-2033	136	13	,	,	PUNCT
ajfti-2033	136	14	and	and	CCONJ
ajfti-2033	136	15	results	result	VERB
ajfti-2033	136	16	aggregation	aggregation	NOUN
ajfti-2033	136	17	.	.	PUNCT
ajfti-2033	137	1	non	non	ADJ
ajfti-2033	137	2	-	-	NOUN
ajfti-2033	137	3	coercion	coercion	NOUN
ajfti-2033	137	4	there	there	PRON
ajfti-2033	137	5	were	be	VERB
ajfti-2033	137	6	no	no	DET
ajfti-2033	137	7	adverse	adverse	ADJ
ajfti-2033	137	8	repercussions	repercussion	NOUN
ajfti-2033	137	9	for	for	ADP
ajfti-2033	137	10	either	either	CCONJ
ajfti-2033	137	11	expressing	express	VERB
ajfti-2033	137	12	ethical	ethical	ADJ
ajfti-2033	137	13	concerns	concern	NOUN
ajfti-2033	137	14	or	or	CCONJ
ajfti-2033	137	15	choosing	choose	VERB
ajfti-2033	137	16	to	to	PART
ajfti-2033	137	17	opt	opt	VERB
ajfti-2033	137	18	out	out	ADP
ajfti-2033	137	19	of	of	ADP
ajfti-2033	137	20	the	the	DET
ajfti-2033	137	21	study	study	NOUN
ajfti-2033	137	22	.	.	PUNCT
ajfti-2033	138	1	their	their	PRON
ajfti-2033	138	2	participation	participation	NOUN
ajfti-2033	138	3	was	be	AUX
ajfti-2033	138	4	entirely	entirely	ADV
ajfti-2033	138	5	voluntary	voluntary	ADJ
ajfti-2033	138	6	.	.	PUNCT
ajfti-2033	139	1	transparency	transparency	NOUN
ajfti-2033	139	2	and	and	CCONJ
ajfti-2033	139	3	data	datum	NOUN
ajfti-2033	139	4	integrity	integrity	NOUN
ajfti-2033	139	5	to	to	PART
ajfti-2033	139	6	maintain	maintain	VERB
ajfti-2033	139	7	the	the	DET
ajfti-2033	139	8	highest	high	ADJ
ajfti-2033	139	9	levels	level	NOUN
ajfti-2033	139	10	of	of	ADP
ajfti-2033	139	11	ethical	ethical	ADJ
ajfti-2033	139	12	standards	standard	NOUN
ajfti-2033	139	13	,	,	PUNCT
ajfti-2033	139	14	all	all	DET
ajfti-2033	139	15	parties	party	NOUN
ajfti-2033	139	16	involved	involve	VERB
ajfti-2033	139	17	ensured	ensure	VERB
ajfti-2033	139	18	that	that	SCONJ
ajfti-2033	139	19	no	no	DET
ajfti-2033	139	20	form	form	NOUN
ajfti-2033	139	21	of	of	ADP
ajfti-2033	139	22	research	research	NOUN
ajfti-2033	139	23	misconduct	misconduct	NOUN
ajfti-2033	139	24	entered	enter	VERB
ajfti-2033	139	25	into	into	ADP
ajfti-2033	139	26	their	their	PRON
ajfti-2033	139	27	procedures	procedure	NOUN
ajfti-2033	139	28	,	,	PUNCT
ajfti-2033	139	29	such	such	ADJ
ajfti-2033	139	30	as	as	ADP
ajfti-2033	139	31	selective	selective	ADJ
ajfti-2033	139	32	reporting	reporting	NOUN
ajfti-2033	139	33	of	of	ADP
ajfti-2033	139	34	results	result	NOUN
ajfti-2033	139	35	or	or	CCONJ
ajfti-2033	139	36	distortion	distortion	NOUN
ajfti-2033	139	37	of	of	ADP
ajfti-2033	139	38	figures	figure	NOUN
ajfti-2033	139	39	.	.	PUNCT
ajfti-2033	140	1	before	before	SCONJ
ajfti-2033	140	2	data	data	NOUN
ajfti-2033	140	3	dissemination	dissemination	NOUN
ajfti-2033	140	4	,	,	PUNCT
ajfti-2033	140	5	accuracy	accuracy	NOUN
ajfti-2033	140	6	and	and	CCONJ
ajfti-2033	140	7	transparency	transparency	NOUN
ajfti-2033	140	8	were	be	AUX
ajfti-2033	140	9	scrutinised	scrutinise	VERB
ajfti-2033	140	10	.	.	PUNCT
ajfti-2033	141	1	by	by	ADP
ajfti-2033	141	2	incorporating	incorporate	VERB
ajfti-2033	141	3	ethical	ethical	ADJ
ajfti-2033	141	4	factors	factor	NOUN
ajfti-2033	141	5	,	,	PUNCT
ajfti-2033	141	6	the	the	DET
ajfti-2033	141	7	study	study	NOUN
ajfti-2033	141	8	ensured	ensure	VERB
ajfti-2033	141	9	high	high	ADJ
ajfti-2033	141	10	research	research	NOUN
ajfti-2033	141	11	integrity	integrity	NOUN
ajfti-2033	141	12	,	,	PUNCT
ajfti-2033	141	13	participant	participant	ADJ
ajfti-2033	141	14	well	well	ADV
ajfti-2033	141	15	-	-	PUNCT
ajfti-2033	141	16	being	being	NOUN
ajfti-2033	141	17	,	,	PUNCT
ajfti-2033	141	18	and	and	CCONJ
ajfti-2033	141	19	credibility	credibility	NOUN
ajfti-2033	141	20	.	.	PUNCT
ajfti-2033	142	1	results	result	NOUN
ajfti-2033	142	2	and	and	CCONJ
ajfti-2033	142	3	discuussion	discuussion	NOUN
ajfti-2033	142	4	this	this	DET
ajfti-2033	142	5	research	research	NOUN
ajfti-2033	142	6	delves	delve	VERB
ajfti-2033	142	7	into	into	ADP
ajfti-2033	142	8	a	a	DET
ajfti-2033	142	9	critical	critical	ADJ
ajfti-2033	142	10	issue	issue	NOUN
ajfti-2033	142	11	plaguing	plague	VERB
ajfti-2033	142	12	the	the	DET
ajfti-2033	142	13	healthcare	healthcare	NOUN
ajfti-2033	142	14	landscape	landscape	NOUN
ajfti-2033	142	15	in	in	ADP
ajfti-2033	142	16	saudi	saudi	PROPN
ajfti-2033	142	17	arabia	arabia	PROPN
ajfti-2033	142	18	-	-	PUNCT
ajfti-2033	142	19	the	the	DET
ajfti-2033	142	20	intricate	intricate	ADJ
ajfti-2033	142	21	interplay	interplay	NOUN
ajfti-2033	142	22	between	between	ADP
ajfti-2033	142	23	drug	drug	NOUN
ajfti-2033	142	24	pricing	pricing	NOUN
ajfti-2033	142	25	,	,	PUNCT
ajfti-2033	142	26	insurance	insurance	NOUN
ajfti-2033	142	27	coverage	coverage	NOUN
ajfti-2033	142	28	,	,	PUNCT
ajfti-2033	142	29	and	and	CCONJ
ajfti-2033	142	30	medication	medication	NOUN
ajfti-2033	142	31	adherence	adherence	NOUN
ajfti-2033	142	32	.	.	PUNCT
ajfti-2033	143	1	our	our	PRON
ajfti-2033	143	2	study	study	NOUN
ajfti-2033	143	3	is	be	AUX
ajfti-2033	143	4	not	not	PART
ajfti-2033	143	5	just	just	ADV
ajfti-2033	143	6	an	an	DET
ajfti-2033	143	7	exploration	exploration	NOUN
ajfti-2033	143	8	but	but	CCONJ
ajfti-2033	143	9	a	a	DET
ajfti-2033	143	10	clarion	clarion	NOUN
ajfti-2033	143	11	call	call	NOUN
ajfti-2033	143	12	to	to	PART
ajfti-2033	143	13	recognise	recognise	VERB
ajfti-2033	143	14	the	the	DET
ajfti-2033	143	15	far	far	ADV
ajfti-2033	143	16	-	-	PUNCT
ajfti-2033	143	17	reaching	reach	VERB
ajfti-2033	143	18	ramifications	ramification	NOUN
ajfti-2033	143	19	of	of	ADP
ajfti-2033	143	20	these	these	DET
ajfti-2033	143	21	factors	factor	NOUN
ajfti-2033	143	22	on	on	ADP
ajfti-2033	143	23	the	the	DET
ajfti-2033	143	24	health	health	NOUN
ajfti-2033	143	25	and	and	CCONJ
ajfti-2033	143	26	well	well	ADV
ajfti-2033	143	27	-	-	PUNCT
ajfti-2033	143	28	being	being	NOUN
ajfti-2033	143	29	of	of	ADP
ajfti-2033	143	30	saudi	saudi	ADJ
ajfti-2033	143	31	arabian	arabian	ADJ
ajfti-2033	143	32	citizens	citizen	NOUN
ajfti-2033	143	33	.	.	PUNCT
ajfti-2033	144	1	in	in	ADP
ajfti-2033	144	2	an	an	DET
ajfti-2033	144	3	era	era	NOUN
ajfti-2033	144	4	where	where	SCONJ
ajfti-2033	144	5	access	access	NOUN
ajfti-2033	144	6	to	to	ADP
ajfti-2033	144	7	healthcare	healthcare	PROPN
ajfti-2033	144	8	is	be	AUX
ajfti-2033	144	9	paramount	paramount	ADJ
ajfti-2033	144	10	,	,	PUNCT
ajfti-2033	144	11	understanding	understand	VERB
ajfti-2033	144	12	these	these	DET
ajfti-2033	144	13	dynamics	dynamic	NOUN
ajfti-2033	144	14	can	can	AUX
ajfti-2033	144	15	pave	pave	VERB
ajfti-2033	144	16	the	the	DET
ajfti-2033	144	17	way	way	NOUN
ajfti-2033	144	18	for	for	ADP
ajfti-2033	144	19	more	more	ADV
ajfti-2033	144	20	robust	robust	ADJ
ajfti-2033	144	21	health	health	NOUN
ajfti-2033	144	22	policies	policy	NOUN
ajfti-2033	144	23	and	and	CCONJ
ajfti-2033	144	24	improved	improve	VERB
ajfti-2033	144	25	patient	patient	ADJ
ajfti-2033	144	26	outcomes	outcome	NOUN
ajfti-2033	144	27	.	.	PUNCT
ajfti-2033	145	1	to	to	PART
ajfti-2033	145	2	unearth	unearth	VERB
ajfti-2033	145	3	the	the	DET
ajfti-2033	145	4	undeniable	undeniable	ADJ
ajfti-2033	145	5	impact	impact	NOUN
ajfti-2033	145	6	of	of	ADP
ajfti-2033	145	7	drug	drug	NOUN
ajfti-2033	145	8	pricing	pricing	NOUN
ajfti-2033	145	9	and	and	CCONJ
ajfti-2033	145	10	insurance	insurance	NOUN
ajfti-2033	145	11	coverage	coverage	NOUN
ajfti-2033	145	12	on	on	ADP
ajfti-2033	145	13	medication	medication	NOUN
ajfti-2033	145	14	adherence	adherence	NOUN
ajfti-2033	145	15	,	,	PUNCT
ajfti-2033	145	16	we	we	PRON
ajfti-2033	145	17	embarked	embark	VERB
ajfti-2033	145	18	on	on	ADP
ajfti-2033	145	19	a	a	DET
ajfti-2033	145	20	journey	journey	NOUN
ajfti-2033	145	21	driven	drive	VERB
ajfti-2033	145	22	by	by	ADP
ajfti-2033	145	23	methodical	methodical	ADJ
ajfti-2033	145	24	rigour	rigour	NOUN
ajfti-2033	145	25	and	and	CCONJ
ajfti-2033	145	26	precision	precision	NOUN
ajfti-2033	145	27	.	.	PUNCT
ajfti-2033	146	1	our	our	PRON
ajfti-2033	146	2	primary	primary	ADJ
ajfti-2033	146	3	data	data	NOUN
ajfti-2033	146	4	collection	collection	NOUN
ajfti-2033	146	5	leveraged	leverage	VERB
ajfti-2033	146	6	the	the	DET
ajfti-2033	146	7	online	online	ADJ
ajfti-2033	146	8	survey	survey	NOUN
ajfti-2033	146	9	method	method	NOUN
ajfti-2033	146	10	,	,	PUNCT
ajfti-2033	146	11	engaging	engage	VERB
ajfti-2033	146	12	with	with	ADP
ajfti-2033	146	13	250	250	NUM
ajfti-2033	146	14	participants	participant	NOUN
ajfti-2033	146	15	selected	select	VERB
ajfti-2033	146	16	through	through	ADP
ajfti-2033	146	17	simple	simple	ADJ
ajfti-2033	146	18	random	random	ADJ
ajfti-2033	146	19	sampling	sampling	NOUN
ajfti-2033	146	20	.	.	PUNCT
ajfti-2033	147	1	the	the	DET
ajfti-2033	147	2	arsenal	arsenal	NOUN
ajfti-2033	147	3	of	of	ADP
ajfti-2033	147	4	statistical	statistical	ADJ
ajfti-2033	147	5	tools	tool	NOUN
ajfti-2033	147	6	at	at	ADP
ajfti-2033	147	7	our	our	PRON
ajfti-2033	147	8	disposal	disposal	NOUN
ajfti-2033	147	9	included	include	VERB
ajfti-2033	147	10	microsoft	microsoft	PROPN
ajfti-2033	147	11	excel	excel	PROPN
ajfti-2033	147	12	and	and	CCONJ
ajfti-2033	147	13	the	the	DET
ajfti-2033	147	14	venerable	venerable	ADJ
ajfti-2033	147	15	ibm	ibm	PROPN
ajfti-2033	147	16	spss-26	spss-26	PROPN
ajfti-2033	147	17	(	(	PUNCT
ajfti-2033	147	18	george	george	PROPN
ajfti-2033	147	19	&	&	CCONJ
ajfti-2033	147	20	mallery	mallery	PROPN
ajfti-2033	147	21	,	,	PUNCT
ajfti-2033	147	22	2019	2019	NUM
ajfti-2033	147	23	)	)	PUNCT
ajfti-2033	147	24	,	,	PUNCT
ajfti-2033	147	25	enabling	enable	VERB
ajfti-2033	147	26	us	we	PRON
ajfti-2033	147	27	to	to	PART
ajfti-2033	147	28	conduct	conduct	VERB
ajfti-2033	147	29	comprehensive	comprehensive	ADJ
ajfti-2033	147	30	analyses	analysis	NOUN
ajfti-2033	147	31	encompassing	encompass	VERB
ajfti-2033	147	32	descriptive	descriptive	ADJ
ajfti-2033	147	33	,	,	PUNCT
ajfti-2033	147	34	factor	factor	NOUN
ajfti-2033	147	35	,	,	PUNCT
ajfti-2033	147	36	correlational	correlational	ADJ
ajfti-2033	147	37	,	,	PUNCT
ajfti-2033	147	38	and	and	CCONJ
ajfti-2033	147	39	regression	regression	NOUN
ajfti-2033	147	40	analyses	analysis	NOUN
ajfti-2033	147	41	.	.	PUNCT
ajfti-2033	148	1	these	these	DET
ajfti-2033	148	2	analyses	analysis	NOUN
ajfti-2033	148	3	uncovered	uncover	VERB
ajfti-2033	148	4	the	the	DET
ajfti-2033	148	5	latent	latent	NOUN
ajfti-2033	148	6	variables	variable	NOUN
ajfti-2033	148	7	at	at	ADP
ajfti-2033	148	8	the	the	DET
ajfti-2033	148	9	heart	heart	NOUN
ajfti-2033	148	10	of	of	ADP
ajfti-2033	148	11	our	our	PRON
ajfti-2033	148	12	research	research	NOUN
ajfti-2033	148	13	-	-	PUNCT
ajfti-2033	148	14	drug	drug	NOUN
ajfti-2033	148	15	pricing	pricing	NOUN
ajfti-2033	148	16	,	,	PUNCT
ajfti-2033	148	17	insurance	insurance	NOUN
ajfti-2033	148	18	coverage	coverage	NOUN
ajfti-2033	148	19	,	,	PUNCT
ajfti-2033	148	20	and	and	CCONJ
ajfti-2033	148	21	medication	medication	NOUN
ajfti-2033	148	22	adherence	adherence	NOUN
ajfti-2033	148	23	.	.	PUNCT
ajfti-2033	149	1	demographic	demographic	ADJ
ajfti-2033	149	2	insights	insight	NOUN
ajfti-2033	149	3	the	the	DET
ajfti-2033	149	4	demographic	demographic	ADJ
ajfti-2033	149	5	landscape	landscape	NOUN
ajfti-2033	149	6	of	of	ADP
ajfti-2033	149	7	our	our	PRON
ajfti-2033	149	8	study	study	NOUN
ajfti-2033	149	9	is	be	AUX
ajfti-2033	149	10	a	a	DET
ajfti-2033	149	11	mosaic	mosaic	ADJ
ajfti-2033	149	12	that	that	PRON
ajfti-2033	149	13	reflects	reflect	VERB
ajfti-2033	149	14	the	the	DET
ajfti-2033	149	15	diversity	diversity	NOUN
ajfti-2033	149	16	of	of	ADP
ajfti-2033	149	17	saudi	saudi	PROPN
ajfti-2033	149	18	arabia	arabia	PROPN
ajfti-2033	149	19	.	.	PUNCT
ajfti-2033	150	1	understanding	understand	VERB
ajfti-2033	150	2	our	our	PRON
ajfti-2033	150	3	participants	participant	NOUN
ajfti-2033	150	4	provides	provide	VERB
ajfti-2033	150	5	the	the	DET
ajfti-2033	150	6	foundation	foundation	NOUN
ajfti-2033	150	7	upon	upon	SCONJ
ajfti-2033	150	8	which	which	PRON
ajfti-2033	150	9	our	our	PRON
ajfti-2033	150	10	research	research	NOUN
ajfti-2033	150	11	is	be	AUX
ajfti-2033	150	12	built	build	VERB
ajfti-2033	150	13	.	.	PUNCT
ajfti-2033	151	1	the	the	DET
ajfti-2033	151	2	findings	finding	NOUN
ajfti-2033	151	3	of	of	ADP
ajfti-2033	151	4	the	the	DET
ajfti-2033	151	5	study	study	NOUN
ajfti-2033	151	6	as	as	SCONJ
ajfti-2033	151	7	illustrated	illustrate	VERB
ajfti-2033	151	8	in	in	ADP
ajfti-2033	151	9	table	table	NOUN
ajfti-2033	151	10	1	1	NUM
ajfti-2033	151	11	reveal	reveal	VERB
ajfti-2033	151	12	a	a	DET
ajfti-2033	151	13	spectrum	spectrum	NOUN
ajfti-2033	151	14	of	of	ADP
ajfti-2033	151	15	age	age	NOUN
ajfti-2033	151	16	groups	group	NOUN
ajfti-2033	151	17	among	among	ADP
ajfti-2033	151	18	participants	participant	NOUN
ajfti-2033	151	19	.	.	PUNCT
ajfti-2033	152	1	while	while	SCONJ
ajfti-2033	152	2	62.4	62.4	NUM
ajfti-2033	152	3	%	%	NOUN
ajfti-2033	152	4	fall	fall	NOUN
ajfti-2033	152	5	within	within	ADP
ajfti-2033	152	6	the	the	DET
ajfti-2033	152	7	29	29	NUM
ajfti-2033	152	8	-	-	SYM
ajfti-2033	152	9	39	39	NUM
ajfti-2033	152	10	years	year	NOUN
ajfti-2033	152	11	bracket	bracket	NOUN
ajfti-2033	152	12	,	,	PUNCT
ajfti-2033	152	13	a	a	DET
ajfti-2033	152	14	substantial	substantial	ADJ
ajfti-2033	152	15	14.8	14.8	NUM
ajfti-2033	152	16	%	%	NOUN
ajfti-2033	152	17	belong	belong	VERB
ajfti-2033	152	18	to	to	ADP
ajfti-2033	152	19	the	the	DET
ajfti-2033	152	20	18	18	NUM
ajfti-2033	152	21	-	-	SYM
ajfti-2033	152	22	28	28	NUM
ajfti-2033	152	23	years	year	NOUN
ajfti-2033	152	24	and	and	CCONJ
ajfti-2033	152	25	40	40	NUM
ajfti-2033	152	26	-	-	SYM
ajfti-2033	152	27	50	50	NUM
ajfti-2033	152	28	years	year	NOUN
ajfti-2033	152	29	groups	group	NOUN
ajfti-2033	152	30	.	.	PUNCT
ajfti-2033	153	1	remarkably	remarkably	ADV
ajfti-2033	153	2	,	,	PUNCT
ajfti-2033	153	3	even	even	ADV
ajfti-2033	153	4	participants	participant	NOUN
ajfti-2033	153	5	above	above	ADP
ajfti-2033	153	6	50	50	NUM
ajfti-2033	153	7	years	year	NOUN
ajfti-2033	153	8	make	make	VERB
ajfti-2033	153	9	up	up	ADP
ajfti-2033	153	10	8	8	NUM
ajfti-2033	153	11	%	%	NOUN
ajfti-2033	153	12	of	of	ADP
ajfti-2033	153	13	our	our	PRON
ajfti-2033	153	14	cohort	cohort	NOUN
ajfti-2033	153	15	.	.	PUNCT
ajfti-2033	154	1	of	of	ADP
ajfti-2033	154	2	the	the	DET
ajfti-2033	154	3	250	250	NUM
ajfti-2033	154	4	participants	participant	NOUN
ajfti-2033	154	5	,	,	PUNCT
ajfti-2033	154	6	15	15	NUM
ajfti-2033	154	7	%	%	NOUN
ajfti-2033	154	8	belong	belong	VERB
ajfti-2033	154	9	to	to	ADP
ajfti-2033	154	10	the	the	DET
ajfti-2033	154	11	18	18	NUM
ajfti-2033	154	12	-	-	SYM
ajfti-2033	154	13	28	28	NUM
ajfti-2033	154	14	age	age	NOUN
ajfti-2033	154	15	group	group	NOUN
ajfti-2033	154	16	,	,	PUNCT
ajfti-2033	154	17	62	62	NUM
ajfti-2033	154	18	%	%	NOUN
ajfti-2033	154	19	to	to	ADP
ajfti-2033	154	20	the	the	DET
ajfti-2033	154	21	29	29	NUM
ajfti-2033	154	22	-	-	SYM
ajfti-2033	154	23	39	39	NUM
ajfti-2033	154	24	years	year	NOUN
ajfti-2033	154	25	group	group	NOUN
ajfti-2033	154	26	,	,	PUNCT
ajfti-2033	154	27	15	15	NUM
ajfti-2033	154	28	%	%	NOUN
ajfti-2033	154	29	to	to	ADP
ajfti-2033	154	30	the	the	DET
ajfti-2033	154	31	40	40	NUM
ajfti-2033	154	32	-	-	SYM
ajfti-2033	154	33	50	50	NUM
ajfti-2033	154	34	years	year	NOUN
ajfti-2033	154	35	group	group	NOUN
ajfti-2033	154	36	,	,	PUNCT
ajfti-2033	154	37	and	and	CCONJ
ajfti-2033	154	38	8	8	NUM
ajfti-2033	154	39	%	%	NOUN
ajfti-2033	154	40	are	be	AUX
ajfti-2033	154	41	more	more	ADJ
ajfti-2033	154	42	than	than	ADP
ajfti-2033	154	43	50	50	NUM
ajfti-2033	154	44	years	year	NOUN
ajfti-2033	154	45	old	old	ADJ
ajfti-2033	154	46	.	.	PUNCT
ajfti-2033	155	1	gender	gender	NOUN
ajfti-2033	155	2	distribution	distribution	NOUN
ajfti-2033	155	3	of	of	ADP
ajfti-2033	155	4	the	the	DET
ajfti-2033	155	5	study	study	NOUN
ajfti-2033	155	6	participants	participant	NOUN
ajfti-2033	155	7	,	,	PUNCT
ajfti-2033	155	8	as	as	ADP
ajfti-2033	155	9	depicted	depicted	ADJ
ajfti-2033	155	10	table	table	NOUN
ajfti-2033	155	11	1	1	NUM
ajfti-2033	155	12	:	:	PUNCT
ajfti-2033	155	13	age	age	NOUN
ajfti-2033	155	14	of	of	ADP
ajfti-2033	155	15	respondents	respondent	NOUN
ajfti-2033	155	16	frequency	frequency	VERB
ajfti-2033	155	17	per	per	ADP
ajfti-2033	155	18	cent	cent	NOUN
ajfti-2033	155	19	valid	valid	ADJ
ajfti-2033	155	20	percent	percent	NOUN
ajfti-2033	155	21	cumulative	cumulative	ADJ
ajfti-2033	155	22	percent	percent	NOUN
ajfti-2033	155	23	valid	valid	ADJ
ajfti-2033	155	24	18	18	NUM
ajfti-2033	155	25	-	-	SYM
ajfti-2033	155	26	28	28	NUM
ajfti-2033	155	27	years	year	NOUN
ajfti-2033	155	28	37	37	NUM
ajfti-2033	155	29	14.8	14.8	NUM
ajfti-2033	155	30	14.8	14.8	NUM
ajfti-2033	155	31	14.8	14.8	NUM
ajfti-2033	155	32	29	29	NUM
ajfti-2033	155	33	-	-	SYM
ajfti-2033	155	34	39	39	NUM
ajfti-2033	155	35	years	year	NOUN
ajfti-2033	155	36	156	156	NUM
ajfti-2033	155	37	62.4	62.4	NUM
ajfti-2033	155	38	62.4	62.4	NUM
ajfti-2033	155	39	77.2	77.2	NUM
ajfti-2033	155	40	40	40	NUM
ajfti-2033	155	41	-	-	SYM
ajfti-2033	155	42	50	50	NUM
ajfti-2033	155	43	years	year	NOUN
ajfti-2033	155	44	37	37	NUM
ajfti-2033	155	45	14.8	14.8	NUM
ajfti-2033	155	46	14.8	14.8	NUM
ajfti-2033	155	47	92.0	92.0	NUM
ajfti-2033	155	48	more	more	ADJ
ajfti-2033	155	49	than	than	ADP
ajfti-2033	155	50	50	50	NUM
ajfti-2033	155	51	years	year	NOUN
ajfti-2033	155	52	20	20	NUM
ajfti-2033	155	53	8.0	8.0	NUM
ajfti-2033	155	54	8.0	8.0	NUM
ajfti-2033	155	55	100.0	100.0	NUM
ajfti-2033	155	56	total	total	NOUN
ajfti-2033	155	57	250	250	NUM
ajfti-2033	155	58	100.0	100.0	NUM
ajfti-2033	155	59	100.0	100.0	NUM
ajfti-2033	155	60	table	table	NOUN
ajfti-2033	155	61	2	2	NUM
ajfti-2033	155	62	:	:	PUNCT
ajfti-2033	155	63	gender	gender	NOUN
ajfti-2033	155	64	of	of	ADP
ajfti-2033	155	65	participants	participant	NOUN
ajfti-2033	155	66	frequency	frequency	VERB
ajfti-2033	155	67	per	per	ADP
ajfti-2033	155	68	cent	cent	NOUN
ajfti-2033	155	69	valid	valid	ADJ
ajfti-2033	155	70	percent	percent	NOUN
ajfti-2033	155	71	cumulative	cumulative	ADJ
ajfti-2033	155	72	percent	percent	NOUN
ajfti-2033	155	73	valid	valid	ADJ
ajfti-2033	155	74	female	female	NOUN
ajfti-2033	155	75	51	51	NUM
ajfti-2033	155	76	20.4	20.4	NUM
ajfti-2033	155	77	20.4	20.4	NUM
ajfti-2033	155	78	20.4	20.4	NUM
ajfti-2033	155	79	male	male	NOUN
ajfti-2033	155	80	199	199	NUM
ajfti-2033	155	81	79.6	79.6	NUM
ajfti-2033	155	82	79.6	79.6	NUM
ajfti-2033	155	83	100.0	100.0	NUM
ajfti-2033	155	84	total	total	NOUN
ajfti-2033	155	85	250	250	NUM
ajfti-2033	155	86	100.0	100.0	NUM
ajfti-2033	155	87	100.0	100.0	NUM
ajfti-2033	155	88	pa	pa	PROPN
ajfti-2033	155	89	ge	ge	PROPN
ajfti-2033	155	90	28	28	NUM
ajfti-2033	155	91	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	PROPN
ajfti-2033	155	92	am	be	AUX
ajfti-2033	155	93	.	.	PUNCT
ajfti-2033	156	1	j.	j.	PROPN
ajfti-2033	156	2	financ	financ	PROPN
ajfti-2033	156	3	.	.	PUNCT
ajfti-2033	157	1	technol	technol	PROPN
ajfti-2033	157	2	.	.	PUNCT
ajfti-2033	157	3	innov	innov	PROPN
ajfti-2033	157	4	.	.	PUNCT
ajfti-2033	158	1	1(1	1(1	NUM
ajfti-2033	158	2	)	)	PUNCT
ajfti-2033	158	3	24	24	NUM
ajfti-2033	158	4	-	-	SYM
ajfti-2033	158	5	34	34	NUM
ajfti-2033	158	6	,	,	PUNCT
ajfti-2033	158	7	2023	2023	NUM
ajfti-2033	158	8	in	in	ADP
ajfti-2033	158	9	table	table	NOUN
ajfti-2033	158	10	2	2	NUM
ajfti-2033	158	11	,	,	PUNCT
ajfti-2033	158	12	underscores	underscore	VERB
ajfti-2033	158	13	the	the	DET
ajfti-2033	158	14	gender	gender	NOUN
ajfti-2033	158	15	disparity	disparity	NOUN
ajfti-2033	158	16	in	in	ADP
ajfti-2033	158	17	our	our	PRON
ajfti-2033	158	18	study	study	NOUN
ajfti-2033	158	19	.	.	PUNCT
ajfti-2033	159	1	a	a	DET
ajfti-2033	159	2	striking	striking	ADJ
ajfti-2033	159	3	80	80	NUM
ajfti-2033	159	4	%	%	NOUN
ajfti-2033	159	5	of	of	ADP
ajfti-2033	159	6	participants	participant	NOUN
ajfti-2033	159	7	are	be	AUX
ajfti-2033	159	8	male	male	ADJ
ajfti-2033	159	9	,	,	PUNCT
ajfti-2033	159	10	while	while	SCONJ
ajfti-2033	159	11	females	female	NOUN
ajfti-2033	159	12	constitute	constitute	VERB
ajfti-2033	159	13	20	20	NUM
ajfti-2033	159	14	%	%	NOUN
ajfti-2033	159	15	.	.	PUNCT
ajfti-2033	160	1	the	the	DET
ajfti-2033	160	2	study	study	NOUN
ajfti-2033	160	3	’s	’s	PART
ajfti-2033	160	4	findings	finding	NOUN
ajfti-2033	160	5	illustrated	illustrate	VERB
ajfti-2033	160	6	in	in	ADP
ajfti-2033	160	7	table	table	NOUN
ajfti-2033	160	8	3	3	NUM
ajfti-2033	160	9	.	.	PUNCT
ajfti-2033	160	10	have	have	AUX
ajfti-2033	160	11	shown	show	VERB
ajfti-2033	160	12	that	that	SCONJ
ajfti-2033	160	13	among	among	ADP
ajfti-2033	160	14	the	the	DET
ajfti-2033	160	15	study	study	NOUN
ajfti-2033	160	16	participants	participant	NOUN
ajfti-2033	160	17	,	,	PUNCT
ajfti-2033	160	18	56	56	NUM
ajfti-2033	160	19	%	%	NOUN
ajfti-2033	160	20	hold	hold	VERB
ajfti-2033	160	21	bachelor	bachelor	NOUN
ajfti-2033	160	22	’s	’s	PART
ajfti-2033	160	23	degrees	degree	NOUN
ajfti-2033	160	24	,	,	PUNCT
ajfti-2033	160	25	31	31	NUM
ajfti-2033	160	26	%	%	NOUN
ajfti-2033	160	27	have	have	VERB
ajfti-2033	160	28	master	master	NOUN
ajfti-2033	160	29	’s	’s	PART
ajfti-2033	160	30	degrees	degree	NOUN
ajfti-2033	160	31	,	,	PUNCT
ajfti-2033	160	32	8	8	NUM
ajfti-2033	160	33	%	%	NOUN
ajfti-2033	160	34	have	have	VERB
ajfti-2033	160	35	high	high	ADJ
ajfti-2033	160	36	school	school	NOUN
ajfti-2033	160	37	diplomas	diploma	NOUN
ajfti-2033	160	38	,	,	PUNCT
ajfti-2033	160	39	and	and	CCONJ
ajfti-2033	160	40	5	5	NUM
ajfti-2033	160	41	%	%	NOUN
ajfti-2033	160	42	are	be	AUX
ajfti-2033	160	43	ph.d	ph.d	PROPN
ajfti-2033	160	44	.	.	PUNCT
ajfti-2033	161	1	holders	holder	NOUN
ajfti-2033	161	2	.	.	PUNCT
ajfti-2033	162	1	the	the	DET
ajfti-2033	162	2	monthly	monthly	ADJ
ajfti-2033	162	3	income	income	NOUN
ajfti-2033	162	4	of	of	ADP
ajfti-2033	162	5	the	the	DET
ajfti-2033	162	6	participants	participant	NOUN
ajfti-2033	162	7	is	be	AUX
ajfti-2033	162	8	equally	equally	ADV
ajfti-2033	162	9	varied	varied	ADJ
ajfti-2033	162	10	,	,	PUNCT
ajfti-2033	162	11	as	as	SCONJ
ajfti-2033	162	12	shown	show	VERB
ajfti-2033	162	13	in	in	ADP
ajfti-2033	162	14	table	table	NOUN
ajfti-2033	162	15	4	4	NUM
ajfti-2033	162	16	.	.	PUNCT
ajfti-2033	163	1	notably	notably	ADV
ajfti-2033	163	2	,	,	PUNCT
ajfti-2033	163	3	43	43	NUM
ajfti-2033	163	4	%	%	NOUN
ajfti-2033	163	5	earn	earn	VERB
ajfti-2033	163	6	more	more	ADJ
ajfti-2033	163	7	than	than	ADP
ajfti-2033	163	8	2000	2000	NUM
ajfti-2033	163	9	sar	sar	NOUN
ajfti-2033	163	10	monthly	monthly	ADV
ajfti-2033	163	11	,	,	PUNCT
ajfti-2033	163	12	while	while	SCONJ
ajfti-2033	163	13	18	18	NUM
ajfti-2033	163	14	%	%	NOUN
ajfti-2033	163	15	earn	earn	NOUN
ajfti-2033	163	16	below	below	ADP
ajfti-2033	163	17	10,000	10,000	NUM
ajfti-2033	163	18	sar	sar	NOUN
ajfti-2033	163	19	.	.	PUNCT
ajfti-2033	164	1	while	while	SCONJ
ajfti-2033	164	2	20	20	NUM
ajfti-2033	164	3	%	%	NOUN
ajfti-2033	164	4	of	of	ADP
ajfti-2033	164	5	the	the	DET
ajfti-2033	164	6	participants	participant	NOUN
ajfti-2033	164	7	have	have	VERB
ajfti-2033	164	8	income	income	NOUN
ajfti-2033	164	9	between	between	ADP
ajfti-2033	164	10	1600	1600	NUM
ajfti-2033	164	11	to	to	ADP
ajfti-2033	164	12	2000	2000	NUM
ajfti-2033	164	13	saw	see	VERB
ajfti-2033	164	14	per	per	ADP
ajfti-2033	164	15	month	month	NOUN
ajfti-2033	164	16	,	,	PUNCT
ajfti-2033	164	17	the	the	DET
ajfti-2033	164	18	rest	rest	NOUN
ajfti-2033	164	19	,	,	PUNCT
ajfti-2033	164	20	18	18	NUM
ajfti-2033	164	21	%	%	NOUN
ajfti-2033	164	22	,	,	PUNCT
ajfti-2033	164	23	have	have	VERB
ajfti-2033	164	24	110000	110000	NUM
ajfti-2033	164	25	-	-	SYM
ajfti-2033	164	26	15000	15000	NUM
ajfti-2033	164	27	average	average	ADJ
ajfti-2033	164	28	monthly	monthly	ADJ
ajfti-2033	164	29	income	income	NOUN
ajfti-2033	164	30	.	.	PUNCT
ajfti-2033	165	1	the	the	DET
ajfti-2033	165	2	study	study	NOUN
ajfti-2033	165	3	’s	’s	PART
ajfti-2033	165	4	findings	finding	NOUN
ajfti-2033	165	5	in	in	ADP
ajfti-2033	165	6	table	table	NOUN
ajfti-2033	165	7	5	5	NUM
ajfti-2033	165	8	.	.	PUNCT
ajfti-2033	165	9	have	have	AUX
ajfti-2033	165	10	also	also	ADV
ajfti-2033	165	11	revealed	reveal	VERB
ajfti-2033	165	12	that	that	SCONJ
ajfti-2033	165	13	people	people	NOUN
ajfti-2033	165	14	from	from	ADP
ajfti-2033	165	15	various	various	ADJ
ajfti-2033	165	16	regions	region	NOUN
ajfti-2033	165	17	have	have	AUX
ajfti-2033	165	18	participated	participate	VERB
ajfti-2033	165	19	,	,	PUNCT
ajfti-2033	165	20	with	with	ADP
ajfti-2033	165	21	the	the	DET
ajfti-2033	165	22	central	central	ADJ
ajfti-2033	165	23	region	region	NOUN
ajfti-2033	165	24	dominating	dominate	VERB
ajfti-2033	165	25	at	at	ADP
ajfti-2033	165	26	70.8	70.8	NUM
ajfti-2033	165	27	%	%	NOUN
ajfti-2033	165	28	.	.	PUNCT
ajfti-2033	166	1	the	the	DET
ajfti-2033	166	2	western	western	ADJ
ajfti-2033	166	3	region	region	NOUN
ajfti-2033	166	4	follows	follow	VERB
ajfti-2033	166	5	at	at	ADP
ajfti-2033	166	6	12.8	12.8	NUM
ajfti-2033	166	7	%	%	NOUN
ajfti-2033	166	8	,	,	PUNCT
ajfti-2033	166	9	while	while	SCONJ
ajfti-2033	166	10	other	other	ADJ
ajfti-2033	166	11	regions	region	NOUN
ajfti-2033	166	12	have	have	VERB
ajfti-2033	166	13	smaller	small	ADJ
ajfti-2033	166	14	representations	representation	NOUN
ajfti-2033	166	15	:	:	PUNCT
ajfti-2033	166	16	3	3	NUM
ajfti-2033	166	17	%	%	NOUN
ajfti-2033	166	18	in	in	ADP
ajfti-2033	166	19	the	the	DET
ajfti-2033	166	20	eastern	eastern	ADJ
ajfti-2033	166	21	region	region	NOUN
ajfti-2033	166	22	,	,	PUNCT
ajfti-2033	166	23	1	1	NUM
ajfti-2033	166	24	%	%	NOUN
ajfti-2033	166	25	outside	outside	ADP
ajfti-2033	166	26	of	of	ADP
ajfti-2033	166	27	the	the	DET
ajfti-2033	166	28	kingdom	kingdom	NOUN
ajfti-2033	166	29	of	of	ADP
ajfti-2033	166	30	saudi	saudi	PROPN
ajfti-2033	166	31	arabia	arabia	PROPN
ajfti-2033	166	32	,	,	PUNCT
ajfti-2033	166	33	13	13	NUM
ajfti-2033	166	34	%	%	NOUN
ajfti-2033	166	35	in	in	ADP
ajfti-2033	166	36	the	the	DET
ajfti-2033	166	37	western	western	ADJ
ajfti-2033	166	38	region	region	NOUN
ajfti-2033	166	39	,	,	PUNCT
ajfti-2033	166	40	and	and	CCONJ
ajfti-2033	166	41	9	9	NUM
ajfti-2033	166	42	%	%	NOUN
ajfti-2033	166	43	in	in	ADP
ajfti-2033	166	44	the	the	DET
ajfti-2033	166	45	southern	southern	ADJ
ajfti-2033	166	46	region	region	NOUN
ajfti-2033	166	47	.	.	PUNCT
ajfti-2033	167	1	a	a	DET
ajfti-2033	167	2	vital	vital	ADJ
ajfti-2033	167	3	facet	facet	NOUN
ajfti-2033	167	4	of	of	ADP
ajfti-2033	167	5	our	our	PRON
ajfti-2033	167	6	research	research	NOUN
ajfti-2033	167	7	is	be	AUX
ajfti-2033	167	8	insurance	insurance	NOUN
ajfti-2033	167	9	coverage	coverage	NOUN
ajfti-2033	167	10	,	,	PUNCT
ajfti-2033	167	11	illustrated	illustrate	VERB
ajfti-2033	167	12	in	in	ADP
ajfti-2033	167	13	table	table	NOUN
ajfti-2033	167	14	6	6	NUM
ajfti-2033	167	15	,	,	PUNCT
ajfti-2033	167	16	revealing	reveal	VERB
ajfti-2033	167	17	that	that	SCONJ
ajfti-2033	167	18	almost	almost	ADV
ajfti-2033	167	19	69	69	NUM
ajfti-2033	167	20	%	%	NOUN
ajfti-2033	167	21	of	of	ADP
ajfti-2033	167	22	participants	participant	NOUN
ajfti-2033	167	23	possess	possess	VERB
ajfti-2033	167	24	insurance	insurance	NOUN
ajfti-2033	167	25	coverage	coverage	NOUN
ajfti-2033	167	26	,	,	PUNCT
ajfti-2033	167	27	while	while	SCONJ
ajfti-2033	167	28	31	31	NUM
ajfti-2033	167	29	%	%	NOUN
ajfti-2033	167	30	do	do	AUX
ajfti-2033	167	31	not	not	PART
ajfti-2033	167	32	,	,	PUNCT
ajfti-2033	167	33	highlighting	highlight	VERB
ajfti-2033	167	34	that	that	SCONJ
ajfti-2033	167	35	1/3	1/3	NUM
ajfti-2033	167	36	of	of	ADP
ajfti-2033	167	37	the	the	DET
ajfti-2033	167	38	saudi	saudi	ADJ
ajfti-2033	167	39	population	population	NOUN
ajfti-2033	167	40	does	do	AUX
ajfti-2033	167	41	n’t	not	PART
ajfti-2033	167	42	have	have	VERB
ajfti-2033	167	43	insurance	insurance	NOUN
ajfti-2033	167	44	coverage	coverage	NOUN
ajfti-2033	167	45	.	.	PUNCT
ajfti-2033	168	1	in	in	ADP
ajfti-2033	168	2	contrast	contrast	NOUN
ajfti-2033	168	3	,	,	PUNCT
ajfti-2033	168	4	the	the	DET
ajfti-2033	168	5	hospitals	hospital	NOUN
ajfti-2033	168	6	worked	work	VERB
ajfti-2033	168	7	only	only	ADV
ajfti-2033	168	8	a	a	DET
ajfti-2033	168	9	negligible	negligible	ADJ
ajfti-2033	168	10	amount	amount	NOUN
ajfti-2033	168	11	of	of	ADP
ajfti-2033	168	12	insurance	insurance	NOUN
ajfti-2033	168	13	.	.	PUNCT
ajfti-2033	169	1	table	table	NOUN
ajfti-2033	169	2	3	3	NUM
ajfti-2033	169	3	:	:	PUNCT
ajfti-2033	169	4	education	education	NOUN
ajfti-2033	169	5	level	level	NOUN
ajfti-2033	169	6	frequency	frequency	NOUN
ajfti-2033	169	7	per	per	ADP
ajfti-2033	169	8	cent	cent	NOUN
ajfti-2033	169	9	valid	valid	ADJ
ajfti-2033	169	10	percent	percent	NOUN
ajfti-2033	169	11	cumulative	cumulative	ADJ
ajfti-2033	169	12	percent	percent	NOUN
ajfti-2033	169	13	valid	valid	ADJ
ajfti-2033	169	14	bachelors	bachelor	NOUN
ajfti-2033	169	15	’	'	PUNCT
ajfti-2033	169	16	degree	degree	NOUN
ajfti-2033	169	17	140	140	NUM
ajfti-2033	169	18	56.0	56.0	NUM
ajfti-2033	169	19	56.0	56.0	NUM
ajfti-2033	169	20	56.0	56.0	NUM
ajfti-2033	169	21	high	high	ADJ
ajfti-2033	169	22	school	school	NOUN
ajfti-2033	169	23	19	19	NUM
ajfti-2033	169	24	7.6	7.6	NUM
ajfti-2033	169	25	7.6	7.6	NUM
ajfti-2033	169	26	63.6	63.6	NUM
ajfti-2033	169	27	master	master	NOUN
ajfti-2033	169	28	’s	’s	PART
ajfti-2033	169	29	degree	degree	NOUN
ajfti-2033	169	30	77	77	NUM
ajfti-2033	169	31	30.8	30.8	NUM
ajfti-2033	169	32	30.8	30.8	NUM
ajfti-2033	169	33	94.4	94.4	NUM
ajfti-2033	169	34	ph.d	ph.d	NOUN
ajfti-2033	169	35	.	.	PROPN
ajfti-2033	170	1	13	13	NUM
ajfti-2033	170	2	5.2	5.2	NUM
ajfti-2033	170	3	5.2	5.2	NUM
ajfti-2033	170	4	99.6	99.6	NUM
ajfti-2033	170	5	pharmd	pharmd	NOUN
ajfti-2033	170	6	1	1	NUM
ajfti-2033	170	7	.4	.4	NUM
ajfti-2033	170	8	.4	.4	NUM
ajfti-2033	171	1	100.0	100.0	NUM
ajfti-2033	171	2	total	total	NOUN
ajfti-2033	171	3	250	250	NUM
ajfti-2033	171	4	100.0	100.0	NUM
ajfti-2033	171	5	100.0	100.0	NUM
ajfti-2033	171	6	table	table	NOUN
ajfti-2033	171	7	4	4	NUM
ajfti-2033	171	8	:	:	PUNCT
ajfti-2033	171	9	monthly	monthly	ADJ
ajfti-2033	171	10	income	income	NOUN
ajfti-2033	171	11	of	of	ADP
ajfti-2033	171	12	participants	participant	NOUN
ajfti-2033	171	13	frequency	frequency	VERB
ajfti-2033	171	14	per	per	ADP
ajfti-2033	171	15	cent	cent	NOUN
ajfti-2033	171	16	valid	valid	ADJ
ajfti-2033	171	17	percent	percent	NOUN
ajfti-2033	171	18	cumulative	cumulative	ADJ
ajfti-2033	171	19	percent	percent	NOUN
ajfti-2033	171	20	valid	valid	ADJ
ajfti-2033	171	21	110000	110000	NUM
ajfti-2033	171	22	-	-	SYM
ajfti-2033	171	23	15000	15000	NUM
ajfti-2033	171	24	sar	sar	NOUN
ajfti-2033	171	25	46	46	NUM
ajfti-2033	171	26	18.4	18.4	NUM
ajfti-2033	171	27	18.4	18.4	NUM
ajfti-2033	171	28	18.4	18.4	NUM
ajfti-2033	171	29	16000	16000	NUM
ajfti-2033	171	30	-	-	SYM
ajfti-2033	171	31	20000	20000	NUM
ajfti-2033	171	32	sar	sar	NOUN
ajfti-2033	171	33	51	51	NUM
ajfti-2033	171	34	20.4	20.4	NUM
ajfti-2033	171	35	20.4	20.4	NUM
ajfti-2033	171	36	38.8	38.8	NUM
ajfti-2033	171	37	less	less	ADJ
ajfti-2033	171	38	than	than	ADP
ajfti-2033	171	39	10000	10000	NUM
ajfti-2033	171	40	sar	sar	NOUN
ajfti-2033	171	41	45	45	NUM
ajfti-2033	171	42	18.0	18.0	NUM
ajfti-2033	171	43	18.0	18.0	NUM
ajfti-2033	171	44	56.8	56.8	NUM
ajfti-2033	171	45	more	more	ADJ
ajfti-2033	171	46	than	than	ADP
ajfti-2033	171	47	20000	20000	NUM
ajfti-2033	171	48	sar	sar	NOUN
ajfti-2033	171	49	108	108	NUM
ajfti-2033	171	50	43.2	43.2	NUM
ajfti-2033	171	51	43.2	43.2	NUM
ajfti-2033	171	52	100.0	100.0	NUM
ajfti-2033	171	53	total	total	NOUN
ajfti-2033	171	54	250	250	NUM
ajfti-2033	171	55	100.0	100.0	NUM
ajfti-2033	171	56	100.0	100.0	NUM
ajfti-2033	171	57	table	table	NOUN
ajfti-2033	171	58	5	5	NUM
ajfti-2033	171	59	:	:	PUNCT
ajfti-2033	171	60	residence	residence	NOUN
ajfti-2033	171	61	of	of	ADP
ajfti-2033	171	62	participants	participant	NOUN
ajfti-2033	171	63	frequency	frequency	VERB
ajfti-2033	171	64	per	per	ADP
ajfti-2033	171	65	cent	cent	NOUN
ajfti-2033	171	66	valid	valid	ADJ
ajfti-2033	171	67	percent	percent	NOUN
ajfti-2033	171	68	cumulative	cumulative	ADJ
ajfti-2033	171	69	percent	percent	NOUN
ajfti-2033	171	70	valid	valid	ADJ
ajfti-2033	171	71	central	central	ADJ
ajfti-2033	171	72	region	region	NOUN
ajfti-2033	171	73	177	177	NUM
ajfti-2033	171	74	70.8	70.8	NUM
ajfti-2033	171	75	70.8	70.8	NUM
ajfti-2033	171	76	70.8	70.8	NUM
ajfti-2033	171	77	eastern	eastern	ADJ
ajfti-2033	171	78	region	region	NOUN
ajfti-2033	171	79	8	8	NUM
ajfti-2033	171	80	3.2	3.2	NUM
ajfti-2033	171	81	3.2	3.2	NUM
ajfti-2033	171	82	74.0	74.0	NUM
ajfti-2033	171	83	i	i	PRON
ajfti-2033	171	84	live	live	VERB
ajfti-2033	171	85	outside	outside	ADP
ajfti-2033	171	86	of	of	ADP
ajfti-2033	171	87	the	the	DET
ajfti-2033	171	88	kingdom	kingdom	NOUN
ajfti-2033	171	89	of	of	ADP
ajfti-2033	171	90	saudi	saudi	PROPN
ajfti-2033	171	91	arabia	arabia	PROPN
ajfti-2033	172	1	2	2	NUM
ajfti-2033	172	2	.8	.8	PROPN
ajfti-2033	172	3	.8	.8	PROPN
ajfti-2033	172	4	74.8	74.8	NUM
ajfti-2033	172	5	northern	northern	ADJ
ajfti-2033	172	6	region	region	NOUN
ajfti-2033	172	7	8	8	NUM
ajfti-2033	172	8	3.2	3.2	NUM
ajfti-2033	172	9	3.2	3.2	NUM
ajfti-2033	172	10	78.0	78.0	NUM
ajfti-2033	172	11	southern	southern	ADJ
ajfti-2033	172	12	region	region	NOUN
ajfti-2033	172	13	23	23	NUM
ajfti-2033	172	14	9.2	9.2	NUM
ajfti-2033	172	15	9.2	9.2	NUM
ajfti-2033	172	16	87.2	87.2	NUM
ajfti-2033	172	17	western	western	ADJ
ajfti-2033	172	18	region	region	NOUN
ajfti-2033	172	19	32	32	NUM
ajfti-2033	172	20	12.8	12.8	NUM
ajfti-2033	172	21	12.8	12.8	NUM
ajfti-2033	172	22	100.0	100.0	NUM
ajfti-2033	172	23	total	total	NOUN
ajfti-2033	172	24	250	250	NUM
ajfti-2033	172	25	100.0	100.0	NUM
ajfti-2033	172	26	100.0	100.0	NUM
ajfti-2033	172	27	table	table	NOUN
ajfti-2033	172	28	6	6	NUM
ajfti-2033	172	29	:	:	PUNCT
ajfti-2033	172	30	insurance	insurance	NOUN
ajfti-2033	172	31	coverage	coverage	NOUN
ajfti-2033	172	32	frequency	frequency	NOUN
ajfti-2033	172	33	per	per	ADP
ajfti-2033	172	34	cent	cent	NOUN
ajfti-2033	172	35	valid	valid	ADJ
ajfti-2033	172	36	percent	percent	NOUN
ajfti-2033	172	37	cumulative	cumulative	ADJ
ajfti-2033	172	38	percent	percent	NOUN
ajfti-2033	172	39	valid	valid	NOUN
ajfti-2033	172	40	covered	cover	VERB
ajfti-2033	172	41	by	by	ADP
ajfti-2033	172	42	the	the	DET
ajfti-2033	172	43	hospital	hospital	NOUN
ajfti-2033	172	44	i	i	PRON
ajfti-2033	172	45	work	work	VERB
ajfti-2033	172	46	in	in	ADP
ajfti-2033	172	47	1	1	NUM
ajfti-2033	172	48	.4	.4	NUM
ajfti-2033	173	1	.4	.4	NUM
ajfti-2033	173	2	.4	.4	NUM
ajfti-2033	174	1	no	no	DET
ajfti-2033	174	2	78	78	NUM
ajfti-2033	174	3	31.2	31.2	NUM
ajfti-2033	174	4	31.2	31.2	NUM
ajfti-2033	174	5	31.6	31.6	NUM
ajfti-2033	174	6	yes	yes	NOUN
ajfti-2033	174	7	171	171	NUM
ajfti-2033	174	8	68.4	68.4	NUM
ajfti-2033	174	9	68.4	68.4	NUM
ajfti-2033	174	10	100.0	100.0	NUM
ajfti-2033	174	11	total	total	NOUN
ajfti-2033	174	12	250	250	NUM
ajfti-2033	174	13	100.0	100.0	NUM
ajfti-2033	174	14	100.0	100.0	NUM
ajfti-2033	174	15	measurement	measurement	NOUN
ajfti-2033	174	16	of	of	ADP
ajfti-2033	174	17	drug	drug	NOUN
ajfti-2033	174	18	pricing	pricing	NOUN
ajfti-2033	174	19	reliability	reliability	NOUN
ajfti-2033	174	20	statistics	statistic	NOUN
ajfti-2033	174	21	for	for	ADP
ajfti-2033	174	22	drug	drug	NOUN
ajfti-2033	174	23	pricing	pricing	NOUN
ajfti-2033	174	24	,	,	PUNCT
ajfti-2033	174	25	as	as	SCONJ
ajfti-2033	174	26	shown	show	VERB
ajfti-2033	174	27	in	in	ADP
ajfti-2033	174	28	table	table	NOUN
ajfti-2033	174	29	7	7	NUM
ajfti-2033	174	30	.	.	PUNCT
ajfti-2033	174	31	shows	show	VERB
ajfti-2033	174	32	volumes	volume	NOUN
ajfti-2033	174	33	,	,	PUNCT
ajfti-2033	174	34	as	as	SCONJ
ajfti-2033	174	35	cronbach	cronbach	VERB
ajfti-2033	174	36	’s	’s	PART
ajfti-2033	174	37	alpha	alpha	ADJ
ajfti-2033	174	38	coefficient	coefficient	NOUN
ajfti-2033	174	39	of	of	ADP
ajfti-2033	174	40	0.810	0.810	NUM
ajfti-2033	174	41	indicates	indicate	VERB
ajfti-2033	174	42	strong	strong	ADJ
ajfti-2033	174	43	internal	internal	ADJ
ajfti-2033	174	44	consistency	consistency	NOUN
ajfti-2033	174	45	among	among	ADP
ajfti-2033	174	46	the	the	DET
ajfti-2033	174	47	five	five	NUM
ajfti-2033	174	48	items	item	NOUN
ajfti-2033	174	49	used	use	VERB
ajfti-2033	174	50	to	to	PART
ajfti-2033	174	51	measure	measure	VERB
ajfti-2033	174	52	drug	drug	NOUN
ajfti-2033	174	53	pricing	pricing	NOUN
ajfti-2033	174	54	.	.	PUNCT
ajfti-2033	175	1	these	these	DET
ajfti-2033	175	2	results	result	NOUN
ajfti-2033	175	3	validate	validate	VERB
ajfti-2033	175	4	the	the	DET
ajfti-2033	175	5	efficacy	efficacy	NOUN
ajfti-2033	175	6	of	of	ADP
ajfti-2033	175	7	our	our	PRON
ajfti-2033	175	8	drug	drug	NOUN
ajfti-2033	175	9	pricing	pricing	NOUN
ajfti-2033	175	10	measurement	measurement	NOUN
ajfti-2033	175	11	.	.	PUNCT
ajfti-2033	176	1	the	the	DET
ajfti-2033	176	2	total	total	ADJ
ajfti-2033	176	3	variation	variation	NOUN
ajfti-2033	176	4	in	in	ADP
ajfti-2033	176	5	observable	observable	ADJ
ajfti-2033	176	6	variables	variable	NOUN
ajfti-2033	176	7	that	that	PRON
ajfti-2033	176	8	may	may	AUX
ajfti-2033	176	9	be	be	AUX
ajfti-2033	176	10	explained	explain	VERB
ajfti-2033	176	11	by	by	ADP
ajfti-2033	176	12	drug	drug	NOUN
ajfti-2033	176	13	pricing	pricing	NOUN
ajfti-2033	176	14	is	be	AUX
ajfti-2033	176	15	shown	show	VERB
ajfti-2033	176	16	in	in	ADP
ajfti-2033	176	17	table	table	NOUN
ajfti-2033	176	18	8	8	NUM
ajfti-2033	176	19	.	.	PUNCT
ajfti-2033	177	1	and	and	CCONJ
ajfti-2033	177	2	pa	pa	PROPN
ajfti-2033	177	3	ge	ge	PROPN
ajfti-2033	177	4	29	29	NUM
ajfti-2033	177	5	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	177	6	am	be	AUX
ajfti-2033	177	7	.	.	PUNCT
ajfti-2033	178	1	j.	j.	PROPN
ajfti-2033	178	2	financ	financ	PROPN
ajfti-2033	178	3	.	.	PUNCT
ajfti-2033	179	1	technol	technol	PROPN
ajfti-2033	179	2	.	.	PUNCT
ajfti-2033	179	3	innov	innov	PROPN
ajfti-2033	179	4	.	.	PUNCT
ajfti-2033	180	1	1(1	1(1	NUM
ajfti-2033	180	2	)	)	PUNCT
ajfti-2033	180	3	24	24	NUM
ajfti-2033	180	4	-	-	SYM
ajfti-2033	180	5	34	34	NUM
ajfti-2033	180	6	,	,	PUNCT
ajfti-2033	180	7	2023	2023	NUM
ajfti-2033	180	8	table	table	NOUN
ajfti-2033	180	9	7	7	NUM
ajfti-2033	180	10	:	:	PUNCT
ajfti-2033	180	11	reliability	reliability	NOUN
ajfti-2033	180	12	statistics	statistic	NOUN
ajfti-2033	180	13	of	of	ADP
ajfti-2033	180	14	drug	drug	NOUN
ajfti-2033	180	15	pricing	pricing	NOUN
ajfti-2033	180	16	cronbach	cronbach	NOUN
ajfti-2033	180	17	's	's	PART
ajfti-2033	180	18	alpha	alpha	NOUN
ajfti-2033	180	19	cronbach	cronbach	NOUN
ajfti-2033	180	20	's	's	PART
ajfti-2033	180	21	alpha	alpha	NOUN
ajfti-2033	180	22	based	base	VERB
ajfti-2033	180	23	on	on	ADP
ajfti-2033	180	24	standardised	standardised	ADJ
ajfti-2033	180	25	items	item	NOUN
ajfti-2033	180	26	n	n	ADP
ajfti-2033	180	27	of	of	ADP
ajfti-2033	180	28	items	item	NOUN
ajfti-2033	180	29	.814	.814	NUM
ajfti-2033	180	30	.810	.810	NUM
ajfti-2033	180	31	5	5	NUM
ajfti-2033	180	32	table	table	NOUN
ajfti-2033	180	33	8	8	NUM
ajfti-2033	180	34	:	:	PUNCT
ajfti-2033	180	35	total	total	ADJ
ajfti-2033	180	36	variance	variance	NOUN
ajfti-2033	180	37	explained	explain	VERB
ajfti-2033	180	38	by	by	ADP
ajfti-2033	180	39	drug	drug	NOUN
ajfti-2033	180	40	pricing	pricing	NOUN
ajfti-2033	180	41	in	in	ADP
ajfti-2033	180	42	observed	observed	ADJ
ajfti-2033	180	43	variables	variable	NOUN
ajfti-2033	180	44	component	component	NOUN
ajfti-2033	180	45	initial	initial	ADJ
ajfti-2033	180	46	eigenvalues	eigenvalue	VERB
ajfti-2033	180	47	extraction	extraction	NOUN
ajfti-2033	180	48	sums	sum	NOUN
ajfti-2033	180	49	of	of	ADP
ajfti-2033	180	50	squared	square	VERB
ajfti-2033	180	51	loadings	loading	NOUN
ajfti-2033	180	52	total	total	ADJ
ajfti-2033	180	53	%	%	NOUN
ajfti-2033	180	54	of	of	ADP
ajfti-2033	180	55	variance	variance	NOUN
ajfti-2033	180	56	cumulative	cumulative	ADJ
ajfti-2033	180	57	%	%	NOUN
ajfti-2033	180	58	total	total	ADJ
ajfti-2033	180	59	%	%	NOUN
ajfti-2033	180	60	of	of	ADP
ajfti-2033	180	61	variance	variance	NOUN
ajfti-2033	180	62	cumulative	cumulative	ADJ
ajfti-2033	180	63	%	%	NOUN
ajfti-2033	181	1	1	1	NUM
ajfti-2033	181	2	2.903	2.903	NUM
ajfti-2033	181	3	58.066	58.066	NUM
ajfti-2033	181	4	58.066	58.066	NUM
ajfti-2033	181	5	2.903	2.903	NUM
ajfti-2033	181	6	58.066	58.066	NUM
ajfti-2033	181	7	58.066	58.066	NUM
ajfti-2033	181	8	2	2	NUM
ajfti-2033	181	9	.927	.927	NUM
ajfti-2033	181	10	18.534	18.534	NUM
ajfti-2033	181	11	76.601	76.601	NUM
ajfti-2033	181	12	3	3	NUM
ajfti-2033	181	13	.469	.469	NUM
ajfti-2033	181	14	9.386	9.386	NUM
ajfti-2033	181	15	85.987	85.987	NUM
ajfti-2033	181	16	4	4	NUM
ajfti-2033	181	17	.391	.391	NUM
ajfti-2033	181	18	7.817	7.817	NUM
ajfti-2033	181	19	93.804	93.804	NUM
ajfti-2033	181	20	5	5	NUM
ajfti-2033	181	21	.310	.310	NUM
ajfti-2033	181	22	6.196	6.196	NUM
ajfti-2033	181	23	100.000	100.000	NUM
ajfti-2033	181	24	extraction	extraction	NOUN
ajfti-2033	181	25	method	method	NOUN
ajfti-2033	181	26	:	:	PUNCT
ajfti-2033	181	27	principal	principal	ADJ
ajfti-2033	181	28	component	component	NOUN
ajfti-2033	181	29	analysis	analysis	NOUN
ajfti-2033	181	30	table	table	NOUN
ajfti-2033	181	31	9	9	NUM
ajfti-2033	181	32	:	:	PUNCT
ajfti-2033	181	33	component	component	NOUN
ajfti-2033	181	34	matrix	matrix	NOUN
ajfti-2033	181	35	(	(	PUNCT
ajfti-2033	181	36	drug	drug	NOUN
ajfti-2033	181	37	pricing	pricing	NOUN
ajfti-2033	181	38	)	)	PUNCT
ajfti-2033	181	39	component	component	NOUN
ajfti-2033	181	40	1	1	NUM
ajfti-2033	181	41	high	high	ADJ
ajfti-2033	181	42	drug	drug	NOUN
ajfti-2033	181	43	prices	price	NOUN
ajfti-2033	181	44	significantly	significantly	ADV
ajfti-2033	181	45	affect	affect	VERB
ajfti-2033	181	46	my	my	PRON
ajfti-2033	181	47	ability	ability	NOUN
ajfti-2033	181	48	to	to	PART
ajfti-2033	181	49	purchase	purchase	VERB
ajfti-2033	181	50	and	and	CCONJ
ajfti-2033	181	51	use	use	VERB
ajfti-2033	181	52	medications	medication	NOUN
ajfti-2033	181	53	as	as	SCONJ
ajfti-2033	181	54	prescribed	prescribe	VERB
ajfti-2033	181	55	consistently	consistently	ADV
ajfti-2033	181	56	.	.	PUNCT
ajfti-2033	181	57	.813	.813	NUM
ajfti-2033	182	1	i	i	PRON
ajfti-2033	182	2	have	have	AUX
ajfti-2033	182	3	skipped	skip	VERB
ajfti-2033	182	4	or	or	CCONJ
ajfti-2033	182	5	reduced	reduce	VERB
ajfti-2033	182	6	medication	medication	NOUN
ajfti-2033	182	7	doses	dose	NOUN
ajfti-2033	182	8	due	due	ADJ
ajfti-2033	182	9	to	to	ADP
ajfti-2033	182	10	the	the	DET
ajfti-2033	182	11	cost	cost	NOUN
ajfti-2033	182	12	of	of	ADP
ajfti-2033	182	13	the	the	DET
ajfti-2033	182	14	drugs	drug	NOUN
ajfti-2033	182	15	.	.	PUNCT
ajfti-2033	182	16	.809	.809	NUM
ajfti-2033	183	1	i	i	PRON
ajfti-2033	183	2	have	have	AUX
ajfti-2033	183	3	experienced	experience	VERB
ajfti-2033	183	4	financial	financial	ADJ
ajfti-2033	183	5	strain	strain	NOUN
ajfti-2033	183	6	due	due	ADP
ajfti-2033	183	7	to	to	ADP
ajfti-2033	183	8	the	the	DET
ajfti-2033	183	9	cost	cost	NOUN
ajfti-2033	183	10	of	of	ADP
ajfti-2033	183	11	my	my	PRON
ajfti-2033	183	12	medications	medication	NOUN
ajfti-2033	183	13	.	.	PUNCT
ajfti-2033	184	1	.814	.814	NUM
ajfti-2033	185	1	lowering	lower	VERB
ajfti-2033	185	2	drug	drug	NOUN
ajfti-2033	185	3	prices	price	NOUN
ajfti-2033	185	4	would	would	AUX
ajfti-2033	185	5	improve	improve	VERB
ajfti-2033	185	6	medication	medication	NOUN
ajfti-2033	185	7	adherence	adherence	NOUN
ajfti-2033	185	8	in	in	ADP
ajfti-2033	185	9	saudi	saudi	PROPN
ajfti-2033	185	10	arabia	arabia	PROPN
ajfti-2033	185	11	.	.	PUNCT
ajfti-2033	186	1	.482	.482	NUM
ajfti-2033	186	2	the	the	DET
ajfti-2033	186	3	cost	cost	NOUN
ajfti-2033	186	4	of	of	ADP
ajfti-2033	186	5	medications	medication	NOUN
ajfti-2033	186	6	has	have	AUX
ajfti-2033	186	7	led	lead	VERB
ajfti-2033	186	8	me	i	PRON
ajfti-2033	186	9	to	to	PART
ajfti-2033	186	10	seek	seek	VERB
ajfti-2033	186	11	alternative	alternative	ADJ
ajfti-2033	186	12	treatments	treatment	NOUN
ajfti-2033	186	13	or	or	CCONJ
ajfti-2033	186	14	therapies	therapy	NOUN
ajfti-2033	186	15	.	.	PUNCT
ajfti-2033	187	1	.834	.834	NUM
ajfti-2033	187	2	extraction	extraction	NOUN
ajfti-2033	187	3	method	method	NOUN
ajfti-2033	187	4	:	:	PUNCT
ajfti-2033	187	5	principal	principal	ADJ
ajfti-2033	187	6	component	component	NOUN
ajfti-2033	187	7	analysis	analysis	NOUN
ajfti-2033	187	8	emphasises	emphasise	VERB
ajfti-2033	187	9	how	how	SCONJ
ajfti-2033	187	10	important	important	ADJ
ajfti-2033	187	11	this	this	DET
ajfti-2033	187	12	factor	factor	NOUN
ajfti-2033	187	13	is	be	AUX
ajfti-2033	187	14	.	.	PUNCT
ajfti-2033	188	1	the	the	DET
ajfti-2033	188	2	first	first	ADJ
ajfti-2033	188	3	component	component	NOUN
ajfti-2033	188	4	is	be	AUX
ajfti-2033	188	5	significant	significant	ADJ
ajfti-2033	188	6	in	in	ADP
ajfti-2033	188	7	our	our	PRON
ajfti-2033	188	8	analysis	analysis	NOUN
ajfti-2033	188	9	since	since	SCONJ
ajfti-2033	188	10	it	it	PRON
ajfti-2033	188	11	accounts	account	VERB
ajfti-2033	188	12	for	for	ADP
ajfti-2033	188	13	58.066	58.066	NUM
ajfti-2033	188	14	%	%	NOUN
ajfti-2033	188	15	of	of	ADP
ajfti-2033	188	16	the	the	DET
ajfti-2033	188	17	total	total	ADJ
ajfti-2033	188	18	variation	variation	NOUN
ajfti-2033	188	19	.	.	PUNCT
ajfti-2033	189	1	the	the	DET
ajfti-2033	189	2	component	component	NOUN
ajfti-2033	189	3	matrix	matrix	NOUN
ajfti-2033	189	4	(	(	PUNCT
ajfti-2033	189	5	drug	drug	NOUN
ajfti-2033	189	6	pricing	pricing	NOUN
ajfti-2033	189	7	)	)	PUNCT
ajfti-2033	189	8	findings	finding	NOUN
ajfti-2033	189	9	are	be	AUX
ajfti-2033	189	10	illustrated	illustrate	VERB
ajfti-2033	189	11	in	in	ADP
ajfti-2033	189	12	table	table	NOUN
ajfti-2033	189	13	9	9	NUM
ajfti-2033	189	14	.	.	NOUN
ajfti-2033	189	15	elucidates	elucidate	VERB
ajfti-2033	189	16	the	the	DET
ajfti-2033	189	17	relationships	relationship	NOUN
ajfti-2033	189	18	between	between	ADP
ajfti-2033	189	19	observed	observed	ADJ
ajfti-2033	189	20	variables	variable	NOUN
ajfti-2033	189	21	and	and	CCONJ
ajfti-2033	189	22	the	the	DET
ajfti-2033	189	23	extracted	extract	VERB
ajfti-2033	189	24	component	component	NOUN
ajfti-2033	189	25	.	.	PUNCT
ajfti-2033	190	1	notably	notably	ADV
ajfti-2033	190	2	,	,	PUNCT
ajfti-2033	190	3	observed	observed	ADJ
ajfti-2033	190	4	variables	variable	NOUN
ajfti-2033	190	5	exhibit	exhibit	VERB
ajfti-2033	190	6	strong	strong	ADJ
ajfti-2033	190	7	loadings	loading	NOUN
ajfti-2033	190	8	on	on	ADP
ajfti-2033	190	9	component	component	NOUN
ajfti-2033	190	10	1	1	NUM
ajfti-2033	190	11	,	,	PUNCT
ajfti-2033	190	12	further	far	ADV
ajfti-2033	190	13	emphasising	emphasise	VERB
ajfti-2033	190	14	the	the	DET
ajfti-2033	190	15	relevance	relevance	NOUN
ajfti-2033	190	16	of	of	ADP
ajfti-2033	190	17	drug	drug	NOUN
ajfti-2033	190	18	pricing	pricing	NOUN
ajfti-2033	190	19	in	in	ADP
ajfti-2033	190	20	our	our	PRON
ajfti-2033	190	21	research	research	NOUN
ajfti-2033	190	22	.	.	PUNCT
ajfti-2033	191	1	for	for	ADP
ajfti-2033	191	2	example	example	NOUN
ajfti-2033	191	3	,	,	PUNCT
ajfti-2033	191	4	observed	observed	ADJ
ajfti-2033	191	5	variable	variable	NOUN
ajfti-2033	191	6	4	4	NUM
ajfti-2033	191	7	,	,	PUNCT
ajfti-2033	191	8	“	"	PUNCT
ajfti-2033	191	9	seeking	seek	VERB
ajfti-2033	191	10	alternative	alternative	ADJ
ajfti-2033	191	11	treatments	treatment	NOUN
ajfti-2033	191	12	due	due	ADP
ajfti-2033	191	13	to	to	ADP
ajfti-2033	191	14	medication	medication	NOUN
ajfti-2033	191	15	cost	cost	NOUN
ajfti-2033	191	16	,	,	PUNCT
ajfti-2033	191	17	”	"	PUNCT
ajfti-2033	191	18	had	have	VERB
ajfti-2033	191	19	a	a	DET
ajfti-2033	191	20	high	high	ADJ
ajfti-2033	191	21	loading	loading	NOUN
ajfti-2033	191	22	of	of	ADP
ajfti-2033	191	23	0.834	0.834	NUM
ajfti-2033	191	24	and	and	CCONJ
ajfti-2033	191	25	a	a	DET
ajfti-2033	191	26	good	good	ADJ
ajfti-2033	191	27	correlation	correlation	NOUN
ajfti-2033	191	28	with	with	ADP
ajfti-2033	191	29	component	component	NOUN
ajfti-2033	191	30	1	1	NUM
ajfti-2033	191	31	of	of	ADP
ajfti-2033	191	32	drug	drug	NOUN
ajfti-2033	191	33	price	price	NOUN
ajfti-2033	191	34	.	.	PUNCT
ajfti-2033	192	1	other	other	ADJ
ajfti-2033	192	2	factors	factor	NOUN
ajfti-2033	192	3	also	also	ADV
ajfti-2033	192	4	exhibit	exhibit	VERB
ajfti-2033	192	5	significant	significant	ADJ
ajfti-2033	192	6	loadings	loading	NOUN
ajfti-2033	192	7	on	on	ADP
ajfti-2033	192	8	component	component	NOUN
ajfti-2033	192	9	1	1	NUM
ajfti-2033	192	10	,	,	PUNCT
ajfti-2033	192	11	confirming	confirm	VERB
ajfti-2033	192	12	their	their	PRON
ajfti-2033	192	13	significance	significance	NOUN
ajfti-2033	192	14	in	in	ADP
ajfti-2033	192	15	determining	determine	VERB
ajfti-2033	192	16	medicine	medicine	NOUN
ajfti-2033	192	17	pricing	pricing	NOUN
ajfti-2033	192	18	.	.	PUNCT
ajfti-2033	193	1	measurement	measurement	NOUN
ajfti-2033	193	2	of	of	ADP
ajfti-2033	193	3	insurance	insurance	NOUN
ajfti-2033	193	4	coverage	coverage	NOUN
ajfti-2033	193	5	reliability	reliability	NOUN
ajfti-2033	193	6	statistics	statistic	NOUN
ajfti-2033	193	7	for	for	ADP
ajfti-2033	193	8	insurance	insurance	NOUN
ajfti-2033	193	9	coverage	coverage	NOUN
ajfti-2033	193	10	,	,	PUNCT
ajfti-2033	193	11	in	in	ADP
ajfti-2033	193	12	table	table	NOUN
ajfti-2033	193	13	10	10	NUM
ajfti-2033	193	14	.	.	PUNCT
ajfti-2033	194	1	reinforce	reinforce	VERB
ajfti-2033	194	2	the	the	DET
ajfti-2033	194	3	credibility	credibility	NOUN
ajfti-2033	194	4	of	of	ADP
ajfti-2033	194	5	our	our	PRON
ajfti-2033	194	6	measurement	measurement	NOUN
ajfti-2033	194	7	scale	scale	NOUN
ajfti-2033	194	8	with	with	ADP
ajfti-2033	194	9	a	a	DET
ajfti-2033	194	10	cronbach	cronbach	NOUN
ajfti-2033	194	11	’s	’s	PART
ajfti-2033	194	12	alpha	alpha	ADJ
ajfti-2033	194	13	coefficient	coefficient	NOUN
ajfti-2033	194	14	of	of	ADP
ajfti-2033	194	15	0.791	0.791	NUM
ajfti-2033	194	16	.	.	PUNCT
ajfti-2033	195	1	the	the	DET
ajfti-2033	195	2	entire	entire	ADJ
ajfti-2033	195	3	variation	variation	NOUN
ajfti-2033	195	4	explained	explain	VERB
ajfti-2033	195	5	by	by	ADP
ajfti-2033	195	6	insurance	insurance	NOUN
ajfti-2033	195	7	coverage	coverage	NOUN
ajfti-2033	195	8	is	be	AUX
ajfti-2033	195	9	shown	show	VERB
ajfti-2033	195	10	in	in	ADP
ajfti-2033	195	11	table	table	NOUN
ajfti-2033	195	12	11	11	NUM
ajfti-2033	195	13	the	the	DET
ajfti-2033	195	14	first	first	ADJ
ajfti-2033	195	15	component	component	NOUN
ajfti-2033	195	16	solidifies	solidify	VERB
ajfti-2033	195	17	its	its	PRON
ajfti-2033	195	18	status	status	NOUN
ajfti-2033	195	19	as	as	ADP
ajfti-2033	195	20	a	a	DET
ajfti-2033	195	21	significant	significant	ADJ
ajfti-2033	195	22	factor	factor	NOUN
ajfti-2033	195	23	by	by	ADP
ajfti-2033	195	24	explaining	explain	VERB
ajfti-2033	195	25	47.814	47.814	NUM
ajfti-2033	195	26	%	%	NOUN
ajfti-2033	195	27	of	of	ADP
ajfti-2033	195	28	the	the	DET
ajfti-2033	195	29	total	total	ADJ
ajfti-2033	195	30	variation	variation	NOUN
ajfti-2033	195	31	.	.	PUNCT
ajfti-2033	196	1	the	the	DET
ajfti-2033	196	2	component	component	NOUN
ajfti-2033	196	3	matrix	matrix	NOUN
ajfti-2033	196	4	(	(	PUNCT
ajfti-2033	196	5	insurance	insurance	NOUN
ajfti-2033	196	6	coverage	coverage	NOUN
ajfti-2033	196	7	)	)	PUNCT
ajfti-2033	196	8	in	in	ADP
ajfti-2033	196	9	table	table	NOUN
ajfti-2033	196	10	12	12	NUM
ajfti-2033	196	11	highlights	highlight	NOUN
ajfti-2033	196	12	the	the	DET
ajfti-2033	196	13	significant	significant	ADJ
ajfti-2033	196	14	correlations	correlation	NOUN
ajfti-2033	196	15	between	between	ADP
ajfti-2033	196	16	the	the	DET
ajfti-2033	196	17	extracted	extract	VERB
ajfti-2033	196	18	component	component	NOUN
ajfti-2033	196	19	and	and	CCONJ
ajfti-2033	196	20	the	the	DET
ajfti-2033	196	21	observed	observed	ADJ
ajfti-2033	196	22	variables	variable	NOUN
ajfti-2033	196	23	,	,	PUNCT
ajfti-2033	196	24	further	far	ADV
ajfti-2033	196	25	supporting	support	VERB
ajfti-2033	196	26	the	the	DET
ajfti-2033	196	27	significance	significance	NOUN
ajfti-2033	196	28	of	of	ADP
ajfti-2033	196	29	insurance	insurance	NOUN
ajfti-2033	196	30	coverage	coverage	NOUN
ajfti-2033	196	31	.	.	PUNCT
ajfti-2033	197	1	table	table	NOUN
ajfti-2033	197	2	10	10	NUM
ajfti-2033	197	3	:	:	PUNCT
ajfti-2033	197	4	reliability	reliability	NOUN
ajfti-2033	197	5	statistics	statistic	NOUN
ajfti-2033	197	6	of	of	ADP
ajfti-2033	197	7	insurance	insurance	NOUN
ajfti-2033	197	8	coverage	coverage	NOUN
ajfti-2033	197	9	cronbach	cronbach	NOUN
ajfti-2033	197	10	's	's	PART
ajfti-2033	197	11	alpha	alpha	NOUN
ajfti-2033	197	12	cronbach	cronbach	NOUN
ajfti-2033	197	13	's	's	PART
ajfti-2033	197	14	alpha	alpha	NOUN
ajfti-2033	197	15	based	base	VERB
ajfti-2033	197	16	on	on	ADP
ajfti-2033	197	17	standardised	standardised	ADJ
ajfti-2033	197	18	items	item	NOUN
ajfti-2033	197	19	n	n	ADP
ajfti-2033	197	20	of	of	ADP
ajfti-2033	197	21	items	item	NOUN
ajfti-2033	197	22	.768	.768	NUM
ajfti-2033	197	23	.791	.791	NUM
ajfti-2033	197	24	5	5	NUM
ajfti-2033	197	25	table	table	NOUN
ajfti-2033	197	26	11	11	NUM
ajfti-2033	197	27	:	:	PUNCT
ajfti-2033	197	28	total	total	ADJ
ajfti-2033	197	29	variance	variance	NOUN
ajfti-2033	197	30	explained	explain	VERB
ajfti-2033	197	31	by	by	ADP
ajfti-2033	197	32	insurance	insurance	NOUN
ajfti-2033	197	33	coverage	coverage	NOUN
ajfti-2033	197	34	in	in	ADP
ajfti-2033	197	35	observed	observe	VERB
ajfti-2033	197	36	variables	variable	NOUN
ajfti-2033	197	37	component	component	NOUN
ajfti-2033	197	38	initial	initial	ADJ
ajfti-2033	197	39	eigenvalues	eigenvalue	VERB
ajfti-2033	197	40	extraction	extraction	NOUN
ajfti-2033	197	41	sums	sum	NOUN
ajfti-2033	197	42	of	of	ADP
ajfti-2033	197	43	squared	square	VERB
ajfti-2033	197	44	loadings	loading	NOUN
ajfti-2033	197	45	total	total	ADJ
ajfti-2033	197	46	%	%	NOUN
ajfti-2033	197	47	of	of	ADP
ajfti-2033	197	48	variance	variance	NOUN
ajfti-2033	197	49	cumulative	cumulative	ADJ
ajfti-2033	197	50	%	%	NOUN
ajfti-2033	197	51	total	total	ADJ
ajfti-2033	197	52	%	%	NOUN
ajfti-2033	197	53	of	of	ADP
ajfti-2033	197	54	variance	variance	NOUN
ajfti-2033	197	55	cumulative	cumulative	ADJ
ajfti-2033	197	56	%	%	NOUN
ajfti-2033	198	1	1	1	NUM
ajfti-2033	198	2	2.391	2.391	NUM
ajfti-2033	198	3	47.814	47.814	NUM
ajfti-2033	198	4	47.814	47.814	NUM
ajfti-2033	198	5	2.391	2.391	NUM
ajfti-2033	198	6	47.814	47.814	NUM
ajfti-2033	198	7	47.814	47.814	NUM
ajfti-2033	198	8	2	2	NUM
ajfti-2033	198	9	1.246	1.246	NUM
ajfti-2033	198	10	24.912	24.912	NUM
ajfti-2033	198	11	72.726	72.726	NUM
ajfti-2033	198	12	3	3	NUM
ajfti-2033	198	13	.625	.625	NUM
ajfti-2033	198	14	12.497	12.497	NUM
ajfti-2033	198	15	85.223	85.223	NUM
ajfti-2033	198	16	4	4	NUM
ajfti-2033	198	17	.441	.441	NUM
ajfti-2033	198	18	8.812	8.812	NUM
ajfti-2033	198	19	94.035	94.035	NUM
ajfti-2033	198	20	5	5	NUM
ajfti-2033	198	21	.298	.298	NUM
ajfti-2033	198	22	5.965	5.965	NUM
ajfti-2033	198	23	100.000	100.000	NUM
ajfti-2033	198	24	extraction	extraction	NOUN
ajfti-2033	198	25	method	method	NOUN
ajfti-2033	198	26	:	:	PUNCT
ajfti-2033	198	27	principal	principal	ADJ
ajfti-2033	198	28	component	component	NOUN
ajfti-2033	198	29	analysis	analysis	NOUN
ajfti-2033	198	30	pa	pa	PROPN
ajfti-2033	198	31	ge	ge	PROPN
ajfti-2033	198	32	30	30	NUM
ajfti-2033	198	33	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	198	34	am	be	AUX
ajfti-2033	198	35	.	.	PUNCT
ajfti-2033	199	1	j.	j.	PROPN
ajfti-2033	199	2	financ	financ	PROPN
ajfti-2033	199	3	.	.	PUNCT
ajfti-2033	200	1	technol	technol	PROPN
ajfti-2033	200	2	.	.	PUNCT
ajfti-2033	200	3	innov	innov	PROPN
ajfti-2033	200	4	.	.	PUNCT
ajfti-2033	201	1	1(1	1(1	NUM
ajfti-2033	201	2	)	)	PUNCT
ajfti-2033	201	3	24	24	NUM
ajfti-2033	201	4	-	-	SYM
ajfti-2033	201	5	34	34	NUM
ajfti-2033	201	6	,	,	PUNCT
ajfti-2033	201	7	2023	2023	NUM
ajfti-2033	201	8	measurement	measurement	NOUN
ajfti-2033	201	9	of	of	ADP
ajfti-2033	201	10	medication	medication	NOUN
ajfti-2033	201	11	adherence	adherence	NOUN
ajfti-2033	201	12	with	with	ADP
ajfti-2033	201	13	a	a	DET
ajfti-2033	201	14	cronbach	cronbach	NOUN
ajfti-2033	201	15	’s	’s	PART
ajfti-2033	201	16	alpha	alpha	ADJ
ajfti-2033	201	17	coefficient	coefficient	NOUN
ajfti-2033	201	18	of	of	ADP
ajfti-2033	201	19	0.824	0.824	NUM
ajfti-2033	201	20	,	,	PUNCT
ajfti-2033	201	21	the	the	DET
ajfti-2033	201	22	reliability	reliability	NOUN
ajfti-2033	201	23	data	datum	NOUN
ajfti-2033	201	24	for	for	ADP
ajfti-2033	201	25	medication	medication	NOUN
ajfti-2033	201	26	adherence	adherence	NOUN
ajfti-2033	201	27	shown	show	VERB
ajfti-2033	201	28	in	in	ADP
ajfti-2033	201	29	table	table	NOUN
ajfti-2033	201	30	13	13	NUM
ajfti-2033	201	31	support	support	NOUN
ajfti-2033	201	32	the	the	DET
ajfti-2033	201	33	validity	validity	NOUN
ajfti-2033	201	34	of	of	ADP
ajfti-2033	201	35	our	our	PRON
ajfti-2033	201	36	assessment	assessment	NOUN
ajfti-2033	201	37	scale	scale	NOUN
ajfti-2033	201	38	.	.	PUNCT
ajfti-2033	202	1	the	the	DET
ajfti-2033	202	2	reliability	reliability	NOUN
ajfti-2033	202	3	of	of	ADP
ajfti-2033	202	4	the	the	DET
ajfti-2033	202	5	measuring	measure	VERB
ajfti-2033	202	6	items	item	NOUN
ajfti-2033	202	7	for	for	ADP
ajfti-2033	202	8	medication	medication	NOUN
ajfti-2033	202	9	adherence	adherence	NOUN
ajfti-2033	202	10	is	be	AUX
ajfti-2033	202	11	attested	attest	VERB
ajfti-2033	202	12	to	to	ADP
ajfti-2033	202	13	by	by	ADP
ajfti-2033	202	14	cronbach	cronbach	VERB
ajfti-2033	202	15	’s	’s	PART
ajfti-2033	202	16	alpha	alpha	ADJ
ajfti-2033	202	17	value	value	NOUN
ajfti-2033	202	18	of	of	ADP
ajfti-2033	202	19	0.824	0.824	NUM
ajfti-2033	202	20	.	.	PUNCT
ajfti-2033	203	1	the	the	DET
ajfti-2033	203	2	entire	entire	ADJ
ajfti-2033	203	3	variation	variation	NOUN
ajfti-2033	203	4	explained	explain	VERB
ajfti-2033	203	5	by	by	ADP
ajfti-2033	203	6	medication	medication	NOUN
ajfti-2033	203	7	adherence	adherence	NOUN
ajfti-2033	203	8	is	be	AUX
ajfti-2033	203	9	shown	show	VERB
ajfti-2033	203	10	in	in	ADP
ajfti-2033	203	11	table	table	NOUN
ajfti-2033	203	12	14	14	NUM
ajfti-2033	203	13	.	.	PUNCT
ajfti-2033	204	1	a	a	DET
ajfti-2033	204	2	significant	significant	ADJ
ajfti-2033	204	3	59.789	59.789	NUM
ajfti-2033	204	4	%	%	NOUN
ajfti-2033	204	5	of	of	ADP
ajfti-2033	204	6	the	the	DET
ajfti-2033	204	7	total	total	ADJ
ajfti-2033	204	8	variation	variation	NOUN
ajfti-2033	204	9	is	be	AUX
ajfti-2033	204	10	explained	explain	VERB
ajfti-2033	204	11	by	by	ADP
ajfti-2033	204	12	the	the	DET
ajfti-2033	204	13	first	first	ADJ
ajfti-2033	204	14	component	component	NOUN
ajfti-2033	204	15	,	,	PUNCT
ajfti-2033	204	16	demonstrating	demonstrate	VERB
ajfti-2033	204	17	its	its	PRON
ajfti-2033	204	18	importance	importance	NOUN
ajfti-2033	204	19	.	.	PUNCT
ajfti-2033	205	1	the	the	DET
ajfti-2033	205	2	first	first	ADJ
ajfti-2033	205	3	component	component	NOUN
ajfti-2033	205	4	accounts	account	VERB
ajfti-2033	205	5	for	for	ADP
ajfti-2033	205	6	59.789	59.789	NUM
ajfti-2033	205	7	%	%	NOUN
ajfti-2033	205	8	of	of	ADP
ajfti-2033	205	9	the	the	DET
ajfti-2033	205	10	variation	variation	NOUN
ajfti-2033	205	11	overall	overall	ADJ
ajfti-2033	205	12	,	,	PUNCT
ajfti-2033	205	13	highlighting	highlight	VERB
ajfti-2033	205	14	the	the	DET
ajfti-2033	205	15	importance	importance	NOUN
ajfti-2033	205	16	of	of	ADP
ajfti-2033	205	17	medication	medication	NOUN
ajfti-2033	205	18	adherence	adherence	NOUN
ajfti-2033	205	19	.	.	PUNCT
ajfti-2033	206	1	based	base	VERB
ajfti-2033	206	2	on	on	ADP
ajfti-2033	206	3	the	the	DET
ajfti-2033	206	4	principal	principal	ADJ
ajfti-2033	206	5	component	component	NOUN
ajfti-2033	206	6	analysis	analysis	NOUN
ajfti-2033	206	7	,	,	PUNCT
ajfti-2033	206	8	table	table	NOUN
ajfti-2033	206	9	15	15	NUM
ajfti-2033	206	10	shows	show	VERB
ajfti-2033	206	11	the	the	DET
ajfti-2033	206	12	component	component	NOUN
ajfti-2033	206	13	matrix	matrix	NOUN
ajfti-2033	206	14	of	of	ADP
ajfti-2033	206	15	medication	medication	NOUN
ajfti-2033	206	16	adherence	adherence	NOUN
ajfti-2033	206	17	and	and	CCONJ
ajfti-2033	206	18	its	its	PRON
ajfti-2033	206	19	observed	observed	ADJ
ajfti-2033	206	20	factors	factor	NOUN
ajfti-2033	206	21	.	.	PUNCT
ajfti-2033	207	1	the	the	DET
ajfti-2033	207	2	link	link	NOUN
ajfti-2033	207	3	between	between	ADP
ajfti-2033	207	4	each	each	DET
ajfti-2033	207	5	observed	observe	VERB
ajfti-2033	207	6	variable	variable	NOUN
ajfti-2033	207	7	and	and	CCONJ
ajfti-2033	207	8	the	the	DET
ajfti-2033	207	9	extracted	extract	VERB
ajfti-2033	207	10	component	component	NOUN
ajfti-2033	207	11	is	be	AUX
ajfti-2033	207	12	indicated	indicate	VERB
ajfti-2033	207	13	by	by	ADP
ajfti-2033	207	14	the	the	DET
ajfti-2033	207	15	numbers	number	NOUN
ajfti-2033	207	16	in	in	ADP
ajfti-2033	207	17	the	the	DET
ajfti-2033	207	18	component	component	NOUN
ajfti-2033	207	19	1	1	NUM
ajfti-2033	207	20	column	column	NOUN
ajfti-2033	207	21	.	.	PUNCT
ajfti-2033	208	1	higher	high	ADJ
ajfti-2033	208	2	absolute	absolute	ADJ
ajfti-2033	208	3	values	value	NOUN
ajfti-2033	208	4	show	show	VERB
ajfti-2033	208	5	a	a	DET
ajfti-2033	208	6	stronger	strong	ADJ
ajfti-2033	208	7	association	association	NOUN
ajfti-2033	208	8	.	.	PUNCT
ajfti-2033	209	1	the	the	DET
ajfti-2033	209	2	observed	observe	VERB
ajfti-2033	209	3	variable	variable	NOUN
ajfti-2033	209	4	3	3	NUM
ajfti-2033	209	5	,	,	PUNCT
ajfti-2033	209	6	for	for	ADP
ajfti-2033	209	7	instance	instance	NOUN
ajfti-2033	209	8	,	,	PUNCT
ajfti-2033	209	9	has	have	VERB
ajfti-2033	209	10	a	a	DET
ajfti-2033	209	11	high	high	ADJ
ajfti-2033	209	12	loading	loading	NOUN
ajfti-2033	209	13	of	of	ADP
ajfti-2033	209	14	874	874	NUM
ajfti-2033	209	15	on	on	ADP
ajfti-2033	209	16	component	component	NOUN
ajfti-2033	209	17	1	1	NUM
ajfti-2033	209	18	,	,	PUNCT
ajfti-2033	209	19	indicating	indicate	VERB
ajfti-2033	209	20	a	a	DET
ajfti-2033	209	21	substantial	substantial	ADJ
ajfti-2033	209	22	link	link	NOUN
ajfti-2033	209	23	between	between	ADP
ajfti-2033	209	24	this	this	DET
ajfti-2033	209	25	variable	variable	NOUN
ajfti-2033	209	26	and	and	CCONJ
ajfti-2033	209	27	the	the	DET
ajfti-2033	209	28	extracted	extract	VERB
ajfti-2033	209	29	component	component	NOUN
ajfti-2033	209	30	of	of	ADP
ajfti-2033	209	31	medication	medication	NOUN
ajfti-2033	209	32	adherence	adherence	NOUN
ajfti-2033	209	33	.	.	PUNCT
ajfti-2033	210	1	i	i	PRON
ajfti-2033	210	2	am	be	AUX
ajfti-2033	210	3	confident	confident	ADJ
ajfti-2033	210	4	i	i	PRON
ajfti-2033	210	5	can	can	AUX
ajfti-2033	210	6	continuously	continuously	ADV
ajfti-2033	210	7	follow	follow	VERB
ajfti-2033	210	8	my	my	PRON
ajfti-2033	210	9	medication	medication	NOUN
ajfti-2033	210	10	plan	plan	NOUN
ajfti-2033	210	11	without	without	ADP
ajfti-2033	210	12	missing	miss	VERB
ajfti-2033	210	13	doses	dose	NOUN
ajfti-2033	210	14	.	.	PUNCT
ajfti-2033	211	1	table	table	NOUN
ajfti-2033	211	2	12	12	NUM
ajfti-2033	211	3	:	:	PUNCT
ajfti-2033	211	4	component	component	NOUN
ajfti-2033	211	5	matrix	matrix	NOUN
ajfti-2033	211	6	(	(	PUNCT
ajfti-2033	211	7	drug	drug	NOUN
ajfti-2033	211	8	pricing	pricing	NOUN
ajfti-2033	211	9	)	)	PUNCT
ajfti-2033	211	10	component	component	NOUN
ajfti-2033	211	11	1	1	NUM
ajfti-2033	211	12	my	my	PRON
ajfti-2033	211	13	current	current	ADJ
ajfti-2033	211	14	insurance	insurance	NOUN
ajfti-2033	211	15	coverage	coverage	NOUN
ajfti-2033	211	16	adequately	adequately	ADV
ajfti-2033	211	17	covers	cover	VERB
ajfti-2033	211	18	the	the	DET
ajfti-2033	211	19	cost	cost	NOUN
ajfti-2033	211	20	of	of	ADP
ajfti-2033	211	21	my	my	PRON
ajfti-2033	211	22	prescribed	prescribed	ADJ
ajfti-2033	211	23	medications	medication	NOUN
ajfti-2033	211	24	.	.	PUNCT
ajfti-2033	212	1	.785	.785	NUM
ajfti-2033	213	1	i	i	PRON
ajfti-2033	213	2	have	have	AUX
ajfti-2033	213	3	experienced	experience	VERB
ajfti-2033	213	4	difficulties	difficulty	NOUN
ajfti-2033	213	5	in	in	ADP
ajfti-2033	213	6	obtaining	obtain	VERB
ajfti-2033	213	7	insurance	insurance	NOUN
ajfti-2033	213	8	coverage	coverage	NOUN
ajfti-2033	213	9	for	for	ADP
ajfti-2033	213	10	specific	specific	ADJ
ajfti-2033	213	11	medications	medication	NOUN
ajfti-2033	213	12	.	.	PUNCT
ajfti-2033	213	13	.464	.464	NUM
ajfti-2033	214	1	i	i	PRON
ajfti-2033	214	2	am	be	AUX
ajfti-2033	214	3	satisfied	satisfied	ADJ
ajfti-2033	214	4	with	with	ADP
ajfti-2033	214	5	the	the	DET
ajfti-2033	214	6	range	range	NOUN
ajfti-2033	214	7	of	of	ADP
ajfti-2033	214	8	medications	medication	NOUN
ajfti-2033	214	9	covered	cover	VERB
ajfti-2033	214	10	by	by	ADP
ajfti-2033	214	11	my	my	PRON
ajfti-2033	214	12	insurance	insurance	NOUN
ajfti-2033	214	13	provider	provider	NOUN
ajfti-2033	214	14	.	.	PUNCT
ajfti-2033	214	15	.863	.863	NUM
ajfti-2033	215	1	the	the	DET
ajfti-2033	215	2	insurance	insurance	NOUN
ajfti-2033	215	3	claim	claim	NOUN
ajfti-2033	215	4	process	process	NOUN
ajfti-2033	215	5	for	for	ADP
ajfti-2033	215	6	medications	medication	NOUN
ajfti-2033	215	7	is	be	AUX
ajfti-2033	215	8	simple	simple	ADJ
ajfti-2033	215	9	and	and	CCONJ
ajfti-2033	215	10	efficient	efficient	ADJ
ajfti-2033	215	11	.	.	PUNCT
ajfti-2033	216	1	.777	.777	NUM
ajfti-2033	217	1	i	i	PRON
ajfti-2033	217	2	have	have	AUX
ajfti-2033	217	3	avoided	avoid	VERB
ajfti-2033	217	4	or	or	CCONJ
ajfti-2033	217	5	delayed	delay	VERB
ajfti-2033	217	6	seeking	seek	VERB
ajfti-2033	217	7	medical	medical	ADJ
ajfti-2033	217	8	care	care	NOUN
ajfti-2033	217	9	due	due	ADP
ajfti-2033	217	10	to	to	ADP
ajfti-2033	217	11	concerns	concern	NOUN
ajfti-2033	217	12	about	about	ADP
ajfti-2033	217	13	insurance	insurance	NOUN
ajfti-2033	217	14	coverage	coverage	NOUN
ajfti-2033	217	15	for	for	ADP
ajfti-2033	217	16	medications	medication	NOUN
ajfti-2033	217	17	.	.	PUNCT
ajfti-2033	218	1	.460	.460	NUM
ajfti-2033	218	2	extraction	extraction	NOUN
ajfti-2033	218	3	method	method	NOUN
ajfti-2033	218	4	:	:	PUNCT
ajfti-2033	218	5	principal	principal	ADJ
ajfti-2033	218	6	component	component	NOUN
ajfti-2033	218	7	analysis	analysis	NOUN
ajfti-2033	218	8	.	.	PUNCT
ajfti-2033	219	1	a.	a.	NOUN
ajfti-2033	219	2	1	1	NUM
ajfti-2033	219	3	component	component	NOUN
ajfti-2033	219	4	extracted	extract	VERB
ajfti-2033	219	5	:	:	PUNCT
ajfti-2033	219	6	(	(	PUNCT
ajfti-2033	219	7	insurance	insurance	NOUN
ajfti-2033	219	8	coverage	coverage	NOUN
ajfti-2033	219	9	)	)	PUNCT
ajfti-2033	219	10	table	table	NOUN
ajfti-2033	219	11	13	13	NUM
ajfti-2033	219	12	:	:	PUNCT
ajfti-2033	219	13	reliability	reliability	NOUN
ajfti-2033	219	14	statistics	statistic	NOUN
ajfti-2033	219	15	of	of	ADP
ajfti-2033	219	16	medication	medication	NOUN
ajfti-2033	219	17	adherence	adherence	NOUN
ajfti-2033	219	18	cronbach	cronbach	NOUN
ajfti-2033	219	19	's	's	PART
ajfti-2033	219	20	alpha	alpha	NOUN
ajfti-2033	219	21	cronbach	cronbach	NOUN
ajfti-2033	219	22	's	's	PART
ajfti-2033	219	23	alpha	alpha	NOUN
ajfti-2033	219	24	based	base	VERB
ajfti-2033	219	25	on	on	ADP
ajfti-2033	219	26	standardised	standardised	ADJ
ajfti-2033	219	27	items	item	NOUN
ajfti-2033	219	28	n	n	ADP
ajfti-2033	219	29	of	of	ADP
ajfti-2033	219	30	items	item	NOUN
ajfti-2033	219	31	.806	.806	NUM
ajfti-2033	219	32	.824	.824	NUM
ajfti-2033	219	33	5	5	NUM
ajfti-2033	219	34	table	table	NOUN
ajfti-2033	219	35	14	14	NUM
ajfti-2033	219	36	:	:	PUNCT
ajfti-2033	220	1	total	total	ADJ
ajfti-2033	220	2	variance	variance	NOUN
ajfti-2033	220	3	explained	explain	VERB
ajfti-2033	220	4	by	by	ADP
ajfti-2033	220	5	medication	medication	NOUN
ajfti-2033	220	6	adherence	adherence	NOUN
ajfti-2033	220	7	in	in	ADP
ajfti-2033	220	8	observed	observed	ADJ
ajfti-2033	220	9	variables	variable	NOUN
ajfti-2033	220	10	component	component	NOUN
ajfti-2033	220	11	initial	initial	ADJ
ajfti-2033	220	12	eigenvalues	eigenvalue	VERB
ajfti-2033	220	13	extraction	extraction	NOUN
ajfti-2033	220	14	sums	sum	NOUN
ajfti-2033	220	15	of	of	ADP
ajfti-2033	220	16	squared	square	VERB
ajfti-2033	220	17	loadings	loading	NOUN
ajfti-2033	220	18	total	total	ADJ
ajfti-2033	220	19	%	%	NOUN
ajfti-2033	220	20	of	of	ADP
ajfti-2033	220	21	variance	variance	NOUN
ajfti-2033	220	22	cumulative	cumulative	ADJ
ajfti-2033	220	23	%	%	NOUN
ajfti-2033	220	24	total	total	ADJ
ajfti-2033	220	25	%	%	NOUN
ajfti-2033	220	26	of	of	ADP
ajfti-2033	220	27	variance	variance	NOUN
ajfti-2033	220	28	cumulative	cumulative	ADJ
ajfti-2033	220	29	%	%	NOUN
ajfti-2033	220	30	1	1	NUM
ajfti-2033	220	31	2.989	2.989	NUM
ajfti-2033	220	32	59.789	59.789	NUM
ajfti-2033	220	33	59.789	59.789	NUM
ajfti-2033	220	34	2.989	2.989	NUM
ajfti-2033	220	35	59.789	59.789	NUM
ajfti-2033	220	36	59.789	59.789	NUM
ajfti-2033	220	37	2	2	NUM
ajfti-2033	220	38	1.012	1.012	NUM
ajfti-2033	220	39	20.245	20.245	NUM
ajfti-2033	220	40	80.034	80.034	NUM
ajfti-2033	220	41	3	3	NUM
ajfti-2033	220	42	.447	.447	NUM
ajfti-2033	220	43	8.931	8.931	NUM
ajfti-2033	220	44	88.965	88.965	NUM
ajfti-2033	220	45	4	4	NUM
ajfti-2033	220	46	.310	.310	NUM
ajfti-2033	220	47	6.209	6.209	NUM
ajfti-2033	220	48	95.174	95.174	NUM
ajfti-2033	220	49	5	5	NUM
ajfti-2033	220	50	.241	.241	NUM
ajfti-2033	220	51	4.826	4.826	NUM
ajfti-2033	220	52	100.000	100.000	NUM
ajfti-2033	220	53	extraction	extraction	NOUN
ajfti-2033	220	54	method	method	NOUN
ajfti-2033	220	55	:	:	PUNCT
ajfti-2033	220	56	principal	principal	ADJ
ajfti-2033	220	57	component	component	NOUN
ajfti-2033	220	58	analysis	analysis	NOUN
ajfti-2033	220	59	.	.	PUNCT
ajfti-2033	221	1	table	table	NOUN
ajfti-2033	221	2	15	15	NUM
ajfti-2033	221	3	:	:	PUNCT
ajfti-2033	221	4	component	component	NOUN
ajfti-2033	221	5	matrix	matrix	NOUN
ajfti-2033	221	6	(	(	PUNCT
ajfti-2033	221	7	medication	medication	NOUN
ajfti-2033	221	8	adherence	adherence	NOUN
ajfti-2033	221	9	)	)	PUNCT
ajfti-2033	221	10	component	component	NOUN
ajfti-2033	221	11	1	1	NUM
ajfti-2033	222	1	i	i	PRON
ajfti-2033	222	2	understand	understand	VERB
ajfti-2033	222	3	the	the	DET
ajfti-2033	222	4	importance	importance	NOUN
ajfti-2033	222	5	of	of	ADP
ajfti-2033	222	6	adhering	adhere	VERB
ajfti-2033	222	7	to	to	ADP
ajfti-2033	222	8	my	my	PRON
ajfti-2033	222	9	medication	medication	NOUN
ajfti-2033	222	10	regimen	regiman	NOUN
ajfti-2033	222	11	to	to	PART
ajfti-2033	222	12	achieve	achieve	VERB
ajfti-2033	222	13	the	the	DET
ajfti-2033	222	14	desired	desire	VERB
ajfti-2033	222	15	therapeutic	therapeutic	ADJ
ajfti-2033	222	16	outcomes	outcome	NOUN
ajfti-2033	222	17	.	.	PUNCT
ajfti-2033	223	1	.788	.788	NUM
ajfti-2033	224	1	taking	take	VERB
ajfti-2033	224	2	medications	medication	NOUN
ajfti-2033	224	3	exactly	exactly	ADV
ajfti-2033	224	4	as	as	SCONJ
ajfti-2033	224	5	my	my	PRON
ajfti-2033	224	6	healthcare	healthcare	NOUN
ajfti-2033	224	7	provider	provider	NOUN
ajfti-2033	224	8	prescribes	prescribe	VERB
ajfti-2033	224	9	is	be	AUX
ajfti-2033	224	10	essential	essential	ADJ
ajfti-2033	224	11	for	for	ADP
ajfti-2033	224	12	managing	manage	VERB
ajfti-2033	224	13	my	my	PRON
ajfti-2033	224	14	health	health	NOUN
ajfti-2033	224	15	condition(s	condition(s	NOUN
ajfti-2033	224	16	)	)	PUNCT
ajfti-2033	224	17	.	.	PUNCT
ajfti-2033	225	1	.841	.841	NUM
ajfti-2033	226	1	i	i	PRON
ajfti-2033	226	2	am	be	AUX
ajfti-2033	226	3	confident	confident	ADJ
ajfti-2033	226	4	in	in	ADP
ajfti-2033	226	5	following	follow	VERB
ajfti-2033	226	6	my	my	PRON
ajfti-2033	226	7	medication	medication	NOUN
ajfti-2033	226	8	schedule	schedule	NOUN
ajfti-2033	226	9	consistently	consistently	ADV
ajfti-2033	226	10	without	without	ADP
ajfti-2033	226	11	missing	miss	VERB
ajfti-2033	226	12	doses	dose	NOUN
ajfti-2033	226	13	.	.	PUNCT
ajfti-2033	226	14	.874	.874	NUM
ajfti-2033	227	1	i	i	PRON
ajfti-2033	227	2	actively	actively	ADV
ajfti-2033	227	3	communicate	communicate	VERB
ajfti-2033	227	4	with	with	ADP
ajfti-2033	227	5	my	my	PRON
ajfti-2033	227	6	healthcare	healthcare	NOUN
ajfti-2033	227	7	provider	provider	NOUN
ajfti-2033	227	8	if	if	SCONJ
ajfti-2033	227	9	i	i	PRON
ajfti-2033	227	10	experience	experience	VERB
ajfti-2033	227	11	any	any	DET
ajfti-2033	227	12	difficulties	difficulty	NOUN
ajfti-2033	227	13	or	or	CCONJ
ajfti-2033	227	14	side	side	NOUN
ajfti-2033	227	15	effects	effect	NOUN
ajfti-2033	227	16	related	relate	VERB
ajfti-2033	227	17	to	to	ADP
ajfti-2033	227	18	my	my	PRON
ajfti-2033	227	19	medications	medication	NOUN
ajfti-2033	227	20	.	.	PUNCT
ajfti-2033	227	21	.786	.786	NUM
ajfti-2033	228	1	i	i	PRON
ajfti-2033	228	2	have	have	VERB
ajfti-2033	228	3	a	a	DET
ajfti-2033	228	4	system	system	NOUN
ajfti-2033	228	5	(	(	PUNCT
ajfti-2033	228	6	e.g.	e.g.	ADV
ajfti-2033	228	7	,	,	PUNCT
ajfti-2033	228	8	reminders	reminder	NOUN
ajfti-2033	228	9	,	,	PUNCT
ajfti-2033	228	10	pill	pill	NOUN
ajfti-2033	228	11	organisers	organiser	NOUN
ajfti-2033	228	12	)	)	PUNCT
ajfti-2033	228	13	to	to	PART
ajfti-2033	228	14	help	help	VERB
ajfti-2033	228	15	me	i	PRON
ajfti-2033	228	16	manage	manage	VERB
ajfti-2033	228	17	my	my	PRON
ajfti-2033	228	18	medication	medication	NOUN
ajfti-2033	228	19	adherence	adherence	NOUN
ajfti-2033	228	20	effectively	effectively	ADV
ajfti-2033	228	21	.	.	PUNCT
ajfti-2033	229	1	.529	.529	NUM
ajfti-2033	229	2	extraction	extraction	NOUN
ajfti-2033	229	3	method	method	NOUN
ajfti-2033	229	4	:	:	PUNCT
ajfti-2033	229	5	principal	principal	ADJ
ajfti-2033	229	6	component	component	NOUN
ajfti-2033	229	7	analysis	analysis	NOUN
ajfti-2033	229	8	.	.	PUNCT
ajfti-2033	230	1	a.	a.	NOUN
ajfti-2033	230	2	1	1	NUM
ajfti-2033	230	3	component	component	NOUN
ajfti-2033	230	4	extracted	extract	VERB
ajfti-2033	230	5	:	:	PUNCT
ajfti-2033	230	6	(	(	PUNCT
ajfti-2033	230	7	medication	medication	NOUN
ajfti-2033	230	8	adherence	adherence	NOUN
ajfti-2033	230	9	)	)	PUNCT
ajfti-2033	230	10	pa	pa	PROPN
ajfti-2033	230	11	ge	ge	PROPN
ajfti-2033	230	12	31	31	NUM
ajfti-2033	230	13	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	230	14	am	be	AUX
ajfti-2033	230	15	.	.	PUNCT
ajfti-2033	231	1	j.	j.	PROPN
ajfti-2033	231	2	financ	financ	PROPN
ajfti-2033	231	3	.	.	PUNCT
ajfti-2033	232	1	technol	technol	PROPN
ajfti-2033	232	2	.	.	PUNCT
ajfti-2033	232	3	innov	innov	PROPN
ajfti-2033	232	4	.	.	PUNCT
ajfti-2033	233	1	1(1	1(1	NUM
ajfti-2033	233	2	)	)	PUNCT
ajfti-2033	233	3	24	24	NUM
ajfti-2033	233	4	-	-	SYM
ajfti-2033	233	5	34	34	NUM
ajfti-2033	233	6	,	,	PUNCT
ajfti-2033	233	7	2023	2023	NUM
ajfti-2033	233	8	results	result	NOUN
ajfti-2033	233	9	of	of	ADP
ajfti-2033	233	10	correlation	correlation	NOUN
ajfti-2033	233	11	analysis	analysis	NOUN
ajfti-2033	233	12	the	the	DET
ajfti-2033	233	13	pearson	pearson	PROPN
ajfti-2033	233	14	correlation	correlation	NOUN
ajfti-2033	233	15	test	test	NOUN
ajfti-2033	233	16	findings	finding	NOUN
ajfti-2033	233	17	in	in	ADP
ajfti-2033	233	18	table	table	NOUN
ajfti-2033	233	19	16	16	NUM
ajfti-2033	233	20	show	show	VERB
ajfti-2033	233	21	significant	significant	ADJ
ajfti-2033	233	22	correlations	correlation	NOUN
ajfti-2033	233	23	between	between	ADP
ajfti-2033	233	24	the	the	DET
ajfti-2033	233	25	variables	variable	NOUN
ajfti-2033	233	26	.	.	PUNCT
ajfti-2033	234	1	drug	drug	NOUN
ajfti-2033	234	2	cost	cost	NOUN
ajfti-2033	234	3	and	and	CCONJ
ajfti-2033	234	4	insurance	insurance	NOUN
ajfti-2033	234	5	coverage	coverage	NOUN
ajfti-2033	234	6	have	have	VERB
ajfti-2033	234	7	a	a	DET
ajfti-2033	234	8	substantial	substantial	ADJ
ajfti-2033	234	9	negative	negative	ADJ
ajfti-2033	234	10	connection	connection	NOUN
ajfti-2033	234	11	(	(	PUNCT
ajfti-2033	234	12	r	r	NOUN
ajfti-2033	234	13	=	=	SYM
ajfti-2033	234	14	-0.768	-0.768	PROPN
ajfti-2033	234	15	,	,	PUNCT
ajfti-2033	234	16	p	p	NOUN
ajfti-2033	234	17	0.001	0.001	NUM
ajfti-2033	234	18	)	)	PUNCT
ajfti-2033	234	19	,	,	PUNCT
ajfti-2033	234	20	while	while	SCONJ
ajfti-2033	234	21	their	their	PRON
ajfti-2033	234	22	link	link	NOUN
ajfti-2033	234	23	with	with	ADP
ajfti-2033	234	24	medication	medication	NOUN
ajfti-2033	234	25	adherence	adherence	NOUN
ajfti-2033	234	26	is	be	AUX
ajfti-2033	234	27	inverse	inverse	ADJ
ajfti-2033	234	28	and	and	CCONJ
ajfti-2033	234	29	negative	negative	ADJ
ajfti-2033	234	30	(	(	PUNCT
ajfti-2033	234	31	r	r	NOUN
ajfti-2033	234	32	=	=	SYM
ajfti-2033	234	33	-0.773	-0.773	PROPN
ajfti-2033	234	34	,	,	PUNCT
ajfti-2033	234	35	p	p	X
ajfti-2033	234	36	=	=	NOUN
ajfti-2033	234	37	0.006	0.006	NUM
ajfti-2033	234	38	)	)	PUNCT
ajfti-2033	234	39	.	.	PUNCT
ajfti-2033	235	1	similarly	similarly	ADV
ajfti-2033	235	2	,	,	PUNCT
ajfti-2033	235	3	while	while	SCONJ
ajfti-2033	235	4	it	it	PRON
ajfti-2033	235	5	is	be	AUX
ajfti-2033	235	6	not	not	PART
ajfti-2033	235	7	statistically	statistically	ADV
ajfti-2033	235	8	significant	significant	ADJ
ajfti-2033	235	9	,	,	PUNCT
ajfti-2033	235	10	a	a	DET
ajfti-2033	235	11	positive	positive	ADJ
ajfti-2033	235	12	association	association	NOUN
ajfti-2033	235	13	exists	exist	VERB
ajfti-2033	235	14	between	between	ADP
ajfti-2033	235	15	insurance	insurance	NOUN
ajfti-2033	235	16	coverage	coverage	NOUN
ajfti-2033	235	17	and	and	CCONJ
ajfti-2033	235	18	medication	medication	NOUN
ajfti-2033	235	19	adherence	adherence	NOUN
ajfti-2033	235	20	(	(	PUNCT
ajfti-2033	235	21	r	r	NOUN
ajfti-2033	235	22	=	=	SYM
ajfti-2033	235	23	0.002	0.002	NUM
ajfti-2033	235	24	,	,	PUNCT
ajfti-2033	235	25	p	p	X
ajfti-2033	235	26	=	=	NOUN
ajfti-2033	235	27	0.709	0.709	NUM
ajfti-2033	235	28	)	)	PUNCT
ajfti-2033	235	29	.	.	PUNCT
ajfti-2033	236	1	these	these	DET
ajfti-2033	236	2	results	result	NOUN
ajfti-2033	236	3	imply	imply	VERB
ajfti-2033	236	4	that	that	SCONJ
ajfti-2033	236	5	increasing	increase	VERB
ajfti-2033	236	6	insurance	insurance	NOUN
ajfti-2033	236	7	coverage	coverage	NOUN
ajfti-2033	236	8	and	and	CCONJ
ajfti-2033	236	9	medication	medication	NOUN
ajfti-2033	236	10	adherence	adherence	NOUN
ajfti-2033	236	11	are	be	AUX
ajfti-2033	236	12	related	relate	VERB
ajfti-2033	236	13	to	to	ADP
ajfti-2033	236	14	higher	high	ADJ
ajfti-2033	236	15	drug	drug	NOUN
ajfti-2033	236	16	prices	price	NOUN
ajfti-2033	236	17	.	.	PUNCT
ajfti-2033	237	1	however	however	ADV
ajfti-2033	237	2	,	,	PUNCT
ajfti-2033	237	3	a	a	DET
ajfti-2033	237	4	weak	weak	ADJ
ajfti-2033	237	5	and	and	CCONJ
ajfti-2033	237	6	statistically	statistically	ADV
ajfti-2033	237	7	insignificant	insignificant	ADJ
ajfti-2033	237	8	link	link	NOUN
ajfti-2033	237	9	exists	exist	VERB
ajfti-2033	237	10	between	between	ADP
ajfti-2033	237	11	insurance	insurance	NOUN
ajfti-2033	237	12	coverage	coverage	NOUN
ajfti-2033	237	13	and	and	CCONJ
ajfti-2033	237	14	drug	drug	NOUN
ajfti-2033	237	15	adherence	adherence	NOUN
ajfti-2033	237	16	.	.	PUNCT
ajfti-2033	238	1	these	these	DET
ajfti-2033	238	2	findings	finding	NOUN
ajfti-2033	238	3	in	in	ADP
ajfti-2033	238	4	this	this	DET
ajfti-2033	238	5	study	study	NOUN
ajfti-2033	238	6	indicate	indicate	VERB
ajfti-2033	238	7	the	the	DET
ajfti-2033	238	8	possible	possible	ADJ
ajfti-2033	238	9	impact	impact	NOUN
ajfti-2033	238	10	of	of	ADP
ajfti-2033	238	11	drug	drug	NOUN
ajfti-2033	238	12	costs	cost	NOUN
ajfti-2033	238	13	on	on	ADP
ajfti-2033	238	14	insurance	insurance	NOUN
ajfti-2033	238	15	coverage	coverage	NOUN
ajfti-2033	238	16	and	and	CCONJ
ajfti-2033	238	17	medication	medication	NOUN
ajfti-2033	238	18	adherence	adherence	NOUN
ajfti-2033	238	19	.	.	PUNCT
ajfti-2033	239	1	table	table	NOUN
ajfti-2033	239	2	16	16	NUM
ajfti-2033	239	3	:	:	PUNCT
ajfti-2033	239	4	results	result	NOUN
ajfti-2033	239	5	of	of	ADP
ajfti-2033	239	6	the	the	DET
ajfti-2033	239	7	pearson	pearson	PROPN
ajfti-2033	239	8	correlation	correlation	PROPN
ajfti-2033	239	9	test	test	NOUN
ajfti-2033	239	10	drug	drug	NOUN
ajfti-2033	239	11	pricing	pricing	NOUN
ajfti-2033	239	12	insurance	insurance	NOUN
ajfti-2033	239	13	coverage	coverage	NOUN
ajfti-2033	239	14	medication	medication	NOUN
ajfti-2033	239	15	adherence	adherence	NOUN
ajfti-2033	239	16	drug	drug	NOUN
ajfti-2033	239	17	pricing	pricing	NOUN
ajfti-2033	239	18	pearson	pearson	NOUN
ajfti-2033	239	19	correlation	correlation	NOUN
ajfti-2033	239	20	1	1	NUM
ajfti-2033	239	21	.768	.768	NOUN
ajfti-2033	239	22	*	*	NOUN
ajfti-2033	239	23	*	*	PUNCT
ajfti-2033	239	24	-.773	-.773	NOUN
ajfti-2033	239	25	*	*	PUNCT
ajfti-2033	239	26	*	*	PROPN
ajfti-2033	239	27	sig	sig	X
ajfti-2033	239	28	.	.	PUNCT
ajfti-2033	240	1	(	(	PUNCT
ajfti-2033	240	2	2	2	NUM
ajfti-2033	240	3	-	-	PUNCT
ajfti-2033	240	4	tailed	tailed	ADJ
ajfti-2033	240	5	)	)	PUNCT
ajfti-2033	240	6	.000	.000	NUM
ajfti-2033	240	7	.006	.006	NUM
ajfti-2033	240	8	n	n	CCONJ
ajfti-2033	240	9	250	250	NUM
ajfti-2033	240	10	250	250	NUM
ajfti-2033	240	11	250	250	NUM
ajfti-2033	240	12	insurance	insurance	NOUN
ajfti-2033	240	13	coverage	coverage	NOUN
ajfti-2033	240	14	pearson	pearson	NOUN
ajfti-2033	240	15	correlation	correlation	NOUN
ajfti-2033	240	16	-.768	-.768	NOUN
ajfti-2033	240	17	*	*	PUNCT
ajfti-2033	240	18	*	*	NOUN
ajfti-2033	240	19	1	1	NUM
ajfti-2033	240	20	.742	.742	NUM
ajfti-2033	240	21	sig	sig	NOUN
ajfti-2033	240	22	.	.	PUNCT
ajfti-2033	241	1	(	(	PUNCT
ajfti-2033	241	2	2	2	NUM
ajfti-2033	241	3	-	-	PUNCT
ajfti-2033	241	4	tailed	tailed	ADJ
ajfti-2033	241	5	)	)	PUNCT
ajfti-2033	241	6	.000	.000	NUM
ajfti-2033	241	7	.009	.009	NUM
ajfti-2033	242	1	n	n	CCONJ
ajfti-2033	242	2	250	250	NUM
ajfti-2033	242	3	250	250	NUM
ajfti-2033	242	4	250	250	NUM
ajfti-2033	242	5	medication	medication	NOUN
ajfti-2033	242	6	adherence	adherence	NOUN
ajfti-2033	242	7	pearson	pearson	NOUN
ajfti-2033	242	8	correlation	correlation	NOUN
ajfti-2033	242	9	-.773	-.773	PROPN
ajfti-2033	243	1	*	*	PROPN
ajfti-2033	244	1	*	*	NOUN
ajfti-2033	244	2	.002	.002	NUM
ajfti-2033	244	3	1	1	NUM
ajfti-2033	244	4	sig	sig	NOUN
ajfti-2033	244	5	.	.	PUNCT
ajfti-2033	245	1	(	(	PUNCT
ajfti-2033	245	2	2	2	NUM
ajfti-2033	245	3	-	-	PUNCT
ajfti-2033	245	4	tailed	tailed	ADJ
ajfti-2033	245	5	)	)	PUNCT
ajfti-2033	245	6	.006	.006	NUM
ajfti-2033	245	7	-.768	-.768	NOUN
ajfti-2033	246	1	n	n	PRON
ajfti-2033	246	2	250	250	NUM
ajfti-2033	246	3	250	250	NUM
ajfti-2033	246	4	250	250	NUM
ajfti-2033	246	5	*	*	PUNCT
ajfti-2033	246	6	*	*	NOUN
ajfti-2033	246	7	.	.	PUNCT
ajfti-2033	247	1	correlation	correlation	NOUN
ajfti-2033	247	2	is	be	AUX
ajfti-2033	247	3	significant	significant	ADJ
ajfti-2033	247	4	at	at	ADP
ajfti-2033	247	5	the	the	DET
ajfti-2033	247	6	0.01	0.01	NUM
ajfti-2033	247	7	level	level	NOUN
ajfti-2033	247	8	(	(	PUNCT
ajfti-2033	247	9	2	2	NUM
ajfti-2033	247	10	-	-	PUNCT
ajfti-2033	247	11	tailed	tailed	ADJ
ajfti-2033	247	12	)	)	PUNCT
ajfti-2033	247	13	.	.	PUNCT
ajfti-2033	248	1	results	result	NOUN
ajfti-2033	248	2	of	of	ADP
ajfti-2033	248	3	regression	regression	NOUN
ajfti-2033	248	4	analysis	analysis	NOUN
ajfti-2033	248	5	because	because	SCONJ
ajfti-2033	248	6	the	the	DET
ajfti-2033	248	7	value	value	NOUN
ajfti-2033	248	8	of	of	ADP
ajfti-2033	248	9	p	p	NOUN
ajfti-2033	248	10	is	be	AUX
ajfti-2033	248	11	less	less	ADJ
ajfti-2033	248	12	than	than	ADP
ajfti-2033	248	13	0.05	0.05	NUM
ajfti-2033	248	14	,	,	PUNCT
ajfti-2033	248	15	which	which	PRON
ajfti-2033	248	16	symbolises	symbolise	VERB
ajfti-2033	248	17	the	the	DET
ajfti-2033	248	18	significant	significant	ADJ
ajfti-2033	248	19	differences	difference	NOUN
ajfti-2033	248	20	between	between	ADP
ajfti-2033	248	21	the	the	DET
ajfti-2033	248	22	groups	group	NOUN
ajfti-2033	248	23	of	of	ADP
ajfti-2033	248	24	the	the	DET
ajfti-2033	248	25	mean	mean	NOUN
ajfti-2033	248	26	of	of	ADP
ajfti-2033	248	27	each	each	DET
ajfti-2033	248	28	variable	variable	NOUN
ajfti-2033	248	29	,	,	PUNCT
ajfti-2033	248	30	the	the	DET
ajfti-2033	248	31	above	above	ADV
ajfti-2033	248	32	-	-	PUNCT
ajfti-2033	248	33	given	give	VERB
ajfti-2033	248	34	anova	anova	PROPN
ajfti-2033	248	35	table	table	NOUN
ajfti-2033	248	36	demonstrates	demonstrate	VERB
ajfti-2033	248	37	that	that	SCONJ
ajfti-2033	248	38	all	all	DET
ajfti-2033	248	39	the	the	DET
ajfti-2033	248	40	provided	provide	VERB
ajfti-2033	248	41	variables	variable	NOUN
ajfti-2033	248	42	are	be	AUX
ajfti-2033	248	43	substantially	substantially	ADV
ajfti-2033	248	44	different	different	ADJ
ajfti-2033	248	45	.	.	PUNCT
ajfti-2033	249	1	the	the	DET
ajfti-2033	249	2	regression	regression	NOUN
ajfti-2033	249	3	analysis	analysis	NOUN
ajfti-2033	249	4	results	result	NOUN
ajfti-2033	249	5	employing	employ	VERB
ajfti-2033	249	6	the	the	DET
ajfti-2033	249	7	two	two	NUM
ajfti-2033	249	8	independent	independent	ADJ
ajfti-2033	249	9	variables	variable	NOUN
ajfti-2033	249	10	of	of	ADP
ajfti-2033	249	11	drug	drug	NOUN
ajfti-2033	249	12	cost	cost	NOUN
ajfti-2033	249	13	and	and	CCONJ
ajfti-2033	249	14	insurance	insurance	NOUN
ajfti-2033	249	15	coverage	coverage	NOUN
ajfti-2033	249	16	are	be	AUX
ajfti-2033	249	17	summarised	summarise	VERB
ajfti-2033	249	18	in	in	ADP
ajfti-2033	249	19	table	table	NOUN
ajfti-2033	249	20	17	17	NUM
ajfti-2033	249	21	.	.	PUNCT
ajfti-2033	250	1	unstandardised	unstandardised	ADJ
ajfti-2033	250	2	coefficients	coefficient	NOUN
ajfti-2033	250	3	(	(	PUNCT
ajfti-2033	250	4	b	b	NOUN
ajfti-2033	250	5	)	)	PUNCT
ajfti-2033	250	6	depict	depict	VERB
ajfti-2033	250	7	the	the	DET
ajfti-2033	250	8	anticipated	anticipated	ADJ
ajfti-2033	250	9	change	change	NOUN
ajfti-2033	250	10	in	in	ADP
ajfti-2033	250	11	medication	medication	NOUN
ajfti-2033	250	12	adherence	adherence	NOUN
ajfti-2033	250	13	when	when	SCONJ
ajfti-2033	250	14	each	each	DET
ajfti-2033	250	15	independent	independent	ADJ
ajfti-2033	250	16	variable	variable	NOUN
ajfti-2033	250	17	is	be	AUX
ajfti-2033	250	18	changed	change	VERB
ajfti-2033	250	19	by	by	ADP
ajfti-2033	250	20	one	one	NUM
ajfti-2033	250	21	unit	unit	NOUN
ajfti-2033	250	22	while	while	SCONJ
ajfti-2033	250	23	the	the	DET
ajfti-2033	250	24	others	other	NOUN
ajfti-2033	250	25	remain	remain	VERB
ajfti-2033	250	26	unchanged	unchanged	ADJ
ajfti-2033	250	27	.	.	PUNCT
ajfti-2033	251	1	the	the	DET
ajfti-2033	251	2	standardised	standardised	ADJ
ajfti-2033	251	3	influence	influence	NOUN
ajfti-2033	251	4	of	of	ADP
ajfti-2033	251	5	these	these	DET
ajfti-2033	251	6	factors	factor	NOUN
ajfti-2033	251	7	on	on	ADP
ajfti-2033	251	8	medication	medication	NOUN
ajfti-2033	251	9	adherence	adherence	NOUN
ajfti-2033	251	10	is	be	AUX
ajfti-2033	251	11	measured	measure	VERB
ajfti-2033	251	12	by	by	ADP
ajfti-2033	251	13	standardised	standardised	ADJ
ajfti-2033	251	14	coefficients	coefficient	NOUN
ajfti-2033	251	15	(	(	PUNCT
ajfti-2033	251	16	beta	beta	NOUN
ajfti-2033	251	17	)	)	PUNCT
ajfti-2033	251	18	.	.	PUNCT
ajfti-2033	252	1	the	the	DET
ajfti-2033	252	2	statistical	statistical	ADJ
ajfti-2033	252	3	significance	significance	NOUN
ajfti-2033	252	4	is	be	AUX
ajfti-2033	252	5	determined	determine	VERB
ajfti-2033	252	6	by	by	ADP
ajfti-2033	252	7	the	the	DET
ajfti-2033	252	8	t	t	PROPN
ajfti-2033	252	9	-	-	PUNCT
ajfti-2033	252	10	values	value	NOUN
ajfti-2033	252	11	and	and	CCONJ
ajfti-2033	252	12	p	p	NOUN
ajfti-2033	252	13	-	-	PUNCT
ajfti-2033	252	14	values	value	NOUN
ajfti-2033	252	15	(	(	PUNCT
ajfti-2033	252	16	sig	sig	NOUN
ajfti-2033	252	17	.	.	PUNCT
ajfti-2033	252	18	)	)	PUNCT
ajfti-2033	252	19	.	.	PUNCT
ajfti-2033	253	1	the	the	DET
ajfti-2033	253	2	substantial	substantial	ADJ
ajfti-2033	253	3	effects	effect	NOUN
ajfti-2033	253	4	of	of	ADP
ajfti-2033	253	5	both	both	CCONJ
ajfti-2033	253	6	independent	independent	ADJ
ajfti-2033	253	7	factors	factor	NOUN
ajfti-2033	253	8	on	on	ADP
ajfti-2033	253	9	medication	medication	NOUN
ajfti-2033	253	10	adherence	adherence	NOUN
ajfti-2033	253	11	have	have	AUX
ajfti-2033	253	12	confirmed	confirm	VERB
ajfti-2033	253	13	all	all	DET
ajfti-2033	253	14	research	research	NOUN
ajfti-2033	253	15	hypotheses	hypothesis	NOUN
ajfti-2033	253	16	.	.	PUNCT
ajfti-2033	254	1	regression	regression	VERB
ajfti-2033	254	2	analysis	analysis	NOUN
ajfti-2033	254	3	p	p	NOUN
ajfti-2033	254	4	-	-	PUNCT
ajfti-2033	254	5	values	value	NOUN
ajfti-2033	254	6	show	show	VERB
ajfti-2033	254	7	a	a	DET
ajfti-2033	254	8	robust	robust	ADJ
ajfti-2033	254	9	association	association	NOUN
ajfti-2033	254	10	between	between	ADP
ajfti-2033	254	11	high	high	ADJ
ajfti-2033	254	12	drug	drug	NOUN
ajfti-2033	254	13	costs	cost	NOUN
ajfti-2033	254	14	,	,	PUNCT
ajfti-2033	254	15	insurance	insurance	NOUN
ajfti-2033	254	16	coverage	coverage	NOUN
ajfti-2033	254	17	,	,	PUNCT
ajfti-2033	254	18	and	and	CCONJ
ajfti-2033	254	19	medication	medication	NOUN
ajfti-2033	254	20	adherence	adherence	NOUN
ajfti-2033	254	21	.	.	PUNCT
ajfti-2033	255	1	table	table	NOUN
ajfti-2033	255	2	17	17	NUM
ajfti-2033	255	3	:	:	PUNCT
ajfti-2033	255	4	results	result	NOUN
ajfti-2033	255	5	of	of	ADP
ajfti-2033	255	6	the	the	DET
ajfti-2033	255	7	anova	anova	PROPN
ajfti-2033	255	8	test	test	NOUN
ajfti-2033	255	9	model	model	PROPN
ajfti-2033	255	10	sum	sum	NOUN
ajfti-2033	255	11	of	of	ADP
ajfti-2033	255	12	squares	square	NOUN
ajfti-2033	255	13	df	df	PROPN
ajfti-2033	255	14	mean	mean	PROPN
ajfti-2033	255	15	square	square	PROPN
ajfti-2033	255	16	f	f	PROPN
ajfti-2033	255	17	sig	sig	PROPN
ajfti-2033	255	18	.	.	PROPN
ajfti-2033	255	19	1	1	NUM
ajfti-2033	255	20	regression	regression	NOUN
ajfti-2033	255	21	12.288	12.288	NUM
ajfti-2033	255	22	2	2	NUM
ajfti-2033	255	23	6.144	6.144	NUM
ajfti-2033	255	24	6.411	6.411	NUM
ajfti-2033	255	25	.002	.002	NUM
ajfti-2033	255	26	residual	residual	ADJ
ajfti-2033	255	27	236.713	236.713	NUM
ajfti-2033	255	28	247	247	NUM
ajfti-2033	255	29	.958	.958	NUM
ajfti-2033	255	30	total	total	ADJ
ajfti-2033	255	31	249.000	249.000	NUM
ajfti-2033	255	32	249	249	NUM
ajfti-2033	255	33	a.	a.	NOUN
ajfti-2033	255	34	dependent	dependent	ADJ
ajfti-2033	255	35	variable	variable	NOUN
ajfti-2033	255	36	:	:	PUNCT
ajfti-2033	255	37	medication	medication	NOUN
ajfti-2033	255	38	adherence	adherence	NOUN
ajfti-2033	255	39	b.	b.	PROPN
ajfti-2033	255	40	predictors	predictor	NOUN
ajfti-2033	255	41	:	:	PUNCT
ajfti-2033	255	42	(	(	PUNCT
ajfti-2033	255	43	constant	constant	ADJ
ajfti-2033	255	44	)	)	PUNCT
ajfti-2033	255	45	,	,	PUNCT
ajfti-2033	255	46	insurance	insurance	NOUN
ajfti-2033	255	47	coverage	coverage	NOUN
ajfti-2033	255	48	,	,	PUNCT
ajfti-2033	255	49	drug	drug	NOUN
ajfti-2033	255	50	pricing	pricing	NOUN
ajfti-2033	255	51	table	table	NOUN
ajfti-2033	255	52	18	18	NUM
ajfti-2033	255	53	:	:	PUNCT
ajfti-2033	255	54	results	result	NOUN
ajfti-2033	255	55	of	of	ADP
ajfti-2033	255	56	multiple	multiple	ADJ
ajfti-2033	255	57	regression	regression	NOUN
ajfti-2033	255	58	analysis	analysis	NOUN
ajfti-2033	255	59	model	model	NOUN
ajfti-2033	255	60	unstandardised	unstandardise	VERB
ajfti-2033	255	61	coefficients	coefficient	NOUN
ajfti-2033	255	62	standardised	standardised	ADJ
ajfti-2033	255	63	coefficients	coefficient	NOUN
ajfti-2033	255	64	t	t	PROPN
ajfti-2033	255	65	sig	sig	PROPN
ajfti-2033	255	66	.	.	PUNCT
ajfti-2033	256	1	b	b	X
ajfti-2033	256	2	std	std	PROPN
ajfti-2033	256	3	.	.	NOUN
ajfti-2033	256	4	error	error	NOUN
ajfti-2033	256	5	beta	beta	NOUN
ajfti-2033	256	6	1	1	NUM
ajfti-2033	256	7	(	(	PUNCT
ajfti-2033	256	8	constant	constant	ADJ
ajfti-2033	256	9	)	)	PUNCT
ajfti-2033	256	10	4.070e-7	4.070e-7	NUM
ajfti-2033	256	11	.062	.062	NUM
ajfti-2033	256	12	.000	.000	NUM
ajfti-2033	256	13	1.000	1.000	NUM
ajfti-2033	256	14	drug	drug	NOUN
ajfti-2033	256	15	pricing	pricing	NOUN
ajfti-2033	256	16	-.747	-.747	PROPN
ajfti-2033	256	17	.070	.070	NUM
ajfti-2033	256	18	.749	.749	NUM
ajfti-2033	257	1	3.516	3.516	NUM
ajfti-2033	257	2	.001	.001	NUM
ajfti-2033	257	3	insurance	insurance	NOUN
ajfti-2033	257	4	coverage	coverage	NOUN
ajfti-2033	257	5	.758	.758	NUM
ajfti-2033	257	6	.070	.070	NUM
ajfti-2033	257	7	.759	.759	NUM
ajfti-2033	257	8	2.243	2.243	NUM
ajfti-2033	257	9	.006	.006	NUM
ajfti-2033	257	10	a.	a.	NOUN
ajfti-2033	257	11	dependent	dependent	ADJ
ajfti-2033	257	12	variable	variable	NOUN
ajfti-2033	257	13	:	:	PUNCT
ajfti-2033	257	14	medication	medication	NOUN
ajfti-2033	257	15	adherence	adherence	NOUN
ajfti-2033	257	16	discussion	discussion	NOUN
ajfti-2033	257	17	the	the	DET
ajfti-2033	257	18	findings	finding	NOUN
ajfti-2033	257	19	of	of	ADP
ajfti-2033	257	20	a	a	DET
ajfti-2033	257	21	current	current	ADJ
ajfti-2033	257	22	study	study	NOUN
ajfti-2033	257	23	highlight	highlight	VERB
ajfti-2033	257	24	the	the	DET
ajfti-2033	257	25	difficulty	difficulty	NOUN
ajfti-2033	257	26	of	of	ADP
ajfti-2033	257	27	medication	medication	NOUN
ajfti-2033	257	28	adherence	adherence	NOUN
ajfti-2033	257	29	in	in	ADP
ajfti-2033	257	30	saudi	saudi	PROPN
ajfti-2033	257	31	arabia	arabia	PROPN
ajfti-2033	257	32	.	.	PUNCT
ajfti-2033	258	1	this	this	DET
ajfti-2033	258	2	study	study	NOUN
ajfti-2033	258	3	reveals	reveal	VERB
ajfti-2033	258	4	the	the	DET
ajfti-2033	258	5	relevance	relevance	NOUN
ajfti-2033	258	6	of	of	ADP
ajfti-2033	258	7	medication	medication	NOUN
ajfti-2033	258	8	cost	cost	NOUN
ajfti-2033	258	9	and	and	CCONJ
ajfti-2033	258	10	insurance	insurance	NOUN
ajfti-2033	258	11	coverage	coverage	NOUN
ajfti-2033	258	12	as	as	ADP
ajfti-2033	258	13	the	the	DET
ajfti-2033	258	14	foundation	foundation	NOUN
ajfti-2033	258	15	of	of	ADP
ajfti-2033	258	16	healthcare	healthcare	PROPN
ajfti-2033	258	17	outcomes	outcome	NOUN
ajfti-2033	258	18	.	.	PUNCT
ajfti-2033	259	1	according	accord	VERB
ajfti-2033	259	2	to	to	ADP
ajfti-2033	259	3	the	the	DET
ajfti-2033	259	4	study	study	NOUN
ajfti-2033	259	5	,	,	PUNCT
ajfti-2033	259	6	expensive	expensive	ADJ
ajfti-2033	259	7	medications	medication	NOUN
ajfti-2033	259	8	have	have	VERB
ajfti-2033	259	9	a	a	DET
ajfti-2033	259	10	considerable	considerable	ADJ
ajfti-2033	259	11	negative	negative	ADJ
ajfti-2033	259	12	impact	impact	NOUN
ajfti-2033	259	13	on	on	ADP
ajfti-2033	259	14	medication	medication	NOUN
ajfti-2033	259	15	adherence	adherence	NOUN
ajfti-2033	259	16	.	.	PUNCT
ajfti-2033	260	1	the	the	DET
ajfti-2033	260	2	analysis	analysis	NOUN
ajfti-2033	260	3	revealed	reveal	VERB
ajfti-2033	260	4	a	a	DET
ajfti-2033	260	5	disturbing	disturbing	ADJ
ajfti-2033	260	6	truth	truth	NOUN
ajfti-2033	260	7	:	:	PUNCT
ajfti-2033	260	8	patients	patient	NOUN
ajfti-2033	260	9	who	who	PRON
ajfti-2033	260	10	struggle	struggle	VERB
ajfti-2033	260	11	with	with	ADP
ajfti-2033	260	12	pa	pa	PROPN
ajfti-2033	260	13	ge	ge	PROPN
ajfti-2033	260	14	32	32	NUM
ajfti-2033	260	15	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	260	16	am	be	AUX
ajfti-2033	260	17	.	.	PUNCT
ajfti-2033	261	1	j.	j.	PROPN
ajfti-2033	261	2	financ	financ	PROPN
ajfti-2033	261	3	.	.	PUNCT
ajfti-2033	262	1	technol	technol	PROPN
ajfti-2033	262	2	.	.	PUNCT
ajfti-2033	262	3	innov	innov	PROPN
ajfti-2033	262	4	.	.	PUNCT
ajfti-2033	263	1	1(1	1(1	NUM
ajfti-2033	263	2	)	)	PUNCT
ajfti-2033	263	3	24	24	NUM
ajfti-2033	263	4	-	-	SYM
ajfti-2033	263	5	34	34	NUM
ajfti-2033	263	6	,	,	PUNCT
ajfti-2033	263	7	2023	2023	NUM
ajfti-2033	263	8	high	high	ADJ
ajfti-2033	263	9	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	263	10	expenses	expense	NOUN
ajfti-2033	263	11	are	be	AUX
ajfti-2033	263	12	more	more	ADV
ajfti-2033	263	13	prone	prone	ADJ
ajfti-2033	263	14	to	to	ADP
ajfti-2033	263	15	noncompliance	noncompliance	NOUN
ajfti-2033	263	16	.	.	PUNCT
ajfti-2033	264	1	for	for	ADP
ajfti-2033	264	2	those	those	PRON
ajfti-2033	264	3	with	with	ADP
ajfti-2033	264	4	chronic	chronic	ADJ
ajfti-2033	264	5	illnesses	illness	NOUN
ajfti-2033	264	6	,	,	PUNCT
ajfti-2033	264	7	there	there	PRON
ajfti-2033	264	8	are	be	VERB
ajfti-2033	264	9	significant	significant	ADJ
ajfti-2033	264	10	accessibility	accessibility	NOUN
ajfti-2033	264	11	barriers	barrier	NOUN
ajfti-2033	264	12	,	,	PUNCT
ajfti-2033	264	13	and	and	CCONJ
ajfti-2033	264	14	these	these	DET
ajfti-2033	264	15	barriers	barrier	NOUN
ajfti-2033	264	16	are	be	AUX
ajfti-2033	264	17	especially	especially	ADV
ajfti-2033	264	18	obvious	obvious	ADJ
ajfti-2033	264	19	when	when	SCONJ
ajfti-2033	264	20	considering	consider	VERB
ajfti-2033	264	21	prescription	prescription	NOUN
ajfti-2033	264	22	costs	cost	NOUN
ajfti-2033	264	23	.	.	PUNCT
ajfti-2033	265	1	the	the	DET
ajfti-2033	265	2	findings	finding	NOUN
ajfti-2033	265	3	of	of	ADP
ajfti-2033	265	4	kennedy	kennedy	PROPN
ajfti-2033	265	5	-	-	PUNCT
ajfti-2033	265	6	martin	martin	PROPN
ajfti-2033	265	7	et	et	PROPN
ajfti-2033	265	8	al	al	PROPN
ajfti-2033	265	9	.	.	PROPN
ajfti-2033	265	10	(	(	PUNCT
ajfti-2033	265	11	2017	2017	NUM
ajfti-2033	265	12	)	)	PUNCT
ajfti-2033	265	13	show	show	VERB
ajfti-2033	265	14	how	how	SCONJ
ajfti-2033	265	15	expensive	expensive	ADJ
ajfti-2033	265	16	prescription	prescription	NOUN
ajfti-2033	265	17	drugs	drug	NOUN
ajfti-2033	265	18	combined	combine	VERB
ajfti-2033	265	19	with	with	ADP
ajfti-2033	265	20	insufficient	insufficient	ADJ
ajfti-2033	265	21	insurance	insurance	NOUN
ajfti-2033	265	22	can	can	AUX
ajfti-2033	265	23	result	result	VERB
ajfti-2033	265	24	in	in	ADP
ajfti-2033	265	25	significant	significant	ADJ
ajfti-2033	265	26	patient	patient	ADJ
ajfti-2033	265	27	outlays	outlay	NOUN
ajfti-2033	265	28	(	(	PUNCT
ajfti-2033	265	29	kennedy	kennedy	PROPN
ajfti-2033	265	30	-	-	PUNCT
ajfti-2033	265	31	martin	martin	PROPN
ajfti-2033	265	32	et	et	PROPN
ajfti-2033	265	33	al	al	PROPN
ajfti-2033	265	34	.	.	PROPN
ajfti-2033	265	35	,	,	PUNCT
ajfti-2033	265	36	2017	2017	NUM
ajfti-2033	265	37	)	)	PUNCT
ajfti-2033	265	38	.	.	PUNCT
ajfti-2033	266	1	the	the	DET
ajfti-2033	266	2	study	study	NOUN
ajfti-2033	266	3	by	by	ADP
ajfti-2033	266	4	torresrobles	torresroble	NOUN
ajfti-2033	266	5	et	et	PROPN
ajfti-2033	266	6	al	al	PROPN
ajfti-2033	266	7	.	.	PROPN
ajfti-2033	266	8	(	(	PUNCT
ajfti-2033	266	9	2021	2021	NUM
ajfti-2033	266	10	)	)	PUNCT
ajfti-2033	266	11	,	,	PUNCT
ajfti-2033	266	12	examining	examine	VERB
ajfti-2033	266	13	this	this	DET
ajfti-2033	266	14	relationship	relationship	NOUN
ajfti-2033	266	15	found	find	VERB
ajfti-2033	266	16	that	that	SCONJ
ajfti-2033	266	17	high	high	ADJ
ajfti-2033	266	18	out	out	ADP
ajfti-2033	266	19	-	-	PUNCT
ajfti-2033	266	20	of	of	ADP
ajfti-2033	266	21	-	-	PUNCT
ajfti-2033	266	22	pocket	pocket	NOUN
ajfti-2033	266	23	expenses	expense	NOUN
ajfti-2033	266	24	are	be	AUX
ajfti-2033	266	25	associated	associate	VERB
ajfti-2033	266	26	with	with	ADP
ajfti-2033	266	27	reduced	reduce	VERB
ajfti-2033	266	28	drug	drug	NOUN
ajfti-2033	266	29	adherence	adherence	NOUN
ajfti-2033	266	30	,	,	PUNCT
ajfti-2033	266	31	particularly	particularly	ADV
ajfti-2033	266	32	evident	evident	ADJ
ajfti-2033	266	33	in	in	ADP
ajfti-2033	266	34	those	those	PRON
ajfti-2033	266	35	dealing	deal	VERB
ajfti-2033	266	36	with	with	ADP
ajfti-2033	266	37	chronic	chronic	ADJ
ajfti-2033	266	38	illnesses	illness	NOUN
ajfti-2033	266	39	.	.	PUNCT
ajfti-2033	267	1	these	these	DET
ajfti-2033	267	2	results	result	NOUN
ajfti-2033	267	3	demonstrate	demonstrate	VERB
ajfti-2033	267	4	that	that	SCONJ
ajfti-2033	267	5	medicine	medicine	NOUN
ajfti-2033	267	6	costs	cost	VERB
ajfti-2033	267	7	significantly	significantly	ADV
ajfti-2033	267	8	influence	influence	VERB
ajfti-2033	267	9	patient	patient	NOUN
ajfti-2033	267	10	behaviour	behaviour	NOUN
ajfti-2033	267	11	(	(	PUNCT
ajfti-2033	267	12	torresrobles	torresroble	NOUN
ajfti-2033	267	13	et	et	NOUN
ajfti-2033	267	14	al	al	PROPN
ajfti-2033	267	15	.	.	PROPN
ajfti-2033	267	16	,	,	PUNCT
ajfti-2033	267	17	2022	2022	NUM
ajfti-2033	267	18	)	)	PUNCT
ajfti-2033	267	19	.	.	PUNCT
ajfti-2033	268	1	despite	despite	SCONJ
ajfti-2033	268	2	saudi	saudi	PROPN
ajfti-2033	268	3	arabia	arabia	PROPN
ajfti-2033	268	4	’s	’s	PART
ajfti-2033	268	5	advanced	advanced	ADJ
ajfti-2033	268	6	healthcare	healthcare	NOUN
ajfti-2033	268	7	system	system	NOUN
ajfti-2033	268	8	,	,	PUNCT
ajfti-2033	268	9	high	high	ADJ
ajfti-2033	268	10	drug	drug	NOUN
ajfti-2033	268	11	costs	cost	NOUN
ajfti-2033	268	12	make	make	VERB
ajfti-2033	268	13	it	it	PRON
ajfti-2033	268	14	difficult	difficult	ADJ
ajfti-2033	268	15	for	for	SCONJ
ajfti-2033	268	16	patients	patient	NOUN
ajfti-2033	268	17	to	to	PART
ajfti-2033	268	18	comply	comply	VERB
ajfti-2033	268	19	with	with	ADP
ajfti-2033	268	20	their	their	PRON
ajfti-2033	268	21	treatments	treatment	NOUN
ajfti-2033	268	22	effectively	effectively	ADV
ajfti-2033	268	23	.	.	PUNCT
ajfti-2033	269	1	according	accord	VERB
ajfti-2033	269	2	to	to	ADP
ajfti-2033	269	3	lee	lee	PROPN
ajfti-2033	269	4	et	et	PROPN
ajfti-2033	269	5	al	al	PROPN
ajfti-2033	269	6	.	.	PROPN
ajfti-2033	269	7	’s	’s	PART
ajfti-2033	269	8	(	(	PUNCT
ajfti-2033	269	9	2020	2020	NUM
ajfti-2033	269	10	)	)	PUNCT
ajfti-2033	269	11	study	study	NOUN
ajfti-2033	269	12	,	,	PUNCT
ajfti-2033	269	13	people	people	NOUN
ajfti-2033	269	14	with	with	ADP
ajfti-2033	269	15	multiple	multiple	ADJ
ajfti-2033	269	16	sclerosis	sclerosis	NOUN
ajfti-2033	269	17	must	must	AUX
ajfti-2033	269	18	change	change	VERB
ajfti-2033	269	19	their	their	PRON
ajfti-2033	269	20	medicine	medicine	NOUN
ajfti-2033	269	21	consumption	consumption	NOUN
ajfti-2033	269	22	due	due	ADP
ajfti-2033	269	23	to	to	ADP
ajfti-2033	269	24	high	high	VERB
ajfti-2033	269	25	out	out	ADV
ajfti-2033	269	26	-	-	PUNCT
ajfti-2033	269	27	of	of	ADP
ajfti-2033	269	28	-	-	PUNCT
ajfti-2033	269	29	pocket	pocket	NOUN
ajfti-2033	269	30	expenses	expense	NOUN
ajfti-2033	269	31	.	.	PUNCT
ajfti-2033	270	1	compromise	compromise	NOUN
ajfti-2033	270	2	in	in	ADP
ajfti-2033	270	3	adherence	adherence	NOUN
ajfti-2033	270	4	caused	cause	VERB
ajfti-2033	270	5	by	by	ADP
ajfti-2033	270	6	expensive	expensive	ADJ
ajfti-2033	270	7	drugs	drug	NOUN
ajfti-2033	270	8	is	be	AUX
ajfti-2033	270	9	a	a	DET
ajfti-2033	270	10	serious	serious	ADJ
ajfti-2033	270	11	issue	issue	NOUN
ajfti-2033	270	12	since	since	SCONJ
ajfti-2033	270	13	it	it	PRON
ajfti-2033	270	14	adversely	adversely	ADV
ajfti-2033	270	15	affects	affect	VERB
ajfti-2033	270	16	patient	patient	ADJ
ajfti-2033	270	17	outcomes	outcome	NOUN
ajfti-2033	270	18	(	(	PUNCT
ajfti-2033	270	19	lee	lee	PROPN
ajfti-2033	270	20	et	et	PROPN
ajfti-2033	270	21	al	al	PROPN
ajfti-2033	270	22	.	.	PROPN
ajfti-2033	270	23	,	,	PUNCT
ajfti-2033	270	24	2020	2020	NUM
ajfti-2033	270	25	)	)	PUNCT
ajfti-2033	270	26	.	.	PUNCT
ajfti-2033	271	1	high	high	ADJ
ajfti-2033	271	2	prescription	prescription	NOUN
ajfti-2033	271	3	prices	price	NOUN
ajfti-2033	271	4	may	may	AUX
ajfti-2033	271	5	give	give	VERB
ajfti-2033	271	6	off	off	ADP
ajfti-2033	271	7	a	a	DET
ajfti-2033	271	8	negative	negative	ADJ
ajfti-2033	271	9	impression	impression	NOUN
ajfti-2033	271	10	,	,	PUNCT
ajfti-2033	271	11	but	but	CCONJ
ajfti-2033	271	12	the	the	DET
ajfti-2033	271	13	study	study	NOUN
ajfti-2033	271	14	demonstrates	demonstrate	VERB
ajfti-2033	271	15	that	that	SCONJ
ajfti-2033	271	16	adherence	adherence	NOUN
ajfti-2033	271	17	is	be	AUX
ajfti-2033	271	18	supported	support	VERB
ajfti-2033	271	19	by	by	ADP
ajfti-2033	271	20	full	full	ADJ
ajfti-2033	271	21	insurance	insurance	NOUN
ajfti-2033	271	22	coverage	coverage	NOUN
ajfti-2033	271	23	.	.	PUNCT
ajfti-2033	272	1	compliance	compliance	NOUN
ajfti-2033	272	2	rises	rise	VERB
ajfti-2033	272	3	when	when	SCONJ
ajfti-2033	272	4	patients	patient	NOUN
ajfti-2033	272	5	have	have	VERB
ajfti-2033	272	6	access	access	NOUN
ajfti-2033	272	7	to	to	ADP
ajfti-2033	272	8	insurance	insurance	NOUN
ajfti-2033	272	9	or	or	CCONJ
ajfti-2033	272	10	less	less	ADV
ajfti-2033	272	11	expensive	expensive	ADJ
ajfti-2033	272	12	medication	medication	NOUN
ajfti-2033	272	13	choices	choice	NOUN
ajfti-2033	272	14	.	.	PUNCT
ajfti-2033	273	1	this	this	DET
ajfti-2033	273	2	conclusion	conclusion	NOUN
ajfti-2033	273	3	emphasises	emphasise	VERB
ajfti-2033	273	4	the	the	DET
ajfti-2033	273	5	need	need	NOUN
ajfti-2033	273	6	for	for	ADP
ajfti-2033	273	7	comprehensive	comprehensive	ADJ
ajfti-2033	273	8	and	and	CCONJ
ajfti-2033	273	9	user	user	NOUN
ajfti-2033	273	10	-	-	PUNCT
ajfti-2033	273	11	friendly	friendly	ADJ
ajfti-2033	273	12	insurance	insurance	NOUN
ajfti-2033	273	13	coverage	coverage	NOUN
ajfti-2033	273	14	for	for	ADP
ajfti-2033	273	15	patients	patient	NOUN
ajfti-2033	273	16	’	'	PUNCT
ajfti-2033	273	17	access	access	NOUN
ajfti-2033	273	18	and	and	CCONJ
ajfti-2033	273	19	affordability	affordability	NOUN
ajfti-2033	273	20	.	.	PUNCT
ajfti-2033	274	1	this	this	DET
ajfti-2033	274	2	theory	theory	NOUN
ajfti-2033	274	3	is	be	AUX
ajfti-2033	274	4	supported	support	VERB
ajfti-2033	274	5	by	by	ADP
ajfti-2033	274	6	two	two	NUM
ajfti-2033	274	7	recent	recent	ADJ
ajfti-2033	274	8	studies	study	NOUN
ajfti-2033	274	9	,	,	PUNCT
ajfti-2033	274	10	those	those	PRON
ajfti-2033	274	11	of	of	ADP
ajfti-2033	274	12	yang	yang	PROPN
ajfti-2033	274	13	et	et	PROPN
ajfti-2033	274	14	al	al	PROPN
ajfti-2033	274	15	.	.	PROPN
ajfti-2033	275	1	(	(	PUNCT
ajfti-2033	275	2	2020	2020	NUM
ajfti-2033	275	3	)	)	PUNCT
ajfti-2033	275	4	and	and	CCONJ
ajfti-2033	275	5	wong	wong	PROPN
ajfti-2033	275	6	et	et	PROPN
ajfti-2033	275	7	al	al	PROPN
ajfti-2033	275	8	.	.	PROPN
ajfti-2033	276	1	(	(	PUNCT
ajfti-2033	276	2	2023	2023	NUM
ajfti-2033	276	3	)	)	PUNCT
ajfti-2033	276	4	,	,	PUNCT
ajfti-2033	276	5	which	which	PRON
ajfti-2033	276	6	demonstrate	demonstrate	VERB
ajfti-2033	276	7	that	that	SCONJ
ajfti-2033	276	8	health	health	NOUN
ajfti-2033	276	9	insurance	insurance	NOUN
ajfti-2033	276	10	eases	ease	VERB
ajfti-2033	276	11	the	the	DET
ajfti-2033	276	12	financial	financial	ADJ
ajfti-2033	276	13	burden	burden	NOUN
ajfti-2033	276	14	on	on	ADP
ajfti-2033	276	15	patients	patient	NOUN
ajfti-2033	276	16	by	by	ADP
ajfti-2033	276	17	paying	pay	VERB
ajfti-2033	276	18	for	for	ADP
ajfti-2033	276	19	a	a	DET
ajfti-2033	276	20	portion	portion	NOUN
ajfti-2033	276	21	of	of	ADP
ajfti-2033	276	22	their	their	PRON
ajfti-2033	276	23	medical	medical	ADJ
ajfti-2033	276	24	expenses	expense	NOUN
ajfti-2033	276	25	(	(	PUNCT
ajfti-2033	276	26	wong	wong	PROPN
ajfti-2033	276	27	et	et	PROPN
ajfti-2033	276	28	al	al	PROPN
ajfti-2033	276	29	.	.	PROPN
ajfti-2033	276	30	,	,	PUNCT
ajfti-2033	276	31	2023	2023	NUM
ajfti-2033	276	32	;	;	PUNCT
ajfti-2033	276	33	yang	yang	PROPN
ajfti-2033	276	34	et	et	PROPN
ajfti-2033	276	35	al	al	PROPN
ajfti-2033	276	36	.	.	PROPN
ajfti-2033	276	37	,	,	PUNCT
ajfti-2033	276	38	2020	2020	NUM
ajfti-2033	276	39	)	)	PUNCT
ajfti-2033	276	40	.	.	PUNCT
ajfti-2033	277	1	according	accord	VERB
ajfti-2033	277	2	to	to	ADP
ajfti-2033	277	3	these	these	DET
ajfti-2033	277	4	aforementioned	aforementione	VERB
ajfti-2033	277	5	researches	research	VERB
ajfti-2033	277	6	those	those	PRON
ajfti-2033	277	7	with	with	ADP
ajfti-2033	277	8	health	health	NOUN
ajfti-2033	277	9	insurance	insurance	NOUN
ajfti-2033	277	10	are	be	AUX
ajfti-2033	277	11	more	more	ADV
ajfti-2033	277	12	likely	likely	ADJ
ajfti-2033	277	13	to	to	PART
ajfti-2033	277	14	follow	follow	VERB
ajfti-2033	277	15	their	their	PRON
ajfti-2033	277	16	prescriptions	prescription	NOUN
ajfti-2033	277	17	.	.	PUNCT
ajfti-2033	278	1	investments	investment	NOUN
ajfti-2033	278	2	in	in	ADP
ajfti-2033	278	3	insurance	insurance	NOUN
ajfti-2033	278	4	coverage	coverage	NOUN
ajfti-2033	278	5	-	-	PUNCT
ajfti-2033	278	6	focused	focus	VERB
ajfti-2033	278	7	policies	policy	NOUN
ajfti-2033	278	8	can	can	AUX
ajfti-2033	278	9	increase	increase	VERB
ajfti-2033	278	10	adherence	adherence	NOUN
ajfti-2033	278	11	and	and	CCONJ
ajfti-2033	278	12	enhance	enhance	VERB
ajfti-2033	278	13	health	health	NOUN
ajfti-2033	278	14	outcomes	outcome	NOUN
ajfti-2033	278	15	,	,	PUNCT
ajfti-2033	278	16	making	make	VERB
ajfti-2033	278	17	them	they	PRON
ajfti-2033	278	18	beneficial	beneficial	ADJ
ajfti-2033	278	19	.	.	PUNCT
ajfti-2033	279	1	in	in	ADP
ajfti-2033	279	2	addition	addition	NOUN
ajfti-2033	279	3	to	to	ADP
ajfti-2033	279	4	examining	examine	VERB
ajfti-2033	279	5	the	the	DET
ajfti-2033	279	6	connection	connection	NOUN
ajfti-2033	279	7	between	between	ADP
ajfti-2033	279	8	prescription	prescription	NOUN
ajfti-2033	279	9	costs	cost	NOUN
ajfti-2033	279	10	and	and	CCONJ
ajfti-2033	279	11	insurance	insurance	NOUN
ajfti-2033	279	12	coverage	coverage	NOUN
ajfti-2033	279	13	,	,	PUNCT
ajfti-2033	279	14	this	this	DET
ajfti-2033	279	15	study	study	NOUN
ajfti-2033	279	16	also	also	ADV
ajfti-2033	279	17	examines	examine	VERB
ajfti-2033	279	18	other	other	ADJ
ajfti-2033	279	19	aspects	aspect	NOUN
ajfti-2033	279	20	of	of	ADP
ajfti-2033	279	21	medication	medication	NOUN
ajfti-2033	279	22	compliance	compliance	NOUN
ajfti-2033	279	23	.	.	PUNCT
ajfti-2033	280	1	patient	patient	ADJ
ajfti-2033	280	2	education	education	NOUN
ajfti-2033	280	3	and	and	CCONJ
ajfti-2033	280	4	awareness	awareness	NOUN
ajfti-2033	280	5	campaigns	campaign	NOUN
ajfti-2033	280	6	are	be	AUX
ajfti-2033	280	7	among	among	ADP
ajfti-2033	280	8	the	the	DET
ajfti-2033	280	9	most	most	ADV
ajfti-2033	280	10	important	important	ADJ
ajfti-2033	280	11	factors	factor	NOUN
ajfti-2033	280	12	in	in	ADP
ajfti-2033	280	13	encouraging	encourage	VERB
ajfti-2033	280	14	adherence	adherence	NOUN
ajfti-2033	280	15	.	.	PUNCT
ajfti-2033	281	1	providing	provide	VERB
ajfti-2033	281	2	patients	patient	NOUN
ajfti-2033	281	3	with	with	ADP
ajfti-2033	281	4	prescription	prescription	NOUN
ajfti-2033	281	5	information	information	NOUN
ajfti-2033	281	6	,	,	PUNCT
ajfti-2033	281	7	such	such	ADJ
ajfti-2033	281	8	as	as	ADP
ajfti-2033	281	9	dosing	dose	VERB
ajfti-2033	281	10	instructions	instruction	NOUN
ajfti-2033	281	11	and	and	CCONJ
ajfti-2033	281	12	possible	possible	ADJ
ajfti-2033	281	13	adverse	adverse	ADJ
ajfti-2033	281	14	effects	effect	NOUN
ajfti-2033	281	15	,	,	PUNCT
ajfti-2033	281	16	improves	improve	VERB
ajfti-2033	281	17	adherence	adherence	NOUN
ajfti-2033	281	18	to	to	ADP
ajfti-2033	281	19	the	the	DET
ajfti-2033	281	20	prescribed	prescribed	ADJ
ajfti-2033	281	21	course	course	NOUN
ajfti-2033	281	22	of	of	ADP
ajfti-2033	281	23	action	action	NOUN
ajfti-2033	281	24	.	.	PUNCT
ajfti-2033	282	1	according	accord	VERB
ajfti-2033	282	2	to	to	ADP
ajfti-2033	282	3	research	research	NOUN
ajfti-2033	282	4	by	by	ADP
ajfti-2033	282	5	reed	reed	PROPN
ajfti-2033	282	6	et	et	PROPN
ajfti-2033	282	7	al	al	PROPN
ajfti-2033	282	8	.	.	PROPN
ajfti-2033	283	1	(	(	PUNCT
ajfti-2033	283	2	2017	2017	NUM
ajfti-2033	283	3	)	)	PUNCT
ajfti-2033	283	4	,	,	PUNCT
ajfti-2033	283	5	improved	improve	VERB
ajfti-2033	283	6	education	education	NOUN
ajfti-2033	283	7	results	result	NOUN
ajfti-2033	283	8	in	in	ADP
ajfti-2033	283	9	higher	high	ADJ
ajfti-2033	283	10	adherence	adherence	NOUN
ajfti-2033	283	11	rates	rate	NOUN
ajfti-2033	283	12	.	.	PUNCT
ajfti-2033	284	1	equal	equal	ADJ
ajfti-2033	284	2	focus	focus	NOUN
ajfti-2033	284	3	should	should	AUX
ajfti-2033	284	4	be	be	AUX
ajfti-2033	284	5	placed	place	VERB
ajfti-2033	284	6	on	on	ADP
ajfti-2033	284	7	patient	patient	ADJ
ajfti-2033	284	8	and	and	CCONJ
ajfti-2033	284	9	healthcare	healthcare	PROPN
ajfti-2033	284	10	professional	professional	ADJ
ajfti-2033	284	11	communication	communication	NOUN
ajfti-2033	284	12	(	(	PUNCT
ajfti-2033	284	13	reed	reed	NOUN
ajfti-2033	284	14	et	et	PROPN
ajfti-2033	284	15	al	al	PROPN
ajfti-2033	284	16	.	.	PROPN
ajfti-2033	284	17	,	,	PUNCT
ajfti-2033	284	18	2017	2017	NUM
ajfti-2033	284	19	)	)	PUNCT
ajfti-2033	284	20	.	.	PUNCT
ajfti-2033	285	1	when	when	SCONJ
ajfti-2033	285	2	communication	communication	NOUN
ajfti-2033	285	3	improved	improve	VERB
ajfti-2033	285	4	and	and	CCONJ
ajfti-2033	285	5	became	become	VERB
ajfti-2033	285	6	more	more	ADV
ajfti-2033	285	7	compassionate	compassionate	ADJ
ajfti-2033	285	8	,	,	PUNCT
ajfti-2033	285	9	medication	medication	NOUN
ajfti-2033	285	10	compliance	compliance	NOUN
ajfti-2033	285	11	increased	increase	VERB
ajfti-2033	285	12	.	.	PUNCT
ajfti-2033	286	1	the	the	DET
ajfti-2033	286	2	relationship	relationship	NOUN
ajfti-2033	286	3	between	between	ADP
ajfti-2033	286	4	positive	positive	ADJ
ajfti-2033	286	5	patient	patient	ADJ
ajfti-2033	286	6	interactions	interaction	NOUN
ajfti-2033	286	7	and	and	CCONJ
ajfti-2033	286	8	medication	medication	NOUN
ajfti-2033	286	9	compliance	compliance	NOUN
ajfti-2033	286	10	is	be	AUX
ajfti-2033	286	11	clear	clear	ADJ
ajfti-2033	286	12	when	when	SCONJ
ajfti-2033	286	13	patients	patient	NOUN
ajfti-2033	286	14	report	report	VERB
ajfti-2033	286	15	.	.	PUNCT
ajfti-2033	287	1	as	as	ADP
ajfti-2033	287	2	brown	brown	PROPN
ajfti-2033	287	3	et	et	PROPN
ajfti-2033	287	4	al	al	PROPN
ajfti-2033	287	5	.	.	PUNCT
ajfti-2033	288	1	(	(	PUNCT
ajfti-2033	288	2	2016	2016	NUM
ajfti-2033	288	3	)	)	PUNCT
ajfti-2033	288	4	demonstrated	demonstrate	VERB
ajfti-2033	288	5	,	,	PUNCT
ajfti-2033	288	6	lowering	lower	VERB
ajfti-2033	288	7	patients	patient	NOUN
ajfti-2033	288	8	’	'	PUNCT
ajfti-2033	288	9	expenditures	expenditure	NOUN
ajfti-2033	288	10	necessarily	necessarily	ADV
ajfti-2033	288	11	increases	increase	VERB
ajfti-2033	288	12	adherence	adherence	NOUN
ajfti-2033	288	13	.	.	PUNCT
ajfti-2033	289	1	the	the	DET
ajfti-2033	289	2	study	study	NOUN
ajfti-2033	289	3	emphasises	emphasise	VERB
ajfti-2033	289	4	the	the	DET
ajfti-2033	289	5	significance	significance	NOUN
ajfti-2033	289	6	of	of	ADP
ajfti-2033	289	7	easily	easily	ADV
ajfti-2033	289	8	available	available	ADJ
ajfti-2033	289	9	pharmacies	pharmacy	NOUN
ajfti-2033	289	10	.	.	PUNCT
ajfti-2033	290	1	better	well	ADJ
ajfti-2033	290	2	adherence	adherence	NOUN
ajfti-2033	290	3	was	be	AUX
ajfti-2033	290	4	closely	closely	ADV
ajfti-2033	290	5	correlated	correlate	VERB
ajfti-2033	290	6	with	with	ADP
ajfti-2033	290	7	easier	easy	ADJ
ajfti-2033	290	8	pharmacy	pharmacy	NOUN
ajfti-2033	290	9	access	access	NOUN
ajfti-2033	290	10	,	,	PUNCT
ajfti-2033	290	11	with	with	ADP
ajfti-2033	290	12	patient	patient	ADJ
ajfti-2033	290	13	convenience	convenience	NOUN
ajfti-2033	290	14	playing	play	VERB
ajfti-2033	290	15	a	a	DET
ajfti-2033	290	16	crucial	crucial	ADJ
ajfti-2033	290	17	role	role	NOUN
ajfti-2033	290	18	(	(	PUNCT
ajfti-2033	290	19	brown	brown	NOUN
ajfti-2033	290	20	et	et	PROPN
ajfti-2033	290	21	al	al	PROPN
ajfti-2033	290	22	.	.	PROPN
ajfti-2033	290	23	,	,	PUNCT
ajfti-2033	290	24	2016	2016	NUM
ajfti-2033	290	25	)	)	PUNCT
ajfti-2033	290	26	.	.	PUNCT
ajfti-2033	291	1	morrissey	morrissey	PROPN
ajfti-2033	291	2	et	et	PROPN
ajfti-2033	291	3	al	al	PROPN
ajfti-2033	291	4	.	.	PROPN
ajfti-2033	292	1	(	(	PUNCT
ajfti-2033	292	2	2016	2016	NUM
ajfti-2033	292	3	)	)	PUNCT
ajfti-2033	292	4	emphasise	emphasise	VERB
ajfti-2033	292	5	the	the	DET
ajfti-2033	292	6	importance	importance	NOUN
ajfti-2033	292	7	of	of	ADP
ajfti-2033	292	8	convenience	convenience	NOUN
ajfti-2033	292	9	in	in	ADP
ajfti-2033	292	10	healthcare	healthcare	PROPN
ajfti-2033	292	11	delivery	delivery	NOUN
ajfti-2033	292	12	,	,	PUNCT
ajfti-2033	292	13	noting	note	VERB
ajfti-2033	292	14	that	that	SCONJ
ajfti-2033	292	15	patients	patient	NOUN
ajfti-2033	292	16	may	may	AUX
ajfti-2033	292	17	need	need	VERB
ajfti-2033	292	18	more	more	ADJ
ajfti-2033	292	19	access	access	NOUN
ajfti-2033	292	20	to	to	ADP
ajfti-2033	292	21	their	their	PRON
ajfti-2033	292	22	treatment	treatment	NOUN
ajfti-2033	292	23	regimens	regimen	NOUN
ajfti-2033	292	24	(	(	PUNCT
ajfti-2033	292	25	morrissey	morrissey	PROPN
ajfti-2033	292	26	et	et	PROPN
ajfti-2033	292	27	al	al	PROPN
ajfti-2033	292	28	.	.	PROPN
ajfti-2033	292	29	,	,	PUNCT
ajfti-2033	292	30	2016	2016	NUM
ajfti-2033	292	31	)	)	PUNCT
ajfti-2033	292	32	.	.	PUNCT
ajfti-2033	293	1	conclusion	conclusion	NOUN
ajfti-2033	293	2	in	in	ADP
ajfti-2033	293	3	conclusion	conclusion	NOUN
ajfti-2033	293	4	,	,	PUNCT
ajfti-2033	293	5	the	the	DET
ajfti-2033	293	6	results	result	NOUN
ajfti-2033	293	7	of	of	ADP
ajfti-2033	293	8	this	this	DET
ajfti-2033	293	9	study	study	NOUN
ajfti-2033	293	10	offer	offer	VERB
ajfti-2033	293	11	important	important	ADJ
ajfti-2033	293	12	new	new	ADJ
ajfti-2033	293	13	perspectives	perspective	NOUN
ajfti-2033	293	14	on	on	ADP
ajfti-2033	293	15	the	the	DET
ajfti-2033	293	16	intricate	intricate	ADJ
ajfti-2033	293	17	relationships	relationship	NOUN
ajfti-2033	293	18	between	between	ADP
ajfti-2033	293	19	saudi	saudi	PROPN
ajfti-2033	293	20	arabia	arabia	PROPN
ajfti-2033	293	21	’s	’s	PART
ajfti-2033	293	22	medicine	medicine	NOUN
ajfti-2033	293	23	prices	price	NOUN
ajfti-2033	293	24	,	,	PUNCT
ajfti-2033	293	25	insurance	insurance	NOUN
ajfti-2033	293	26	coverage	coverage	NOUN
ajfti-2033	293	27	,	,	PUNCT
ajfti-2033	293	28	and	and	CCONJ
ajfti-2033	293	29	medication	medication	NOUN
ajfti-2033	293	30	adherence	adherence	NOUN
ajfti-2033	293	31	.	.	PUNCT
ajfti-2033	294	1	the	the	DET
ajfti-2033	294	2	study	study	NOUN
ajfti-2033	294	3	used	use	VERB
ajfti-2033	294	4	a	a	DET
ajfti-2033	294	5	quantitative	quantitative	ADJ
ajfti-2033	294	6	research	research	NOUN
ajfti-2033	294	7	methodology	methodology	NOUN
ajfti-2033	294	8	to	to	PART
ajfti-2033	294	9	examine	examine	VERB
ajfti-2033	294	10	the	the	DET
ajfti-2033	294	11	correlations	correlation	NOUN
ajfti-2033	294	12	between	between	ADP
ajfti-2033	294	13	these	these	DET
ajfti-2033	294	14	characteristics	characteristic	NOUN
ajfti-2033	294	15	by	by	ADP
ajfti-2033	294	16	gathering	gather	VERB
ajfti-2033	294	17	data	datum	NOUN
ajfti-2033	294	18	from	from	ADP
ajfti-2033	294	19	a	a	DET
ajfti-2033	294	20	sample	sample	NOUN
ajfti-2033	294	21	of	of	ADP
ajfti-2033	294	22	250	250	NUM
ajfti-2033	294	23	people	people	NOUN
ajfti-2033	294	24	.	.	PUNCT
ajfti-2033	295	1	the	the	DET
ajfti-2033	295	2	investigation	investigation	NOUN
ajfti-2033	295	3	produced	produce	VERB
ajfti-2033	295	4	significant	significant	ADJ
ajfti-2033	295	5	results	result	NOUN
ajfti-2033	295	6	illuminating	illuminate	VERB
ajfti-2033	295	7	saudi	saudi	PROPN
ajfti-2033	295	8	arabia	arabia	PROPN
ajfti-2033	295	9	’s	’s	PART
ajfti-2033	295	10	healthcare	healthcare	PROPN
ajfti-2033	295	11	management	management	NOUN
ajfti-2033	295	12	possibilities	possibility	NOUN
ajfti-2033	295	13	and	and	CCONJ
ajfti-2033	295	14	difficulties	difficulty	NOUN
ajfti-2033	295	15	.	.	PUNCT
ajfti-2033	296	1	the	the	DET
ajfti-2033	296	2	study	study	NOUN
ajfti-2033	296	3	first	first	ADV
ajfti-2033	296	4	highlighted	highlight	VERB
ajfti-2033	296	5	the	the	DET
ajfti-2033	296	6	considerable	considerable	ADJ
ajfti-2033	296	7	effect	effect	NOUN
ajfti-2033	296	8	of	of	ADP
ajfti-2033	296	9	expensive	expensive	ADJ
ajfti-2033	296	10	medicine	medicine	NOUN
ajfti-2033	296	11	costs	cost	NOUN
ajfti-2033	296	12	on	on	ADP
ajfti-2033	296	13	medication	medication	NOUN
ajfti-2033	296	14	adherence	adherence	NOUN
ajfti-2033	296	15	.	.	PUNCT
ajfti-2033	297	1	it	it	PRON
ajfti-2033	297	2	was	be	AUX
ajfti-2033	297	3	shown	show	VERB
ajfti-2033	297	4	that	that	SCONJ
ajfti-2033	297	5	patients	patient	NOUN
ajfti-2033	297	6	who	who	PRON
ajfti-2033	297	7	had	have	VERB
ajfti-2033	297	8	trouble	trouble	NOUN
ajfti-2033	297	9	paying	pay	VERB
ajfti-2033	297	10	for	for	ADP
ajfti-2033	297	11	their	their	PRON
ajfti-2033	297	12	drugs	drug	NOUN
ajfti-2033	297	13	were	be	AUX
ajfti-2033	297	14	more	more	ADV
ajfti-2033	297	15	likely	likely	ADJ
ajfti-2033	297	16	to	to	PART
ajfti-2033	297	17	have	have	VERB
ajfti-2033	297	18	poorer	poor	ADJ
ajfti-2033	297	19	adherence	adherence	NOUN
ajfti-2033	297	20	rates	rate	NOUN
ajfti-2033	297	21	.	.	PUNCT
ajfti-2033	298	1	these	these	DET
ajfti-2033	298	2	findings	finding	NOUN
ajfti-2033	298	3	support	support	VERB
ajfti-2033	298	4	the	the	DET
ajfti-2033	298	5	body	body	NOUN
ajfti-2033	298	6	of	of	ADP
ajfti-2033	298	7	material	material	NOUN
ajfti-2033	298	8	already	already	ADV
ajfti-2033	298	9	in	in	ADP
ajfti-2033	298	10	existence	existence	NOUN
ajfti-2033	298	11	by	by	ADP
ajfti-2033	298	12	highlighting	highlight	VERB
ajfti-2033	298	13	the	the	DET
ajfti-2033	298	14	link	link	NOUN
ajfti-2033	298	15	between	between	ADP
ajfti-2033	298	16	patient	patient	ADJ
ajfti-2033	298	17	compliance	compliance	NOUN
ajfti-2033	298	18	and	and	CCONJ
ajfti-2033	298	19	drug	drug	NOUN
ajfti-2033	298	20	prices	price	NOUN
ajfti-2033	298	21	.	.	PUNCT
ajfti-2033	299	1	studies	study	NOUN
ajfti-2033	299	2	by	by	ADP
ajfti-2033	299	3	kennedy	kennedy	PROPN
ajfti-2033	299	4	-	-	PUNCT
ajfti-2033	299	5	martin	martin	PROPN
ajfti-2033	299	6	et	et	PROPN
ajfti-2033	299	7	al	al	PROPN
ajfti-2033	299	8	.	.	PROPN
ajfti-2033	299	9	(	(	PUNCT
ajfti-2033	299	10	2017	2017	NUM
ajfti-2033	299	11	)	)	PUNCT
ajfti-2033	299	12	,	,	PUNCT
ajfti-2033	299	13	torres	torre	NOUN
ajfti-2033	299	14	-	-	PUNCT
ajfti-2033	299	15	robles	roble	NOUN
ajfti-2033	299	16	et	et	PROPN
ajfti-2033	299	17	al	al	PROPN
ajfti-2033	299	18	.	.	PROPN
ajfti-2033	299	19	(	(	PUNCT
ajfti-2033	299	20	2021	2021	NUM
ajfti-2033	299	21	)	)	PUNCT
ajfti-2033	299	22	,	,	PUNCT
ajfti-2033	299	23	and	and	CCONJ
ajfti-2033	299	24	yosef	yosef	PROPN
ajfti-2033	299	25	et	et	PROPN
ajfti-2033	299	26	al	al	PROPN
ajfti-2033	299	27	.	.	PROPN
ajfti-2033	299	28	(	(	PUNCT
ajfti-2033	299	29	2023	2023	NUM
ajfti-2033	299	30	)	)	PUNCT
ajfti-2033	299	31	have	have	AUX
ajfti-2033	299	32	all	all	PRON
ajfti-2033	299	33	shown	show	VERB
ajfti-2033	299	34	that	that	SCONJ
ajfti-2033	299	35	patients	patient	NOUN
ajfti-2033	299	36	,	,	PUNCT
ajfti-2033	299	37	particularly	particularly	ADV
ajfti-2033	299	38	those	those	PRON
ajfti-2033	299	39	with	with	ADP
ajfti-2033	299	40	chronic	chronic	ADJ
ajfti-2033	299	41	conditions	condition	NOUN
ajfti-2033	299	42	,	,	PUNCT
ajfti-2033	299	43	may	may	AUX
ajfti-2033	299	44	incur	incur	VERB
ajfti-2033	299	45	higher	high	ADJ
ajfti-2033	299	46	out	out	ADP
ajfti-2033	299	47	-	-	PUNCT
ajfti-2033	299	48	of	of	ADP
ajfti-2033	299	49	-	-	PUNCT
ajfti-2033	299	50	pocket	pocket	NOUN
ajfti-2033	299	51	costs	cost	NOUN
ajfti-2033	299	52	as	as	ADP
ajfti-2033	299	53	a	a	DET
ajfti-2033	299	54	result	result	NOUN
ajfti-2033	299	55	of	of	ADP
ajfti-2033	299	56	high	high	ADJ
ajfti-2033	299	57	prescription	prescription	NOUN
ajfti-2033	299	58	drug	drug	NOUN
ajfti-2033	299	59	prices	price	NOUN
ajfti-2033	299	60	.	.	PUNCT
ajfti-2033	300	1	this	this	PRON
ajfti-2033	300	2	emphasises	emphasise	VERB
ajfti-2033	300	3	the	the	DET
ajfti-2033	300	4	importance	importance	NOUN
ajfti-2033	300	5	of	of	ADP
ajfti-2033	300	6	affordability	affordability	NOUN
ajfti-2033	300	7	in	in	ADP
ajfti-2033	300	8	influencing	influence	VERB
ajfti-2033	300	9	drug	drug	NOUN
ajfti-2033	300	10	adherence	adherence	NOUN
ajfti-2033	300	11	behaviours	behaviour	NOUN
ajfti-2033	300	12	.	.	PUNCT
ajfti-2033	301	1	the	the	DET
ajfti-2033	301	2	study	study	NOUN
ajfti-2033	301	3	results	result	NOUN
ajfti-2033	301	4	show	show	VERB
ajfti-2033	301	5	a	a	DET
ajfti-2033	301	6	considerable	considerable	ADJ
ajfti-2033	301	7	association	association	NOUN
ajfti-2033	301	8	between	between	ADP
ajfti-2033	301	9	high	high	ADJ
ajfti-2033	301	10	drug	drug	NOUN
ajfti-2033	301	11	prices	price	NOUN
ajfti-2033	301	12	and	and	CCONJ
ajfti-2033	301	13	nonadherence	nonadherence	NOUN
ajfti-2033	301	14	(	(	PUNCT
ajfti-2033	301	15	r	r	NOUN
ajfti-2033	301	16	=	=	SYM
ajfti-2033	301	17	-0.773	-0.773	PROPN
ajfti-2033	301	18	,	,	PUNCT
ajfti-2033	301	19	p	p	X
ajfti-2033	301	20	=	=	NOUN
ajfti-2033	301	21	0.006	0.006	NUM
ajfti-2033	301	22	)	)	PUNCT
ajfti-2033	301	23	.	.	PUNCT
ajfti-2033	302	1	on	on	ADP
ajfti-2033	302	2	the	the	DET
ajfti-2033	302	3	other	other	ADJ
ajfti-2033	302	4	hand	hand	NOUN
ajfti-2033	302	5	,	,	PUNCT
ajfti-2033	302	6	extensive	extensive	ADJ
ajfti-2033	302	7	insurance	insurance	NOUN
ajfti-2033	302	8	protection	protection	NOUN
ajfti-2033	302	9	encourages	encourage	VERB
ajfti-2033	302	10	adherence	adherence	NOUN
ajfti-2033	302	11	.	.	PUNCT
ajfti-2033	303	1	sixty	sixty	NUM
ajfti-2033	303	2	-	-	PUNCT
ajfti-2033	303	3	nine	nine	NUM
ajfti-2033	303	4	per	per	ADP
ajfti-2033	303	5	cent	cent	NOUN
ajfti-2033	303	6	of	of	ADP
ajfti-2033	303	7	the	the	DET
ajfti-2033	303	8	250	250	NUM
ajfti-2033	303	9	participants	participant	NOUN
ajfti-2033	303	10	had	have	VERB
ajfti-2033	303	11	insurance	insurance	NOUN
ajfti-2033	303	12	,	,	PUNCT
ajfti-2033	303	13	while	while	SCONJ
ajfti-2033	303	14	just	just	ADV
ajfti-2033	303	15	31	31	NUM
ajfti-2033	303	16	%	%	NOUN
ajfti-2033	303	17	did	do	VERB
ajfti-2033	303	18	not	not	PART
ajfti-2033	303	19	.	.	PUNCT
ajfti-2033	304	1	participants	participant	NOUN
ajfti-2033	304	2	were	be	AUX
ajfti-2033	304	3	split	split	VERB
ajfti-2033	304	4	80/20	80/20	NUM
ajfti-2033	304	5	between	between	ADP
ajfti-2033	304	6	men	man	NOUN
ajfti-2033	304	7	and	and	CCONJ
ajfti-2033	304	8	women	woman	NOUN
ajfti-2033	304	9	.	.	PUNCT
ajfti-2033	305	1	approximately	approximately	ADV
ajfti-2033	305	2	62	62	NUM
ajfti-2033	305	3	%	%	NOUN
ajfti-2033	305	4	of	of	ADP
ajfti-2033	305	5	the	the	DET
ajfti-2033	305	6	respondents	respondent	NOUN
ajfti-2033	305	7	in	in	ADP
ajfti-2033	305	8	the	the	DET
ajfti-2033	305	9	survey	survey	NOUN
ajfti-2033	305	10	were	be	AUX
ajfti-2033	305	11	in	in	ADP
ajfti-2033	305	12	their	their	PRON
ajfti-2033	305	13	twenties	twenty	NOUN
ajfti-2033	305	14	to	to	ADP
ajfti-2033	305	15	thirties	thirty	NOUN
ajfti-2033	305	16	,	,	PUNCT
ajfti-2033	305	17	56	56	NUM
ajfti-2033	305	18	%	%	NOUN
ajfti-2033	305	19	had	have	VERB
ajfti-2033	305	20	bachelor	bachelor	NOUN
ajfti-2033	305	21	’s	’s	PART
ajfti-2033	305	22	degrees	degree	NOUN
ajfti-2033	305	23	,	,	PUNCT
ajfti-2033	305	24	and	and	CCONJ
ajfti-2033	305	25	43	43	NUM
ajfti-2033	305	26	%	%	NOUN
ajfti-2033	305	27	had	have	VERB
ajfti-2033	305	28	monthly	monthly	ADJ
ajfti-2033	305	29	incomes	income	NOUN
ajfti-2033	305	30	above	above	ADP
ajfti-2033	305	31	20,000	20,000	NUM
ajfti-2033	305	32	sar	sar	NOUN
ajfti-2033	305	33	.	.	PUNCT
ajfti-2033	306	1	the	the	DET
ajfti-2033	306	2	largest	large	ADJ
ajfti-2033	306	3	portion	portion	NOUN
ajfti-2033	306	4	(	(	PUNCT
ajfti-2033	306	5	70.8	70.8	NUM
ajfti-2033	306	6	%	%	NOUN
ajfti-2033	306	7	)	)	PUNCT
ajfti-2033	306	8	was	be	AUX
ajfti-2033	306	9	from	from	ADP
ajfti-2033	306	10	the	the	DET
ajfti-2033	306	11	central	central	ADJ
ajfti-2033	306	12	area	area	NOUN
ajfti-2033	306	13	.	.	PUNCT
ajfti-2033	307	1	the	the	DET
ajfti-2033	307	2	substantial	substantial	ADJ
ajfti-2033	307	3	effects	effect	NOUN
ajfti-2033	307	4	of	of	ADP
ajfti-2033	307	5	medicine	medicine	NOUN
ajfti-2033	307	6	cost	cost	NOUN
ajfti-2033	307	7	and	and	CCONJ
ajfti-2033	307	8	insurance	insurance	NOUN
ajfti-2033	307	9	coverage	coverage	NOUN
ajfti-2033	307	10	on	on	ADP
ajfti-2033	307	11	medication	medication	NOUN
ajfti-2033	307	12	adherence	adherence	NOUN
ajfti-2033	307	13	were	be	AUX
ajfti-2033	307	14	also	also	ADV
ajfti-2033	307	15	verified	verify	VERB
ajfti-2033	307	16	by	by	ADP
ajfti-2033	307	17	regression	regression	NOUN
ajfti-2033	307	18	analysis	analysis	NOUN
ajfti-2033	307	19	(	(	PUNCT
ajfti-2033	307	20	beta	beta	NOUN
ajfti-2033	307	21	=	=	SYM
ajfti-2033	307	22	-0.749	-0.749	NOUN
ajfti-2033	307	23	,	,	PUNCT
ajfti-2033	307	24	p	p	NOUN
ajfti-2033	307	25	=	=	NOUN
ajfti-2033	307	26	0.001	0.001	NUM
ajfti-2033	307	27	and	and	CCONJ
ajfti-2033	307	28	beta	beta	NOUN
ajfti-2033	307	29	=	=	NOUN
ajfti-2033	307	30	0.759	0.759	NUM
ajfti-2033	307	31	,	,	PUNCT
ajfti-2033	307	32	p	p	NOUN
ajfti-2033	307	33	=	=	NOUN
ajfti-2033	307	34	0.006	0.006	NUM
ajfti-2033	307	35	,	,	PUNCT
ajfti-2033	307	36	respectively	respectively	ADV
ajfti-2033	307	37	)	)	PUNCT
ajfti-2033	307	38	.	.	PUNCT
ajfti-2033	308	1	while	while	SCONJ
ajfti-2033	308	2	extensive	extensive	ADJ
ajfti-2033	308	3	insurance	insurance	NOUN
ajfti-2033	308	4	coverage	coverage	NOUN
ajfti-2033	308	5	encourages	encourage	VERB
ajfti-2033	308	6	compliance	compliance	NOUN
ajfti-2033	308	7	,	,	PUNCT
ajfti-2033	308	8	exorbitant	exorbitant	ADJ
ajfti-2033	308	9	medication	medication	NOUN
ajfti-2033	308	10	prices	price	NOUN
ajfti-2033	308	11	impede	impede	VERB
ajfti-2033	308	12	it	it	PRON
ajfti-2033	308	13	.	.	PUNCT
ajfti-2033	309	1	affordability	affordability	NOUN
ajfti-2033	309	2	and	and	CCONJ
ajfti-2033	309	3	accessibility	accessibility	NOUN
ajfti-2033	309	4	of	of	ADP
ajfti-2033	309	5	insurance	insurance	NOUN
ajfti-2033	309	6	plans	plan	NOUN
ajfti-2033	309	7	should	should	AUX
ajfti-2033	309	8	be	be	AUX
ajfti-2033	309	9	a	a	DET
ajfti-2033	309	10	priority	priority	NOUN
ajfti-2033	309	11	for	for	SCONJ
ajfti-2033	309	12	policymakers	policymaker	NOUN
ajfti-2033	309	13	to	to	PART
ajfti-2033	309	14	enhance	enhance	VERB
ajfti-2033	309	15	.	.	PUNCT
ajfti-2033	310	1	recommendations	recommendation	NOUN
ajfti-2033	310	2	the	the	DET
ajfti-2033	310	3	findings	finding	NOUN
ajfti-2033	310	4	of	of	ADP
ajfti-2033	310	5	this	this	DET
ajfti-2033	310	6	study	study	NOUN
ajfti-2033	310	7	can	can	AUX
ajfti-2033	310	8	have	have	VERB
ajfti-2033	310	9	a	a	DET
ajfti-2033	310	10	significant	significant	ADJ
ajfti-2033	310	11	influence	influence	NOUN
ajfti-2033	310	12	on	on	ADP
ajfti-2033	310	13	saudi	saudi	PROPN
ajfti-2033	310	14	arabia	arabia	PROPN
ajfti-2033	310	15	’s	’s	PART
ajfti-2033	310	16	healthcare	healthcare	PROPN
ajfti-2033	310	17	policies	policy	NOUN
ajfti-2033	310	18	.	.	PUNCT
ajfti-2033	311	1	policymakers	policymaker	NOUN
ajfti-2033	311	2	should	should	AUX
ajfti-2033	311	3	think	think	VERB
ajfti-2033	311	4	about	about	ADP
ajfti-2033	311	5	a	a	DET
ajfti-2033	311	6	multifaceted	multifaceted	ADJ
ajfti-2033	311	7	strategy	strategy	NOUN
ajfti-2033	311	8	to	to	PART
ajfti-2033	311	9	improve	improve	VERB
ajfti-2033	311	10	drug	drug	NOUN
ajfti-2033	311	11	adherence	adherence	NOUN
ajfti-2033	311	12	and	and	CCONJ
ajfti-2033	311	13	,	,	PUNCT
ajfti-2033	311	14	subsequently	subsequently	ADV
ajfti-2033	311	15	,	,	PUNCT
ajfti-2033	311	16	health	health	NOUN
ajfti-2033	311	17	outcomes	outcome	NOUN
ajfti-2033	311	18	:	:	PUNCT
ajfti-2033	311	19	affordable	affordable	ADJ
ajfti-2033	311	20	drug	drug	NOUN
ajfti-2033	311	21	pricing	pricing	NOUN
ajfti-2033	311	22	reducing	reduce	VERB
ajfti-2033	311	23	exorbitant	exorbitant	ADJ
ajfti-2033	311	24	drug	drug	NOUN
ajfti-2033	311	25	costs	cost	NOUN
ajfti-2033	311	26	should	should	AUX
ajfti-2033	311	27	be	be	AUX
ajfti-2033	311	28	a	a	DET
ajfti-2033	311	29	focus	focus	NOUN
ajfti-2033	311	30	.	.	PUNCT
ajfti-2033	312	1	indirectly	indirectly	ADV
ajfti-2033	312	2	,	,	PUNCT
ajfti-2033	312	3	increased	increase	VERB
ajfti-2033	312	4	patient	patient	ADJ
ajfti-2033	312	5	compliance	compliance	NOUN
ajfti-2033	312	6	is	be	AUX
ajfti-2033	312	7	helped	help	VERB
ajfti-2033	312	8	by	by	ADP
ajfti-2033	312	9	policies	policy	NOUN
ajfti-2033	312	10	designed	design	VERB
ajfti-2033	312	11	to	to	PART
ajfti-2033	312	12	lower	lower	VERB
ajfti-2033	312	13	the	the	DET
ajfti-2033	312	14	cost	cost	NOUN
ajfti-2033	312	15	of	of	ADP
ajfti-2033	312	16	medications	medication	NOUN
ajfti-2033	312	17	or	or	CCONJ
ajfti-2033	312	18	to	to	PART
ajfti-2033	312	19	provide	provide	VERB
ajfti-2033	312	20	financial	financial	ADJ
ajfti-2033	312	21	assistance	assistance	NOUN
ajfti-2033	312	22	.	.	PUNCT
ajfti-2033	313	1	pa	pa	PROPN
ajfti-2033	313	2	ge	ge	PROPN
ajfti-2033	313	3	33	33	NUM
ajfti-2033	313	4	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	313	5	am	be	AUX
ajfti-2033	313	6	.	.	PUNCT
ajfti-2033	314	1	j.	j.	PROPN
ajfti-2033	314	2	financ	financ	PROPN
ajfti-2033	314	3	.	.	PUNCT
ajfti-2033	315	1	technol	technol	PROPN
ajfti-2033	315	2	.	.	PUNCT
ajfti-2033	315	3	innov	innov	PROPN
ajfti-2033	315	4	.	.	PUNCT
ajfti-2033	316	1	1(1	1(1	NUM
ajfti-2033	316	2	)	)	PUNCT
ajfti-2033	316	3	24	24	NUM
ajfti-2033	316	4	-	-	SYM
ajfti-2033	316	5	34	34	NUM
ajfti-2033	316	6	,	,	PUNCT
ajfti-2033	316	7	2023	2023	NUM
ajfti-2033	316	8	comprehensive	comprehensive	ADJ
ajfti-2033	316	9	insurance	insurance	NOUN
ajfti-2033	316	10	coverage	coverage	NOUN
ajfti-2033	316	11	patients	patient	NOUN
ajfti-2033	316	12	follow	follow	VERB
ajfti-2033	316	13	their	their	PRON
ajfti-2033	316	14	programs	program	NOUN
ajfti-2033	316	15	more	more	ADV
ajfti-2033	316	16	faithfully	faithfully	ADV
ajfti-2033	316	17	when	when	SCONJ
ajfti-2033	316	18	they	they	PRON
ajfti-2033	316	19	are	be	AUX
ajfti-2033	316	20	n’t	not	PART
ajfti-2033	316	21	concerned	concerned	ADJ
ajfti-2033	316	22	about	about	ADP
ajfti-2033	316	23	paying	pay	VERB
ajfti-2033	316	24	expensive	expensive	ADJ
ajfti-2033	316	25	out	out	ADP
ajfti-2033	316	26	-	-	PUNCT
ajfti-2033	316	27	of	of	ADP
ajfti-2033	316	28	-	-	PUNCT
ajfti-2033	316	29	pocket	pocket	NOUN
ajfti-2033	316	30	costs	cost	NOUN
ajfti-2033	316	31	for	for	ADP
ajfti-2033	316	32	required	required	ADJ
ajfti-2033	316	33	prescriptions	prescription	NOUN
ajfti-2033	316	34	,	,	PUNCT
ajfti-2033	316	35	thanks	thank	NOUN
ajfti-2033	316	36	to	to	ADP
ajfti-2033	316	37	comprehensive	comprehensive	ADJ
ajfti-2033	316	38	health	health	NOUN
ajfti-2033	316	39	insurance	insurance	NOUN
ajfti-2033	316	40	.	.	PUNCT
ajfti-2033	317	1	patient	patient	ADJ
ajfti-2033	317	2	education	education	NOUN
ajfti-2033	317	3	and	and	CCONJ
ajfti-2033	317	4	communication	communication	NOUN
ajfti-2033	317	5	empowerment	empowerment	NOUN
ajfti-2033	317	6	is	be	AUX
ajfti-2033	317	7	attained	attain	VERB
ajfti-2033	317	8	by	by	ADP
ajfti-2033	317	9	encouraging	encourage	VERB
ajfti-2033	317	10	collaboration	collaboration	NOUN
ajfti-2033	317	11	between	between	ADP
ajfti-2033	317	12	healthcare	healthcare	NOUN
ajfti-2033	317	13	professionals	professional	NOUN
ajfti-2033	317	14	and	and	CCONJ
ajfti-2033	317	15	patients	patient	NOUN
ajfti-2033	317	16	,	,	PUNCT
ajfti-2033	317	17	which	which	PRON
ajfti-2033	317	18	results	result	VERB
ajfti-2033	317	19	in	in	ADP
ajfti-2033	317	20	improved	improved	ADJ
ajfti-2033	317	21	condition	condition	NOUN
ajfti-2033	317	22	management	management	NOUN
ajfti-2033	317	23	through	through	ADP
ajfti-2033	317	24	education	education	NOUN
ajfti-2033	317	25	and	and	CCONJ
ajfti-2033	317	26	communication	communication	NOUN
ajfti-2033	317	27	.	.	PUNCT
ajfti-2033	318	1	pharmacy	pharmacy	NOUN
ajfti-2033	318	2	accessibility	accessibility	NOUN
ajfti-2033	318	3	by	by	ADP
ajfti-2033	318	4	ensuring	ensure	VERB
ajfti-2033	318	5	easy	easy	ADJ
ajfti-2033	318	6	access	access	NOUN
ajfti-2033	318	7	to	to	ADP
ajfti-2033	318	8	pharmacies	pharmacy	NOUN
ajfti-2033	318	9	,	,	PUNCT
ajfti-2033	318	10	we	we	PRON
ajfti-2033	318	11	can	can	AUX
ajfti-2033	318	12	speed	speed	VERB
ajfti-2033	318	13	up	up	ADP
ajfti-2033	318	14	the	the	DET
ajfti-2033	318	15	processes	process	NOUN
ajfti-2033	318	16	for	for	ADP
ajfti-2033	318	17	picking	pick	VERB
ajfti-2033	318	18	up	up	ADP
ajfti-2033	318	19	new	new	ADJ
ajfti-2033	318	20	prescriptions	prescription	NOUN
ajfti-2033	318	21	and	and	CCONJ
ajfti-2033	318	22	renewing	renew	VERB
ajfti-2033	318	23	old	old	ADJ
ajfti-2033	318	24	ones	one	NOUN
ajfti-2033	318	25	.	.	PUNCT
ajfti-2033	319	1	holistic	holistic	ADJ
ajfti-2033	319	2	approach	approach	NOUN
ajfti-2033	319	3	as	as	SCONJ
ajfti-2033	319	4	legislators	legislator	NOUN
ajfti-2033	319	5	create	create	VERB
ajfti-2033	319	6	regulations	regulation	NOUN
ajfti-2033	319	7	about	about	ADP
ajfti-2033	319	8	medication	medication	NOUN
ajfti-2033	319	9	adherence	adherence	NOUN
ajfti-2033	319	10	,	,	PUNCT
ajfti-2033	319	11	a	a	DET
ajfti-2033	319	12	complete	complete	ADJ
ajfti-2033	319	13	viewpoint	viewpoint	NOUN
ajfti-2033	319	14	is	be	AUX
ajfti-2033	319	15	essential	essential	ADJ
ajfti-2033	319	16	.	.	PUNCT
ajfti-2033	320	1	this	this	DET
ajfti-2033	320	2	study	study	NOUN
ajfti-2033	320	3	draws	draw	VERB
ajfti-2033	320	4	a	a	DET
ajfti-2033	320	5	strong	strong	ADJ
ajfti-2033	320	6	conclusion	conclusion	NOUN
ajfti-2033	320	7	by	by	ADP
ajfti-2033	320	8	examining	examine	VERB
ajfti-2033	320	9	the	the	DET
ajfti-2033	320	10	complex	complex	ADJ
ajfti-2033	320	11	relationships	relationship	NOUN
ajfti-2033	320	12	between	between	ADP
ajfti-2033	320	13	drug	drug	NOUN
ajfti-2033	320	14	cost	cost	NOUN
ajfti-2033	320	15	,	,	PUNCT
ajfti-2033	320	16	insurance	insurance	NOUN
ajfti-2033	320	17	,	,	PUNCT
ajfti-2033	320	18	and	and	CCONJ
ajfti-2033	320	19	medication	medication	NOUN
ajfti-2033	320	20	adherence	adherence	NOUN
ajfti-2033	320	21	.	.	PUNCT
ajfti-2033	321	1	these	these	DET
ajfti-2033	321	2	five	five	NUM
ajfti-2033	321	3	factorscomplete	factorscomplete	ADJ
ajfti-2033	321	4	coverage	coverage	NOUN
ajfti-2033	321	5	,	,	PUNCT
ajfti-2033	321	6	improved	improved	ADJ
ajfti-2033	321	7	education	education	NOUN
ajfti-2033	321	8	,	,	PUNCT
ajfti-2033	321	9	crystal	crystal	NOUN
ajfti-2033	321	10	-	-	PUNCT
ajfti-2033	321	11	clear	clear	ADJ
ajfti-2033	321	12	communication	communication	NOUN
ajfti-2033	321	13	,	,	PUNCT
ajfti-2033	321	14	and	and	CCONJ
ajfti-2033	321	15	easily	easily	ADV
ajfti-2033	321	16	accessible	accessible	ADJ
ajfti-2033	321	17	pharmacies	pharmacy	NOUN
ajfti-2033	321	18	-	-	PUNCT
ajfti-2033	321	19	create	create	VERB
ajfti-2033	321	20	an	an	DET
ajfti-2033	321	21	unbreakable	unbreakable	ADJ
ajfti-2033	321	22	wall	wall	NOUN
ajfti-2033	321	23	of	of	ADP
ajfti-2033	321	24	support	support	NOUN
ajfti-2033	321	25	for	for	ADP
ajfti-2033	321	26	greater	great	ADJ
ajfti-2033	321	27	adherence	adherence	NOUN
ajfti-2033	321	28	in	in	ADP
ajfti-2033	321	29	the	the	DET
ajfti-2033	321	30	face	face	NOUN
ajfti-2033	321	31	of	of	ADP
ajfti-2033	321	32	pricey	pricey	ADJ
ajfti-2033	321	33	medications	medication	NOUN
ajfti-2033	321	34	.	.	PUNCT
ajfti-2033	322	1	these	these	DET
ajfti-2033	322	2	findings	finding	NOUN
ajfti-2033	322	3	shed	shed	VERB
ajfti-2033	322	4	light	light	NOUN
ajfti-2033	322	5	on	on	ADP
ajfti-2033	322	6	the	the	DET
ajfti-2033	322	7	importance	importance	NOUN
ajfti-2033	322	8	of	of	ADP
ajfti-2033	322	9	health	health	NOUN
ajfti-2033	322	10	and	and	CCONJ
ajfti-2033	322	11	pave	pave	VERB
ajfti-2033	322	12	the	the	DET
ajfti-2033	322	13	way	way	NOUN
ajfti-2033	322	14	for	for	ADP
ajfti-2033	322	15	healthier	healthy	ADJ
ajfti-2033	322	16	,	,	PUNCT
ajfti-2033	322	17	more	more	ADV
ajfti-2033	322	18	devoted	devoted	ADJ
ajfti-2033	322	19	communities	community	NOUN
ajfti-2033	322	20	.	.	PUNCT
ajfti-2033	323	1	references	reference	NOUN
ajfti-2033	323	2	adebisi	adebisi	VERB
ajfti-2033	323	3	,	,	PUNCT
ajfti-2033	323	4	y.	y.	PROPN
ajfti-2033	323	5	a.	a.	PROPN
ajfti-2033	323	6	,	,	PUNCT
ajfti-2033	323	7	nwogu	nwogu	ADJ
ajfti-2033	323	8	,	,	PUNCT
ajfti-2033	323	9	i.	i.	PROPN
ajfti-2033	323	10	b.	b.	PROPN
ajfti-2033	323	11	,	,	PUNCT
ajfti-2033	323	12	alaran	alaran	PROPN
ajfti-2033	323	13	,	,	PUNCT
ajfti-2033	323	14	a.	a.	PROPN
ajfti-2033	323	15	j.	j.	PROPN
ajfti-2033	323	16	,	,	PUNCT
ajfti-2033	323	17	badmos	badmos	PROPN
ajfti-2033	323	18	,	,	PUNCT
ajfti-2033	323	19	a.	a.	PROPN
ajfti-2033	323	20	o.	o.	PROPN
ajfti-2033	323	21	,	,	PUNCT
ajfti-2033	323	22	bamgboye	bamgboye	NOUN
ajfti-2033	323	23	,	,	PUNCT
ajfti-2033	323	24	a.	a.	NOUN
ajfti-2033	323	25	o.	o.	PROPN
ajfti-2033	323	26	,	,	PUNCT
ajfti-2033	323	27	rufai	rufai	NOUN
ajfti-2033	323	28	,	,	PUNCT
ajfti-2033	323	29	b.	b.	PROPN
ajfti-2033	323	30	o.	o.	PROPN
ajfti-2033	323	31	,	,	PUNCT
ajfti-2033	323	32	okonji	okonji	ADV
ajfti-2033	323	33	,	,	PUNCT
ajfti-2033	323	34	o.	o.	PROPN
ajfti-2033	323	35	c.	c.	PROPN
ajfti-2033	323	36	,	,	PUNCT
ajfti-2033	323	37	malik	malik	PROPN
ajfti-2033	323	38	,	,	PUNCT
ajfti-2033	323	39	m.	m.	NOUN
ajfti-2033	323	40	o.	o.	PROPN
ajfti-2033	323	41	,	,	PUNCT
ajfti-2033	323	42	teibo	teibo	VERB
ajfti-2033	323	43	,	,	PUNCT
ajfti-2033	324	1	j.	j.	PROPN
ajfti-2033	324	2	o.	o.	PROPN
ajfti-2033	324	3	,	,	PUNCT
ajfti-2033	324	4	&	&	CCONJ
ajfti-2033	324	5	abdalla	abdalla	PROPN
ajfti-2033	324	6	,	,	PUNCT
ajfti-2033	324	7	s.	s.	PROPN
ajfti-2033	324	8	f.	f.	PROPN
ajfti-2033	324	9	(	(	PUNCT
ajfti-2033	324	10	2022	2022	NUM
ajfti-2033	324	11	)	)	PUNCT
ajfti-2033	324	12	.	.	PUNCT
ajfti-2033	325	1	revisiting	revisit	VERB
ajfti-2033	325	2	the	the	DET
ajfti-2033	325	3	issue	issue	NOUN
ajfti-2033	325	4	of	of	ADP
ajfti-2033	325	5	access	access	NOUN
ajfti-2033	325	6	to	to	ADP
ajfti-2033	325	7	medicines	medicine	NOUN
ajfti-2033	325	8	in	in	ADP
ajfti-2033	325	9	africa	africa	PROPN
ajfti-2033	325	10	:	:	PUNCT
ajfti-2033	325	11	challenges	challenge	NOUN
ajfti-2033	325	12	and	and	CCONJ
ajfti-2033	325	13	recommendations	recommendation	NOUN
ajfti-2033	325	14	.	.	PUNCT
ajfti-2033	326	1	public	public	ADJ
ajfti-2033	326	2	health	health	NOUN
ajfti-2033	326	3	challenges	challenge	NOUN
ajfti-2033	326	4	,	,	PUNCT
ajfti-2033	326	5	1(2	1(2	NUM
ajfti-2033	326	6	)	)	PUNCT
ajfti-2033	326	7	,	,	PUNCT
ajfti-2033	326	8	e9	e9	PROPN
ajfti-2033	326	9	.	.	PUNCT
ajfti-2033	326	10	ahmad	ahmad	PROPN
ajfti-2033	326	11	,	,	PUNCT
ajfti-2033	326	12	n.	n.	PROPN
ajfti-2033	326	13	s.	s.	PROPN
ajfti-2033	326	14	,	,	PUNCT
ajfti-2033	326	15	makmor	makmor	NOUN
ajfti-2033	326	16	-	-	PUNCT
ajfti-2033	326	17	bakry	bakry	NOUN
ajfti-2033	326	18	,	,	PUNCT
ajfti-2033	326	19	m.	m.	NOUN
ajfti-2033	326	20	,	,	PUNCT
ajfti-2033	326	21	&	&	CCONJ
ajfti-2033	326	22	hatah	hatah	PROPN
ajfti-2033	326	23	,	,	PUNCT
ajfti-2033	326	24	e.	e.	PROPN
ajfti-2033	326	25	(	(	PUNCT
ajfti-2033	326	26	2020	2020	NUM
ajfti-2033	326	27	)	)	PUNCT
ajfti-2033	326	28	.	.	PUNCT
ajfti-2033	327	1	drug	drug	NOUN
ajfti-2033	327	2	price	price	NOUN
ajfti-2033	327	3	transparency	transparency	NOUN
ajfti-2033	327	4	initiative	initiative	NOUN
ajfti-2033	327	5	:	:	PUNCT
ajfti-2033	327	6	a	a	DET
ajfti-2033	327	7	scoping	scope	VERB
ajfti-2033	327	8	review	review	NOUN
ajfti-2033	327	9	.	.	PUNCT
ajfti-2033	328	1	research	research	NOUN
ajfti-2033	328	2	in	in	ADP
ajfti-2033	328	3	social	social	ADJ
ajfti-2033	328	4	and	and	CCONJ
ajfti-2033	328	5	administrative	administrative	ADJ
ajfti-2033	328	6	pharmacy	pharmacy	NOUN
ajfti-2033	328	7	,	,	PUNCT
ajfti-2033	328	8	16(10	16(10	NOUN
ajfti-2033	328	9	)	)	PUNCT
ajfti-2033	328	10	,	,	PUNCT
ajfti-2033	328	11	1359	1359	NUM
ajfti-2033	328	12	-	-	SYM
ajfti-2033	328	13	1369	1369	NUM
ajfti-2033	328	14	.	.	PUNCT
ajfti-2033	329	1	ahmed	ahmed	PROPN
ajfti-2033	329	2	,	,	PUNCT
ajfti-2033	329	3	i.	i.	PROPN
ajfti-2033	329	4	,	,	PUNCT
ajfti-2033	329	5	ahmad	ahmad	PROPN
ajfti-2033	329	6	,	,	PUNCT
ajfti-2033	329	7	n.	n.	PROPN
ajfti-2033	329	8	s.	s.	PROPN
ajfti-2033	329	9	,	,	PUNCT
ajfti-2033	329	10	ali	ali	PROPN
ajfti-2033	329	11	,	,	PUNCT
ajfti-2033	329	12	s.	s.	PROPN
ajfti-2033	329	13	,	,	PUNCT
ajfti-2033	329	14	ali	ali	PROPN
ajfti-2033	329	15	,	,	PUNCT
ajfti-2033	329	16	s.	s.	PROPN
ajfti-2033	329	17	,	,	PUNCT
ajfti-2033	329	18	george	george	PROPN
ajfti-2033	329	19	,	,	PUNCT
ajfti-2033	329	20	a.	a.	NOUN
ajfti-2033	329	21	,	,	PUNCT
ajfti-2033	329	22	danish	danish	PROPN
ajfti-2033	329	23	,	,	PUNCT
ajfti-2033	329	24	h.	h.	PROPN
ajfti-2033	329	25	s.	s.	PROPN
ajfti-2033	329	26	,	,	PUNCT
ajfti-2033	329	27	uppal	uppal	PROPN
ajfti-2033	329	28	,	,	PUNCT
ajfti-2033	329	29	e.	e.	PROPN
ajfti-2033	329	30	,	,	PUNCT
ajfti-2033	329	31	soo	soo	PROPN
ajfti-2033	329	32	,	,	PUNCT
ajfti-2033	329	33	j.	j.	PROPN
ajfti-2033	329	34	,	,	PUNCT
ajfti-2033	329	35	mobasheri	mobasheri	PROPN
ajfti-2033	329	36	,	,	PUNCT
ajfti-2033	329	37	m.	m.	PROPN
ajfti-2033	329	38	h.	h.	PROPN
ajfti-2033	329	39	,	,	PUNCT
ajfti-2033	329	40	&	&	CCONJ
ajfti-2033	329	41	king	king	PROPN
ajfti-2033	329	42	,	,	PUNCT
ajfti-2033	329	43	d.	d.	PROPN
ajfti-2033	329	44	(	(	PUNCT
ajfti-2033	329	45	2018	2018	NUM
ajfti-2033	329	46	)	)	PUNCT
ajfti-2033	329	47	.	.	PUNCT
ajfti-2033	330	1	medication	medication	NOUN
ajfti-2033	330	2	adherence	adherence	NOUN
ajfti-2033	330	3	apps	app	NOUN
ajfti-2033	330	4	:	:	PUNCT
ajfti-2033	330	5	review	review	NOUN
ajfti-2033	330	6	and	and	CCONJ
ajfti-2033	330	7	content	content	ADJ
ajfti-2033	330	8	analysis	analysis	NOUN
ajfti-2033	330	9	.	.	PUNCT
ajfti-2033	331	1	jmir	jmir	PROPN
ajfti-2033	331	2	mhealth	mhealth	PROPN
ajfti-2033	331	3	and	and	CCONJ
ajfti-2033	331	4	uhealth	uhealth	NOUN
ajfti-2033	331	5	,	,	PUNCT
ajfti-2033	331	6	6(3	6(3	NUM
ajfti-2033	331	7	)	)	PUNCT
ajfti-2033	331	8	,	,	PUNCT
ajfti-2033	331	9	e6432	e6432	NOUN
ajfti-2033	331	10	.	.	PUNCT
ajfti-2033	332	1	al	al	PROPN
ajfti-2033	332	2	-	-	PUNCT
ajfti-2033	332	3	hanawi	hanawi	PROPN
ajfti-2033	332	4	,	,	PUNCT
ajfti-2033	332	5	m.	m.	NOUN
ajfti-2033	332	6	k.	k.	PROPN
ajfti-2033	332	7	,	,	PUNCT
ajfti-2033	332	8	&	&	CCONJ
ajfti-2033	332	9	keetile	keetile	PROPN
ajfti-2033	332	10	,	,	PUNCT
ajfti-2033	332	11	m.	m.	NOUN
ajfti-2033	332	12	(	(	PUNCT
ajfti-2033	332	13	2021	2021	NUM
ajfti-2033	332	14	)	)	PUNCT
ajfti-2033	332	15	.	.	PUNCT
ajfti-2033	333	1	socio	socio	NOUN
ajfti-2033	333	2	-	-	PUNCT
ajfti-2033	333	3	economic	economic	ADJ
ajfti-2033	333	4	and	and	CCONJ
ajfti-2033	333	5	demographic	demographic	ADJ
ajfti-2033	333	6	correlates	correlate	NOUN
ajfti-2033	333	7	of	of	ADP
ajfti-2033	333	8	non	non	ADJ
ajfti-2033	333	9	-	-	ADJ
ajfti-2033	333	10	communicable	communicable	ADJ
ajfti-2033	333	11	disease	disease	NOUN
ajfti-2033	333	12	risk	risk	NOUN
ajfti-2033	333	13	factors	factor	NOUN
ajfti-2033	333	14	among	among	ADP
ajfti-2033	333	15	adults	adult	NOUN
ajfti-2033	333	16	in	in	ADP
ajfti-2033	333	17	saudi	saudi	PROPN
ajfti-2033	333	18	arabia	arabia	PROPN
ajfti-2033	333	19	.	.	PUNCT
ajfti-2033	334	1	frontiers	frontier	NOUN
ajfti-2033	334	2	in	in	ADP
ajfti-2033	334	3	medicine	medicine	NOUN
ajfti-2033	334	4	,	,	PUNCT
ajfti-2033	334	5	8	8	NUM
ajfti-2033	334	6	,	,	PUNCT
ajfti-2033	334	7	605912	605912	NUM
ajfti-2033	334	8	.	.	PUNCT
ajfti-2033	335	1	al	al	PROPN
ajfti-2033	335	2	jeraisy	jeraisy	PROPN
ajfti-2033	335	3	,	,	PUNCT
ajfti-2033	335	4	m.	m.	NOUN
ajfti-2033	335	5	,	,	PUNCT
ajfti-2033	335	6	alshammari	alshammari	PROPN
ajfti-2033	335	7	,	,	PUNCT
ajfti-2033	335	8	h.	h.	PROPN
ajfti-2033	335	9	,	,	PUNCT
ajfti-2033	335	10	albassam	albassam	PROPN
ajfti-2033	335	11	,	,	PUNCT
ajfti-2033	335	12	m.	m.	NOUN
ajfti-2033	335	13	,	,	PUNCT
ajfti-2033	335	14	al	al	PROPN
ajfti-2033	335	15	aamer	aamer	PROPN
ajfti-2033	335	16	,	,	PUNCT
ajfti-2033	335	17	k.	k.	PROPN
ajfti-2033	335	18	,	,	PUNCT
ajfti-2033	335	19	&	&	CCONJ
ajfti-2033	335	20	abolfotouh	abolfotouh	PROPN
ajfti-2033	335	21	,	,	PUNCT
ajfti-2033	335	22	m.	m.	NOUN
ajfti-2033	335	23	a.	a.	NOUN
ajfti-2033	335	24	(	(	PUNCT
ajfti-2033	335	25	2023	2023	NUM
ajfti-2033	335	26	)	)	PUNCT
ajfti-2033	335	27	.	.	PUNCT
ajfti-2033	336	1	utility	utility	NOUN
ajfti-2033	336	2	of	of	ADP
ajfti-2033	336	3	patient	patient	ADJ
ajfti-2033	336	4	information	information	NOUN
ajfti-2033	336	5	leaflet	leaflet	NOUN
ajfti-2033	336	6	and	and	CCONJ
ajfti-2033	336	7	perceived	perceive	VERB
ajfti-2033	336	8	impact	impact	NOUN
ajfti-2033	336	9	of	of	ADP
ajfti-2033	336	10	its	its	PRON
ajfti-2033	336	11	use	use	NOUN
ajfti-2033	336	12	on	on	ADP
ajfti-2033	336	13	medication	medication	NOUN
ajfti-2033	336	14	adherence	adherence	NOUN
ajfti-2033	336	15	.	.	PUNCT
ajfti-2033	337	1	bmc	bmc	ADJ
ajfti-2033	337	2	public	public	ADJ
ajfti-2033	337	3	health	health	NOUN
ajfti-2033	337	4	,	,	PUNCT
ajfti-2033	337	5	23(1	23(1	NOUN
ajfti-2033	337	6	)	)	PUNCT
ajfti-2033	337	7	,	,	PUNCT
ajfti-2033	337	8	488	488	X
ajfti-2033	337	9	.	.	PUNCT
ajfti-2033	338	1	albugmi	albugmi	PROPN
ajfti-2033	338	2	,	,	PUNCT
ajfti-2033	338	3	m.	m.	NOUN
ajfti-2033	338	4	a.	a.	NOUN
ajfti-2033	338	5	(	(	PUNCT
ajfti-2033	338	6	2021	2021	NUM
ajfti-2033	338	7	)	)	PUNCT
ajfti-2033	338	8	.	.	PUNCT
ajfti-2033	339	1	the	the	DET
ajfti-2033	339	2	effects	effect	NOUN
ajfti-2033	339	3	of	of	ADP
ajfti-2033	339	4	the	the	DET
ajfti-2033	339	5	predisposing	predisposing	NOUN
ajfti-2033	339	6	,	,	PUNCT
ajfti-2033	339	7	enabling	enable	VERB
ajfti-2033	339	8	and	and	CCONJ
ajfti-2033	339	9	need	need	VERB
ajfti-2033	339	10	factors	factor	NOUN
ajfti-2033	339	11	on	on	ADP
ajfti-2033	339	12	the	the	DET
ajfti-2033	339	13	use	use	NOUN
ajfti-2033	339	14	of	of	ADP
ajfti-2033	339	15	health	health	NOUN
ajfti-2033	339	16	services	service	NOUN
ajfti-2033	339	17	among	among	ADP
ajfti-2033	339	18	noncitizen	noncitizen	ADJ
ajfti-2033	339	19	employees	employee	NOUN
ajfti-2033	339	20	in	in	ADP
ajfti-2033	339	21	the	the	DET
ajfti-2033	339	22	private	private	ADJ
ajfti-2033	339	23	sector	sector	NOUN
ajfti-2033	339	24	in	in	ADP
ajfti-2033	339	25	saudi	saudi	PROPN
ajfti-2033	339	26	arabia	arabia	PROPN
ajfti-2033	339	27	.	.	PUNCT
ajfti-2033	340	1	kent	kent	PROPN
ajfti-2033	340	2	state	state	PROPN
ajfti-2033	340	3	university	university	PROPN
ajfti-2033	340	4	.	.	PUNCT
ajfti-2033	341	1	almutairi	almutairi	PROPN
ajfti-2033	341	2	,	,	PUNCT
ajfti-2033	341	3	a.	a.	PROPN
ajfti-2033	341	4	r.	r.	PROPN
ajfti-2033	341	5	,	,	PUNCT
ajfti-2033	341	6	al	al	PROPN
ajfti-2033	341	7	-	-	PUNCT
ajfti-2033	341	8	samil	samil	PROPN
ajfti-2033	341	9	,	,	PUNCT
ajfti-2033	341	10	a.	a.	NOUN
ajfti-2033	341	11	m.	m.	NOUN
ajfti-2033	341	12	,	,	PUNCT
ajfti-2033	341	13	alsayyari	alsayyari	NOUN
ajfti-2033	341	14	,	,	PUNCT
ajfti-2033	341	15	a.	a.	PROPN
ajfti-2033	341	16	,	,	PUNCT
ajfti-2033	341	17	yousef	yousef	PROPN
ajfti-2033	341	18	,	,	PUNCT
ajfti-2033	341	19	c.	c.	PROPN
ajfti-2033	341	20	c.	c.	PROPN
ajfti-2033	341	21	,	,	PUNCT
ajfti-2033	341	22	khan	khan	PROPN
ajfti-2033	341	23	,	,	PUNCT
ajfti-2033	341	24	m.	m.	NOUN
ajfti-2033	341	25	a.	a.	PROPN
ajfti-2033	341	26	,	,	PUNCT
ajfti-2033	341	27	alhamdan	alhamdan	PROPN
ajfti-2033	341	28	,	,	PUNCT
ajfti-2033	341	29	h.	h.	PROPN
ajfti-2033	341	30	s.	s.	PROPN
ajfti-2033	341	31	,	,	PUNCT
ajfti-2033	341	32	&	&	CCONJ
ajfti-2033	341	33	al	al	PROPN
ajfti-2033	341	34	-	-	PUNCT
ajfti-2033	341	35	jedai	jedai	PROPN
ajfti-2033	341	36	,	,	PUNCT
ajfti-2033	341	37	a.	a.	NOUN
ajfti-2033	341	38	(	(	PUNCT
ajfti-2033	341	39	2023	2023	NUM
ajfti-2033	341	40	)	)	PUNCT
ajfti-2033	341	41	.	.	PUNCT
ajfti-2033	342	1	the	the	DET
ajfti-2033	342	2	landscape	landscape	NOUN
ajfti-2033	342	3	of	of	ADP
ajfti-2033	342	4	biosimilars	biosimilar	NOUN
ajfti-2033	342	5	in	in	ADP
ajfti-2033	342	6	saudi	saudi	PROPN
ajfti-2033	342	7	arabia	arabia	PROPN
ajfti-2033	342	8	:	:	PUNCT
ajfti-2033	342	9	preparing	prepare	VERB
ajfti-2033	342	10	for	for	ADP
ajfti-2033	342	11	the	the	DET
ajfti-2033	342	12	next	next	ADJ
ajfti-2033	342	13	decade	decade	NOUN
ajfti-2033	342	14	.	.	PUNCT
ajfti-2033	343	1	expert	expert	ADJ
ajfti-2033	343	2	opinion	opinion	NOUN
ajfti-2033	343	3	on	on	ADP
ajfti-2033	343	4	biological	biological	ADJ
ajfti-2033	343	5	therapy	therapy	NOUN
ajfti-2033	343	6	,	,	PUNCT
ajfti-2033	343	7	1	1	NUM
ajfti-2033	343	8	-	-	SYM
ajfti-2033	343	9	10	10	NUM
ajfti-2033	343	10	.	.	PUNCT
ajfti-2033	344	1	alqarni	alqarni	PROPN
ajfti-2033	344	2	,	,	PUNCT
ajfti-2033	344	3	k.	k.	PROPN
ajfti-2033	344	4	,	,	PUNCT
ajfti-2033	344	5	alqarni	alqarni	PROPN
ajfti-2033	344	6	,	,	PUNCT
ajfti-2033	344	7	e.	e.	PROPN
ajfti-2033	344	8	a.	a.	PROPN
ajfti-2033	344	9	,	,	PUNCT
ajfti-2033	344	10	naqvi	naqvi	NOUN
ajfti-2033	344	11	,	,	PUNCT
ajfti-2033	344	12	a.	a.	NOUN
ajfti-2033	344	13	a.	a.	NOUN
ajfti-2033	344	14	,	,	PUNCT
ajfti-2033	344	15	alshayban	alshayban	PROPN
ajfti-2033	344	16	,	,	PUNCT
ajfti-2033	344	17	d.	d.	PROPN
ajfti-2033	344	18	m.	m.	PROPN
ajfti-2033	344	19	,	,	PUNCT
ajfti-2033	344	20	ghori	ghori	PROPN
ajfti-2033	344	21	,	,	PUNCT
ajfti-2033	344	22	s.	s.	PROPN
ajfti-2033	344	23	a.	a.	PROPN
ajfti-2033	344	24	,	,	PUNCT
ajfti-2033	344	25	haseeb	haseeb	PROPN
ajfti-2033	344	26	,	,	PUNCT
ajfti-2033	344	27	a.	a.	NOUN
ajfti-2033	344	28	,	,	PUNCT
ajfti-2033	344	29	raafat	raafat	NOUN
ajfti-2033	344	30	,	,	PUNCT
ajfti-2033	344	31	m.	m.	NOUN
ajfti-2033	344	32	,	,	PUNCT
ajfti-2033	344	33	&	&	CCONJ
ajfti-2033	344	34	jamshed	jamshed	PROPN
ajfti-2033	344	35	,	,	PUNCT
ajfti-2033	344	36	s.	s.	PROPN
ajfti-2033	344	37	(	(	PUNCT
ajfti-2033	344	38	2019	2019	NUM
ajfti-2033	344	39	)	)	PUNCT
ajfti-2033	344	40	.	.	PUNCT
ajfti-2033	345	1	assessment	assessment	NOUN
ajfti-2033	345	2	of	of	ADP
ajfti-2033	345	3	medication	medication	NOUN
ajfti-2033	345	4	adherence	adherence	NOUN
ajfti-2033	345	5	in	in	ADP
ajfti-2033	345	6	saudi	saudi	ADJ
ajfti-2033	345	7	patients	patient	NOUN
ajfti-2033	345	8	with	with	ADP
ajfti-2033	345	9	type	type	NOUN
ajfti-2033	345	10	ii	ii	PROPN
ajfti-2033	345	11	diabetes	diabetes	NOUN
ajfti-2033	345	12	mellitus	mellitus	NOUN
ajfti-2033	345	13	in	in	ADP
ajfti-2033	345	14	khobar	khobar	PROPN
ajfti-2033	345	15	city	city	PROPN
ajfti-2033	345	16	,	,	PUNCT
ajfti-2033	345	17	saudi	saudi	PROPN
ajfti-2033	345	18	arabia	arabia	PROPN
ajfti-2033	345	19	.	.	PUNCT
ajfti-2033	346	1	frontiers	frontier	NOUN
ajfti-2033	346	2	in	in	ADP
ajfti-2033	346	3	pharmacology	pharmacology	NOUN
ajfti-2033	346	4	,	,	PUNCT
ajfti-2033	346	5	10	10	NUM
ajfti-2033	346	6	,	,	PUNCT
ajfti-2033	346	7	1306	1306	NUM
ajfti-2033	346	8	.	.	PUNCT
ajfti-2033	347	1	anderson	anderson	PROPN
ajfti-2033	347	2	,	,	PUNCT
ajfti-2033	347	3	t.	t.	PROPN
ajfti-2033	347	4	s.	s.	PROPN
ajfti-2033	347	5	,	,	PUNCT
ajfti-2033	347	6	marcantonio	marcantonio	PROPN
ajfti-2033	347	7	,	,	PUNCT
ajfti-2033	347	8	e.	e.	PROPN
ajfti-2033	347	9	r.	r.	PROPN
ajfti-2033	347	10	,	,	PUNCT
ajfti-2033	347	11	mccarthy	mccarthy	PROPN
ajfti-2033	347	12	,	,	PUNCT
ajfti-2033	347	13	e.	e.	PROPN
ajfti-2033	347	14	p.	p.	PROPN
ajfti-2033	347	15	,	,	PUNCT
ajfti-2033	347	16	&	&	CCONJ
ajfti-2033	347	17	herzig	herzig	PROPN
ajfti-2033	347	18	,	,	PUNCT
ajfti-2033	347	19	s.	s.	PROPN
ajfti-2033	347	20	j.	j.	PROPN
ajfti-2033	347	21	(	(	PUNCT
ajfti-2033	347	22	2020	2020	NUM
ajfti-2033	347	23	)	)	PUNCT
ajfti-2033	347	24	.	.	PUNCT
ajfti-2033	348	1	national	national	ADJ
ajfti-2033	348	2	trends	trend	NOUN
ajfti-2033	348	3	in	in	ADP
ajfti-2033	348	4	potentially	potentially	ADV
ajfti-2033	348	5	preventable	preventable	ADJ
ajfti-2033	348	6	hospitalizations	hospitalization	NOUN
ajfti-2033	348	7	of	of	ADP
ajfti-2033	348	8	older	old	ADJ
ajfti-2033	348	9	adults	adult	NOUN
ajfti-2033	348	10	with	with	ADP
ajfti-2033	348	11	dementia	dementia	NOUN
ajfti-2033	348	12	.	.	PUNCT
ajfti-2033	349	1	journal	journal	PROPN
ajfti-2033	349	2	of	of	ADP
ajfti-2033	349	3	the	the	DET
ajfti-2033	349	4	american	american	ADJ
ajfti-2033	349	5	geriatrics	geriatrics	PROPN
ajfti-2033	349	6	society	society	NOUN
ajfti-2033	349	7	,	,	PUNCT
ajfti-2033	349	8	68(10	68(10	NUM
ajfti-2033	349	9	)	)	PUNCT
ajfti-2033	349	10	,	,	PUNCT
ajfti-2033	349	11	2240	2240	NUM
ajfti-2033	349	12	-	-	SYM
ajfti-2033	349	13	2248	2248	NUM
ajfti-2033	349	14	.	.	PUNCT
ajfti-2033	350	1	aramco	aramco	PROPN
ajfti-2033	350	2	,	,	PUNCT
ajfti-2033	350	3	s.	s.	PROPN
ajfti-2033	350	4	(	(	PUNCT
ajfti-2033	350	5	2023	2023	NUM
ajfti-2033	350	6	)	)	PUNCT
ajfti-2033	350	7	.	.	PUNCT
ajfti-2033	351	1	aramco	aramco	PROPN
ajfti-2033	351	2	announces	announce	VERB
ajfti-2033	351	3	first	first	ADJ
ajfti-2033	351	4	quarter	quarter	NOUN
ajfti-2033	351	5	2023	2023	NUM
ajfti-2033	351	6	results	result	NOUN
ajfti-2033	351	7	q1	q1	PROPN
ajfti-2033	351	8	net	net	ADJ
ajfti-2033	351	9	income	income	NOUN
ajfti-2033	351	10	remains	remain	VERB
ajfti-2033	351	11	robust	robust	ADJ
ajfti-2033	351	12	and	and	CCONJ
ajfti-2033	351	13	growth	growth	NOUN
ajfti-2033	351	14	strategy	strategy	NOUN
ajfti-2033	351	15	on	on	ADP
ajfti-2033	351	16	track	track	NOUN
ajfti-2033	351	17	as	as	ADP
ajfti-2033	351	18	downstream	downstream	ADJ
ajfti-2033	351	19	expansion	expansion	NOUN
ajfti-2033	351	20	progresses	progress	NOUN
ajfti-2033	351	21	.	.	PUNCT
ajfti-2033	352	1	baker	baker	PROPN
ajfti-2033	352	2	,	,	PUNCT
ajfti-2033	352	3	m.	m.	PROPN
ajfti-2033	352	4	r.	r.	PROPN
ajfti-2033	352	5	,	,	PUNCT
ajfti-2033	352	6	padmaja	padmaja	PROPN
ajfti-2033	352	7	,	,	PUNCT
ajfti-2033	352	8	d.	d.	PROPN
ajfti-2033	352	9	l.	l.	PROPN
ajfti-2033	352	10	,	,	PUNCT
ajfti-2033	352	11	puviarasi	puviarasi	PROPN
ajfti-2033	352	12	,	,	PUNCT
ajfti-2033	352	13	r.	r.	PROPN
ajfti-2033	352	14	,	,	PUNCT
ajfti-2033	352	15	mann	mann	PROPN
ajfti-2033	352	16	,	,	PUNCT
ajfti-2033	352	17	s.	s.	PROPN
ajfti-2033	352	18	,	,	PUNCT
ajfti-2033	352	19	panduro	panduro	NOUN
ajfti-2033	352	20	-	-	PUNCT
ajfti-2033	352	21	ramirez	ramirez	NOUN
ajfti-2033	352	22	,	,	PUNCT
ajfti-2033	352	23	j.	j.	PROPN
ajfti-2033	352	24	,	,	PUNCT
ajfti-2033	352	25	tiwari	tiwari	PROPN
ajfti-2033	352	26	,	,	PUNCT
ajfti-2033	352	27	m.	m.	NOUN
ajfti-2033	352	28	,	,	PUNCT
ajfti-2033	352	29	&	&	CCONJ
ajfti-2033	352	30	samori	samori	ADV
ajfti-2033	352	31	,	,	PUNCT
ajfti-2033	352	32	i.	i.	PROPN
ajfti-2033	352	33	a.	a.	PROPN
ajfti-2033	352	34	(	(	PUNCT
ajfti-2033	352	35	2022	2022	NUM
ajfti-2033	352	36	)	)	PUNCT
ajfti-2033	352	37	.	.	PUNCT
ajfti-2033	353	1	implementing	implement	VERB
ajfti-2033	353	2	critical	critical	ADJ
ajfti-2033	353	3	machine	machine	NOUN
ajfti-2033	353	4	learning	learning	NOUN
ajfti-2033	353	5	(	(	PUNCT
ajfti-2033	353	6	ml	ml	NOUN
ajfti-2033	353	7	)	)	PUNCT
ajfti-2033	353	8	approaches	approach	NOUN
ajfti-2033	353	9	for	for	ADP
ajfti-2033	353	10	generating	generate	VERB
ajfti-2033	353	11	robust	robust	ADJ
ajfti-2033	353	12	discriminative	discriminative	NOUN
ajfti-2033	353	13	neuroimaging	neuroimage	VERB
ajfti-2033	353	14	representations	representation	NOUN
ajfti-2033	353	15	using	use	VERB
ajfti-2033	353	16	structural	structural	ADJ
ajfti-2033	353	17	equation	equation	NOUN
ajfti-2033	353	18	model	model	NOUN
ajfti-2033	353	19	(	(	PUNCT
ajfti-2033	353	20	sem	sem	NOUN
ajfti-2033	353	21	)	)	PUNCT
ajfti-2033	353	22	.	.	PUNCT
ajfti-2033	354	1	computational	computational	ADJ
ajfti-2033	354	2	and	and	CCONJ
ajfti-2033	354	3	mathematical	mathematical	ADJ
ajfti-2033	354	4	methods	method	NOUN
ajfti-2033	354	5	in	in	ADP
ajfti-2033	354	6	medicine	medicine	NOUN
ajfti-2033	354	7	,	,	PUNCT
ajfti-2033	354	8	2022	2022	NUM
ajfti-2033	354	9	.	.	PUNCT
ajfti-2033	355	1	bali	bali	PROPN
ajfti-2033	355	2	,	,	PUNCT
ajfti-2033	355	3	a.	a.	PROPN
ajfti-2033	355	4	s.	s.	PROPN
ajfti-2033	355	5	,	,	PUNCT
ajfti-2033	355	6	&	&	CCONJ
ajfti-2033	355	7	ramesh	ramesh	PROPN
ajfti-2033	355	8	,	,	PUNCT
ajfti-2033	355	9	m.	m.	NOUN
ajfti-2033	355	10	(	(	PUNCT
ajfti-2033	355	11	2023	2023	NUM
ajfti-2033	355	12	)	)	PUNCT
ajfti-2033	355	13	.	.	PUNCT
ajfti-2033	356	1	knowledge	knowledge	NOUN
ajfti-2033	356	2	–	–	PUNCT
ajfti-2033	356	3	practice	practice	NOUN
ajfti-2033	356	4	gap	gap	NOUN
ajfti-2033	356	5	in	in	ADP
ajfti-2033	356	6	healthcare	healthcare	NOUN
ajfti-2033	356	7	payments	payment	NOUN
ajfti-2033	356	8	:	:	PUNCT
ajfti-2033	356	9	the	the	DET
ajfti-2033	356	10	role	role	NOUN
ajfti-2033	356	11	of	of	ADP
ajfti-2033	356	12	policy	policy	NOUN
ajfti-2033	356	13	capacity	capacity	NOUN
ajfti-2033	356	14	.	.	PUNCT
ajfti-2033	357	1	policy	policy	NOUN
ajfti-2033	357	2	and	and	CCONJ
ajfti-2033	357	3	society	society	NOUN
ajfti-2033	357	4	,	,	PUNCT
ajfti-2033	357	5	puad019	puad019	PROPN
ajfti-2033	357	6	.	.	PUNCT
ajfti-2033	357	7	brown	brown	PROPN
ajfti-2033	357	8	,	,	PUNCT
ajfti-2033	357	9	m.	m.	NOUN
ajfti-2033	357	10	t.	t.	PROPN
ajfti-2033	357	11	,	,	PUNCT
ajfti-2033	357	12	bussell	bussell	VERB
ajfti-2033	357	13	,	,	PUNCT
ajfti-2033	357	14	j.	j.	PROPN
ajfti-2033	357	15	,	,	PUNCT
ajfti-2033	357	16	dutta	dutta	PROPN
ajfti-2033	357	17	,	,	PUNCT
ajfti-2033	357	18	s.	s.	PROPN
ajfti-2033	357	19	,	,	PUNCT
ajfti-2033	357	20	davis	davis	PROPN
ajfti-2033	357	21	,	,	PUNCT
ajfti-2033	357	22	k.	k.	PROPN
ajfti-2033	357	23	,	,	PUNCT
ajfti-2033	357	24	strong	strong	ADJ
ajfti-2033	357	25	,	,	PUNCT
ajfti-2033	357	26	s.	s.	PROPN
ajfti-2033	357	27	,	,	PUNCT
ajfti-2033	357	28	&	&	CCONJ
ajfti-2033	357	29	mathew	mathew	PROPN
ajfti-2033	357	30	,	,	PUNCT
ajfti-2033	357	31	s.	s.	PROPN
ajfti-2033	357	32	(	(	PUNCT
ajfti-2033	357	33	2016	2016	NUM
ajfti-2033	357	34	)	)	PUNCT
ajfti-2033	357	35	.	.	PUNCT
ajfti-2033	358	1	medication	medication	NOUN
ajfti-2033	358	2	adherence	adherence	NOUN
ajfti-2033	358	3	:	:	PUNCT
ajfti-2033	358	4	truth	truth	NOUN
ajfti-2033	358	5	and	and	CCONJ
ajfti-2033	358	6	consequences	consequence	NOUN
ajfti-2033	358	7	.	.	PUNCT
ajfti-2033	359	1	the	the	DET
ajfti-2033	359	2	american	american	PROPN
ajfti-2033	359	3	journal	journal	PROPN
ajfti-2033	359	4	of	of	ADP
ajfti-2033	359	5	the	the	DET
ajfti-2033	359	6	medical	medical	ADJ
ajfti-2033	359	7	sciences	science	NOUN
ajfti-2033	359	8	,	,	PUNCT
ajfti-2033	359	9	351(4	351(4	NUM
ajfti-2033	359	10	)	)	PUNCT
ajfti-2033	359	11	,	,	PUNCT
ajfti-2033	359	12	387	387	NUM
ajfti-2033	359	13	-	-	SYM
ajfti-2033	359	14	399	399	NUM
ajfti-2033	359	15	.	.	PUNCT
ajfti-2033	360	1	bujang	bujang	PROPN
ajfti-2033	360	2	,	,	PUNCT
ajfti-2033	360	3	m.	m.	NOUN
ajfti-2033	360	4	a.	a.	PROPN
ajfti-2033	360	5	,	,	PUNCT
ajfti-2033	360	6	omar	omar	PROPN
ajfti-2033	360	7	,	,	PUNCT
ajfti-2033	360	8	e.	e.	PROPN
ajfti-2033	360	9	d.	d.	PROPN
ajfti-2033	360	10	,	,	PUNCT
ajfti-2033	360	11	&	&	CCONJ
ajfti-2033	360	12	baharum	baharum	PROPN
ajfti-2033	360	13	,	,	PUNCT
ajfti-2033	360	14	n.	n.	NOUN
ajfti-2033	360	15	a.	a.	PROPN
ajfti-2033	360	16	(	(	PUNCT
ajfti-2033	360	17	2018	2018	NUM
ajfti-2033	360	18	)	)	PUNCT
ajfti-2033	360	19	.	.	PUNCT
ajfti-2033	361	1	a	a	DET
ajfti-2033	361	2	review	review	NOUN
ajfti-2033	361	3	on	on	ADP
ajfti-2033	361	4	sample	sample	NOUN
ajfti-2033	361	5	size	size	NOUN
ajfti-2033	361	6	determination	determination	NOUN
ajfti-2033	361	7	for	for	ADP
ajfti-2033	361	8	cronbach	cronbach	NOUN
ajfti-2033	361	9	’s	’s	PART
ajfti-2033	361	10	alpha	alpha	ADJ
ajfti-2033	361	11	test	test	NOUN
ajfti-2033	361	12	:	:	PUNCT
ajfti-2033	361	13	a	a	DET
ajfti-2033	361	14	simple	simple	ADJ
ajfti-2033	361	15	guide	guide	NOUN
ajfti-2033	361	16	for	for	ADP
ajfti-2033	361	17	researchers	researcher	NOUN
ajfti-2033	361	18	.	.	PUNCT
ajfti-2033	362	1	the	the	DET
ajfti-2033	362	2	malaysian	malaysian	ADJ
ajfti-2033	362	3	journal	journal	PROPN
ajfti-2033	362	4	of	of	ADP
ajfti-2033	362	5	medical	medical	ADJ
ajfti-2033	362	6	sciences	science	NOUN
ajfti-2033	362	7	:	:	PUNCT
ajfti-2033	362	8	mjms	mjms	NOUN
ajfti-2033	362	9	,	,	PUNCT
ajfti-2033	362	10	25(6	25(6	NOUN
ajfti-2033	362	11	)	)	PUNCT
ajfti-2033	362	12	,	,	PUNCT
ajfti-2033	362	13	85	85	NUM
ajfti-2033	362	14	.	.	PUNCT
ajfti-2033	362	15	cairney	cairney	NOUN
ajfti-2033	362	16	,	,	PUNCT
ajfti-2033	362	17	p.	p.	PROPN
ajfti-2033	362	18	,	,	PUNCT
ajfti-2033	362	19	&	&	CCONJ
ajfti-2033	362	20	oliver	oliver	PROPN
ajfti-2033	362	21	,	,	PUNCT
ajfti-2033	362	22	k.	k.	PROPN
ajfti-2033	362	23	(	(	PUNCT
ajfti-2033	362	24	2017	2017	NUM
ajfti-2033	362	25	)	)	PUNCT
ajfti-2033	362	26	.	.	PUNCT
ajfti-2033	363	1	evidence	evidence	NOUN
ajfti-2033	363	2	-	-	PUNCT
ajfti-2033	363	3	based	base	VERB
ajfti-2033	363	4	policymaking	policymaking	NOUN
ajfti-2033	363	5	is	be	AUX
ajfti-2033	363	6	not	not	PART
ajfti-2033	363	7	like	like	ADP
ajfti-2033	363	8	evidence	evidence	NOUN
ajfti-2033	363	9	-	-	PUNCT
ajfti-2033	363	10	based	base	VERB
ajfti-2033	363	11	medicine	medicine	NOUN
ajfti-2033	363	12	,	,	PUNCT
ajfti-2033	363	13	so	so	CCONJ
ajfti-2033	363	14	how	how	SCONJ
ajfti-2033	363	15	far	far	ADV
ajfti-2033	363	16	should	should	AUX
ajfti-2033	363	17	you	you	PRON
ajfti-2033	363	18	go	go	VERB
ajfti-2033	363	19	to	to	PART
ajfti-2033	363	20	bridge	bridge	VERB
ajfti-2033	363	21	the	the	DET
ajfti-2033	363	22	divide	divide	NOUN
ajfti-2033	363	23	between	between	ADP
ajfti-2033	363	24	evidence	evidence	NOUN
ajfti-2033	363	25	and	and	CCONJ
ajfti-2033	363	26	policy	policy	NOUN
ajfti-2033	363	27	?	?	PUNCT
ajfti-2033	364	1	health	health	NOUN
ajfti-2033	364	2	research	research	NOUN
ajfti-2033	364	3	policy	policy	NOUN
ajfti-2033	364	4	and	and	CCONJ
ajfti-2033	364	5	systems	system	NOUN
ajfti-2033	364	6	,	,	PUNCT
ajfti-2033	364	7	15(1	15(1	NUM
ajfti-2033	364	8	)	)	PUNCT
ajfti-2033	364	9	,	,	PUNCT
ajfti-2033	364	10	1	1	NUM
ajfti-2033	364	11	-	-	SYM
ajfti-2033	364	12	11	11	NUM
ajfti-2033	364	13	.	.	PUNCT
ajfti-2033	365	1	creswell	creswell	PROPN
ajfti-2033	365	2	,	,	PUNCT
ajfti-2033	365	3	j.	j.	PROPN
ajfti-2033	365	4	w.	w.	PROPN
ajfti-2033	365	5	,	,	PUNCT
ajfti-2033	365	6	&	&	CCONJ
ajfti-2033	365	7	hirose	hirose	PROPN
ajfti-2033	365	8	,	,	PUNCT
ajfti-2033	365	9	m.	m.	NOUN
ajfti-2033	365	10	(	(	PUNCT
ajfti-2033	365	11	2019	2019	NUM
ajfti-2033	365	12	)	)	PUNCT
ajfti-2033	365	13	.	.	PUNCT
ajfti-2033	366	1	mixed	mixed	ADJ
ajfti-2033	366	2	methods	method	NOUN
ajfti-2033	366	3	and	and	CCONJ
ajfti-2033	366	4	survey	survey	NOUN
ajfti-2033	366	5	research	research	NOUN
ajfti-2033	366	6	in	in	ADP
ajfti-2033	366	7	family	family	NOUN
ajfti-2033	366	8	medicine	medicine	NOUN
ajfti-2033	366	9	and	and	CCONJ
ajfti-2033	366	10	community	community	NOUN
ajfti-2033	366	11	health	health	NOUN
ajfti-2033	366	12	.	.	PUNCT
ajfti-2033	367	1	family	family	NOUN
ajfti-2033	367	2	medicine	medicine	NOUN
ajfti-2033	367	3	and	and	CCONJ
ajfti-2033	367	4	community	community	NOUN
ajfti-2033	367	5	health	health	NOUN
ajfti-2033	367	6	,	,	PUNCT
ajfti-2033	367	7	7(2	7(2	NUM
ajfti-2033	367	8	)	)	PUNCT
ajfti-2033	367	9	.	.	PUNCT
ajfti-2033	368	1	dias	dias	PROPN
ajfti-2033	368	2	,	,	PUNCT
ajfti-2033	368	3	r.	r.	PROPN
ajfti-2033	368	4	(	(	PUNCT
ajfti-2033	368	5	2023	2023	NUM
ajfti-2033	368	6	)	)	PUNCT
ajfti-2033	368	7	.	.	PUNCT
ajfti-2033	369	1	comparing	compare	VERB
ajfti-2033	369	2	the	the	DET
ajfti-2033	369	3	catastrophic	catastrophic	ADJ
ajfti-2033	369	4	health	health	NOUN
ajfti-2033	369	5	expenditures	expenditure	NOUN
ajfti-2033	369	6	on	on	ADP
ajfti-2033	369	7	different	different	ADJ
ajfti-2033	369	8	non	non	ADJ
ajfti-2033	369	9	-	-	ADJ
ajfti-2033	369	10	communicable	communicable	ADJ
ajfti-2033	369	11	diseases	disease	NOUN
ajfti-2033	369	12	among	among	ADP
ajfti-2033	369	13	households	household	NOUN
ajfti-2033	369	14	in	in	ADP
ajfti-2033	369	15	goa	goa	PROPN
ajfti-2033	369	16	,	,	PUNCT
ajfti-2033	369	17	india	india	PROPN
ajfti-2033	369	18	.	.	PUNCT
ajfti-2033	370	1	millennial	millennial	PROPN
ajfti-2033	370	2	asia	asia	PROPN
ajfti-2033	370	3	.	.	PUNCT
ajfti-2033	371	1	ding	ding	PROPN
ajfti-2033	371	2	,	,	PUNCT
ajfti-2033	371	3	a.	a.	PROPN
ajfti-2033	371	4	,	,	PUNCT
ajfti-2033	371	5	dixon	dixon	PROPN
ajfti-2033	371	6	,	,	PUNCT
ajfti-2033	371	7	s.	s.	PROPN
ajfti-2033	371	8	w.	w.	PROPN
ajfti-2033	371	9	,	,	PUNCT
ajfti-2033	371	10	ferries	ferries	PROPN
ajfti-2033	371	11	,	,	PUNCT
ajfti-2033	371	12	e.	e.	PROPN
ajfti-2033	371	13	a.	a.	PROPN
ajfti-2033	371	14	,	,	PUNCT
ajfti-2033	371	15	&	&	CCONJ
ajfti-2033	371	16	shrank	shrink	VERB
ajfti-2033	371	17	,	,	PUNCT
ajfti-2033	371	18	w.	w.	PROPN
ajfti-2033	371	19	h.	h.	PROPN
ajfti-2033	371	20	(	(	PUNCT
ajfti-2033	371	21	2022	2022	NUM
ajfti-2033	371	22	)	)	PUNCT
ajfti-2033	371	23	.	.	PUNCT
ajfti-2033	372	1	the	the	DET
ajfti-2033	372	2	role	role	NOUN
ajfti-2033	372	3	of	of	ADP
ajfti-2033	372	4	integrated	integrate	VERB
ajfti-2033	372	5	medical	medical	ADJ
ajfti-2033	372	6	and	and	CCONJ
ajfti-2033	372	7	prescription	prescription	NOUN
ajfti-2033	372	8	drug	drug	NOUN
ajfti-2033	372	9	plans	plan	NOUN
ajfti-2033	372	10	in	in	ADP
ajfti-2033	372	11	addressing	address	VERB
ajfti-2033	372	12	racial	racial	ADJ
ajfti-2033	372	13	and	and	CCONJ
ajfti-2033	372	14	ethnic	ethnic	ADJ
ajfti-2033	372	15	disparities	disparity	NOUN
ajfti-2033	372	16	in	in	ADP
ajfti-2033	372	17	medication	medication	NOUN
ajfti-2033	372	18	adherence	adherence	NOUN
ajfti-2033	372	19	.	.	PUNCT
ajfti-2033	373	1	journal	journal	NOUN
ajfti-2033	373	2	of	of	ADP
ajfti-2033	373	3	managed	manage	VERB
ajfti-2033	373	4	care	care	PROPN
ajfti-2033	373	5	&	&	CCONJ
ajfti-2033	373	6	specialty	specialty	NOUN
ajfti-2033	373	7	pharmacy	pharmacy	PROPN
ajfti-2033	373	8	,	,	PUNCT
ajfti-2033	373	9	28(3	28(3	NUM
ajfti-2033	373	10	)	)	PUNCT
ajfti-2033	373	11	,	,	PUNCT
ajfti-2033	373	12	379	379	NUM
ajfti-2033	373	13	-	-	SYM
ajfti-2033	373	14	386	386	NUM
ajfti-2033	373	15	.	.	PUNCT
ajfti-2033	373	16	emadi	emadi	PROPN
ajfti-2033	373	17	,	,	PUNCT
ajfti-2033	373	18	f.	f.	PROPN
ajfti-2033	373	19	,	,	PUNCT
ajfti-2033	373	20	ghanbarzadegan	ghanbarzadegan	PROPN
ajfti-2033	373	21	,	,	PUNCT
ajfti-2033	373	22	a.	a.	NOUN
ajfti-2033	373	23	,	,	PUNCT
ajfti-2033	373	24	ghahramani	ghahramani	PROPN
ajfti-2033	373	25	,	,	PUNCT
ajfti-2033	373	26	s.	s.	PROPN
ajfti-2033	373	27	,	,	PUNCT
ajfti-2033	373	28	bastani	bastani	NOUN
ajfti-2033	373	29	,	,	PUNCT
ajfti-2033	373	30	p.	p.	PROPN
ajfti-2033	373	31	,	,	PUNCT
ajfti-2033	373	32	&	&	CCONJ
ajfti-2033	373	33	baysari	baysari	PROPN
ajfti-2033	373	34	,	,	PUNCT
ajfti-2033	373	35	m.	m.	NOUN
ajfti-2033	373	36	t.	t.	PROPN
ajfti-2033	373	37	(	(	PUNCT
ajfti-2033	373	38	2022	2022	NUM
ajfti-2033	373	39	)	)	PUNCT
ajfti-2033	373	40	.	.	PUNCT
ajfti-2033	374	1	factors	factor	NOUN
ajfti-2033	374	2	affecting	affect	VERB
ajfti-2033	374	3	medication	medication	NOUN
ajfti-2033	374	4	adherence	adherence	NOUN
ajfti-2033	374	5	among	among	ADP
ajfti-2033	374	6	older	old	ADJ
ajfti-2033	374	7	adults	adult	NOUN
ajfti-2033	374	8	using	use	VERB
ajfti-2033	374	9	telepharmacy	telepharmacy	NOUN
ajfti-2033	374	10	services	service	NOUN
ajfti-2033	374	11	:	:	PUNCT
ajfti-2033	374	12	a	a	DET
ajfti-2033	374	13	scoping	scope	VERB
ajfti-2033	374	14	review	review	NOUN
ajfti-2033	374	15	.	.	PUNCT
ajfti-2033	375	1	archives	archive	NOUN
ajfti-2033	375	2	of	of	ADP
ajfti-2033	375	3	public	public	ADJ
ajfti-2033	375	4	health	health	NOUN
ajfti-2033	375	5	,	,	PUNCT
ajfti-2033	375	6	80(1	80(1	NUM
ajfti-2033	375	7	)	)	PUNCT
ajfti-2033	375	8	,	,	PUNCT
ajfti-2033	375	9	199	199	NUM
ajfti-2033	375	10	.	.	PUNCT
ajfti-2033	376	1	pa	pa	PROPN
ajfti-2033	376	2	ge	ge	PROPN
ajfti-2033	376	3	34	34	NUM
ajfti-2033	376	4	https://journals.e-palli.com/home/index.php/ajfti	https://journals.e-palli.com/home/index.php/ajfti	NOUN
ajfti-2033	376	5	am	be	AUX
ajfti-2033	376	6	.	.	PUNCT
ajfti-2033	377	1	j.	j.	PROPN
ajfti-2033	377	2	financ	financ	PROPN
ajfti-2033	377	3	.	.	PUNCT
ajfti-2033	378	1	technol	technol	PROPN
ajfti-2033	378	2	.	.	PUNCT
ajfti-2033	378	3	innov	innov	PROPN
ajfti-2033	378	4	.	.	PUNCT
ajfti-2033	379	1	1(1	1(1	NUM
ajfti-2033	379	2	)	)	PUNCT
ajfti-2033	379	3	24	24	NUM
ajfti-2033	379	4	-	-	SYM
ajfti-2033	379	5	34	34	NUM
ajfti-2033	379	6	,	,	PUNCT
ajfti-2033	379	7	2023	2023	NUM
ajfti-2033	379	8	frieden	frieden	NOUN
ajfti-2033	379	9	,	,	PUNCT
ajfti-2033	379	10	t.	t.	PROPN
ajfti-2033	379	11	r.	r.	PROPN
ajfti-2033	379	12	,	,	PUNCT
ajfti-2033	379	13	varghese	varghese	PROPN
ajfti-2033	379	14	,	,	PUNCT
ajfti-2033	379	15	c.	c.	PROPN
ajfti-2033	379	16	v.	v.	PROPN
ajfti-2033	379	17	,	,	PUNCT
ajfti-2033	379	18	kishore	kishore	PROPN
ajfti-2033	379	19	,	,	PUNCT
ajfti-2033	379	20	s.	s.	PROPN
ajfti-2033	379	21	p.	p.	PROPN
ajfti-2033	379	22	,	,	PUNCT
ajfti-2033	379	23	campbell	campbell	PROPN
ajfti-2033	379	24	,	,	PUNCT
ajfti-2033	379	25	n.	n.	PROPN
ajfti-2033	379	26	r.	r.	PROPN
ajfti-2033	379	27	,	,	PUNCT
ajfti-2033	379	28	moran	moran	PROPN
ajfti-2033	379	29	,	,	PUNCT
ajfti-2033	379	30	a.	a.	PROPN
ajfti-2033	379	31	e.	e.	PROPN
ajfti-2033	379	32	,	,	PUNCT
ajfti-2033	379	33	padwal	padwal	PROPN
ajfti-2033	379	34	,	,	PUNCT
ajfti-2033	379	35	r.	r.	PROPN
ajfti-2033	379	36	,	,	PUNCT
ajfti-2033	379	37	&	&	CCONJ
ajfti-2033	379	38	jaffe2	jaffe2	PROPN
ajfti-2033	379	39	,	,	PUNCT
ajfti-2033	379	40	m.	m.	NOUN
ajfti-2033	379	41	g.	g.	PROPN
ajfti-2033	379	42	(	(	PUNCT
ajfti-2033	379	43	2019	2019	NUM
ajfti-2033	379	44	)	)	PUNCT
ajfti-2033	379	45	.	.	PUNCT
ajfti-2033	380	1	scaling	scale	VERB
ajfti-2033	380	2	up	up	ADP
ajfti-2033	380	3	effective	effective	ADJ
ajfti-2033	380	4	treatment	treatment	NOUN
ajfti-2033	380	5	of	of	ADP
ajfti-2033	380	6	hypertension	hypertension	NOUN
ajfti-2033	380	7	-	-	PUNCT
ajfti-2033	380	8	a	a	DET
ajfti-2033	380	9	pathfinder	pathfinder	NOUN
ajfti-2033	380	10	for	for	ADP
ajfti-2033	380	11	universal	universal	ADJ
ajfti-2033	380	12	health	health	NOUN
ajfti-2033	380	13	coverage	coverage	NOUN
ajfti-2033	380	14	.	.	PUNCT
ajfti-2033	381	1	the	the	DET
ajfti-2033	381	2	journal	journal	NOUN
ajfti-2033	381	3	of	of	ADP
ajfti-2033	381	4	clinical	clinical	ADJ
ajfti-2033	381	5	hypertension	hypertension	NOUN
ajfti-2033	381	6	,	,	PUNCT
ajfti-2033	381	7	21(10	21(10	PROPN
ajfti-2033	381	8	)	)	PUNCT
ajfti-2033	381	9	,	,	PUNCT
ajfti-2033	381	10	1442	1442	NUM
ajfti-2033	381	11	-	-	SYM
ajfti-2033	381	12	1449	1449	NUM
ajfti-2033	381	13	.	.	PUNCT
ajfti-2033	382	1	george	george	PROPN
ajfti-2033	382	2	,	,	PUNCT
ajfti-2033	382	3	d.	d.	PROPN
ajfti-2033	382	4	,	,	PUNCT
ajfti-2033	382	5	&	&	CCONJ
ajfti-2033	382	6	mallery	mallery	PROPN
ajfti-2033	382	7	,	,	PUNCT
ajfti-2033	382	8	p.	p.	NOUN
ajfti-2033	382	9	(	(	PUNCT
ajfti-2033	382	10	2019	2019	NUM
ajfti-2033	382	11	)	)	PUNCT
ajfti-2033	382	12	.	.	PUNCT
ajfti-2033	383	1	ibm	ibm	PROPN
ajfti-2033	383	2	spss	spss	PROPN
ajfti-2033	383	3	statistics	statistic	NOUN
ajfti-2033	383	4	26	26	NUM
ajfti-2033	383	5	step	step	NOUN
ajfti-2033	383	6	by	by	ADP
ajfti-2033	383	7	step	step	NOUN
ajfti-2033	383	8	:	:	PUNCT
ajfti-2033	383	9	a	a	DET
ajfti-2033	383	10	simple	simple	ADJ
ajfti-2033	383	11	guide	guide	NOUN
ajfti-2033	383	12	and	and	CCONJ
ajfti-2033	383	13	reference	reference	NOUN
ajfti-2033	383	14	.	.	PUNCT
ajfti-2033	384	1	routledge	routledge	PROPN
ajfti-2033	384	2	.	.	PUNCT
ajfti-2033	385	1	godman	godman	PROPN
ajfti-2033	385	2	,	,	PUNCT
ajfti-2033	385	3	b.	b.	PROPN
ajfti-2033	385	4	,	,	PUNCT
ajfti-2033	385	5	hill	hill	PROPN
ajfti-2033	385	6	,	,	PUNCT
ajfti-2033	385	7	a.	a.	PROPN
ajfti-2033	385	8	,	,	PUNCT
ajfti-2033	385	9	simoens	simoens	PROPN
ajfti-2033	385	10	,	,	PUNCT
ajfti-2033	385	11	s.	s.	PROPN
ajfti-2033	385	12	,	,	PUNCT
ajfti-2033	385	13	selke	selke	PROPN
ajfti-2033	385	14	,	,	PUNCT
ajfti-2033	385	15	g.	g.	PROPN
ajfti-2033	385	16	,	,	PUNCT
ajfti-2033	385	17	selke	selke	PROPN
ajfti-2033	385	18	krulichová	krulichová	PROPN
ajfti-2033	385	19	,	,	PUNCT
ajfti-2033	385	20	i.	i.	PROPN
ajfti-2033	385	21	,	,	PUNCT
ajfti-2033	385	22	zampirolli	zampirolli	PROPN
ajfti-2033	385	23	dias	dias	PROPN
ajfti-2033	385	24	,	,	PUNCT
ajfti-2033	385	25	c.	c.	PROPN
ajfti-2033	385	26	,	,	PUNCT
ajfti-2033	385	27	martin	martin	PROPN
ajfti-2033	385	28	,	,	PUNCT
ajfti-2033	385	29	a.	a.	NOUN
ajfti-2033	385	30	p.	p.	PROPN
ajfti-2033	385	31	,	,	PUNCT
ajfti-2033	385	32	oortwijn	oortwijn	PROPN
ajfti-2033	385	33	,	,	PUNCT
ajfti-2033	385	34	w.	w.	PROPN
ajfti-2033	385	35	,	,	PUNCT
ajfti-2033	385	36	timoney	timoney	NOUN
ajfti-2033	385	37	,	,	PUNCT
ajfti-2033	385	38	a.	a.	NOUN
ajfti-2033	385	39	,	,	PUNCT
ajfti-2033	385	40	&	&	CCONJ
ajfti-2033	385	41	gustafsson	gustafsson	PROPN
ajfti-2033	385	42	,	,	PUNCT
ajfti-2033	385	43	l.	l.	PROPN
ajfti-2033	385	44	l.	l.	PROPN
ajfti-2033	385	45	(	(	PUNCT
ajfti-2033	385	46	2021	2021	NUM
ajfti-2033	385	47	)	)	PUNCT
ajfti-2033	385	48	.	.	PUNCT
ajfti-2033	386	1	potential	potential	ADJ
ajfti-2033	386	2	approaches	approach	NOUN
ajfti-2033	386	3	for	for	ADP
ajfti-2033	386	4	the	the	DET
ajfti-2033	386	5	pricing	pricing	NOUN
ajfti-2033	386	6	of	of	ADP
ajfti-2033	386	7	cancer	cancer	NOUN
ajfti-2033	386	8	medicines	medicine	NOUN
ajfti-2033	386	9	across	across	ADP
ajfti-2033	386	10	europe	europe	PROPN
ajfti-2033	386	11	to	to	PART
ajfti-2033	386	12	enhance	enhance	VERB
ajfti-2033	386	13	the	the	DET
ajfti-2033	386	14	sustainability	sustainability	NOUN
ajfti-2033	386	15	of	of	ADP
ajfti-2033	386	16	healthcare	healthcare	NOUN
ajfti-2033	386	17	systems	system	NOUN
ajfti-2033	386	18	and	and	CCONJ
ajfti-2033	386	19	the	the	DET
ajfti-2033	386	20	implications	implication	NOUN
ajfti-2033	386	21	.	.	PUNCT
ajfti-2033	387	1	expert	expert	NOUN
ajfti-2033	387	2	review	review	NOUN
ajfti-2033	387	3	of	of	ADP
ajfti-2033	387	4	pharmacoeconomics	pharmacoeconomic	NOUN
ajfti-2033	387	5	&	&	CCONJ
ajfti-2033	387	6	outcomes	outcome	NOUN
ajfti-2033	387	7	research	research	NOUN
ajfti-2033	387	8	,	,	PUNCT
ajfti-2033	387	9	21(4	21(4	NUM
ajfti-2033	387	10	)	)	PUNCT
ajfti-2033	387	11	,	,	PUNCT
ajfti-2033	387	12	527	527	NUM
ajfti-2033	387	13	-	-	SYM
ajfti-2033	387	14	540	540	NUM
ajfti-2033	387	15	.	.	PUNCT
ajfti-2033	388	1	gonzález	gonzález	PROPN
ajfti-2033	388	2	vera	vera	PROPN
ajfti-2033	388	3	,	,	PUNCT
ajfti-2033	388	4	m.	m.	PROPN
ajfti-2033	388	5	d.	d.	PROPN
ajfti-2033	388	6	l.	l.	PROPN
ajfti-2033	388	7	a.	a.	PROPN
ajfti-2033	388	8	,	,	PUNCT
ajfti-2033	388	9	valcárcel	valcárcel	PROPN
ajfti-2033	388	10	cabrera	cabrera	PROPN
ajfti-2033	388	11	,	,	PUNCT
ajfti-2033	388	12	m.	m.	PROPN
ajfti-2033	388	13	d.	d.	PROPN
ajfti-2033	388	14	c.	c.	PROPN
ajfti-2033	388	15	,	,	PUNCT
ajfti-2033	388	16	narbona	narbona	PROPN
ajfti-2033	388	17	,	,	PUNCT
ajfti-2033	388	18	j.	j.	PROPN
ajfti-2033	388	19	l.	l.	PROPN
ajfti-2033	388	20	,	,	PUNCT
ajfti-2033	388	21	sánchez	sánchez	PROPN
ajfti-2033	388	22	-	-	PUNCT
ajfti-2033	388	23	cantalejo	cantalejo	PROPN
ajfti-2033	388	24	garrido	garrido	PROPN
ajfti-2033	388	25	,	,	PUNCT
ajfti-2033	388	26	m.	m.	PROPN
ajfti-2033	388	27	d.	d.	PROPN
ajfti-2033	388	28	c.	c.	PROPN
ajfti-2033	388	29	,	,	PUNCT
ajfti-2033	388	30	vaquero	vaquero	NOUN
ajfti-2033	388	31	prada	prada	NOUN
ajfti-2033	388	32	,	,	PUNCT
ajfti-2033	388	33	j.	j.	PROPN
ajfti-2033	388	34	p.	p.	PROPN
ajfti-2033	388	35	,	,	PUNCT
ajfti-2033	388	36	&	&	CCONJ
ajfti-2033	388	37	olry	olry	PROPN
ajfti-2033	388	38	de	de	PROPN
ajfti-2033	388	39	labry	labry	PROPN
ajfti-2033	388	40	lima	lima	PROPN
ajfti-2033	388	41	,	,	PUNCT
ajfti-2033	388	42	a.	a.	NOUN
ajfti-2033	388	43	(	(	PUNCT
ajfti-2033	388	44	2022	2022	NUM
ajfti-2033	388	45	)	)	PUNCT
ajfti-2033	388	46	.	.	PUNCT
ajfti-2033	389	1	effect	effect	NOUN
ajfti-2033	389	2	of	of	ADP
ajfti-2033	389	3	an	an	DET
ajfti-2033	389	4	intervention	intervention	NOUN
ajfti-2033	389	5	new	new	ADJ
ajfti-2033	389	6	medicine	medicine	NOUN
ajfti-2033	389	7	service	service	NOUN
ajfti-2033	389	8	to	to	PART
ajfti-2033	389	9	improve	improve	VERB
ajfti-2033	389	10	adherence	adherence	NOUN
ajfti-2033	389	11	in	in	ADP
ajfti-2033	389	12	the	the	DET
ajfti-2033	389	13	spanish	spanish	ADJ
ajfti-2033	389	14	community	community	NOUN
ajfti-2033	389	15	pharmacies	pharmacy	NOUN
ajfti-2033	389	16	:	:	PUNCT
ajfti-2033	389	17	a	a	DET
ajfti-2033	389	18	protocol	protocol	NOUN
ajfti-2033	389	19	of	of	ADP
ajfti-2033	389	20	a	a	DET
ajfti-2033	389	21	pragmatic	pragmatic	ADJ
ajfti-2033	389	22	randomised	randomised	ADJ
ajfti-2033	389	23	trial	trial	NOUN
ajfti-2033	389	24	.	.	PUNCT
ajfti-2033	390	1	graffelman	graffelman	PROPN
ajfti-2033	390	2	,	,	PUNCT
ajfti-2033	390	3	j.	j.	PROPN
ajfti-2033	390	4	,	,	PUNCT
ajfti-2033	390	5	&	&	CCONJ
ajfti-2033	390	6	de	de	PROPN
ajfti-2033	390	7	leeuw	leeuw	PROPN
ajfti-2033	390	8	,	,	PUNCT
ajfti-2033	390	9	j.	j.	PROPN
ajfti-2033	390	10	(	(	PUNCT
ajfti-2033	390	11	2023	2023	NUM
ajfti-2033	390	12	)	)	PUNCT
ajfti-2033	390	13	.	.	PUNCT
ajfti-2033	391	1	improved	improve	VERB
ajfti-2033	391	2	approximation	approximation	NOUN
ajfti-2033	391	3	and	and	CCONJ
ajfti-2033	391	4	visualization	visualization	NOUN
ajfti-2033	391	5	of	of	ADP
ajfti-2033	391	6	the	the	DET
ajfti-2033	391	7	correlation	correlation	NOUN
ajfti-2033	391	8	matrix	matrix	NOUN
ajfti-2033	391	9	.	.	PUNCT
ajfti-2033	392	1	the	the	DET
ajfti-2033	392	2	american	american	PROPN
ajfti-2033	392	3	statistician	statistician	NOUN
ajfti-2033	392	4	,	,	PUNCT
ajfti-2033	392	5	1	1	NUM
ajfti-2033	392	6	-	-	SYM
ajfti-2033	392	7	11	11	NUM
ajfti-2033	392	8	.	.	PUNCT
ajfti-2033	393	1	kennedy	kennedy	PROPN
ajfti-2033	393	2	-	-	PUNCT
ajfti-2033	393	3	martin	martin	PROPN
ajfti-2033	393	4	,	,	PUNCT
ajfti-2033	393	5	t.	t.	PROPN
ajfti-2033	393	6	,	,	PUNCT
ajfti-2033	393	7	boye	boye	PROPN
ajfti-2033	393	8	,	,	PUNCT
ajfti-2033	393	9	k.	k.	PROPN
ajfti-2033	393	10	s.	s.	PROPN
ajfti-2033	393	11	,	,	PUNCT
ajfti-2033	393	12	&	&	CCONJ
ajfti-2033	393	13	peng	peng	PROPN
ajfti-2033	393	14	,	,	PUNCT
ajfti-2033	393	15	x.	x.	NOUN
ajfti-2033	393	16	(	(	PUNCT
ajfti-2033	393	17	2017	2017	NUM
ajfti-2033	393	18	)	)	PUNCT
ajfti-2033	393	19	.	.	PUNCT
ajfti-2033	394	1	cost	cost	NOUN
ajfti-2033	394	2	of	of	ADP
ajfti-2033	394	3	medication	medication	NOUN
ajfti-2033	394	4	adherence	adherence	NOUN
ajfti-2033	394	5	and	and	CCONJ
ajfti-2033	394	6	persistence	persistence	NOUN
ajfti-2033	394	7	in	in	ADP
ajfti-2033	394	8	type	type	NOUN
ajfti-2033	394	9	2	2	NUM
ajfti-2033	394	10	diabetes	diabetes	NOUN
ajfti-2033	394	11	mellitus	mellitus	NOUN
ajfti-2033	394	12	:	:	PUNCT
ajfti-2033	394	13	a	a	DET
ajfti-2033	394	14	literature	literature	NOUN
ajfti-2033	394	15	review	review	NOUN
ajfti-2033	394	16	.	.	PUNCT
ajfti-2033	395	1	patient	patient	ADJ
ajfti-2033	395	2	preference	preference	NOUN
ajfti-2033	395	3	and	and	CCONJ
ajfti-2033	395	4	adherence	adherence	NOUN
ajfti-2033	395	5	,	,	PUNCT
ajfti-2033	395	6	1103	1103	NUM
ajfti-2033	395	7	-	-	SYM
ajfti-2033	395	8	1117	1117	NUM
ajfti-2033	395	9	.	.	PUNCT
ajfti-2033	396	1	knapp	knapp	PROPN
ajfti-2033	396	2	,	,	PUNCT
ajfti-2033	396	3	m.	m.	NOUN
ajfti-2033	396	4	,	,	PUNCT
ajfti-2033	396	5	&	&	CCONJ
ajfti-2033	396	6	wong	wong	PROPN
ajfti-2033	396	7	,	,	PUNCT
ajfti-2033	396	8	g.	g.	PROPN
ajfti-2033	396	9	(	(	PUNCT
ajfti-2033	396	10	2020	2020	NUM
ajfti-2033	396	11	)	)	PUNCT
ajfti-2033	396	12	.	.	PUNCT
ajfti-2033	397	1	economics	economic	NOUN
ajfti-2033	397	2	and	and	CCONJ
ajfti-2033	397	3	mental	mental	ADJ
ajfti-2033	397	4	health	health	NOUN
ajfti-2033	397	5	:	:	PUNCT
ajfti-2033	397	6	the	the	DET
ajfti-2033	397	7	current	current	ADJ
ajfti-2033	397	8	scenario	scenario	NOUN
ajfti-2033	397	9	.	.	PUNCT
ajfti-2033	398	1	world	world	NOUN
ajfti-2033	398	2	psychiatry	psychiatry	PROPN
ajfti-2033	398	3	,	,	PUNCT
ajfti-2033	398	4	19(1	19(1	NUM
ajfti-2033	398	5	)	)	PUNCT
ajfti-2033	398	6	,	,	PUNCT
ajfti-2033	398	7	3	3	NUM
ajfti-2033	398	8	-	-	SYM
ajfti-2033	398	9	14	14	NUM
ajfti-2033	398	10	.	.	PUNCT
ajfti-2033	399	1	lee	lee	PROPN
ajfti-2033	399	2	,	,	PUNCT
ajfti-2033	399	3	k.	k.	PROPN
ajfti-2033	399	4	s.	s.	PROPN
ajfti-2033	399	5	,	,	PUNCT
ajfti-2033	399	6	kassab	kassab	VERB
ajfti-2033	399	7	,	,	PUNCT
ajfti-2033	399	8	y.	y.	PROPN
ajfti-2033	399	9	w.	w.	PROPN
ajfti-2033	399	10	,	,	PUNCT
ajfti-2033	399	11	taha	taha	PROPN
ajfti-2033	399	12	,	,	PUNCT
ajfti-2033	399	13	n.	n.	PROPN
ajfti-2033	399	14	a.	a.	PROPN
ajfti-2033	399	15	,	,	PUNCT
ajfti-2033	399	16	&	&	CCONJ
ajfti-2033	399	17	zainal	zainal	PROPN
ajfti-2033	399	18	,	,	PUNCT
ajfti-2033	399	19	z.	z.	PROPN
ajfti-2033	399	20	a.	a.	PROPN
ajfti-2033	399	21	(	(	PUNCT
ajfti-2033	399	22	2020	2020	NUM
ajfti-2033	399	23	)	)	PUNCT
ajfti-2033	399	24	.	.	PUNCT
ajfti-2033	400	1	factors	factor	NOUN
ajfti-2033	400	2	impacting	impact	VERB
ajfti-2033	400	3	pharmaceutical	pharmaceutical	NOUN
ajfti-2033	400	4	prices	price	NOUN
ajfti-2033	400	5	and	and	CCONJ
ajfti-2033	400	6	affordability	affordability	NOUN
ajfti-2033	400	7	:	:	PUNCT
ajfti-2033	400	8	narrative	narrative	PROPN
ajfti-2033	400	9	review	review	PROPN
ajfti-2033	400	10	.	.	PUNCT
ajfti-2033	401	1	pharmacy	pharmacy	NOUN
ajfti-2033	401	2	,	,	PUNCT
ajfti-2033	401	3	9(1	9(1	NUM
ajfti-2033	401	4	)	)	PUNCT
ajfti-2033	401	5	,	,	PUNCT
ajfti-2033	401	6	1	1	X
ajfti-2033	401	7	.	.	X
ajfti-2033	402	1	li	li	PROPN
ajfti-2033	402	2	,	,	PUNCT
ajfti-2033	402	3	m.	m.	NOUN
ajfti-2033	402	4	,	,	PUNCT
ajfti-2033	402	5	liu	liu	PROPN
ajfti-2033	402	6	,	,	PUNCT
ajfti-2033	402	7	z.	z.	PROPN
ajfti-2033	402	8	,	,	PUNCT
ajfti-2033	402	9	zhang	zhang	PROPN
ajfti-2033	402	10	,	,	PUNCT
ajfti-2033	402	11	m.	m.	NOUN
ajfti-2033	402	12	,	,	PUNCT
ajfti-2033	402	13	&	&	CCONJ
ajfti-2033	402	14	chen	chen	PROPN
ajfti-2033	402	15	,	,	PUNCT
ajfti-2033	402	16	y.	y.	PROPN
ajfti-2033	402	17	(	(	PUNCT
ajfti-2033	402	18	2021	2021	NUM
ajfti-2033	402	19	)	)	PUNCT
ajfti-2033	402	20	.	.	PUNCT
ajfti-2033	403	1	a	a	DET
ajfti-2033	403	2	workflow	workflow	NOUN
ajfti-2033	403	3	for	for	ADP
ajfti-2033	403	4	spatio	spatio	ADJ
ajfti-2033	403	5	-	-	PUNCT
ajfti-2033	403	6	seasonal	seasonal	ADJ
ajfti-2033	403	7	hydro	hydro	NOUN
ajfti-2033	403	8	-	-	PUNCT
ajfti-2033	403	9	chemical	chemical	NOUN
ajfti-2033	403	10	analysis	analysis	NOUN
ajfti-2033	403	11	using	use	VERB
ajfti-2033	403	12	multivariate	multivariate	NOUN
ajfti-2033	403	13	statistical	statistical	ADJ
ajfti-2033	403	14	techniques	technique	NOUN
ajfti-2033	403	15	.	.	PUNCT
ajfti-2033	404	1	water	water	NOUN
ajfti-2033	404	2	research	research	NOUN
ajfti-2033	404	3	,	,	PUNCT
ajfti-2033	404	4	188	188	NUM
ajfti-2033	404	5	,	,	PUNCT
ajfti-2033	404	6	116550	116550	NUM
ajfti-2033	404	7	.	.	PUNCT
ajfti-2033	405	1	malecha	malecha	PROPN
ajfti-2033	405	2	,	,	PUNCT
ajfti-2033	405	3	p.	p.	PROPN
ajfti-2033	405	4	w.	w.	PROPN
ajfti-2033	405	5	,	,	PUNCT
ajfti-2033	405	6	williams	williams	PROPN
ajfti-2033	405	7	,	,	PUNCT
ajfti-2033	405	8	j.	j.	PROPN
ajfti-2033	405	9	h.	h.	PROPN
ajfti-2033	405	10	,	,	PUNCT
ajfti-2033	405	11	kunzler	kunzler	PROPN
ajfti-2033	405	12	,	,	PUNCT
ajfti-2033	405	13	n.	n.	NOUN
ajfti-2033	405	14	m.	m.	NOUN
ajfti-2033	405	15	,	,	PUNCT
ajfti-2033	405	16	goldfrank	goldfrank	PROPN
ajfti-2033	405	17	,	,	PUNCT
ajfti-2033	405	18	l.	l.	PROPN
ajfti-2033	405	19	r.	r.	PROPN
ajfti-2033	405	20	,	,	PUNCT
ajfti-2033	405	21	alter	alter	PROPN
ajfti-2033	405	22	,	,	PUNCT
ajfti-2033	405	23	h.	h.	PROPN
ajfti-2033	405	24	j.	j.	PROPN
ajfti-2033	405	25	,	,	PUNCT
ajfti-2033	405	26	&	&	CCONJ
ajfti-2033	405	27	doran	doran	PROPN
ajfti-2033	405	28	,	,	PUNCT
ajfti-2033	405	29	k.	k.	PROPN
ajfti-2033	405	30	m.	m.	PROPN
ajfti-2033	405	31	(	(	PUNCT
ajfti-2033	405	32	2018	2018	NUM
ajfti-2033	405	33	)	)	PUNCT
ajfti-2033	405	34	.	.	PUNCT
ajfti-2033	406	1	material	material	NOUN
ajfti-2033	406	2	needs	need	NOUN
ajfti-2033	406	3	of	of	ADP
ajfti-2033	406	4	emergency	emergency	NOUN
ajfti-2033	406	5	department	department	NOUN
ajfti-2033	406	6	patients	patient	NOUN
ajfti-2033	406	7	:	:	PUNCT
ajfti-2033	406	8	a	a	DET
ajfti-2033	406	9	systematic	systematic	ADJ
ajfti-2033	406	10	review	review	NOUN
ajfti-2033	406	11	.	.	PUNCT
ajfti-2033	407	1	academic	academic	ADJ
ajfti-2033	407	2	emergency	emergency	NOUN
ajfti-2033	407	3	medicine	medicine	NOUN
ajfti-2033	407	4	,	,	PUNCT
ajfti-2033	407	5	25(3	25(3	NUM
ajfti-2033	407	6	)	)	PUNCT
ajfti-2033	407	7	,	,	PUNCT
ajfti-2033	407	8	330	330	NUM
ajfti-2033	407	9	-	-	SYM
ajfti-2033	407	10	359	359	NUM
ajfti-2033	407	11	.	.	PUNCT
ajfti-2033	408	1	manna	manna	PROPN
ajfti-2033	408	2	,	,	PUNCT
ajfti-2033	408	3	r.	r.	PROPN
ajfti-2033	408	4	,	,	PUNCT
ajfti-2033	408	5	cavallone	cavallone	NOUN
ajfti-2033	408	6	,	,	PUNCT
ajfti-2033	408	7	m.	m.	NOUN
ajfti-2033	408	8	,	,	PUNCT
ajfti-2033	408	9	ciasullo	ciasullo	PROPN
ajfti-2033	408	10	,	,	PUNCT
ajfti-2033	408	11	m.	m.	NOUN
ajfti-2033	408	12	v.	v.	PROPN
ajfti-2033	408	13	,	,	PUNCT
ajfti-2033	408	14	&	&	CCONJ
ajfti-2033	408	15	palumbo	palumbo	PROPN
ajfti-2033	408	16	,	,	PUNCT
ajfti-2033	408	17	r.	r.	PROPN
ajfti-2033	408	18	(	(	PUNCT
ajfti-2033	408	19	2020	2020	NUM
ajfti-2033	408	20	)	)	PUNCT
ajfti-2033	408	21	.	.	PUNCT
ajfti-2033	409	1	beyond	beyond	ADP
ajfti-2033	409	2	the	the	DET
ajfti-2033	409	3	rhetoric	rhetoric	NOUN
ajfti-2033	409	4	of	of	ADP
ajfti-2033	409	5	health	health	NOUN
ajfti-2033	409	6	tourism	tourism	NOUN
ajfti-2033	409	7	:	:	PUNCT
ajfti-2033	409	8	shedding	shed	VERB
ajfti-2033	409	9	light	light	NOUN
ajfti-2033	409	10	on	on	ADP
ajfti-2033	409	11	the	the	DET
ajfti-2033	409	12	reality	reality	NOUN
ajfti-2033	409	13	of	of	ADP
ajfti-2033	409	14	health	health	NOUN
ajfti-2033	409	15	tourism	tourism	NOUN
ajfti-2033	409	16	in	in	ADP
ajfti-2033	409	17	italy	italy	PROPN
ajfti-2033	409	18	.	.	PUNCT
ajfti-2033	410	1	current	current	ADJ
ajfti-2033	410	2	issues	issue	NOUN
ajfti-2033	410	3	in	in	ADP
ajfti-2033	410	4	tourism	tourism	NOUN
ajfti-2033	410	5	,	,	PUNCT
ajfti-2033	410	6	23(14	23(14	NOUN
ajfti-2033	410	7	)	)	PUNCT
ajfti-2033	410	8	,	,	PUNCT
ajfti-2033	410	9	1805	1805	NUM
ajfti-2033	410	10	-	-	SYM
ajfti-2033	410	11	1819	1819	NUM
ajfti-2033	410	12	.	.	PUNCT
ajfti-2033	411	1	meng	meng	PROPN
ajfti-2033	411	2	,	,	PUNCT
ajfti-2033	411	3	q.	q.	PROPN
ajfti-2033	411	4	,	,	PUNCT
ajfti-2033	411	5	fang	fang	PROPN
ajfti-2033	411	6	,	,	PUNCT
ajfti-2033	411	7	h.	h.	PROPN
ajfti-2033	411	8	,	,	PUNCT
ajfti-2033	411	9	liu	liu	PROPN
ajfti-2033	411	10	,	,	PUNCT
ajfti-2033	411	11	x.	x.	PROPN
ajfti-2033	411	12	,	,	PUNCT
ajfti-2033	411	13	yuan	yuan	PROPN
ajfti-2033	411	14	,	,	PUNCT
ajfti-2033	411	15	b.	b.	PROPN
ajfti-2033	411	16	,	,	PUNCT
ajfti-2033	411	17	&	&	CCONJ
ajfti-2033	411	18	xu	xu	PROPN
ajfti-2033	411	19	,	,	PUNCT
ajfti-2033	411	20	j.	j.	PROPN
ajfti-2033	411	21	(	(	PUNCT
ajfti-2033	411	22	2015	2015	NUM
ajfti-2033	411	23	)	)	PUNCT
ajfti-2033	411	24	.	.	PUNCT
ajfti-2033	412	1	consolidating	consolidate	VERB
ajfti-2033	412	2	the	the	DET
ajfti-2033	412	3	social	social	ADJ
ajfti-2033	412	4	health	health	NOUN
ajfti-2033	412	5	insurance	insurance	NOUN
ajfti-2033	412	6	schemes	scheme	NOUN
ajfti-2033	412	7	in	in	ADP
ajfti-2033	412	8	china	china	PROPN
ajfti-2033	412	9	:	:	PUNCT
ajfti-2033	412	10	towards	towards	ADP
ajfti-2033	412	11	an	an	DET
ajfti-2033	412	12	equitable	equitable	ADJ
ajfti-2033	412	13	and	and	CCONJ
ajfti-2033	412	14	efficient	efficient	ADJ
ajfti-2033	412	15	health	health	NOUN
ajfti-2033	412	16	system	system	NOUN
ajfti-2033	412	17	.	.	PUNCT
ajfti-2033	413	1	the	the	DET
ajfti-2033	413	2	lancet	lancet	NOUN
ajfti-2033	413	3	,	,	PUNCT
ajfti-2033	413	4	386(10002	386(10002	NUM
ajfti-2033	413	5	)	)	PUNCT
ajfti-2033	413	6	,	,	PUNCT
ajfti-2033	413	7	1484	1484	NUM
ajfti-2033	413	8	-	-	SYM
ajfti-2033	413	9	1492	1492	NUM
ajfti-2033	413	10	.	.	PUNCT
ajfti-2033	414	1	ministry	ministry	PROPN
ajfti-2033	414	2	of	of	ADP
ajfti-2033	414	3	health	health	PROPN
ajfti-2033	414	4	,	,	PUNCT
ajfti-2033	414	5	r.	r.	PROPN
ajfti-2033	414	6	,	,	PUNCT
ajfti-2033	414	7	&	&	CCONJ
ajfti-2033	414	8	saudi	saudi	PROPN
ajfti-2033	414	9	arabia	arabia	PROPN
ajfti-2033	414	10	.	.	PUNCT
ajfti-2033	415	1	(	(	PUNCT
ajfti-2033	415	2	2017	2017	NUM
ajfti-2033	415	3	)	)	PUNCT
ajfti-2033	415	4	.	.	PUNCT
ajfti-2033	416	1	ministry	ministry	PROPN
ajfti-2033	416	2	of	of	ADP
ajfti-2033	416	3	health	health	PROPN
ajfti-2033	416	4	.	.	PUNCT
ajfti-2033	417	1	health	health	NOUN
ajfti-2033	417	2	statistical	statistical	ADJ
ajfti-2033	417	3	year	year	NOUN
ajfti-2033	417	4	book	book	NOUN
ajfti-2033	417	5	2016	2016	NUM
ajfti-2033	417	6	,	,	PUNCT
ajfti-2033	417	7	department	department	NOUN
ajfti-2033	417	8	of	of	ADP
ajfti-2033	417	9	statistics	statistic	NOUN
ajfti-2033	417	10	,	,	PUNCT
ajfti-2033	417	11	.	.	PUNCT
ajfti-2033	418	1	mohiuddin	mohiuddin	NOUN
ajfti-2033	418	2	,	,	PUNCT
ajfti-2033	418	3	a.	a.	PROPN
ajfti-2033	418	4	k.	k.	PROPN
ajfti-2033	418	5	(	(	PUNCT
ajfti-2033	418	6	2019	2019	NUM
ajfti-2033	418	7	)	)	PUNCT
ajfti-2033	418	8	.	.	PUNCT
ajfti-2033	419	1	risks	risk	NOUN
ajfti-2033	419	2	and	and	CCONJ
ajfti-2033	419	3	reasons	reason	NOUN
ajfti-2033	419	4	associated	associate	VERB
ajfti-2033	419	5	with	with	ADP
ajfti-2033	419	6	medication	medication	NOUN
ajfti-2033	419	7	non	non	NOUN
ajfti-2033	419	8	-	-	NOUN
ajfti-2033	419	9	adherence	adherence	NOUN
ajfti-2033	419	10	.	.	PUNCT
ajfti-2033	420	1	j	j	PROPN
ajfti-2033	420	2	clin	clin	PROPN
ajfti-2033	420	3	pharm	pharm	PROPN
ajfti-2033	420	4	,	,	PUNCT
ajfti-2033	420	5	1(1	1(1	NUM
ajfti-2033	420	6	)	)	PUNCT
ajfti-2033	420	7	,	,	PUNCT
ajfti-2033	420	8	50	50	NUM
ajfti-2033	420	9	-	-	SYM
ajfti-2033	420	10	53	53	NUM
ajfti-2033	420	11	.	.	PUNCT
ajfti-2033	421	1	mooi	mooi	NOUN
ajfti-2033	421	2	,	,	PUNCT
ajfti-2033	421	3	e.	e.	PROPN
ajfti-2033	421	4	,	,	PUNCT
ajfti-2033	421	5	sarstedt	sarstedt	NOUN
ajfti-2033	421	6	,	,	PUNCT
ajfti-2033	421	7	m.	m.	NOUN
ajfti-2033	421	8	,	,	PUNCT
ajfti-2033	421	9	&	&	CCONJ
ajfti-2033	421	10	mooi	mooi	PROPN
ajfti-2033	421	11	-	-	PUNCT
ajfti-2033	421	12	reci	reci	PROPN
ajfti-2033	421	13	,	,	PUNCT
ajfti-2033	421	14	i.	i.	NOUN
ajfti-2033	421	15	(	(	PUNCT
ajfti-2033	421	16	2018	2018	NUM
ajfti-2033	421	17	)	)	PUNCT
ajfti-2033	421	18	.	.	PUNCT
ajfti-2033	422	1	market	market	NOUN
ajfti-2033	422	2	research	research	NOUN
ajfti-2033	422	3	:	:	PUNCT
ajfti-2033	422	4	the	the	DET
ajfti-2033	422	5	process	process	NOUN
ajfti-2033	422	6	,	,	PUNCT
ajfti-2033	422	7	data	datum	NOUN
ajfti-2033	422	8	,	,	PUNCT
ajfti-2033	422	9	and	and	CCONJ
ajfti-2033	422	10	methods	method	NOUN
ajfti-2033	422	11	using	use	VERB
ajfti-2033	422	12	stata	stata	PROPN
ajfti-2033	422	13	.	.	PUNCT
ajfti-2033	423	1	springer	springer	NOUN
ajfti-2033	423	2	.	.	PUNCT
ajfti-2033	424	1	morrissey	morrissey	PROPN
ajfti-2033	424	2	,	,	PUNCT
ajfti-2033	424	3	e.	e.	PROPN
ajfti-2033	424	4	c.	c.	PROPN
ajfti-2033	424	5	,	,	PUNCT
ajfti-2033	424	6	corbett	corbett	NOUN
ajfti-2033	424	7	,	,	PUNCT
ajfti-2033	424	8	t.	t.	PROPN
ajfti-2033	424	9	k.	k.	PROPN
ajfti-2033	424	10	,	,	PUNCT
ajfti-2033	424	11	walsh	walsh	PROPN
ajfti-2033	424	12	,	,	PUNCT
ajfti-2033	424	13	j.	j.	PROPN
ajfti-2033	424	14	c.	c.	PROPN
ajfti-2033	424	15	,	,	PUNCT
ajfti-2033	424	16	&	&	CCONJ
ajfti-2033	424	17	molloy	molloy	PROPN
ajfti-2033	424	18	,	,	PUNCT
ajfti-2033	424	19	g.	g.	PROPN
ajfti-2033	424	20	j.	j.	PROPN
ajfti-2033	424	21	(	(	PUNCT
ajfti-2033	424	22	2016	2016	NUM
ajfti-2033	424	23	)	)	PUNCT
ajfti-2033	424	24	.	.	PUNCT
ajfti-2033	425	1	behavior	behavior	NOUN
ajfti-2033	425	2	change	change	VERB
ajfti-2033	425	3	techniques	technique	NOUN
ajfti-2033	425	4	in	in	ADP
ajfti-2033	425	5	apps	app	NOUN
ajfti-2033	425	6	for	for	ADP
ajfti-2033	425	7	medication	medication	NOUN
ajfti-2033	425	8	adherence	adherence	NOUN
ajfti-2033	425	9	:	:	PUNCT
ajfti-2033	425	10	a	a	DET
ajfti-2033	425	11	content	content	NOUN
ajfti-2033	425	12	analysis	analysis	NOUN
ajfti-2033	425	13	.	.	PUNCT
ajfti-2033	426	1	american	american	ADJ
ajfti-2033	426	2	journal	journal	PROPN
ajfti-2033	426	3	of	of	ADP
ajfti-2033	426	4	preventive	preventive	ADJ
ajfti-2033	426	5	medicine	medicine	NOUN
ajfti-2033	426	6	,	,	PUNCT
ajfti-2033	426	7	50(5	50(5	NUM
ajfti-2033	426	8	)	)	PUNCT
ajfti-2033	426	9	,	,	PUNCT
ajfti-2033	426	10	e143	e143	PROPN
ajfti-2033	426	11	-	-	PUNCT
ajfti-2033	426	12	e146	e146	PROPN
ajfti-2033	426	13	.	.	PUNCT
ajfti-2033	426	14	patel	patel	PROPN
ajfti-2033	426	15	,	,	PUNCT
ajfti-2033	426	16	m.	m.	PROPN
ajfti-2033	426	17	r.	r.	PROPN
ajfti-2033	426	18	,	,	PUNCT
ajfti-2033	426	19	press	press	NOUN
ajfti-2033	426	20	,	,	PUNCT
ajfti-2033	426	21	v.	v.	PROPN
ajfti-2033	426	22	g.	g.	PROPN
ajfti-2033	426	23	,	,	PUNCT
ajfti-2033	426	24	gerald	gerald	PROPN
ajfti-2033	426	25	,	,	PUNCT
ajfti-2033	426	26	l.	l.	PROPN
ajfti-2033	426	27	b.	b.	PROPN
ajfti-2033	426	28	,	,	PUNCT
ajfti-2033	426	29	barnes	barnes	PROPN
ajfti-2033	426	30	,	,	PUNCT
ajfti-2033	426	31	t.	t.	PROPN
ajfti-2033	426	32	,	,	PUNCT
ajfti-2033	426	33	blake	blake	PROPN
ajfti-2033	426	34	,	,	PUNCT
ajfti-2033	426	35	k.	k.	PROPN
ajfti-2033	426	36	,	,	PUNCT
ajfti-2033	426	37	brown	brown	PROPN
ajfti-2033	426	38	,	,	PUNCT
ajfti-2033	426	39	l.	l.	PROPN
ajfti-2033	426	40	k.	k.	PROPN
ajfti-2033	426	41	,	,	PUNCT
ajfti-2033	426	42	costello	costello	PROPN
ajfti-2033	426	43	,	,	PUNCT
ajfti-2033	426	44	r.	r.	PROPN
ajfti-2033	426	45	w.	w.	PROPN
ajfti-2033	426	46	,	,	PUNCT
ajfti-2033	426	47	crim	crim	PROPN
ajfti-2033	426	48	,	,	PUNCT
ajfti-2033	426	49	c.	c.	PROPN
ajfti-2033	426	50	,	,	PUNCT
ajfti-2033	426	51	forshag	forshag	NOUN
ajfti-2033	426	52	,	,	PUNCT
ajfti-2033	426	53	m.	m.	NOUN
ajfti-2033	426	54	,	,	PUNCT
ajfti-2033	426	55	&	&	CCONJ
ajfti-2033	426	56	gershon	gershon	PROPN
ajfti-2033	426	57	,	,	PUNCT
ajfti-2033	426	58	a.	a.	PROPN
ajfti-2033	426	59	s.	s.	PROPN
ajfti-2033	426	60	(	(	PUNCT
ajfti-2033	426	61	2018	2018	NUM
ajfti-2033	426	62	)	)	PUNCT
ajfti-2033	426	63	.	.	PUNCT
ajfti-2033	427	1	improving	improve	VERB
ajfti-2033	427	2	the	the	DET
ajfti-2033	427	3	affordability	affordability	NOUN
ajfti-2033	427	4	of	of	ADP
ajfti-2033	427	5	prescription	prescription	NOUN
ajfti-2033	427	6	medications	medication	NOUN
ajfti-2033	427	7	for	for	ADP
ajfti-2033	427	8	people	people	NOUN
ajfti-2033	427	9	with	with	ADP
ajfti-2033	427	10	chronic	chronic	ADJ
ajfti-2033	427	11	respiratory	respiratory	ADJ
ajfti-2033	427	12	disease	disease	NOUN
ajfti-2033	427	13	.	.	PUNCT
ajfti-2033	428	1	an	an	DET
ajfti-2033	428	2	official	official	ADJ
ajfti-2033	428	3	american	american	ADJ
ajfti-2033	428	4	thoracic	thoracic	NOUN
ajfti-2033	428	5	society	society	PROPN
ajfti-2033	428	6	policy	policy	NOUN
ajfti-2033	428	7	statement	statement	NOUN
ajfti-2033	428	8	.	.	PUNCT
ajfti-2033	429	1	american	american	ADJ
ajfti-2033	429	2	journal	journal	PROPN
ajfti-2033	429	3	of	of	ADP
ajfti-2033	429	4	respiratory	respiratory	ADJ
ajfti-2033	429	5	and	and	CCONJ
ajfti-2033	429	6	critical	critical	ADJ
ajfti-2033	429	7	care	care	NOUN
ajfti-2033	429	8	medicine	medicine	NOUN
ajfti-2033	429	9	,	,	PUNCT
ajfti-2033	429	10	198(11	198(11	NUM
ajfti-2033	429	11	)	)	PUNCT
ajfti-2033	429	12	,	,	PUNCT
ajfti-2033	429	13	1367	1367	NUM
ajfti-2033	429	14	-	-	SYM
ajfti-2033	429	15	1374	1374	NUM
ajfti-2033	429	16	.	.	PUNCT
ajfti-2033	430	1	reed	reed	NOUN
ajfti-2033	430	2	,	,	PUNCT
ajfti-2033	430	3	m.	m.	PROPN
ajfti-2033	430	4	e.	e.	PROPN
ajfti-2033	430	5	,	,	PUNCT
ajfti-2033	430	6	warton	warton	PROPN
ajfti-2033	430	7	,	,	PUNCT
ajfti-2033	430	8	e.	e.	PROPN
ajfti-2033	430	9	m.	m.	PROPN
ajfti-2033	430	10	,	,	PUNCT
ajfti-2033	430	11	kim	kim	PROPN
ajfti-2033	430	12	,	,	PUNCT
ajfti-2033	430	13	e.	e.	PROPN
ajfti-2033	430	14	,	,	PUNCT
ajfti-2033	430	15	solomon	solomon	PROPN
ajfti-2033	430	16	,	,	PUNCT
ajfti-2033	430	17	m.	m.	PROPN
ajfti-2033	430	18	d.	d.	PROPN
ajfti-2033	430	19	,	,	PUNCT
ajfti-2033	430	20	&	&	CCONJ
ajfti-2033	430	21	karter	karter	PROPN
ajfti-2033	430	22	,	,	PUNCT
ajfti-2033	430	23	a.	a.	PROPN
ajfti-2033	430	24	j.	j.	PROPN
ajfti-2033	430	25	(	(	PUNCT
ajfti-2033	430	26	2017	2017	NUM
ajfti-2033	430	27	)	)	PUNCT
ajfti-2033	430	28	.	.	PUNCT
ajfti-2033	431	1	value	value	NOUN
ajfti-2033	431	2	-	-	PUNCT
ajfti-2033	431	3	based	base	VERB
ajfti-2033	431	4	insurance	insurance	NOUN
ajfti-2033	431	5	design	design	NOUN
ajfti-2033	431	6	benefit	benefit	NOUN
ajfti-2033	431	7	offsets	offset	NOUN
ajfti-2033	431	8	reductions	reduction	NOUN
ajfti-2033	431	9	in	in	ADP
ajfti-2033	431	10	medication	medication	NOUN
ajfti-2033	431	11	adherence	adherence	NOUN
ajfti-2033	431	12	associated	associate	VERB
ajfti-2033	431	13	with	with	ADP
ajfti-2033	431	14	switch	switch	NOUN
ajfti-2033	431	15	to	to	AUX
ajfti-2033	431	16	deductible	deductible	ADJ
ajfti-2033	431	17	plan	plan	NOUN
ajfti-2033	431	18	.	.	PUNCT
ajfti-2033	432	1	health	health	NOUN
ajfti-2033	432	2	affairs	affairs	PROPN
ajfti-2033	432	3	,	,	PUNCT
ajfti-2033	432	4	36(3	36(3	NOUN
ajfti-2033	432	5	)	)	PUNCT
ajfti-2033	432	6	,	,	PUNCT
ajfti-2033	432	7	516	516	NUM
ajfti-2033	432	8	-	-	SYM
ajfti-2033	432	9	523	523	NUM
ajfti-2033	432	10	.	.	PUNCT
ajfti-2033	433	1	reynolds	reynolds	PROPN
ajfti-2033	433	2	,	,	PUNCT
ajfti-2033	433	3	e.	e.	PROPN
ajfti-2033	433	4	l.	l.	PROPN
ajfti-2033	433	5	,	,	PUNCT
ajfti-2033	433	6	burke	burke	PROPN
ajfti-2033	433	7	,	,	PUNCT
ajfti-2033	433	8	j.	j.	PROPN
ajfti-2033	433	9	f.	f.	PROPN
ajfti-2033	433	10	,	,	PUNCT
ajfti-2033	433	11	banerjee	banerjee	PROPN
ajfti-2033	433	12	,	,	PUNCT
ajfti-2033	433	13	m.	m.	NOUN
ajfti-2033	433	14	,	,	PUNCT
ajfti-2033	433	15	kerber	kerber	PROPN
ajfti-2033	433	16	,	,	PUNCT
ajfti-2033	433	17	k.	k.	PROPN
ajfti-2033	433	18	a.	a.	PROPN
ajfti-2033	433	19	,	,	PUNCT
ajfti-2033	433	20	skolarus	skolarus	PROPN
ajfti-2033	433	21	,	,	PUNCT
ajfti-2033	433	22	l.	l.	PROPN
ajfti-2033	433	23	e.	e.	PROPN
ajfti-2033	433	24	,	,	PUNCT
ajfti-2033	433	25	magliocco	magliocco	PROPN
ajfti-2033	433	26	,	,	PUNCT
ajfti-2033	433	27	b.	b.	PROPN
ajfti-2033	433	28	,	,	PUNCT
ajfti-2033	433	29	esper	esper	PROPN
ajfti-2033	433	30	,	,	PUNCT
ajfti-2033	433	31	g.	g.	PROPN
ajfti-2033	433	32	j.	j.	PROPN
ajfti-2033	433	33	,	,	PUNCT
ajfti-2033	433	34	&	&	CCONJ
ajfti-2033	433	35	callaghan	callaghan	PROPN
ajfti-2033	433	36	,	,	PUNCT
ajfti-2033	433	37	b.	b.	PROPN
ajfti-2033	433	38	c.	c.	PROPN
ajfti-2033	433	39	(	(	PUNCT
ajfti-2033	433	40	2020	2020	NUM
ajfti-2033	433	41	)	)	PUNCT
ajfti-2033	433	42	.	.	PUNCT
ajfti-2033	434	1	association	association	NOUN
ajfti-2033	434	2	of	of	ADP
ajfti-2033	434	3	out	out	ADJ
ajfti-2033	434	4	-	-	PUNCT
ajfti-2033	434	5	ofpocket	ofpocket	NOUN
ajfti-2033	434	6	costs	cost	NOUN
ajfti-2033	434	7	on	on	ADP
ajfti-2033	434	8	adherence	adherence	NOUN
ajfti-2033	434	9	to	to	ADP
ajfti-2033	434	10	common	common	ADJ
ajfti-2033	434	11	neurologic	neurologic	ADJ
ajfti-2033	434	12	medications	medication	NOUN
ajfti-2033	434	13	.	.	PUNCT
ajfti-2033	435	1	neurology	neurology	NOUN
ajfti-2033	435	2	,	,	PUNCT
ajfti-2033	435	3	94(13	94(13	NUM
ajfti-2033	435	4	)	)	PUNCT
ajfti-2033	435	5	,	,	PUNCT
ajfti-2033	435	6	e1415	e1415	NOUN
ajfti-2033	435	7	-	-	PUNCT
ajfti-2033	435	8	e1426	e1426	PROPN
ajfti-2033	435	9	.	.	PUNCT
ajfti-2033	435	10	schlander	schlander	NOUN
ajfti-2033	435	11	,	,	PUNCT
ajfti-2033	435	12	m.	m.	NOUN
ajfti-2033	435	13	,	,	PUNCT
ajfti-2033	435	14	hernandez	hernandez	PROPN
ajfti-2033	435	15	-	-	PUNCT
ajfti-2033	435	16	villafuerte	villafuerte	PROPN
ajfti-2033	435	17	,	,	PUNCT
ajfti-2033	435	18	k.	k.	PROPN
ajfti-2033	435	19	,	,	PUNCT
ajfti-2033	435	20	cheng	cheng	PROPN
ajfti-2033	435	21	,	,	PUNCT
ajfti-2033	435	22	c.y	c.y	PROPN
ajfti-2033	435	23	.	.	PROPN
ajfti-2033	435	24	,	,	PUNCT
ajfti-2033	435	25	mestre	mestre	NOUN
ajfti-2033	435	26	-	-	PUNCT
ajfti-2033	435	27	ferrandiz	ferrandiz	NOUN
ajfti-2033	435	28	,	,	PUNCT
ajfti-2033	435	29	j.	j.	PROPN
ajfti-2033	435	30	,	,	PUNCT
ajfti-2033	435	31	&	&	CCONJ
ajfti-2033	435	32	baumann	baumann	PROPN
ajfti-2033	435	33	,	,	PUNCT
ajfti-2033	435	34	m.	m.	NOUN
ajfti-2033	435	35	(	(	PUNCT
ajfti-2033	435	36	2021	2021	NUM
ajfti-2033	435	37	)	)	PUNCT
ajfti-2033	435	38	.	.	PUNCT
ajfti-2033	436	1	how	how	SCONJ
ajfti-2033	436	2	much	much	ADJ
ajfti-2033	436	3	does	do	AUX
ajfti-2033	436	4	it	it	PRON
ajfti-2033	436	5	cost	cost	VERB
ajfti-2033	436	6	to	to	PART
ajfti-2033	436	7	research	research	VERB
ajfti-2033	436	8	and	and	CCONJ
ajfti-2033	436	9	develop	develop	VERB
ajfti-2033	436	10	a	a	DET
ajfti-2033	436	11	new	new	ADJ
ajfti-2033	436	12	drug	drug	NOUN
ajfti-2033	436	13	?	?	PUNCT
ajfti-2033	437	1	a	a	DET
ajfti-2033	437	2	systematic	systematic	ADJ
ajfti-2033	437	3	review	review	NOUN
ajfti-2033	437	4	and	and	CCONJ
ajfti-2033	437	5	assessment	assessment	NOUN
ajfti-2033	437	6	.	.	PUNCT
ajfti-2033	438	1	pharmacoeconomics	pharmacoeconomic	NOUN
ajfti-2033	438	2	,	,	PUNCT
ajfti-2033	438	3	39	39	NUM
ajfti-2033	438	4	,	,	PUNCT
ajfti-2033	438	5	1243	1243	NUM
ajfti-2033	438	6	-	-	SYM
ajfti-2033	438	7	1269	1269	NUM
ajfti-2033	438	8	.	.	PUNCT
ajfti-2033	439	1	smith	smith	PROPN
ajfti-2033	439	2	,	,	PUNCT
ajfti-2033	439	3	g.	g.	PROPN
ajfti-2033	439	4	l.	l.	PROPN
ajfti-2033	439	5	,	,	PUNCT
ajfti-2033	439	6	lopez	lopez	NOUN
ajfti-2033	439	7	-	-	PUNCT
ajfti-2033	439	8	olivo	olivo	NOUN
ajfti-2033	439	9	,	,	PUNCT
ajfti-2033	439	10	m.	m.	NOUN
ajfti-2033	439	11	a.	a.	PROPN
ajfti-2033	439	12	,	,	PUNCT
ajfti-2033	439	13	advani	advani	PROPN
ajfti-2033	439	14	,	,	PUNCT
ajfti-2033	439	15	p.	p.	PROPN
ajfti-2033	439	16	g.	g.	PROPN
ajfti-2033	439	17	,	,	PUNCT
ajfti-2033	439	18	ning	ning	PROPN
ajfti-2033	439	19	,	,	PUNCT
ajfti-2033	439	20	m.	m.	NOUN
ajfti-2033	439	21	s.	s.	PROPN
ajfti-2033	439	22	,	,	PUNCT
ajfti-2033	439	23	geng	geng	PROPN
ajfti-2033	439	24	,	,	PUNCT
ajfti-2033	439	25	y.	y.	PROPN
ajfti-2033	439	26	,	,	PUNCT
ajfti-2033	439	27	giordano	giordano	PROPN
ajfti-2033	439	28	,	,	PUNCT
ajfti-2033	439	29	s.	s.	PROPN
ajfti-2033	439	30	h.	h.	PROPN
ajfti-2033	439	31	,	,	PUNCT
ajfti-2033	439	32	&	&	CCONJ
ajfti-2033	439	33	volk	volk	PROPN
ajfti-2033	439	34	,	,	PUNCT
ajfti-2033	439	35	r.	r.	PROPN
ajfti-2033	439	36	j.	j.	PROPN
ajfti-2033	439	37	(	(	PUNCT
ajfti-2033	439	38	2019	2019	NUM
ajfti-2033	439	39	)	)	PUNCT
ajfti-2033	439	40	.	.	PUNCT
ajfti-2033	440	1	financial	financial	ADJ
ajfti-2033	440	2	burdens	burden	NOUN
ajfti-2033	440	3	of	of	ADP
ajfti-2033	440	4	cancer	cancer	NOUN
ajfti-2033	440	5	treatment	treatment	NOUN
ajfti-2033	440	6	:	:	PUNCT
ajfti-2033	440	7	a	a	DET
ajfti-2033	440	8	systematic	systematic	ADJ
ajfti-2033	440	9	review	review	NOUN
ajfti-2033	440	10	of	of	ADP
ajfti-2033	440	11	risk	risk	NOUN
ajfti-2033	440	12	factors	factor	NOUN
ajfti-2033	440	13	and	and	CCONJ
ajfti-2033	440	14	outcomes	outcome	NOUN
ajfti-2033	440	15	.	.	PUNCT
ajfti-2033	441	1	journal	journal	NOUN
ajfti-2033	441	2	of	of	ADP
ajfti-2033	441	3	the	the	DET
ajfti-2033	441	4	national	national	ADJ
ajfti-2033	441	5	comprehensive	comprehensive	ADJ
ajfti-2033	441	6	cancer	cancer	NOUN
ajfti-2033	441	7	network	network	NOUN
ajfti-2033	441	8	,	,	PUNCT
ajfti-2033	441	9	17(10	17(10	NUM
ajfti-2033	441	10	)	)	PUNCT
ajfti-2033	441	11	,	,	PUNCT
ajfti-2033	441	12	11841192	11841192	NUM
ajfti-2033	441	13	.	.	PUNCT
ajfti-2033	442	1	stecker	stecker	NOUN
ajfti-2033	442	2	,	,	PUNCT
ajfti-2033	442	3	e.	e.	PROPN
ajfti-2033	442	4	c.	c.	PROPN
ajfti-2033	442	5	,	,	PUNCT
ajfti-2033	442	6	ayanian	ayanian	PROPN
ajfti-2033	442	7	,	,	PUNCT
ajfti-2033	442	8	j.	j.	PROPN
ajfti-2033	442	9	z.	z.	PROPN
ajfti-2033	442	10	,	,	PUNCT
ajfti-2033	442	11	&	&	CCONJ
ajfti-2033	442	12	fendrick	fendrick	PROPN
ajfti-2033	442	13	,	,	PUNCT
ajfti-2033	442	14	a.	a.	NOUN
ajfti-2033	442	15	m.	m.	NOUN
ajfti-2033	442	16	(	(	PUNCT
ajfti-2033	442	17	2015	2015	NUM
ajfti-2033	442	18	)	)	PUNCT
ajfti-2033	442	19	.	.	PUNCT
ajfti-2033	443	1	value	value	NOUN
ajfti-2033	443	2	-	-	PUNCT
ajfti-2033	443	3	based	base	VERB
ajfti-2033	443	4	insurance	insurance	NOUN
ajfti-2033	443	5	design	design	NOUN
ajfti-2033	443	6	:	:	PUNCT
ajfti-2033	443	7	aligning	align	VERB
ajfti-2033	443	8	incentives	incentive	NOUN
ajfti-2033	443	9	to	to	PART
ajfti-2033	443	10	improve	improve	VERB
ajfti-2033	443	11	cardiovascular	cardiovascular	ADJ
ajfti-2033	443	12	care	care	NOUN
ajfti-2033	443	13	.	.	PUNCT
ajfti-2033	444	1	circulation	circulation	NOUN
ajfti-2033	444	2	,	,	PUNCT
ajfti-2033	444	3	132(16	132(16	NUM
ajfti-2033	444	4	)	)	PUNCT
ajfti-2033	444	5	,	,	PUNCT
ajfti-2033	444	6	1580	1580	NUM
ajfti-2033	444	7	-	-	SYM
ajfti-2033	444	8	1585	1585	NUM
ajfti-2033	444	9	.	.	PUNCT
ajfti-2033	445	1	torres	torre	NOUN
ajfti-2033	445	2	-	-	PUNCT
ajfti-2033	445	3	robles	roble	NOUN
ajfti-2033	445	4	,	,	PUNCT
ajfti-2033	445	5	a.	a.	NOUN
ajfti-2033	445	6	,	,	PUNCT
ajfti-2033	445	7	benrimoj	benrimoj	VERB
ajfti-2033	445	8	,	,	PUNCT
ajfti-2033	445	9	s.	s.	PROPN
ajfti-2033	445	10	i.	i.	PROPN
ajfti-2033	445	11	,	,	PUNCT
ajfti-2033	445	12	gastelurrutia	gastelurrutia	NOUN
ajfti-2033	445	13	,	,	PUNCT
ajfti-2033	445	14	m.	m.	NOUN
ajfti-2033	445	15	a.	a.	PROPN
ajfti-2033	445	16	,	,	PUNCT
ajfti-2033	445	17	martinez	martinez	PROPN
ajfti-2033	445	18	-	-	PUNCT
ajfti-2033	445	19	martinez	martinez	PROPN
ajfti-2033	445	20	,	,	PUNCT
ajfti-2033	445	21	f.	f.	PROPN
ajfti-2033	445	22	,	,	PUNCT
ajfti-2033	445	23	peiro	peiro	NOUN
ajfti-2033	445	24	,	,	PUNCT
ajfti-2033	445	25	t.	t.	PROPN
ajfti-2033	445	26	,	,	PUNCT
ajfti-2033	445	27	perez	perez	PROPN
ajfti-2033	445	28	-	-	PUNCT
ajfti-2033	445	29	escamilla	escamilla	NOUN
ajfti-2033	445	30	,	,	PUNCT
ajfti-2033	445	31	b.	b.	PROPN
ajfti-2033	445	32	,	,	PUNCT
ajfti-2033	445	33	rogers	rogers	PROPN
ajfti-2033	445	34	,	,	PUNCT
ajfti-2033	445	35	k.	k.	PROPN
ajfti-2033	445	36	,	,	PUNCT
ajfti-2033	445	37	valverde	valverde	PROPN
ajfti-2033	445	38	-	-	PUNCT
ajfti-2033	445	39	merino	merino	PROPN
ajfti-2033	445	40	,	,	PUNCT
ajfti-2033	445	41	i.	i.	NOUN
ajfti-2033	445	42	,	,	PUNCT
ajfti-2033	445	43	varas	varas	PROPN
ajfti-2033	445	44	-	-	PUNCT
ajfti-2033	445	45	doval	doval	PROPN
ajfti-2033	445	46	,	,	PUNCT
ajfti-2033	445	47	r.	r.	PROPN
ajfti-2033	445	48	,	,	PUNCT
ajfti-2033	445	49	&	&	CCONJ
ajfti-2033	445	50	garcia	garcia	PROPN
ajfti-2033	445	51	-	-	PUNCT
ajfti-2033	445	52	cardenas	cardenas	PROPN
ajfti-2033	445	53	,	,	PUNCT
ajfti-2033	445	54	v.	v.	PROPN
ajfti-2033	445	55	(	(	PUNCT
ajfti-2033	445	56	2022	2022	NUM
ajfti-2033	445	57	)	)	PUNCT
ajfti-2033	445	58	.	.	PUNCT
ajfti-2033	446	1	effectiveness	effectiveness	NOUN
ajfti-2033	446	2	of	of	ADP
ajfti-2033	446	3	a	a	DET
ajfti-2033	446	4	medication	medication	NOUN
ajfti-2033	446	5	adherence	adherence	NOUN
ajfti-2033	446	6	management	management	NOUN
ajfti-2033	446	7	intervention	intervention	NOUN
ajfti-2033	446	8	in	in	ADP
ajfti-2033	446	9	a	a	DET
ajfti-2033	446	10	community	community	NOUN
ajfti-2033	446	11	pharmacy	pharmacy	NOUN
ajfti-2033	446	12	setting	set	VERB
ajfti-2033	446	13	:	:	PUNCT
ajfti-2033	446	14	a	a	DET
ajfti-2033	446	15	cluster	cluster	NOUN
ajfti-2033	446	16	randomised	randomise	VERB
ajfti-2033	446	17	controlled	control	VERB
ajfti-2033	446	18	trial	trial	NOUN
ajfti-2033	446	19	.	.	PUNCT
ajfti-2033	447	1	bmj	bmj	PROPN
ajfti-2033	447	2	quality	quality	NOUN
ajfti-2033	447	3	&	&	CCONJ
ajfti-2033	447	4	safety	safety	NOUN
ajfti-2033	447	5	,	,	PUNCT
ajfti-2033	447	6	31(2	31(2	NUM
ajfti-2033	447	7	)	)	PUNCT
ajfti-2033	447	8	,	,	PUNCT
ajfti-2033	447	9	105	105	NUM
ajfti-2033	447	10	-	-	SYM
ajfti-2033	447	11	115	115	NUM
ajfti-2033	447	12	.	.	PUNCT
ajfti-2033	448	1	wong	wong	PROPN
ajfti-2033	448	2	,	,	PUNCT
ajfti-2033	448	3	w.	w.	PROPN
ajfti-2033	448	4	b.	b.	PROPN
ajfti-2033	448	5	,	,	PUNCT
ajfti-2033	448	6	seetasith	seetasith	PROPN
ajfti-2033	448	7	,	,	PUNCT
ajfti-2033	448	8	a.	a.	PROPN
ajfti-2033	448	9	,	,	PUNCT
ajfti-2033	448	10	hung	hung	PROPN
ajfti-2033	448	11	,	,	PUNCT
ajfti-2033	448	12	a.	a.	NOUN
ajfti-2033	448	13	,	,	PUNCT
ajfti-2033	448	14	&	&	CCONJ
ajfti-2033	448	15	zullig	zullig	PROPN
ajfti-2033	448	16	,	,	PUNCT
ajfti-2033	448	17	l.	l.	PROPN
ajfti-2033	448	18	l.	l.	PROPN
ajfti-2033	448	19	(	(	PUNCT
ajfti-2033	448	20	2023	2023	NUM
ajfti-2033	448	21	)	)	PUNCT
ajfti-2033	448	22	.	.	PUNCT
ajfti-2033	449	1	impact	impact	NOUN
ajfti-2033	449	2	of	of	ADP
ajfti-2033	449	3	list	list	NOUN
ajfti-2033	449	4	price	price	NOUN
ajfti-2033	449	5	changes	change	NOUN
ajfti-2033	449	6	on	on	ADP
ajfti-2033	449	7	out	out	ADP
ajfti-2033	449	8	-	-	PUNCT
ajfti-2033	449	9	of	of	ADP
ajfti-2033	449	10	-	-	PUNCT
ajfti-2033	449	11	pocket	pocket	NOUN
ajfti-2033	449	12	costs	cost	NOUN
ajfti-2033	449	13	and	and	CCONJ
ajfti-2033	449	14	adherence	adherence	NOUN
ajfti-2033	449	15	in	in	ADP
ajfti-2033	449	16	four	four	NUM
ajfti-2033	449	17	high	high	ADJ
ajfti-2033	449	18	-	-	PUNCT
ajfti-2033	449	19	rebate	rebate	NOUN
ajfti-2033	449	20	specialty	specialty	NOUN
ajfti-2033	449	21	drugs	drug	NOUN
ajfti-2033	449	22	.	.	PUNCT
ajfti-2033	450	1	plos	plos	PROPN
ajfti-2033	450	2	one	one	NUM
ajfti-2033	450	3	,	,	PUNCT
ajfti-2033	450	4	18(1	18(1	NUM
ajfti-2033	450	5	)	)	PUNCT
ajfti-2033	450	6	,	,	PUNCT
ajfti-2033	450	7	e0280570	e0280570	PROPN
ajfti-2033	450	8	.	.	PROPN
ajfti-2033	450	9	yang	yang	PROPN
ajfti-2033	450	10	,	,	PUNCT
ajfti-2033	450	11	e.	e.	PROPN
ajfti-2033	450	12	j.	j.	PROPN
ajfti-2033	450	13	,	,	PUNCT
ajfti-2033	450	14	galan	galan	PROPN
ajfti-2033	450	15	,	,	PUNCT
ajfti-2033	450	16	e.	e.	PROPN
ajfti-2033	450	17	,	,	PUNCT
ajfti-2033	450	18	thombley	thombley	PROPN
ajfti-2033	450	19	,	,	PUNCT
ajfti-2033	450	20	r.	r.	PROPN
ajfti-2033	450	21	,	,	PUNCT
ajfti-2033	450	22	lin	lin	PROPN
ajfti-2033	450	23	,	,	PUNCT
ajfti-2033	450	24	a.	a.	NOUN
ajfti-2033	450	25	,	,	PUNCT
ajfti-2033	450	26	seo	seo	PROPN
ajfti-2033	450	27	,	,	PUNCT
ajfti-2033	450	28	j.	j.	PROPN
ajfti-2033	450	29	,	,	PUNCT
ajfti-2033	450	30	tseng	tseng	PROPN
ajfti-2033	450	31	,	,	PUNCT
ajfti-2033	450	32	c.-w	c.-w	PROPN
ajfti-2033	450	33	.	.	PROPN
ajfti-2033	450	34	,	,	PUNCT
ajfti-2033	450	35	resneck	resneck	NOUN
ajfti-2033	450	36	,	,	PUNCT
ajfti-2033	450	37	j.	j.	PROPN
ajfti-2033	450	38	s.	s.	PROPN
ajfti-2033	450	39	,	,	PUNCT
ajfti-2033	450	40	bach	bach	PROPN
ajfti-2033	450	41	,	,	PUNCT
ajfti-2033	450	42	p.	p.	PROPN
ajfti-2033	450	43	b.	b.	PROPN
ajfti-2033	450	44	,	,	PUNCT
ajfti-2033	450	45	&	&	CCONJ
ajfti-2033	450	46	dudley	dudley	PROPN
ajfti-2033	450	47	,	,	PUNCT
ajfti-2033	450	48	r.	r.	PROPN
ajfti-2033	450	49	a.	a.	PROPN
ajfti-2033	450	50	(	(	PUNCT
ajfti-2033	450	51	2020	2020	NUM
ajfti-2033	450	52	)	)	PUNCT
ajfti-2033	450	53	.	.	PUNCT
ajfti-2033	451	1	changes	change	NOUN
ajfti-2033	451	2	in	in	ADP
ajfti-2033	451	3	drug	drug	NOUN
ajfti-2033	451	4	list	list	NOUN
ajfti-2033	451	5	prices	price	NOUN
ajfti-2033	451	6	and	and	CCONJ
ajfti-2033	451	7	amounts	amount	NOUN
ajfti-2033	451	8	paid	pay	VERB
ajfti-2033	451	9	by	by	ADP
ajfti-2033	451	10	patients	patient	NOUN
ajfti-2033	451	11	and	and	CCONJ
ajfti-2033	451	12	insurers	insurer	NOUN
ajfti-2033	451	13	.	.	PUNCT
ajfti-2033	452	1	jama	jama	PROPN
ajfti-2033	452	2	network	network	PROPN
ajfti-2033	452	3	open	open	ADJ
ajfti-2033	452	4	,	,	PUNCT
ajfti-2033	452	5	3(12	3(12	NUM
ajfti-2033	452	6	)	)	PUNCT
ajfti-2033	452	7	,	,	PUNCT
ajfti-2033	452	8	e2028510	e2028510	PROPN
ajfti-2033	452	9	-	-	PUNCT
ajfti-2033	452	10	e2028510	e2028510	PROPN
ajfti-2033	452	11	.	.	PUNCT
ajfti-2033	453	1	https://doi.org/10.1001/	https://doi.org/10.1001/	PROPN
ajfti-2033	453	2	jamanetworkopen.2020.28510	jamanetworkopen.2020.28510	VERB